[
  {
    "text": "Successful Hemostasis With Platelet Transfusion and Tranexamic Acid, and",
    "entities": []
  },
  {
    "text": "Inhibitor Elimination With Cyclosporine, in Steroid-Resistant Acquired",
    "entities": [
      {
        "text": "Steroid-Resistant",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Coagulation Factor V Deficiency Caused by Antibiotic Readministration.",
    "entities": [
      {
        "text": "Coagulation Factor V Deficiency",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Author information:",
    "entities": []
  },
  {
    "text": "(1)Department of Hematology, Chikamori Hospital, Kochi, Japan.",
    "entities": [
      {
        "text": "Hematology",
        "label": "ORG"
      },
      {
        "text": "Chikamori Hospital",
        "label": "ORG"
      },
      {
        "text": "Kochi",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Gastroenterology, Chikamori Hospital, Kochi, Japan.",
    "entities": [
      {
        "text": "Gastroenterology",
        "label": "ORG"
      },
      {
        "text": "Kochi",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiology, Chikamori Hospital, Kochi, Japan.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Kochi",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Acquired factor V deficiency (AFVD) is a rare coagulation abnormality associated",
    "entities": [
      {
        "text": "AFVD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "with infectious diseases, antibiotics, surgery, autoimmune diseases, and",
    "entities": []
  },
  {
    "text": "malignancy, which causality is difficult to prove. Here, we report a case of a",
    "entities": []
  },
  {
    "text": "90-year-old woman who developed melena following antibiotic treatment for",
    "entities": [
      {
        "text": "90-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pneumonia. She had been on cefepime for bacterial pneumonia for 2 months to",
    "entities": [
      {
        "text": "2 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2 weeks prior to her arrival in the emergency room. Upon presentation, she had",
    "entities": [
      {
        "text": "2 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "severe anemia (Hb: 6.7 g/dL) and prolonged PT (74.3 s) and activated partial",
    "entities": [
      {
        "text": "Hb",
        "label": "ORG"
      },
      {
        "text": "6.7",
        "label": "CARDINAL"
      },
      {
        "text": "74.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "thromboplastin time (APTT) (161.9 s). Coagulation studies revealed incomplete",
    "entities": [
      {
        "text": "thromboplastin time",
        "label": "PERSON"
      },
      {
        "text": "161.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "correction of the APTT in a 1:1 mixing study with normal pooled plasma, factor V",
    "entities": [
      {
        "text": "APTT",
        "label": "ORG"
      },
      {
        "text": "1:1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "activity of 0%, and a factor V inhibitor titer of 13 Bethesda units, confirming",
    "entities": [
      {
        "text": "0%",
        "label": "PERCENT"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the diagnosis of AFVD. Since the antibiotics were not recognized as the cause,",
    "entities": [
      {
        "text": "AFVD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the coagulation abnormality worsened after their readministration. The melena",
    "entities": []
  },
  {
    "text": "subsequently improved with platelet transfusion and administration of tranexamic",
    "entities": []
  },
  {
    "text": "acid, while prednisolone-resistant coagulation abnormalities improved with",
    "entities": []
  },
  {
    "text": "cyclosporine A (CsA) treatment. This case shows the importance of avoiding",
    "entities": [
      {
        "text": "CsA",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "suspected drugs and the effectiveness of CsA as a second-line treatment of AFVD.",
    "entities": [
      {
        "text": "CsA",
        "label": "GPE"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "AFVD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Kazuto Togitani et al. Case Reports in Hematology published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Kazuto Togitani",
        "label": "PERSON"
      },
      {
        "text": "Hematology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "Extracellular Vesicle-Mediated Delivery of Genetic Material for Transformation",
    "entities": []
  },
  {
    "text": "and CRISPR/Cas9-based Gene Editing in Pneumocystis murina.",
    "entities": [
      {
        "text": "CRISPR/Cas9",
        "label": "ORG"
      },
      {
        "text": "Gene Editing",
        "label": "PERSON"
      },
      {
        "text": "Pneumocystis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Sayson SG, Ashbaugh A, Bauer LC, Smulian G.",
    "entities": [
      {
        "text": "Sayson SG",
        "label": "PERSON"
      },
      {
        "text": "Ashbaugh A",
        "label": "PERSON"
      },
      {
        "text": "Smulian G.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pneumocystis species are obligate fungal pathogens that cause severe pneumonia,",
    "entities": []
  },
  {
    "text": "particularly in immunocompromised individuals. The absence of robust genetic",
    "entities": []
  },
  {
    "text": "manipulation tools has impeded our mechanistic understanding of Pneumocystis",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "biology and the development of novel therapeutic strategies. Herein, we describe",
    "entities": []
  },
  {
    "text": "a novel method for the stable transformation and CRISPR/Cas9-mediated genetic",
    "entities": [
      {
        "text": "CRISPR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "editing of Pneumocystis murina utilizing extracellular vesicles (EVs) as a",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "delivery vehicle. Building upon our prior investigations demonstrating",
    "entities": []
  },
  {
    "text": "EV-mediated delivery of exogenous material to Pneumocystis , we engineered mouse",
    "entities": [
      {
        "text": "EV",
        "label": "GPE"
      },
      {
        "text": "Pneumocystis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "lung EVs to deliver plasmid DNA encoding reporter genes and CRISPR/Cas9",
    "entities": [
      {
        "text": "lung EVs",
        "label": "ORG"
      },
      {
        "text": "CRISPR/Cas9",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "components. Our initial findings demonstrated successful in vitro transformation",
    "entities": []
  },
  {
    "text": "and subsequent expression of mNeonGreen and Dhps ARS in P. murina organisms.",
    "entities": [
      {
        "text": "P.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Subsequently, we established stable in vivo expression of mNeonGreen in mice",
    "entities": []
  },
  {
    "text": "infected with transformed P. murina for a duration of up to 5 weeks.",
    "entities": [
      {
        "text": "up to 5 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Furthermore, we designed and validated a CRISPR/Cas9 system targeting the P.",
    "entities": []
  },
  {
    "text": "murina Dhps gene, confirming its in vitro cleavage efficiency. Ultimately, we",
    "entities": [
      {
        "text": "Dhps",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "achieved successful in vivo CRISPR/Cas9-mediated homologous recombination,",
    "entities": []
  },
  {
    "text": "precisely introducing a Dhps ARS mutation into the P. murina genome, which was",
    "entities": [
      {
        "text": "Dhps",
        "label": "ORG"
      },
      {
        "text": "P.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "confirmed by Sanger sequencing across all tested animals. Here, we establish a",
    "entities": [
      {
        "text": "Sanger",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "foundational methodology for genetic manipulation in Pneumocystis , thereby",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "opening avenues for functional genomics, drug target validation, and the",
    "entities": []
  },
  {
    "text": "generation of genetically modified strains for advanced research and potential",
    "entities": []
  },
  {
    "text": "therapeutic applications.",
    "entities": []
  },
  {
    "text": "IMPORTANCE: Pneumocystis species are obligate fungal pathogens and major causes",
    "entities": []
  },
  {
    "text": "of pneumonia in immunocompromised individuals. However, their strict dependence",
    "entities": []
  },
  {
    "text": "on the mammalian lung environment has precluded the development of genetic",
    "entities": []
  },
  {
    "text": "manipulation systems, limiting our ability to interrogate gene function, study",
    "entities": []
  },
  {
    "text": "antifungal resistance mechanisms, or validate therapeutic targets. Here, we",
    "entities": []
  },
  {
    "text": "report the first successful approach for stable transformation and",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "CRISPR/Cas9-based genome editing of Pneumocystis murina , achieved through in",
    "entities": [
      {
        "text": "CRISPR/Cas9",
        "label": "PERSON"
      },
      {
        "text": "Pneumocystis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "vivo delivery of engineered extracellular vesicles (EVs) containing plasmid DNA",
    "entities": []
  },
  {
    "text": "and encoding CRISPR/Cas9 components. We demonstrate sustained transgene",
    "entities": [
      {
        "text": "CRISPR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "expression and precise modification of the dhps locus via homology-directed",
    "entities": []
  },
  {
    "text": "repair. This modular, scalable platform overcomes a long-standing barrier in the",
    "entities": []
  },
  {
    "text": "field and establishes a foundation for functional genomics in Pneumocystis and",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "other obligate, host-adapted microbes.",
    "entities": []
  },
  {
    "text": "The Maximum-Tolerated Dose and Pharmacokinetics of ISFP10 a Novel Inhibitor of",
    "entities": [
      {
        "text": "The Maximum-Tolerated Dose",
        "label": "ORG"
      },
      {
        "text": "Pharmacokinetics of ISFP10 a Novel Inhibitor of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "BACKGROUND: The newly identified small molecule ISFP10 has demonstrated the",
    "entities": []
  },
  {
    "text": "ability to inhibit fungal phosphoglucomutases (PGM), leading to decreased fungal",
    "entities": [
      {
        "text": "PGM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "growth and survival. Exhibiting 50 times greater selectivity for fungal PGM",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "PGM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compared to the human homolog, ISFP10 shows promise as a broad-spectrum",
    "entities": []
  },
  {
    "text": "antifungal and a candidate for preliminary testing in rodent models of fungal",
    "entities": []
  },
  {
    "text": "infections, including Pneumocystis pneumonia (PCP). In preparation for targeted",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "PRODUCT"
      },
      {
        "text": "PCP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and relevant administration of the drug in fungal mouse models of infection, the",
    "entities": [
      {
        "text": "fungal mouse",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "current study describes the maximum-tolerated-dose (MTD) and pharmacokinetics",
    "entities": []
  },
  {
    "text": "(PK) of ISFP10 in mice.",
    "entities": []
  },
  {
    "text": "METHODS: For the MTD study, 24 C57BL/6 mice were randomly distributed into 6",
    "entities": [
      {
        "text": "MTD",
        "label": "ORG"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "groups (2M/2F per group): Placebo (vehicle; 10% DMSO with 90% of 0.5%",
    "entities": [
      {
        "text": "2M/2F",
        "label": "CARDINAL"
      },
      {
        "text": "Placebo",
        "label": "LOC"
      },
      {
        "text": "10%",
        "label": "PERCENT"
      },
      {
        "text": "90%",
        "label": "PERCENT"
      },
      {
        "text": "0.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "methylcellulose in 0.9% NaCl) at various doses (12.5, 25, 50, 100, 200 mg/kg),",
    "entities": [
      {
        "text": "0.9%",
        "label": "PERCENT"
      },
      {
        "text": "12.5",
        "label": "CARDINAL"
      },
      {
        "text": "25",
        "label": "DATE"
      },
      {
        "text": "50",
        "label": "DATE"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "200 mg/kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "were administered twice daily by intraperitoneally (IP) for 7 consecutive days.",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      },
      {
        "text": "IP",
        "label": "ORG"
      },
      {
        "text": "7 consecutive days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "For the PK study, 108 mice were administered either vehicle or ISFP10 in",
    "entities": [
      {
        "text": "108",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "single-dose intraperitoneal (IP) injections twice daily for 7 consecutive days",
    "entities": [
      {
        "text": "IP",
        "label": "ORG"
      },
      {
        "text": "7 consecutive days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "at concentrations of 0, 12.5, 25, 50, and 100 mg/kg. Pharmacokinetics were",
    "entities": [
      {
        "text": "0",
        "label": "CARDINAL"
      },
      {
        "text": "12.5",
        "label": "DATE"
      },
      {
        "text": "25",
        "label": "DATE"
      },
      {
        "text": "50",
        "label": "DATE"
      },
      {
        "text": "100 mg/kg",
        "label": "QUANTITY"
      },
      {
        "text": "Pharmacokinetics",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "assessed in plasma, and epithelial lining fluid (ELF). Analysis of this test",
    "entities": [
      {
        "text": "ELF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compound was performed using LC-MS/MS for PK evaluation on blood samples drawn",
    "entities": [
      {
        "text": "LC-MS/MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from mice at multiple time points.",
    "entities": []
  },
  {
    "text": "RESULTS: IP administered, ISFP10 did not produce significant changes in body",
    "entities": []
  },
  {
    "text": "weight, food consumption or adverse events in the MTD up to 100 mg/kg dosing.",
    "entities": [
      {
        "text": "100 mg/kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "The plasma PK study demonstrated T max values ranging from 2 to 8 h.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Non-compartmental analysis (NCA) yielded elimination half-life values, t 1/2 ,",
    "entities": [
      {
        "text": "NCA",
        "label": "ORG"
      },
      {
        "text": "half",
        "label": "CARDINAL"
      },
      {
        "text": "1/2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of 4.39 and 5.31 h for the 12.5 and 50 mg/kg dose groups. Concentration",
    "entities": [
      {
        "text": "4.39",
        "label": "CARDINAL"
      },
      {
        "text": "5.31",
        "label": "CARDINAL"
      },
      {
        "text": "12.5 and",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "dependent peak-blood concentration (C max ) at the dosing and length tested",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: In conclusion, ISFP10, administered intraperitoneally to mice twice",
    "entities": []
  },
  {
    "text": "daily at doses up to 100 mg/kg, exhibited no inherent safety concerns based on",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      },
      {
        "text": "100 mg/kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "the analyzed parameters. Pharmacokinetic analysis revealed slow absorption and",
    "entities": []
  },
  {
    "text": "distribution kinetics, with plasma T max values ranging from 2 to 8 hours and",
    "entities": [
      {
        "text": "distribution kinetics",
        "label": "ORG"
      },
      {
        "text": "2 to 8 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "elimination half-lives of approximately 4-5 hours at lower doses. These data",
    "entities": [
      {
        "text": "4-5 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "support broader in vivo testing of the inhibitor as potential novel antifungal",
    "entities": []
  },
  {
    "text": "in fungal diseases including PCP.",
    "entities": [
      {
        "text": "PCP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in",
    "entities": [
      {
        "text": "Identification of Chlamydia",
        "label": "ORG"
      },
      {
        "text": "NLRP3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Alzheimer's disease retina.",
    "entities": []
  },
  {
    "text": "Gaire BP, Koronyo Y, Vit JP, Hutton A, Swerdlow N, Fuchs DT, Rentsendorj A,",
    "entities": [
      {
        "text": "Koronyo Y",
        "label": "PERSON"
      },
      {
        "text": "Vit JP",
        "label": "PERSON"
      },
      {
        "text": "Hutton A",
        "label": "ORG"
      },
      {
        "text": "Swerdlow N",
        "label": "ORG"
      },
      {
        "text": "Fuchs DT",
        "label": "PERSON"
      },
      {
        "text": "Rentsendorj A",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Gupta VK, Mirzaei M, Black KL, Meyer JG, Arditi M, Crother TR, Koronyo-Hamaoui",
    "entities": [
      {
        "text": "Gupta VK",
        "label": "PERSON"
      },
      {
        "text": "Mirzaei M",
        "label": "ORG"
      },
      {
        "text": "Black KL",
        "label": "PERSON"
      },
      {
        "text": "Meyer JG",
        "label": "PERSON"
      },
      {
        "text": "Arditi M",
        "label": "PERSON"
      },
      {
        "text": "Crother TR",
        "label": "PERSON"
      },
      {
        "text": "Koronyo-Hamaoui",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chlamydia pneumoniae (Cp), an obligate intracellular bacterium, has been",
    "entities": [
      {
        "text": "Chlamydia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "implicated in Alzheimer's disease (AD), yet its role in retinal pathology",
    "entities": []
  },
  {
    "text": "remains unexplored. We analyzed postmortem tissues from 95 human donors and",
    "entities": [
      {
        "text": "95",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "found 2.9-4.1-fold increases in Cp inclusions in AD retinas and brains, with no",
    "entities": [
      {
        "text": "2.9-4.1-fold",
        "label": "CARDINAL"
      },
      {
        "text": "Cp",
        "label": "GPE"
      },
      {
        "text": "AD",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "significant elevation in mild cognitive impairment (MCI). Proteomics revealed",
    "entities": [
      {
        "text": "MCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dysregulation of retinal and brain bacterial infection-related proteins and",
    "entities": []
  },
  {
    "text": "NLRP3 inflammasome pathways. NLRP3 expression was markedly elevated in MCI and",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      },
      {
        "text": "NLRP3",
        "label": "PRODUCT"
      },
      {
        "text": "MCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AD retinas, and its activation was evident by increased N-terminal gasdermin D",
    "entities": [
      {
        "text": "AD",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(NGSDMD) and mature interleukin-1\u03b2. Retinal Cp strongly correlated with A\u03b2 42",
    "entities": [
      {
        "text": "Retinal Cp",
        "label": "PERSON"
      },
      {
        "text": "A\u03b2 42\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and NLRP3 inflammasome components, which tightly linked to cleaved",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "caspase-3-apoptotic and NGSDMD-pyroptotic cell death. Although retinal",
    "entities": []
  },
  {
    "text": "microgliosis was elevated in AD, Cp-associated microglia were reduced by 62%,",
    "entities": [
      {
        "text": "62%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "suggesting impaired Cp phagocytosis. Higher retinal Cp burden correlated with",
    "entities": []
  },
  {
    "text": "APOE\u03b54, Braak stage, and cognitive deficit. Machine learning identified retinal",
    "entities": [
      {
        "text": "Braak",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cp or NLRP3 combined with A\u03b2 42 as strong predictors of AD diagnosis, staging,",
    "entities": [
      {
        "text": "NLRP3",
        "label": "PRODUCT"
      },
      {
        "text": "42",
        "label": "DATE"
      },
      {
        "text": "AD",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and cognitive impairment. Our findings suggest that Cp infection contributes to",
    "entities": []
  },
  {
    "text": "AD dementia but not initiating pathology, whereas early NLRP3 activation may",
    "entities": [
      {
        "text": "AD",
        "label": "CARDINAL"
      },
      {
        "text": "NLRP3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "promote disease development, warranting studies on Cp's role in AD pathogenesis",
    "entities": [
      {
        "text": "Cp",
        "label": "PERSON"
      },
      {
        "text": "AD",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and early antibiotic or inflammasome-targeted therapies.",
    "entities": []
  },
  {
    "text": "5. Arch Clin Cases. 2025 Jul 15;12(2):98-101. doi: 10.22551/2025.47.1202.10320.",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "Arch Clin Cases",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15;12(2):98",
        "label": "CARDINAL"
      },
      {
        "text": "10.22551/2025.47.1202.10320",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Teclistamab-associated cytokine release syndrome in multiple myeloma: a",
    "entities": []
  },
  {
    "text": "case-based literature review of mechanisms, management, and clinical",
    "entities": []
  },
  {
    "text": "implications.",
    "entities": []
  },
  {
    "text": "Cheema M(1), Syed S(1), Ghuman Z(1), Iftikhar A(2)(3).",
    "entities": [
      {
        "text": "Syed S(1",
        "label": "LAW"
      },
      {
        "text": "Ghuman Z(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, Mather Hospital, Northwell Health, Port",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Mather Hospital",
        "label": "ORG"
      },
      {
        "text": "Northwell Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Jefferson, NY, USA.",
    "entities": [
      {
        "text": "Jefferson",
        "label": "ORG"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Intensive Care Medicine and Pulmonary Medicine, Northwell Health,",
    "entities": [
      {
        "text": "Intensive Care Medicine and Pulmonary Medicine",
        "label": "ORG"
      },
      {
        "text": "Northwell Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Port Jefferson, NY, USA.",
    "entities": [
      {
        "text": "Port Jefferson",
        "label": "PERSON"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Donald and Barbara School of Medicine, Hofstra/Northwell, Hempstead, NY, USA.",
    "entities": [
      {
        "text": "Barbara School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Hempstead",
        "label": "PERSON"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Cytokine release syndrome (CRS) is a potentially life-threatening inflammatory",
    "entities": []
  },
  {
    "text": "condition that can occur after immune-based therapies, such as bispecific",
    "entities": []
  },
  {
    "text": "antibodies. We present the case of a 66-year-old woman with relapsed/refractory",
    "entities": [
      {
        "text": "66-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "multiple myeloma who developed fatal CRS following treatment with Teclistamab, a",
    "entities": [
      {
        "text": "Teclistamab",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "bispecific antibody that targets CD3 on T cells and B-cell maturation antigen on",
    "entities": []
  },
  {
    "text": "myeloma cells. The patient had previously achieved remission with rituximab,",
    "entities": []
  },
  {
    "text": "bortezomib, and autologous stem cell transplantation but experienced a relapse",
    "entities": []
  },
  {
    "text": "after eight years. Teclistamab was initiated with a step-up dosing regimen.",
    "entities": [
      {
        "text": "eight years",
        "label": "DATE"
      },
      {
        "text": "Teclistamab",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Before treatment, she received premedication with intravenous fluids, steroids,",
    "entities": []
  },
  {
    "text": "and tocilizumab. Despite this premedication, the patient was readmitted with",
    "entities": []
  },
  {
    "text": "fever, chills, and shortness of breath, leukopenia, and hypoxia. Imaging studies",
    "entities": []
  },
  {
    "text": "indicated pneumonia. During her hospitalization, her condition deteriorated",
    "entities": []
  },
  {
    "text": "rapidly, resulting in respiratory failure and refractory shock. She was",
    "entities": []
  },
  {
    "text": "transferred to the intensive care unit (ICU), where she required mechanical",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "efforts, she progressed to multi-organ failure, and the family ultimately chose",
    "entities": []
  },
  {
    "text": "to withdraw care. CRS is characterized by a systemic inflammatory response with",
    "entities": []
  },
  {
    "text": "rapid and excessive release of cytokines, particularly IL-6, IL-2, IL-10, IFN-\u03b3,",
    "entities": [
      {
        "text": "IL-10",
        "label": "PRODUCT"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and GM-CSF. Severe CRS can clinically resemble sepsis. Management strategies",
    "entities": [
      {
        "text": "GM-CSF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "include early recognition, supportive care, and immunomodulatory therapy,",
    "entities": []
  },
  {
    "text": "particularly with tocilizumab and corticosteroids. This case underscores the",
    "entities": []
  },
  {
    "text": "diagnostic and therapeutic challenges of differentiating severe CRS from",
    "entities": []
  },
  {
    "text": "infection. This case uniquely contributes to current understanding by",
    "entities": []
  },
  {
    "text": "highlighting the limitations of current premedication protocols and emphasizing",
    "entities": []
  },
  {
    "text": "the critical need for enhanced monitoring and rapid intervention protocols in",
    "entities": []
  },
  {
    "text": "managing Teclistamab-induced CRS. It highlights the critical need for prompt,",
    "entities": []
  },
  {
    "text": "targeted intervention to prevent fatal outcomes in patients receiving novel",
    "entities": []
  },
  {
    "text": "immunotherapies.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no competing",
    "entities": []
  },
  {
    "text": "interests.",
    "entities": []
  },
  {
    "text": "Evaluation of the efficacy of cephalosporin antibiotics sold in Kano, Nigeria,",
    "entities": [
      {
        "text": "Kano, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "against clinical bacterial isolates.",
    "entities": []
  },
  {
    "text": "(1)Department of Microbiology, Faculty of Life Sciences, College of Natural and",
    "entities": [
      {
        "text": "Microbiology, Faculty of Life Sciences",
        "label": "ORG"
      },
      {
        "text": "College of Natural",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Sciences, Bayero University, P.M.B. 3011, Kano, Nigeria.",
    "entities": [
      {
        "text": "Pharmaceutical Sciences",
        "label": "ORG"
      },
      {
        "text": "Bayero University",
        "label": "ORG"
      },
      {
        "text": "Kano, Nigeria",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Biotechnology, Delft University of Technology, Van der Maasweg",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biotechnology, Delft University of Technology",
        "label": "ORG"
      },
      {
        "text": "Van",
        "label": "ORG"
      },
      {
        "text": "Maasweg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Microbiology, School of Science and Information Technology,",
    "entities": [
      {
        "text": "Microbiology, School of Science and Information Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Introduction. The evaluation of the efficacy of cephalosporin antibiotics sold",
    "entities": []
  },
  {
    "text": "in Kano, Nigeria, against clinical bacterial isolates is a timely and crucial",
    "entities": [
      {
        "text": "Kano, Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "public health concern. Cephalosporins are among the most widely used antibiotic",
    "entities": []
  },
  {
    "text": "classes globally due to their broad-spectrum activity and low toxicity. They",
    "entities": []
  },
  {
    "text": "play a vital role in the empirical treatment of infections involving both",
    "entities": []
  },
  {
    "text": "Gram-positive and Gram-negative bacteria. However, the increasing misuse and",
    "entities": [
      {
        "text": "Gram-negative",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "circulation of substandard or falsified antibiotics, especially in informal",
    "entities": []
  },
  {
    "text": "markets, threatens their therapeutic effectiveness. Gap statement. In Nigeria,",
    "entities": [
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "several formal and informal reports of substandard antibiotics and their",
    "entities": []
  },
  {
    "text": "unregulated sale in open markets, such as Sabon Gari in Kano, raise serious",
    "entities": [
      {
        "text": "Sabon Gari",
        "label": "PERSON"
      },
      {
        "text": "Kano",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "concerns about the quality of drug and their potential contribution to",
    "entities": []
  },
  {
    "text": "antimicrobial resistance (AMR). Cephalosporins sold in these markets are often",
    "entities": [
      {
        "text": "AMR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sourced and stored under questionable conditions, which increases the risk of",
    "entities": []
  },
  {
    "text": "reduced potency or inefficacy. At the same time, AMR continues to rise globally,",
    "entities": [
      {
        "text": "AMR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and in low and middle-income countries like Nigeria, poor-quality antibiotics",
    "entities": [
      {
        "text": "Nigeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "can worsen treatment failure and drive resistance. Sabon Gari market is a major",
    "entities": []
  },
  {
    "text": "distribution centre for pharmaceuticals, yet research on its impact and extent",
    "entities": []
  },
  {
    "text": "of substandard drugs is lacking. Aim. This study aims to assess the",
    "entities": [
      {
        "text": "Aim",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pharmaceutical quality of commonly sold cephalosporins purchased from drug",
    "entities": []
  },
  {
    "text": "distributors in Sabon Gari Market, Kano, by comparing their antimicrobial",
    "entities": [
      {
        "text": "Sabon Gari Market",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Kano",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "activity against a panel of clinical bacterial isolates (Escherichia coli,",
    "entities": [
      {
        "text": "Escherichia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pseudomonas aeruginosa and Salmonella sp.) with that of standard reference",
    "entities": [
      {
        "text": "Salmonella",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antibiotics. Methodology. Antimicrobial susceptibility pattern of the test",
    "entities": []
  },
  {
    "text": "isolates was determined by the disc diffusion method. Fourier transform infrared",
    "entities": []
  },
  {
    "text": "spectroscopy analysis was used to confirm the functional group of the active",
    "entities": []
  },
  {
    "text": "ingredients of all the antibiotics tested. Molecular identification of the",
    "entities": []
  },
  {
    "text": "resistant gene (CTX-M1) was carried out using PCR. Results. Market survey",
    "entities": [
      {
        "text": "CTX-M1",
        "label": "ORG"
      },
      {
        "text": "PCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(n=100) reveals that among drug distributors in Sabon Gari Market, Kano,",
    "entities": [
      {
        "text": "Sabon Gari Market",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Kano",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "cephalexin 61% (first generation); cefuroxime 72% (second generation); cefixime",
    "entities": [
      {
        "text": "61%",
        "label": "PERCENT"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "72%",
        "label": "PERCENT"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "generation); cefepime 84% (fourth generation) were the most commonly sold",
    "entities": [
      {
        "text": "84%",
        "label": "PERCENT"
      },
      {
        "text": "fourth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "cephalosporins, with different brands and company names. These percentages",
    "entities": []
  },
  {
    "text": "represent the proportion of respondents who reported each antibiotic as one of",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "their most frequently sold products. There is no significant difference between",
    "entities": []
  },
  {
    "text": "the branded antibiotics (drugs purchased in the market) and standard drugs.",
    "entities": []
  },
  {
    "text": "Exactly 20% of E. coli and K. pneumoniae were resistant, while 80% of",
    "entities": [
      {
        "text": "20%",
        "label": "PERCENT"
      },
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "80%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were susceptible. The CTX-M1 resistant gene was identified in E. coli and K.",
    "entities": [
      {
        "text": "CTX",
        "label": "ORG"
      },
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "pneumoniae, which further confirms their resistance to cefotaxime and",
    "entities": []
  },
  {
    "text": "ceftriaxone antibiotics. Conclusion. Branded cephalosporins sold in Kano were",
    "entities": [
      {
        "text": "ceftriaxone antibiotics",
        "label": "ORG"
      },
      {
        "text": "Kano",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "chemically intact and structurally aligned with their respective formulations.",
    "entities": []
  },
  {
    "text": "No missing or anomalous functional groups were observed that would suggest",
    "entities": []
  },
  {
    "text": "substandard or counterfeit products, thus fit for human intake.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Authors.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that there are no conflicts",
    "entities": []
  },
  {
    "text": "of interest.",
    "entities": []
  },
  {
    "text": "7. J Arrhythm. 2025 Jul 15;41(4):e70079. doi: 10.1002/joa3.70079. eCollection",
    "entities": [
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Cardiac arrhythmias in cancer patients using the nationwide claim-based database",
    "entities": [
      {
        "text": "Cardiac",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Cardiovascular Medicine National Cerebral and Cardiovascular",
    "entities": [
      {
        "text": "Cardiovascular Medicine National Cerebral",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Preventive Cardiology National Cerebral and Cardiovascular",
    "entities": [
      {
        "text": "Preventive Cardiology National Cerebral and Cardiovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Division of Cardiovascular Medicine Department of Internal Medicine, Sensoji",
    "entities": [
      {
        "text": "Cardiovascular Medicine Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Sensoji",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Present address: Division of Cardiovascular Medicine, Department of Internal",
    "entities": [
      {
        "text": "Division of Cardiovascular Medicine,",
        "label": "ORG"
      },
      {
        "text": "Department of Internal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Cardio-oncology has recently developed as a new discipline. No study",
    "entities": []
  },
  {
    "text": "using a Nationwide Claim-Based Database has examined the association between",
    "entities": []
  },
  {
    "text": "cancer and arrhythmia in Japan.",
    "entities": [
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: JROAD-DPC (Japanese Registry Of All cardiac and vascular Diseases -",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Diagnosis Procedure Combination) is a nationwide claims database using data from",
    "entities": []
  },
  {
    "text": "the Japanese Diagnosis Procedure Combination/Per Diem Payment System. Among",
    "entities": [
      {
        "text": "the Japanese Diagnosis Procedure Combination/Per Diem Payment System",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "11 297 525 records found between April 2012 and March 2021 from 1119 hospitals,",
    "entities": [
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "297",
        "label": "CARDINAL"
      },
      {
        "text": "525",
        "label": "CARDINAL"
      },
      {
        "text": "April 2012 and March 2021",
        "label": "DATE"
      },
      {
        "text": "1119",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2 976 362 patients with arrhythmias were studied and divided into categories",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "using cancer.",
    "entities": []
  },
  {
    "text": "RESULTS: The prevalence rate of cancers was 7.51% of the patients hospitalized",
    "entities": [
      {
        "text": "7.51%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "for arrhythmias, and the prevalence of cancer increased with time. The",
    "entities": []
  },
  {
    "text": "prevalence rate of Atrial fibrillation (AF) and/or atrial flutter (AFL) was",
    "entities": [
      {
        "text": "Atrial",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "70.6% and 60.7% of arrhythmic patients with and without cancer, respectively.",
    "entities": [
      {
        "text": "70.6%",
        "label": "PERCENT"
      },
      {
        "text": "60.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Pneumonia (7.41%) was the first major infectious complication in arrhythmic",
    "entities": [
      {
        "text": "Pneumonia",
        "label": "PERSON"
      },
      {
        "text": "7.41%",
        "label": "PERCENT"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "patients with cancers. Arrhythmic patients with cancers had significantly higher",
    "entities": []
  },
  {
    "text": "Barthel index (65.2 at admission and 72.5 at discharge) and prevalences of",
    "entities": [
      {
        "text": "Barthel",
        "label": "ORG"
      },
      {
        "text": "65.2",
        "label": "CARDINAL"
      },
      {
        "text": "72.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hyperuricemia (HU) and chronic kidney disease (CKD) (6.13% and 9.67%) than those",
    "entities": [
      {
        "text": "HU",
        "label": "PERSON"
      },
      {
        "text": "6.13%",
        "label": "PERCENT"
      },
      {
        "text": "9.67%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "without cancer. The rate of emergency hospitalization was higher in arrhythmic",
    "entities": []
  },
  {
    "text": "patients with cancers than those without cancer (58.9% vs. 57.6%).",
    "entities": [
      {
        "text": "58.9%",
        "label": "PERCENT"
      },
      {
        "text": "57.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: Cancers were frequently observed in arrhythmic patients, and the",
    "entities": []
  },
  {
    "text": "prevalences increased with time. AF and/or AFL were the most common arrhythmias",
    "entities": [
      {
        "text": "AF and/or AFL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of cancer patients. Arrhythmic patients with cancers had significantly higher",
    "entities": []
  },
  {
    "text": "Barthel index and prevalences of HU and CKD than those without cancer.",
    "entities": [
      {
        "text": "Barthel",
        "label": "ORG"
      },
      {
        "text": "HU",
        "label": "GPE"
      },
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Journal of Arrhythmia published by John Wiley & Sons",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Australia, Ltd on behalf of Japanese Heart Rhythm Society.",
    "entities": [
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Authors declare no conflict of interests for",
    "entities": []
  },
  {
    "text": "this article.",
    "entities": []
  },
  {
    "text": "Paraneoplastic Amyopathic Dermatomyositis Associated With a Bone and Medullary",
    "entities": []
  },
  {
    "text": "Location of Breast Adenocarcinoma.",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI,",
    "entities": [
      {
        "text": "Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Mohammed VI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Oncology, Cadi Ayyad University, Marrakesh, MAR.",
    "entities": [
      {
        "text": "Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Cadi Ayyad University",
        "label": "ORG"
      },
      {
        "text": "Marrakesh",
        "label": "GPE"
      },
      {
        "text": "MAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Paraneoplastic amyopathic dermatomyositis (ADM) is a rare connective tissue",
    "entities": [
      {
        "text": "ADM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disease presenting with characteristic dermatomyositis-like skin findings in the",
    "entities": []
  },
  {
    "text": "absence of muscle involvement. It is associated with malignancies in 15%-30% of",
    "entities": [
      {
        "text": "15%-30%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "cases and may portend a fatal outcome, especially when linked to advanced",
    "entities": []
  },
  {
    "text": "cancers. We report the case of a 58-year-old woman who presented with",
    "entities": [
      {
        "text": "58-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "progressive low back pain and erythroderma. Imaging revealed diffuse bone",
    "entities": []
  },
  {
    "text": "metastases, and bone biopsy confirmed a poorly differentiated adenocarcinoma of",
    "entities": []
  },
  {
    "text": "erythema and other cutaneous findings consistent with ADM. The patient was",
    "entities": [
      {
        "text": "ADM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "started on endocrine therapy with palbociclib and letrozole, along with",
    "entities": []
  },
  {
    "text": "corticosteroids and hydroxychloroquine, resulting in partial clinical",
    "entities": []
  },
  {
    "text": "improvement. However, within six months of diagnosis, she developed severe",
    "entities": [
      {
        "text": "six months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19 pneumonia, complicated by pancytopenia and sepsis, and ultimately",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "succumbed to multiorgan failure despite intensive care support. This case",
    "entities": []
  },
  {
    "text": "underlines the importance of recognizing paraneoplastic ADM as an initial",
    "entities": [
      {
        "text": "ADM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "manifestation of malignancy. A multidisciplinary approach is key, but the",
    "entities": []
  },
  {
    "text": "prognosis largely depends on the cancer's burden and complications such as",
    "entities": []
  },
  {
    "text": "treatment-induced immunosuppression.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Haboub et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Informed consent for treatment",
    "entities": []
  },
  {
    "text": "and open access publication was obtained or waived by all participants in this",
    "entities": []
  },
  {
    "text": "study. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "form, all authors declare the following: Payment/services info: All authors have",
    "entities": []
  },
  {
    "text": "declared that no financial support was received from any organization for the",
    "entities": []
  },
  {
    "text": "submitted work. Financial relationships: All authors have declared that they",
    "entities": []
  },
  {
    "text": "have no financial relationships at present or within the previous three years",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with any organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that there are no other relationships",
    "entities": []
  },
  {
    "text": "or activities that could appear to have influenced the submitted work.",
    "entities": []
  },
  {
    "text": "Lessons From Recurrent Dropped Head Syndrome After Inadequate Short Fixation: A",
    "entities": [
      {
        "text": "Lessons From Recurrent",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Case Series.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurosurgery, Shiroishi Kyoritsu Hospital, Shiroishi, JPN.",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      },
      {
        "text": "Shiroishi",
        "label": "GPE"
      },
      {
        "text": "JPN",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurosurgery, International University of Health and Welfare",
    "entities": [
      {
        "text": "Neurosurgery, International University of Health and Welfare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Dropped head syndrome (DHS) is a condition in which the head falls forward due",
    "entities": [
      {
        "text": "DHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to dysfunction or atrophy of the cervical extensor muscles. It is more commonly",
    "entities": []
  },
  {
    "text": "observed in elderly women and significantly affects horizontal gaze and",
    "entities": []
  },
  {
    "text": "activities of daily living (ADL). For cases in which conservative treatment is",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      },
      {
        "text": "ADL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ineffective, surgical corrective fixation is considered; however, indications",
    "entities": []
  },
  {
    "text": "and standardized procedures have not yet been fully established. We",
    "entities": []
  },
  {
    "text": "retrospectively analyzed five cases of DHS treated surgically at our institution",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "DHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and examined the efficacy of corrective fixation and potential treatment",
    "entities": []
  },
  {
    "text": "strategies. Five patients (mean age: 82.6 years; all female) who underwent",
    "entities": [
      {
        "text": "Five",
        "label": "CARDINAL"
      },
      {
        "text": "82.6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "surgery for DHS between 2018 and 2024 were included. Three patients initially",
    "entities": [
      {
        "text": "DHS",
        "label": "ORG"
      },
      {
        "text": "between 2018 and 2024",
        "label": "DATE"
      },
      {
        "text": "Three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "underwent short-segment fixation or laminoplasty, but DHS recurred. Eventually,",
    "entities": [
      {
        "text": "DHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "all cases required long-segment fixation extending from C2 or the occiput to",
    "entities": [
      {
        "text": "C2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Th1/Th2. Radiological evaluations included measurements of the C2-C7 Cobb",
    "entities": []
  },
  {
    "text": "angles, sagittal vertical axis (SVA), and T1 slope before and after surgery. All",
    "entities": [
      {
        "text": "T1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients exhibited cervical kyphosis and sagittal imbalance. Postoperatively,",
    "entities": []
  },
  {
    "text": "cervical lordosis was restored, and improvements were noted in SVA and T1 slope.",
    "entities": [
      {
        "text": "SVA",
        "label": "GPE"
      },
      {
        "text": "T1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "In four cases, patients were able to maintain horizontal gaze for over 30",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "minutes, and improvements in ADL living were observed. One patient died from",
    "entities": [
      {
        "text": "minutes",
        "label": "TIME"
      },
      {
        "text": "ADL",
        "label": "ORG"
      },
      {
        "text": "One",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "aspiration pneumonia, although horizontal gaze was maintained postoperatively.",
    "entities": []
  },
  {
    "text": "Long-segment corrective fixation within an appropriate range is considered a",
    "entities": []
  },
  {
    "text": "safe and effective treatment option.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Honda et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Honda",
        "label": "ORG"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A Rare Case of Polymicrobial Empyema Associated With COVID-19 Infection",
    "entities": []
  },
  {
    "text": "Complicated by a Bronchopleural Fistula.",
    "entities": []
  },
  {
    "text": "(1)Internal Medicine, Nepalese Army Institute of Health Sciences, Kathmandu,",
    "entities": [
      {
        "text": "Medicine, Nepalese Army Institute of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Internal Medicine, Tribhuvan University Institute of Medicine, Kathmandu,",
    "entities": [
      {
        "text": "Tribhuvan University Institute of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Empyema is a rare but serious complication in patients with COVID-19, and its",
    "entities": [
      {
        "text": "Empyema",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "association with bronchopleural fistula (BPF) is even more uncommon. We present",
    "entities": [
      {
        "text": "BPF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the case of a 40-year-old woman with a history of intravenous drug use who",
    "entities": [
      {
        "text": "40-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "developed polymicrobial empyema in the setting of COVID-19, further complicated",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BPF. She presented with hypoxic respiratory failure, leukocytosis, and lactic",
    "entities": [
      {
        "text": "BPF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acidosis. Imaging revealed a large right-sided hydropneumothorax and bilateral",
    "entities": []
  },
  {
    "text": "lung opacities. Broad-spectrum antibiotics, antivirals, and corticosteroids were",
    "entities": []
  },
  {
    "text": "initiated, and 3 liters of purulent fluid were drained via chest tube,",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "confirming empyema. Cultures identified multiple pathogens, including",
    "entities": []
  },
  {
    "text": "Bacteroides fragilis, Arcanobacterium hemolyticum, methicillin-sensitive",
    "entities": [
      {
        "text": "Arcanobacterium",
        "label": "LOC"
      },
      {
        "text": "methicillin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Staphylococcus aureus, and Group C/G streptococci. Persistent air leak and",
    "entities": [
      {
        "text": "Group C/G",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incomplete lung re-expansion led to a diagnosis of BPF. The patient was",
    "entities": [
      {
        "text": "BPF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "successfully managed with prolonged antibiotic therapy and chest tube drainage",
    "entities": []
  },
  {
    "text": "without requiring surgical or bronchoscopic intervention. This case highlights",
    "entities": []
  },
  {
    "text": "the importance of recognizing and conservatively managing small BPFs in",
    "entities": []
  },
  {
    "text": "COVID-19-associated empyema, emphasizing the potential for non-surgical",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resolution in select cases.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Regmi et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Correlation of Radiographic and High-Resolution Computed Tomography (HRCT)",
    "entities": [
      {
        "text": "Correlation of Radiographic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Features in Lower Lobe Tuberculosis With Microbiological Findings: A Study in",
    "entities": []
  },
  {
    "text": "the Konaseema Region.",
    "entities": [
      {
        "text": "the Konaseema Region",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)Department of Radiology, Konaseema Institute of Medical Sciences and Research",
    "entities": [
      {
        "text": "Radiology, Konaseema Institute of Medical Sciences and Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Microbiology, Konaseema Institute of Medical Sciences and",
    "entities": [
      {
        "text": "Microbiology, Konaseema Institute of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Foundation, Amalapuram, IND.",
    "entities": [
      {
        "text": "Research Foundation",
        "label": "ORG"
      },
      {
        "text": "Amalapuram",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pulmonology, Konaseema Institute of Medical Sciences and",
    "entities": [
      {
        "text": "Pulmonology, Konaseema Institute of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study aimed to evaluate the radiographic, high-resolution",
    "entities": []
  },
  {
    "text": "computed tomography (HRCT), and microbiological characteristics of pulmonary",
    "entities": []
  },
  {
    "text": "tuberculosis (PTB) in general, with a focused correlation analysis in a subset",
    "entities": []
  },
  {
    "text": "of patients with lower lobe tuberculosis (LLTB), to aid in the accurate",
    "entities": [
      {
        "text": "LLTB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diagnosis and clinical differentiation of this atypical presentation.",
    "entities": []
  },
  {
    "text": "METHODS: A prospective observational study was conducted in the pulmonology,",
    "entities": []
  },
  {
    "text": "radiology, and microbiology departments of Konaseema Institute of Medical",
    "entities": [
      {
        "text": "Konaseema Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences and Research Foundation, Andhra Pradesh. The study period was from",
    "entities": [
      {
        "text": "Sciences and Research Foundation",
        "label": "ORG"
      },
      {
        "text": "Andhra Pradesh",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "December 2022 to June 2024. The study included 40 confirmed cases of LLTB, which",
    "entities": [
      {
        "text": "December 2022 to June 2024",
        "label": "DATE"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "LLTB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were identified based on microbiological and radiological findings. HRCT and",
    "entities": []
  },
  {
    "text": "chest radiographs were analyzed for characteristic patterns. At the same time,",
    "entities": []
  },
  {
    "text": "microbial confirmation was obtained through Ziehl-Neelsen (ZN) staining,",
    "entities": [
      {
        "text": "Ziehl-Neelsen",
        "label": "ORG"
      },
      {
        "text": "ZN",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "GeneXpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA), and culture",
    "entities": [
      {
        "text": "GeneXpert MTB/RIF",
        "label": "PERSON"
      },
      {
        "text": "Cepheid",
        "label": "NORP"
      },
      {
        "text": "Sunnyvale",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "India). Spearman's correlation was used to assess the correlation between",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      },
      {
        "text": "Spearman",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: Patchy opacities were the most frequently observed radiological",
    "entities": []
  },
  {
    "text": "abnormality, identified in 37 (50.0%) out of 74 patients, followed by",
    "entities": [
      {
        "text": "37",
        "label": "DATE"
      },
      {
        "text": "50.0%",
        "label": "PERCENT"
      },
      {
        "text": "74",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "homogeneous consolidation in 31 (41.9%) and cavitation in 14 (18.9%) cases.",
    "entities": [
      {
        "text": "31",
        "label": "DATE"
      },
      {
        "text": "41.9%",
        "label": "PERCENT"
      },
      {
        "text": "14",
        "label": "DATE"
      },
      {
        "text": "18.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Nodular opacities and para-pneumonic effusion were noted in nine (12.2%) and",
    "entities": [
      {
        "text": "Nodular",
        "label": "ORG"
      },
      {
        "text": "nine",
        "label": "CARDINAL"
      },
      {
        "text": "12.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "eight (10.8%) patients, respectively, reflecting the heterogeneous imaging",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "10.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patterns associated with LLTB. Sputum smear microscopy for acid-fast bacilli",
    "entities": [
      {
        "text": "LLTB",
        "label": "ORG"
      },
      {
        "text": "Sputum",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(AFB) yielded positive results in 33 (18.2%) cases, while bronchoalveolar lavage",
    "entities": [
      {
        "text": "AFB",
        "label": "ORG"
      },
      {
        "text": "33",
        "label": "CARDINAL"
      },
      {
        "text": "18.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(BAL) confirmed tuberculosis in 12 (6.6%) patients. HRCT findings contributed to",
    "entities": [
      {
        "text": "BAL",
        "label": "ORG"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "6.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the diagnosis in 16 (8.8%) cases. Additionally, nine (5.0%) cases of",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "8.8%",
        "label": "PERCENT"
      },
      {
        "text": "nine",
        "label": "CARDINAL"
      },
      {
        "text": "5.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "non-resolving pneumonia and 11 (6.1%) cases presenting with hemoptysis",
    "entities": [
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "6.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "underscored the diagnostic complexity of lower lobe involvement.",
    "entities": []
  },
  {
    "text": "CONCLUSION: In conclusion, LLTB shows atypical radiological features, often",
    "entities": [
      {
        "text": "LLTB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mimicking pneumonia, with patchy opacities and consolidation. Cavitation is a",
    "entities": []
  },
  {
    "text": "combined clinical, radiological, and microbial approach is essential for",
    "entities": []
  },
  {
    "text": "study. Institutional Ethical Committee, Konaseema Institute of Medical Sciences",
    "entities": [
      {
        "text": "Institutional Ethical Committee",
        "label": "ORG"
      },
      {
        "text": "Konaseema Institute of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Research Foundation issued approval 83/02.12.2022. Animal subjects: All",
    "entities": [
      {
        "text": "Research Foundation",
        "label": "ORG"
      },
      {
        "text": "83/02.12.2022",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors have confirmed that this study did not involve animal subjects or",
    "entities": []
  },
  {
    "text": "tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "12. Mediastinum. 2025 May 21;9:12. doi: 10.21037/med-24-33. eCollection 2025.",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "Mediastinum",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "May 21;9:12",
        "label": "DATE"
      },
      {
        "text": "10.21037",
        "label": "CARDINAL"
      },
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Complications of linear endobronchial ultrasound guided biopsies: narrative",
    "entities": []
  },
  {
    "text": "review.",
    "entities": []
  },
  {
    "text": "(1)Department of Pulmonary and Critical Care Medicine, United Health Services",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "United Health Services",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Southern California Medical Education Consortium, Temecula, CA, USA.",
    "entities": [
      {
        "text": "Southern California Medical Education Consortium",
        "label": "ORG"
      },
      {
        "text": "Temecula",
        "label": "PERSON"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Interventional Pulmonology, Division of Pulmonary, Critical Care, Sleep",
    "entities": [
      {
        "text": "2)Interventional",
        "label": "CARDINAL"
      },
      {
        "text": "Pulmonology, Division of Pulmonary, Critical Care",
        "label": "ORG"
      },
      {
        "text": "Sleep\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Medicine & Physiology, University of California San Diego, San Diego, CA, USA.",
    "entities": [
      {
        "text": "Medicine & Physiology",
        "label": "ORG"
      },
      {
        "text": "University of California San Diego",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND AND OBJECTIVE: Linear endobronchial ultrasound (EBUS) has become a",
    "entities": [
      {
        "text": "Linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "key tool for diagnosing pulmonary diseases, offering high diagnostic yield for",
    "entities": []
  },
  {
    "text": "both malignant and non-malignant conditions. With its increased use, more",
    "entities": []
  },
  {
    "text": "complications are being reported. The objective of this narrative review is to",
    "entities": []
  },
  {
    "text": "discuss the complications associated with linear EBUS.",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: A literature search using PubMed and Google Scholar from 2009 to 2024",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "Google Scholar",
        "label": "ORG"
      },
      {
        "text": "2009",
        "label": "DATE"
      },
      {
        "text": "2024",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was done. We included case reports, prospective, and retrospective studies",
    "entities": []
  },
  {
    "text": "reporting linear EBUS complications.",
    "entities": []
  },
  {
    "text": "KEY CONTENT AND FINDINGS: Overall complications from EBUS range from 0.04% to",
    "entities": [
      {
        "text": "0.04%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "17%. Most common are infectious complications which are 0.04-4%. These include",
    "entities": [
      {
        "text": "17%",
        "label": "PERCENT"
      },
      {
        "text": "0.04-4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "mediastinitis, pneumonia, pericarditis, bacteremia, tumor bed infection, lung",
    "entities": [
      {
        "text": "mediastinitis",
        "label": "ORG"
      },
      {
        "text": "pericarditis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "abscess, empyema, and septic shock. Other complications include pneumothorax,",
    "entities": []
  },
  {
    "text": "emphysema. Complications due to anesthesia or equipment malfunction can occur as",
    "entities": [
      {
        "text": "emphysema",
        "label": "PERSON"
      },
      {
        "text": "anesthesia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "well. Hemorrhagic complications have been reported as well. Mortality is low",
    "entities": [
      {
        "text": "Hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.01-0.04%, and four cases have been reported that led to death from",
    "entities": [
      {
        "text": "0.01-0.04%",
        "label": "PERCENT"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "complications.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: With increased use of EBUS as a diagnostic tool, number of",
    "entities": []
  },
  {
    "text": "complications will increase. Clinicians performing the procedures should be",
    "entities": [
      {
        "text": "Clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "aware of types of possible complications that can occur and follow the patients",
    "entities": []
  },
  {
    "text": "closely after the procedure. Rapid diagnosis and treatment should be done to",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 AME Publishing Company. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "AME Publishing Company",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflicts of Interest: All authors have",
    "entities": []
  },
  {
    "text": "completed the ICMJE uniform disclosure form (available at",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "https://med.amegroups.com/article/view/10.21037/med-24-33/coif). G.C. received",
    "entities": [
      {
        "text": "G.C.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Harvard patent on SLIPS from BIDMC, and other patent pending, and received",
    "entities": [
      {
        "text": "Harvard",
        "label": "ORG"
      },
      {
        "text": "BIDMC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consulting fees from Intuitive, Ajax, Olympus, Cook, Pinnicle Biologics,",
    "entities": [
      {
        "text": "Intuitive",
        "label": "ORG"
      },
      {
        "text": "Ajax, Olympus",
        "label": "ORG"
      },
      {
        "text": "Cook",
        "label": "PERSON"
      },
      {
        "text": "Pinnicle Biologics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Siemens, Leadoptiks. G.C. also has a leadership role in AABIP board of directors",
    "entities": [
      {
        "text": "Siemens",
        "label": "ORG"
      },
      {
        "text": "Leadoptiks",
        "label": "PERSON"
      },
      {
        "text": "G.C.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and in ACCP. N.M.P. received consulting proctoring fees from Intuitive Surgical",
    "entities": [
      {
        "text": "ACCP",
        "label": "ORG"
      },
      {
        "text": "N.M.P.",
        "label": "ORG"
      },
      {
        "text": "Intuitive Surgical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and support for meeting attendance from European Respiratory Society. The other",
    "entities": [
      {
        "text": "European Respiratory Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors have no conflicts of interest to declare.",
    "entities": []
  },
  {
    "text": "STING regulates NETs formation by activating GSDMD in influenza viral pneumonia.",
    "entities": [
      {
        "text": "GSDMD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical",
    "entities": [
      {
        "text": "1)School of",
        "label": "ORG"
      },
      {
        "text": "Basic Medical Sciences & Forensic Medicine",
        "label": "ORG"
      },
      {
        "text": "Hangzhou Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, Hangzhou, China.",
    "entities": [
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Public Health, Hangzhou Medical College, Hangzhou, China.",
    "entities": [
      {
        "text": "Hangzhou Medical College",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Key Discipline of Zhejiang Province in Public Health and Preventive Medicine",
    "entities": [
      {
        "text": "3)Key",
        "label": "CARDINAL"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(First Class, Category A), Hangzhou Medical College, Hangzhou, China.",
    "entities": [
      {
        "text": "First",
        "label": "ORDINAL"
      },
      {
        "text": "Hangzhou Medical College",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Center for Safety Evaluation and Research, Hangzhou Medical College,",
    "entities": [
      {
        "text": "Safety Evaluation and Research",
        "label": "ORG"
      },
      {
        "text": "Hangzhou Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Viral pneumonia is the most common and lethal pandemic disease, but",
    "entities": []
  },
  {
    "text": "there are no broad-spectrum antiviral drugs with high genetic barriers to",
    "entities": []
  },
  {
    "text": "resistance. To elucidate the mechanisms of viral pneumonia progression and",
    "entities": []
  },
  {
    "text": "potential targets for its treatment.",
    "entities": []
  },
  {
    "text": "METHODS: Viral pneumonia models were induced by the PR8 virus strain in",
    "entities": []
  },
  {
    "text": "wild-type (WT) and STING knockout (STING-KO) mice. Series of molecular biology",
    "entities": []
  },
  {
    "text": "techniques were used to evaluate the severity of pneumonia and cytokine levels.",
    "entities": []
  },
  {
    "text": "RESULTS: In this study, STING (stimulator of interferon genes) was activated in",
    "entities": []
  },
  {
    "text": "the lungs of virus-infected mice, leading to cytokine production and",
    "entities": []
  },
  {
    "text": "amplification of the immune response, thereby causing rapid deterioration of",
    "entities": []
  },
  {
    "text": "symptoms. Furthermore, excessive activation of innate immune response via STING",
    "entities": []
  },
  {
    "text": "was prevented by a STING inhibitor (C-176), which significantly reduced viral",
    "entities": [
      {
        "text": "C-176",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "lung inflammation. The formation of neutrophil extracellular traps (NETs) was",
    "entities": []
  },
  {
    "text": "similarly suppressed during viral pneumonia treatment with STING inhibitors",
    "entities": []
  },
  {
    "text": "(C-176), and NETs formation and STING expression were positively correlated,",
    "entities": [
      {
        "text": "C-176",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "indicating that STING plays an important role in NETs formation. Symptoms of",
    "entities": []
  },
  {
    "text": "pneumonia in STING-KO mice infected with PR8 were significantly milder than",
    "entities": []
  },
  {
    "text": "those in WT mice, and NETs were less likely to form in the lung tissue of",
    "entities": [
      {
        "text": "WT",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "STING-KO mice. Additionally, transcriptomic analysis revealed that",
    "entities": []
  },
  {
    "text": "STING-mediated regulation of NETs may be associated with gasdermin D (GSDMD),",
    "entities": []
  },
  {
    "text": "and immunoprecipitation experiments revealed that STING, GSDMD, and NETs-related",
    "entities": [
      {
        "text": "GSDMD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "proteins interact with each other. Immunofluorescence assays revealed that in",
    "entities": []
  },
  {
    "text": "neutrophils from WT mice, STING and GSDMD were colocalized on the membrane after",
    "entities": [
      {
        "text": "WT",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "viral infection, whereas in neutrophils from STING-KO mice, GSDMD expression was",
    "entities": []
  },
  {
    "text": "decreased after exposure to the virus.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Our study demonstrated that targeted intervention with STING",
    "entities": []
  },
  {
    "text": "alleviated pneumonia by inhibiting inflammation and NETs formation. The study",
    "entities": []
  },
  {
    "text": "also revealed that blocking STING could inhibit the activation of GSDMD to",
    "entities": [
      {
        "text": "GSDMD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inhibit NETs formation, slowing the progression of viral pneumonia.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Huang, Chen, Xing, Wu, Zhu, Jing, Zhou, Wu, Zhang and You.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Huang",
        "label": "PERSON"
      },
      {
        "text": "Chen",
        "label": "PERSON"
      },
      {
        "text": "Xing",
        "label": "PERSON"
      },
      {
        "text": "Wu",
        "label": "PERSON"
      },
      {
        "text": "Zhu",
        "label": "PERSON"
      },
      {
        "text": "Zhou",
        "label": "PERSON"
      },
      {
        "text": "Wu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that the research was",
    "entities": []
  },
  {
    "text": "conducted in the absence of any commercial or financial relationships that could",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer",
    "entities": [
      {
        "text": "Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Patients With Concurrent Advanced Malignancies With Expected Poor Prognosis.",
    "entities": []
  },
  {
    "text": "(1)Department of Gastroenterology Hiroshima University Hospital Hiroshima Japan.",
    "entities": [
      {
        "text": "Gastroenterology Hiroshima University Hospital",
        "label": "ORG"
      },
      {
        "text": "Hiroshima",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Gastrointestinal Endoscopy and Medicine Hiroshima University Hospital",
    "entities": [
      {
        "text": "2)Gastrointestinal",
        "label": "CARDINAL"
      },
      {
        "text": "Endoscopy",
        "label": "ORG"
      },
      {
        "text": "Medicine Hiroshima University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AIMS: Despite improved outcomes for malignant tumors, evidence regarding the",
    "entities": []
  },
  {
    "text": "management of patients with multiple malignancies remains limited. We aimed to",
    "entities": []
  },
  {
    "text": "evaluate the clinical outcomes and prognosis of patients undergoing endoscopic",
    "entities": []
  },
  {
    "text": "submucosal dissection (ESD) for early gastric cancer (EGC) complicated by",
    "entities": [
      {
        "text": "ESD",
        "label": "ORG"
      },
      {
        "text": "EGC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "advanced malignancies in other organs with a poor prognosis.",
    "entities": []
  },
  {
    "text": "METHODS AND RESULTS: We retrospectively reviewed 3703 gastric cancer patients",
    "entities": [
      {
        "text": "3703",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "who underwent ESD at our hospital (2005-2022), focusing on those with advanced",
    "entities": [
      {
        "text": "2005-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "extra-gastric malignancies with a 5-year survival rate of < 50%. ESD was",
    "entities": [
      {
        "text": "5-year",
        "label": "DATE"
      },
      {
        "text": "50%",
        "label": "PERCENT"
      },
      {
        "text": "ESD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "performed for local tumor control based on patient preference when feasible,",
    "entities": []
  },
  {
    "text": "including lesions meeting standard, expanded, or relative indications where",
    "entities": []
  },
  {
    "text": "curative resection was unachievable. Clinicopathological characteristics and",
    "entities": []
  },
  {
    "text": "outcomes were analyzed. Twenty-six patients met the inclusion criteria. En bloc",
    "entities": [
      {
        "text": "Twenty-six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resection was achieved in all cases (100%), with curative and non-curative",
    "entities": [
      {
        "text": "100%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "resection in 16 (62%) and 10 (38%) cases, respectively. None of the 10 patients",
    "entities": [
      {
        "text": "16",
        "label": "DATE"
      },
      {
        "text": "62%",
        "label": "PERCENT"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "38%",
        "label": "PERCENT"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with non-curative resection exhibited lymphovascular invasion or GC recurrence.",
    "entities": [
      {
        "text": "GC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Complications included delayed bleeding, perforation, and pneumonia, each in one",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patient (4%), all leading to disseminated intravascular coagulation (DIC) and",
    "entities": [
      {
        "text": "4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "death within 30 days post-ESD. Notably, no complications were reported after",
    "entities": [
      {
        "text": "30 days",
        "label": "DATE"
      },
      {
        "text": "post-ESD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2010. Eleven patients died from advanced malignant tumors, with no GC",
    "entities": [
      {
        "text": "2010",
        "label": "DATE"
      },
      {
        "text": "GC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recurrences observed during follow-up in surviving patients.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Recently, no severe complications have been observed with ESD.",
    "entities": [
      {
        "text": "ESD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Although ESD for local control in EGC with concurrent advanced extra-gastric",
    "entities": [
      {
        "text": "ESD",
        "label": "ORG"
      },
      {
        "text": "EGC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "malignancies may be acceptable, the risk of severe complications, including DIC,",
    "entities": [
      {
        "text": "DIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remains. Therefore, careful patient selection and thorough informed consent are",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). JGH Open published by Journal of Gastroenterology and",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Journal of Gastroenterology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hepatology Foundation and John Wiley & Sons Australia, Ltd.",
    "entities": [
      {
        "text": "Hepatology Foundation",
        "label": "ORG"
      },
      {
        "text": "John Wiley & Sons Australia, Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul.",
    "entities": [
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025 Jul.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Gastrografin Enema to the Rescue of the Glorious Cecal Bascule.",
    "entities": [
      {
        "text": "Gastrografin Enema",
        "label": "PERSON"
      },
      {
        "text": "the Glorious Cecal Bascule",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, HCA Healthcare Houston Kingwood, Kingwood,",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Houston Kingwood",
        "label": "PERSON"
      },
      {
        "text": "Kingwood",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Gastroenterology, HCA Healthcare Houston Kingwood, Kingwood,",
    "entities": [
      {
        "text": "Gastroenterology",
        "label": "ORG"
      },
      {
        "text": "Houston Kingwood",
        "label": "PERSON"
      },
      {
        "text": "Kingwood",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A 74-year-old woman with a history of gastroesophageal reflux disease, hiatal",
    "entities": [
      {
        "text": "74-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hernia, Barrett's esophagus, chronic obstructive pulmonary disease, and chronic",
    "entities": [
      {
        "text": "hernia",
        "label": "GPE"
      },
      {
        "text": "Barrett",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "constipation was hospitalized for community-acquired pneumonia. During her",
    "entities": []
  },
  {
    "text": "hospitalization, she developed progressive lower abdominal discomfort and",
    "entities": []
  },
  {
    "text": "reported no bowel movement for 8 days. Conservative measures, including oral",
    "entities": [
      {
        "text": "8 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "laxatives, enemas, and manual disimpaction, were unsuccessful, prompting",
    "entities": [
      {
        "text": "enemas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gastroenterology consultation. Imaging revealed colonic pseudo-obstruction with",
    "entities": []
  },
  {
    "text": "a markedly dilated cecum, suggestive of a type III cecal bascule-a rare upward",
    "entities": []
  },
  {
    "text": "folding of the cecum without torsion. Owing to her clinical stability, absence",
    "entities": []
  },
  {
    "text": "of peritoneal signs, and lack of ischemia on imaging, a nonsurgical approach was",
    "entities": []
  },
  {
    "text": "pursued. The patient was treated with a Gastrografin enema, resulting in",
    "entities": [
      {
        "text": "Gastrografin",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "immediate decompression and clinical improvement. This case contributes to",
    "entities": []
  },
  {
    "text": "emerging literature supporting conservative management of cecal bascule in",
    "entities": []
  },
  {
    "text": "select patients and emphasizes the importance of careful patient selection.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "American College of Gastroenterology.",
    "entities": [
      {
        "text": "American College of Gastroenterology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Association of follow-up neutrophil-lymphocyte ratio with postoperative",
    "entities": []
  },
  {
    "text": "pneumonia in aneurysmal subarachnoid hemorrhage patients after endovascular",
    "entities": []
  },
  {
    "text": "treatment: a retrospective analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurosurgery, The Second Affiliated Hospital, Fujian Medical",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Fujian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Quanzhou, China.",
    "entities": [
      {
        "text": "Quanzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, The Second Affiliated Hospital, Fujian Medical",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Fujian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Division of Public Management, The Second Affiliated Hospital, Fujian Medical",
    "entities": [
      {
        "text": "Public Management",
        "label": "ORG"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Fujian Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Division of Neurosurgery, Jinjiang Municipal Hospital (Shanghai Sixth",
    "entities": [
      {
        "text": "Neurosurgery, Jinjiang Municipal Hospital",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Sixth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "People's Hospital Fujian Campus), Quanzhou, China.",
    "entities": [
      {
        "text": "People's Hospital Fujian Campus",
        "label": "ORG"
      },
      {
        "text": "Quanzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(#)Contributed equally",
    "entities": []
  },
  {
    "text": "INTRODUCTION: Research on the relationship between dynamic",
    "entities": []
  },
  {
    "text": "neutrophil-to-lymphocyte ratio (NLR)-measured at different time points around",
    "entities": [
      {
        "text": "NLR)-measured",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "endovascular treatment-and the occurrence of postoperative pneumonia (POP) in",
    "entities": []
  },
  {
    "text": "patients with aneurysmal subarachnoid hemorrhage (aSAH) is still relatively",
    "entities": []
  },
  {
    "text": "scarce. This study aims to explore the association between dynamic NLR and the",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incidence of POP in patients with aSAH undergoing endovascular therapy.",
    "entities": [
      {
        "text": "POP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This study included patients with aSAH who underwent endovascular",
    "entities": []
  },
  {
    "text": "treatment between January 2019 and April 2023. The follow-up endpoint was the",
    "entities": [
      {
        "text": "January 2019",
        "label": "DATE"
      },
      {
        "text": "April 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "presence of POP at 30 days postoperatively. Logistic regression analysis was",
    "entities": [
      {
        "text": "POP",
        "label": "ORG"
      },
      {
        "text": "30 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "conducted using POP as the dependent variable. The NLR was calculated at",
    "entities": [
      {
        "text": "POP",
        "label": "ORG"
      },
      {
        "text": "NLR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "admission (NLR1), 24 h after endovascular treatment (NLR2), and 3-7 days after",
    "entities": [
      {
        "text": "NLR1",
        "label": "PERSON"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "3-7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "endovascular treatment (NLR3). Four prediction models were constructed: Model 1",
    "entities": [
      {
        "text": "NLR3",
        "label": "GPE"
      },
      {
        "text": "Four",
        "label": "CARDINAL"
      },
      {
        "text": "Model 1\n",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(variables with p < 0.05, except for the NLR), Model 2 (Model 1 plus NLR1),",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      },
      {
        "text": "Model 2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "RESULTS: Among the 154 patients with aSAH, POP occurred in 101 (65.6%) patients.",
    "entities": [
      {
        "text": "154",
        "label": "CARDINAL"
      },
      {
        "text": "POP",
        "label": "ORG"
      },
      {
        "text": "101",
        "label": "CARDINAL"
      },
      {
        "text": "65.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Higher NLRs at admission [odds ratio (OR) = 1.08; 95% confidence interval (CI):",
    "entities": [
      {
        "text": "1.08",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.02, 1.16; p = 0.019], 24 h postoperatively (OR = 1.14; 95% CI = 1.05, 1.25;",
    "entities": [
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "1.16",
        "label": "CARDINAL"
      },
      {
        "text": "0.019",
        "label": "CARDINAL"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "1.25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.005) and 3-7 days postoperatively (OR = 1.17; 95% CI = 1.02, 1.38;",
    "entities": [
      {
        "text": "0.005",
        "label": "CARDINAL"
      },
      {
        "text": "3-7 days",
        "label": "DATE"
      },
      {
        "text": "1.17",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "1.38",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.04) were associated with the occurrence of POP.",
    "entities": [
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "POP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Follow-up NLR may be associated with POP in patients with aSAH",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      },
      {
        "text": "POP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treated endovascularly. Elevated NLR at admission, 24 h postoperatively, and",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "3-7 days postoperatively correlated with a high risk for POP.",
    "entities": [
      {
        "text": "3-7 days",
        "label": "DATE"
      },
      {
        "text": "POP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a",
    "entities": [
      {
        "text": "Pregnancy Reflects Healthcare Utilization",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pandemic: A Two-Stage Individual Participant Data Meta-Analysis Combining",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "Meta-Analysis Combining",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Case-Based Registries.",
    "entities": []
  },
  {
    "text": "Schuler-Faccini L(34), Goncalves Pereira N(35), Etchegaray A(36), Nieto-Calvache",
    "entities": [
      {
        "text": "Schuler",
        "label": "ORG"
      },
      {
        "text": "Goncalves Pereira N(35",
        "label": "PERSON"
      },
      {
        "text": "Etchegaray A(36",
        "label": "PERSON"
      },
      {
        "text": "Nieto-Calvache",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Materno-Fetal and Obstetrics Research Unit, Department \"Femme-M\u00e8re-Enfant\",",
    "entities": [
      {
        "text": "1)Materno-Fetal and Obstetrics Research Unit",
        "label": "ORG"
      },
      {
        "text": "Femme-M\u00e8re-Enfant",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "University Hospital, Lausanne, Switzerland.",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Lausanne",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Institute of Primary Health Care (BIHAM), University of Bern, Bern,",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "University of Bern",
        "label": "ORG"
      },
      {
        "text": "Bern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Graduate School for Health Sciences (GHS), University of Bern, Bern,",
    "entities": [
      {
        "text": "3)Graduate School for Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Bern",
        "label": "ORG"
      },
      {
        "text": "Bern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Data Science and Biostatistics, Julius Global Health,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Data Science and Biostatistics",
        "label": "ORG"
      },
      {
        "text": "Julius Global Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "University Medical Center Utrecht",
        "label": "ORG"
      },
      {
        "text": "UMCU",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Obstetrics, Wilhelmina Children's Hospital, University Medical",
    "entities": [
      {
        "text": "Obstetrics",
        "label": "GPE"
      },
      {
        "text": "University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center Utrecht (UMCU), Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "UMCU",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Obstetrics and Gynecology, Riviera-Chablais Hospital, Rennaz,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Riviera-Chablais Hospital",
        "label": "ORG"
      },
      {
        "text": "Rennaz",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(8)Department of Global Health, The George Washington University Milken",
    "entities": [
      {
        "text": "Global Health",
        "label": "ORG"
      },
      {
        "text": "The George Washington University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute School of Public Health, Washington, DC, USA.",
    "entities": [
      {
        "text": "Institute School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Washington, DC,",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Saudi Food and Drug Authority, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "Food and Drug Authority",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Obstetrics and Gynecology Department, Hospital Universitario La Paz, Madrid,",
    "entities": [
      {
        "text": "11)Obstetrics and Gynecology Department",
        "label": "ORG"
      },
      {
        "text": "Hospital Universitario La",
        "label": "FAC"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.",
    "entities": [
      {
        "text": "12)School",
        "label": "CARDINAL"
      },
      {
        "text": "Universidad Francisco de Vitoria",
        "label": "PERSON"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)University of Padova, Padova, Italy.",
    "entities": [
      {
        "text": "13)University",
        "label": "CARDINAL"
      },
      {
        "text": "Padova",
        "label": "GPE"
      },
      {
        "text": "Padova",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Obstetrics and Gynecology, Universidade Estadual de Campinas",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Estadual de Campinas",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(16)St. Luke's University Health Network, Bethlehem, PA, USA.",
    "entities": [
      {
        "text": "Luke's University Health Network",
        "label": "ORG"
      },
      {
        "text": "Bethlehem",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Oregon Health & Science University, Oregon, USA.",
    "entities": [
      {
        "text": "17)Oregon Health & Science University",
        "label": "ORG"
      },
      {
        "text": "Oregon",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Helen Schneider Hospital for Women, Rabin Medical Center, and the Faculty of",
    "entities": [
      {
        "text": "18)Helen",
        "label": "CARDINAL"
      },
      {
        "text": "Schneider Hospital for Women",
        "label": "ORG"
      },
      {
        "text": "Rabin Medical Center",
        "label": "ORG"
      },
      {
        "text": "the Faculty of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical and Health Sciences, Tel-Aviv University, Tel Aviv, Israel.",
    "entities": [
      {
        "text": "Medical and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Tel-Aviv University",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Maternal-Fetal Medicine Department, BCNatal-Fetal Medicine Research Center,",
    "entities": [
      {
        "text": "19)Maternal-Fetal Medicine Department",
        "label": "ORG"
      },
      {
        "text": "BCNatal-Fetal Medicine Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Barcelona, Spain.",
    "entities": [
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Department of Obstetrics and Gynecology, H\u00f4pital NOVO Site de Pontoise,",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(21)Department of Obstetrics, Maternit\u00e9 Poissy Saint Germain, Poissy, France.",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Poissy",
        "label": "PERSON"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)Obstetrics Division, Department of Pediatrics, Gynecology, and Obstetrics,",
    "entities": [
      {
        "text": "22)Obstetrics Division",
        "label": "ORG"
      },
      {
        "text": "Department of Pediatrics, Gynecology",
        "label": "ORG"
      },
      {
        "text": "Obstetrics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.",
    "entities": [
      {
        "text": "Geneva University Hospitals",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Department of Obstetrics and Gynecology, RHNE, Neuch\u00e2tel, Switzerland.",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "RHNE",
        "label": "ORG"
      },
      {
        "text": "Neuch\u00e2tel",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Department of Obstetrics and Feto-Maternal Medicine, University Hospital of",
    "entities": [
      {
        "text": "24)Department",
        "label": "CARDINAL"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bern, University of Bern, Bern, Switzerland.",
    "entities": [
      {
        "text": "Bern",
        "label": "ORG"
      },
      {
        "text": "University of Bern",
        "label": "ORG"
      },
      {
        "text": "Bern",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(25)Department of Obstetrics and Gynecology, Cantonal Hospital Aarau, Aarau,",
    "entities": [
      {
        "text": "25)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Cantonal Hospital Aarau",
        "label": "ORG"
      },
      {
        "text": "Aarau",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Department of Obstetrics and Gynecology, University Hospital Basel, Basel,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "University Hospital Basel",
        "label": "ORG"
      },
      {
        "text": "Basel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(27)Division of Obstetrics, Baden Cantonal Hospital, Baden, Switzerland.",
    "entities": [
      {
        "text": "27)Division of Obstetrics",
        "label": "ORG"
      },
      {
        "text": "Baden Cantonal Hospital",
        "label": "ORG"
      },
      {
        "text": "Baden",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(28)Medical Research Center, Kateb University, Kabul, Afghanistan.",
    "entities": [
      {
        "text": "28)Medical Research Center",
        "label": "ORG"
      },
      {
        "text": "Kateb University",
        "label": "ORG"
      },
      {
        "text": "Kabul",
        "label": "GPE"
      },
      {
        "text": "Afghanistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(29)Department of Research, Afghanistan National Charity Organization for",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Afghanistan National Charity Organization",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Special Diseases (ANCOSD), Kabul, Afghanistan.",
    "entities": [
      {
        "text": "Special Diseases",
        "label": "ORG"
      },
      {
        "text": "ANCOSD",
        "label": "ORG"
      },
      {
        "text": "Kabul",
        "label": "GPE"
      },
      {
        "text": "Afghanistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Department of Obstetrics and Gynecology, Medical School, University of",
    "entities": [
      {
        "text": "30)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology, Medical School, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lisbon; Santa Maria University Hospital, Lisbon, Portugal.",
    "entities": [
      {
        "text": "Lisbon",
        "label": "GPE"
      },
      {
        "text": "Santa Maria University Hospital",
        "label": "ORG"
      },
      {
        "text": "Lisbon",
        "label": "GPE"
      },
      {
        "text": "Portugal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(31)School of Health Sciences (HESAV), University of Applied Sciences and Arts",
    "entities": [
      {
        "text": "31)School of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "HESAV",
        "label": "ORG"
      },
      {
        "text": "University of Applied Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(32)Department of Obstetrics and Fetal Medicine, Necker-Enfants Malades",
    "entities": [
      {
        "text": "32)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Fetal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Paris, France.",
    "entities": [
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)Department of Gynecology and Obstetrics, Ente Ospedaliero Cantonale, Lugano,",
    "entities": [
      {
        "text": "Lugano",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(36)Fetal Medicine Unit, Hospital Universitario Austral, Buenos Aires,",
    "entities": [
      {
        "text": "36)Fetal Medicine Unit",
        "label": "ORG"
      },
      {
        "text": "Hospital Universitario Austral",
        "label": "ORG"
      },
      {
        "text": "Buenos Aires",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(38)Department of Obstetrics and Gynecology, Rotunda Hospital, Dublin, Ireland.",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Rotunda Hospital",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(40)Department of Obstetrics and Gynecology, Stadtspital Triemli, Z\u00fcrich,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Z\u00fcrich",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(41)Department of Epidemiology of Microbial Diseases, Yale School of Public",
    "entities": [
      {
        "text": "Epidemiology of Microbial Diseases",
        "label": "ORG"
      },
      {
        "text": "Yale School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, New Haven, USA.",
    "entities": [
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)Department of Gynecology and Obstetrics, Hospital of the Upper Valais, Visp,",
    "entities": [
      {
        "text": "42)Department of Gynecology and Obstetrics, Hospital of",
        "label": "MONEY"
      },
      {
        "text": "Visp",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(44)Department of Obstetrics, Grabs Hospital, Grabs, Switzerland.",
    "entities": [
      {
        "text": "Obstetrics, Grabs Hospital",
        "label": "ORG"
      },
      {
        "text": "Grabs",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)West French Guiana Hospital Center, University of French Guiana, Saint",
    "entities": [
      {
        "text": "French",
        "label": "NORP"
      },
      {
        "text": "Guiana Hospital Center,",
        "label": "ORG"
      },
      {
        "text": "University of French Guiana",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(46)Division of Infectious Diseases, Department of Pediatrics, David Geffen UCLA",
    "entities": [
      {
        "text": "46)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "David Geffen UCLA",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "School of Medicine, Los Angeles, CA, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(47)Department of Obstetrics, CHU Lille, Univ Lille, ULR 2694-METRICS, Lille,",
    "entities": [
      {
        "text": "47)Department of Obstetrics",
        "label": "ORG"
      },
      {
        "text": "Univ Lille",
        "label": "PERSON"
      },
      {
        "text": "ULR",
        "label": "PERSON"
      },
      {
        "text": "Lille",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(48)Department of Obstetrics and Gynecology, Bordeaux University Hospital,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Bordeaux University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(50)Department of Obstetrics, Kantonsspital Baselland, Liestal, Switzerland.",
    "entities": [
      {
        "text": "50)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Kantonsspital Baselland",
        "label": "ORG"
      },
      {
        "text": "Liestal",
        "label": "ORG"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(51)Obstetrics and Gynecology Department, Faculty of Medicine, Universitas",
    "entities": [
      {
        "text": "51)Obstetrics and Gynecology Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(52)Department of Obstetrics Gynecology, \"Koco Gliozheni' University Hospital,",
    "entities": [
      {
        "text": "Obstetrics Gynecology",
        "label": "ORG"
      },
      {
        "text": "Koco Gliozheni' University Hospital",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "(53)Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht",
    "entities": [
      {
        "text": "53)Division of Pharmacoepidemiology and Clinical Pharmacology",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the",
    "entities": [
      {
        "text": "Institute for Pharmaceutical Sciences",
        "label": "ORG"
      },
      {
        "text": "Utrecht University",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(54)Service of Pharmacy, Lausanne University Hospital and University of",
    "entities": [
      {
        "text": "Lausanne University Hospital and University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE: To describe an international response to the COVID-19 pandemic by",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "estimating the prevalence of medication use for COVID-19 treatment in pregnancy,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stratified by hospitalization, trimester of pregnancy, and country.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a two-stage individual participant data meta-analysis of",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "proportions from primary data on medications used to treat COVID-19 during",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pregnancy. A common data model was developed to pool the data from",
    "entities": []
  },
  {
    "text": "single-country and international registries. Data from pregnant individuals with",
    "entities": []
  },
  {
    "text": "COVID-19 between February 2020 and October 2022 were included in study platforms",
    "entities": [
      {
        "text": "between February 2020 and October 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "across 9 data sources. Patient information was abstracted from medical records.",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: Among 24 937 pregnant individuals, the pooled prevalences of",
    "entities": [
      {
        "text": "24 937",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "individuals receiving medications to treat COVID-19 were: 34.7% heparin, 9.8%",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "34.7%",
        "label": "PERCENT"
      },
      {
        "text": "9.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Prevalence of medication use was higher in hospitalized individuals than in",
    "entities": []
  },
  {
    "text": "non-hospitalized individuals: 58.4% versus 17.9% for heparin, 26.9% versus 5.7%",
    "entities": [
      {
        "text": "58.4%",
        "label": "PERCENT"
      },
      {
        "text": "17.9%",
        "label": "PERCENT"
      },
      {
        "text": "26.9%",
        "label": "PERCENT"
      },
      {
        "text": "5.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "for antibiotics, 17.5% versus 1.3% for corticosteroids, 10.3% versus 0.3% for",
    "entities": [
      {
        "text": "17.5%",
        "label": "PERCENT"
      },
      {
        "text": "1.3%",
        "label": "PERCENT"
      },
      {
        "text": "10.3%",
        "label": "PERCENT"
      },
      {
        "text": "0.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "antivirals, and 4.5% versus 0.1% for antimalarials. The prevalence of",
    "entities": [
      {
        "text": "4.5%",
        "label": "PERCENT"
      },
      {
        "text": "0.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "corticosteroid use was lower in the first trimester (0.1%) compared with the",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "0.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "second (7.2%) and third (4.9%) trimesters of pregnancy. The prevalence of",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "7.2%",
        "label": "PERCENT"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      },
      {
        "text": "4.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "medications differed widely across countries.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Medication to treat COVID-19 was more frequently used in pregnant",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "individuals hospitalized for COVID-19. Corticosteroids were used less in the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "first trimester of pregnancy. The differences in use between countries could",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "reflect differences in the clinical management and access to medications for",
    "entities": []
  },
  {
    "text": "this population at risk of severe disease.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665803 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665803",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "18. J Intensive Care Med. 2025 Jul 16:8850666251359546. doi:",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1177/08850666251359546. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/08850666251359546",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Severe Community-Acquired Pneumonia: Impact of HIV on Clinical Presentation,",
    "entities": []
  },
  {
    "text": "Microbiological and Laboratory Findings, and Outcome.",
    "entities": []
  },
  {
    "text": "Venturas JP(1), Titus A(2), Richards GA(3), Feldman C(4).",
    "entities": [
      {
        "text": "Venturas JP(1",
        "label": "PERSON"
      },
      {
        "text": "Titus A(2",
        "label": "PERSON"
      },
      {
        "text": "Richards",
        "label": "ORG"
      },
      {
        "text": "Feldman C(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, Faculty of Health Sciences, University of",
    "entities": [
      {
        "text": "Internal Medicine, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Witwatersrand Medical School, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "the Witwatersrand Medical School",
        "label": "ORG"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Independent Statistician, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "2)Independent",
        "label": "CARDINAL"
      },
      {
        "text": "Statistician",
        "label": "NORP"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Dept of Surgery, Division of Critical Care, Faculty of Health Sciences,",
    "entities": [
      {
        "text": "Surgery, Division of Critical Care, Faculty of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of the Witwatersrand, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "University of the Witwatersrand",
        "label": "ORG"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine, Faculty of Health Sciences, University of",
    "entities": [
      {
        "text": "Internal Medicine, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Witwatersrand, Johannesburg, South Africa.",
    "entities": [
      {
        "text": "Witwatersrand",
        "label": "GPE"
      },
      {
        "text": "Johannesburg",
        "label": "GPE"
      },
      {
        "text": "South Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Severe community-acquired pneumonia (SCAP) is associated with significant",
    "entities": [
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "morbidity and mortality, but there is a paucity of data regarding these",
    "entities": []
  },
  {
    "text": "infections in sub-Saharan Africa, especially among people living with HIV",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(PLWH). This study investigated the impact of HIV on clinical presentation,",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "microbial aetiology, laboratory findings, and outcome of SCAP. This was",
    "entities": [
      {
        "text": "microbial aetiology",
        "label": "ORG"
      },
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "additional analysis of data from a large, single-centre, retrospective,",
    "entities": []
  },
  {
    "text": "observational study conducted among consecutive adult patients (\u226518 years)",
    "entities": []
  },
  {
    "text": "admitted to the multidisciplinary ICU at the Charlotte Maxeke Johannesburg",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "the Charlotte Maxeke Johannesburg\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Academic Hospital, between 1 July 2007 and 31 May 2019, with SCAP. The current",
    "entities": [
      {
        "text": "Academic Hospital",
        "label": "ORG"
      },
      {
        "text": "between 1 July 2007",
        "label": "DATE"
      },
      {
        "text": "31 May 2019",
        "label": "DATE"
      },
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study describes 718 PLWH and 131 HIV-negative cases extracted from the initial",
    "entities": [
      {
        "text": "718",
        "label": "CARDINAL"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "131",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cohort. The median age was 37 [IQR 30-46] years with PLWH significantly younger",
    "entities": [
      {
        "text": "37",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "than their HIV-negative counterparts (36 years [IQR 29-44] years vs 52 years",
    "entities": [
      {
        "text": "36 years",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "52 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "[IQR 34-65] years; P < .001). PLWH were more commonly female (P = .053), while",
    "entities": [
      {
        "text": "P < .001",
        "label": "ORG"
      },
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": ".053",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "more of the HIV-negative patients were male. The median CD4 count of the PLWH",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was 42 [IQR 14-108] cells/mm3 and only 15.5% were on anti-retroviral therapy",
    "entities": [
      {
        "text": "42",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "only 15.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(ART) prior to hospitalisation. Differences were noted in clinical, laboratory",
    "entities": []
  },
  {
    "text": "and radiological features between the groups. Overall, Mycobacterium",
    "entities": []
  },
  {
    "text": "tuberculosis was the most common microbial aetiology in both groups, followed by",
    "entities": []
  },
  {
    "text": "Streptococcus pneumoniae, which was associated with a significantly lower",
    "entities": []
  },
  {
    "text": "mortality, whereas mortality with Pneumocystis jirovecii infection, which",
    "entities": [
      {
        "text": "Pneumocystis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "occurred only in PLWH, was high. Overall ICU mortality was high (48.9%), and",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "48.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "while HIV was an independent risk factor for mortality (OR 0.58, 95% CI",
    "entities": [
      {
        "text": "0.58",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.37-0.92; p = .02) on univariate analysis, this finding was not true when HIV",
    "entities": [
      {
        "text": "0.37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "considered within the multivariable analysis. This study describes one of the",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "largest cohorts of PLWH with SCAP and compares their findings with HIV-negative",
    "entities": [
      {
        "text": "PLWH",
        "label": "ORG"
      },
      {
        "text": "SCAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cases. HIV was not a significant predictor of mortality when considered in the",
    "entities": []
  },
  {
    "text": "context of other covariables on multivariable analysis.",
    "entities": []
  },
  {
    "text": "T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2",
    "entities": []
  },
  {
    "text": "Vaccine Using Multiparametric Flow Cytometry.",
    "entities": []
  },
  {
    "text": "(1)Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias",
    "entities": [
      {
        "text": "Institute on Immunology",
        "label": "ORG"
      },
      {
        "text": "Facultad de Ciencias",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Millennium Institute on Immunology and Immunotherapy, Programa de",
    "entities": [
      {
        "text": "Institute on Immunology",
        "label": "ORG"
      },
      {
        "text": "Programa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The T cell response induced by SARS-CoV-2 vaccines is an essential component of",
    "entities": []
  },
  {
    "text": "immune protection against COVID-19. Multiparametric flow cytometry analysis",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "emerges as a valuable tool for in-depth assessment of T cell phenotype nuances",
    "entities": []
  },
  {
    "text": "that occur after booster vaccination, such as a fifth dose of an inactivated",
    "entities": [
      {
        "text": "fifth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 vaccine. Figure created with BioRender.com.",
    "entities": [
      {
        "text": "BioRender.com",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 Wiley\u2010VCH GmbH.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PMID: 40665756 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665756",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "20. Tuberc Respir Dis (Seoul). 2025 Jul 16. doi: 10.4046/trd.2024.0185. Online",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "Tuberc",
        "label": "GPE"
      },
      {
        "text": "Respir Dis",
        "label": "PERSON"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.4046",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ahead of print.",
    "entities": []
  },
  {
    "text": "Clinical characteristics and impact of Clostridium difficile infection during",
    "entities": [
      {
        "text": "Clostridium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment of rifampicin-susceptible pulmonary tuberculosis.",
    "entities": []
  },
  {
    "text": "(1)Department of Thoracic Surgery, Masan National Tuberculosis Hospital,",
    "entities": [
      {
        "text": "Thoracic",
        "label": "ORG"
      },
      {
        "text": "Masan National Tuberculosis Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Changwon, Republic of Korea.",
    "entities": [
      {
        "text": "Changwon",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Anti-tuberculosis (TB) treatment, although infrequently associated",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with Clostridium difficile infection (CDI), necessitates updated research on the",
    "entities": [
      {
        "text": "Clostridium",
        "label": "ORG"
      },
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incidence and clinical features of CDI among TB patients, especially as the",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "demographic of older TB patients in South Korea is growing.",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: A total of 168 patients with rifampin-susceptible",
    "entities": [
      {
        "text": "168",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pulmonary TB were enrolled in this study. Initial clinical features of the",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CDI-suspected group, risk factors for CDI, the primary outcome of all-cause",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      },
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mortality, and secondary outcomes, including delayed conversion of AFB smear and",
    "entities": [
      {
        "text": "AFB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "culture, were analyzed.",
    "entities": []
  },
  {
    "text": "RESULTS: The incidence rate of CDI among TB patients was 15.0 cases per 10,000",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      },
      {
        "text": "TB",
        "label": "ORG"
      },
      {
        "text": "15.0",
        "label": "CARDINAL"
      },
      {
        "text": "10,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patient-days. Among initial features associated with TB-related CDI, patients",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exhibiting diarrhea of Bristol Stool Scale type 7 for more than two days were",
    "entities": [
      {
        "text": "Bristol Stool Scale",
        "label": "ORG"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "more than two days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "more likely to receive a CDI diagnosis. Old age and hypoalbuminemia were",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant risk factors for CDI occurrence. In the primary outcome analysis,",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CDI was associated with a 4.63-fold increase in all-cause mortality according to",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      },
      {
        "text": "4.63-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the unadjusted analysis. However, this association dissipated in the adjusted",
    "entities": []
  },
  {
    "text": "analysis. Older age, underlying respiratory disease, and pneumonia at baseline",
    "entities": []
  },
  {
    "text": "were strong predictors of all-cause mortality. No significant factors were",
    "entities": []
  },
  {
    "text": "detected in the analysis of delayed AFB smear and culture conversion.",
    "entities": [
      {
        "text": "AFB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Despite the lack of an independent association between CDI and",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "all-cause mortality among TB patients, monitoring older adults with",
    "entities": [
      {
        "text": "TB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "undernutrition and persistent diarrhea for CDI is crucial.",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "21. Hum Vaccin Immunother. 2025 Dec;21(1):2528409. doi:",
    "entities": [
      {
        "text": "21",
        "label": "CARDINAL"
      },
      {
        "text": "Hum Vaccin Immunother",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Economic evaluations of vaccines against respiratory infections in adults in",
    "entities": []
  },
  {
    "text": "Southeast Asia: A systematic review.",
    "entities": [
      {
        "text": "Southeast Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)Department of Health Sciences, University of Groningen, University Medical",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Groningen, University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Faculty of Public Health, Thai Nguyen University of Medicine and Pharmacy,",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Thai Nguyen University of Medicine and Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Center of Excellence in Higher Education for Pharmaceutical Care Innovation,",
    "entities": [
      {
        "text": "Excellence in Higher Education for Pharmaceutical Care Innovation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Economics, Econometrics, and Finance, University of Groningen,",
    "entities": [
      {
        "text": "Economics, Econometrics",
        "label": "ORG"
      },
      {
        "text": "Finance",
        "label": "ORG"
      },
      {
        "text": "University of Groningen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Division of Pharmacology & Therapy, Faculty of Medicine, Universitas",
    "entities": [
      {
        "text": "Pharmacology & Therapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Economics, Econometrics and Finance, Faculty of Economics and",
    "entities": [
      {
        "text": "Economics",
        "label": "ORG"
      },
      {
        "text": "Econometrics",
        "label": "ORG"
      },
      {
        "text": "Faculty of Economics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Business, University of Groningen, Groningen, Netherlands.",
    "entities": [
      {
        "text": "Business, University of Groningen",
        "label": "ORG"
      },
      {
        "text": "Groningen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Faculty of Management Sciences, Open University, Heerlen, Netherlands.",
    "entities": [
      {
        "text": "Management Sciences",
        "label": "ORG"
      },
      {
        "text": "Open University",
        "label": "ORG"
      },
      {
        "text": "Heerlen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Respiratory infections significantly impact adult health in Southeast Asia, yet",
    "entities": [
      {
        "text": "Southeast Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "vaccine coverage remains low. This systematic review evaluated the economic",
    "entities": []
  },
  {
    "text": "evaluations of vaccines targeting respiratory infections in the region. A",
    "entities": []
  },
  {
    "text": "comprehensive search was conducted across several databases, including",
    "entities": []
  },
  {
    "text": "MEDLINE/PubMed, EMBASE, NHSEED, CINAHL, EconLit, Web of Science, Scopus, and",
    "entities": [
      {
        "text": "MEDLINE/PubMed",
        "label": "ORG"
      },
      {
        "text": "EMBASE",
        "label": "ORG"
      },
      {
        "text": "NHSEED",
        "label": "ORG"
      },
      {
        "text": "EconLit",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cochrane Library, up to April 24, 2024. Nineteen eligible studies were",
    "entities": [
      {
        "text": "Cochrane Library",
        "label": "PERSON"
      },
      {
        "text": "April 24, 2024",
        "label": "DATE"
      },
      {
        "text": "Nineteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "identified, focusing primarily on influenza (8 studies) and COVID-19 vaccines (7",
    "entities": [
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "studies), with fewer studies on pneumococcal (2 studies), varicella (1 study),",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and pertussis (1 study) vaccines. Overall, influenza, COVID-19 (boosters), and",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pneumococcal vaccines were found to be cost-effective or highly cost-effective",
    "entities": []
  },
  {
    "text": "compared to no-vaccine or no-booster scenarios. The only study on maternal",
    "entities": []
  },
  {
    "text": "pertussis vaccination found it not to be cost-effective. The most common",
    "entities": []
  },
  {
    "text": "parameters considered in sensitivity analyses were vaccine efficacy and discount",
    "entities": []
  },
  {
    "text": "rates. This review highlights the economic evaluations of influenza, COVID-19,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and pneumococcal vaccines in Southeast Asia, providing essential evidence to",
    "entities": [
      {
        "text": "Southeast Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "guide vaccine policy. Future studies should address limitations in model",
    "entities": []
  },
  {
    "text": "selection, incorporate herd immunity, ensure the model validation (i.e. validity",
    "entities": []
  },
  {
    "text": "of cost and benefit measurements), and explore the cost-effectiveness of other",
    "entities": []
  },
  {
    "text": "vaccines across the region.",
    "entities": []
  },
  {
    "text": "PMID: 40665593 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665593",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "22. J Rural Health. 2025 Jun;41(3):e70049. doi: 10.1111/jrh.70049.",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "J Rural Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1111/jrh.70049",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Enduring lessons from the COVID-19 pandemic: Advancing virtual care for",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "substance use disorders in rural America.",
    "entities": [
      {
        "text": "America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "LaPorte TM(1), McGinnis S(1), Lacy G(1).",
    "entities": [
      {
        "text": "LaPorte TM(1",
        "label": "PERSON"
      },
      {
        "text": "McGinnis S(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Center for Human Services Research, University at Albany, Albany, New York,",
    "entities": [
      {
        "text": "Human Services Research, University at Albany",
        "label": "ORG"
      },
      {
        "text": "Albany",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: This study explores how rural substance use disorder (SUD) treatment",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "providers in New York State adapted to pandemic-era policy changes by rapidly",
    "entities": [
      {
        "text": "New York State",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "adopting virtual care, identifying both challenges and opportunities to inform",
    "entities": []
  },
  {
    "text": "METHODS: Thematic analysis of qualitative data from individual interviews with",
    "entities": []
  },
  {
    "text": "12 SUD treatment providers and a focus group with an additional 6 providers in",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "an additional 6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rural New York State was conducted between February and May 2021, capturing",
    "entities": [
      {
        "text": "New York State",
        "label": "GPE"
      },
      {
        "text": "between February and May 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "experiences with virtual care during the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "FINDINGS: The pandemic drove swift virtual care adoption, overcoming some rural",
    "entities": []
  },
  {
    "text": "barriers to SUD treatment access, like limited transportation and provider",
    "entities": []
  },
  {
    "text": "shortages. Providers noted enhanced flexibility, allowing more person-centered",
    "entities": []
  },
  {
    "text": "care adapting to clients' logistical challenges. However, limitations emerged,",
    "entities": []
  },
  {
    "text": "including digital access disparities, reduced client accountability, and",
    "entities": []
  },
  {
    "text": "challenges establishing therapeutic relationships-especially for new clients or",
    "entities": []
  },
  {
    "text": "group sessions. Virtual care effectiveness varied by treatment stage, client",
    "entities": []
  },
  {
    "text": "demographics, and access to reliable technology.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Although virtual care presents opportunities to expand rural SUD",
    "entities": []
  },
  {
    "text": "treatment access, a hybrid model combining in-person and virtual care may better",
    "entities": []
  },
  {
    "text": "meet diverse client needs. Addressing technological inequities and tailoring",
    "entities": []
  },
  {
    "text": "approaches to individual circumstances are essential for future interventions.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 National Rural Health Association.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "National Rural Health Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665549 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665549",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Association of COPD With Clinical Outcomes After Hospital Admission in",
    "entities": [
      {
        "text": "Association of COPD With Clinical Outcomes After Hospital Admission",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 Patients During the Omicron Variant Period: A Retrospective Cohort",
    "entities": []
  },
  {
    "text": "(1)Department of Pulmonary and Critical Care Medicine, Hebei Medical University,",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Hebei Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pulmonary and Critical Care Medicine, China-Japan Friendship",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital, National Clinical Research Center of Respiratory Diseases, Beijing,",
    "entities": [
      {
        "text": "National Clinical Research Center of Respiratory Diseases",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pulmonary and Critical Care Medicine, Tangshan Gongren",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Tangshan Gongren",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Pulmonary and Critical Care Medicine, The Second Hospital of",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "The Second Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hebei Medical University, Shijiazhuang, China.",
    "entities": [
      {
        "text": "Hebei Medical University",
        "label": "ORG"
      },
      {
        "text": "Shijiazhuang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Pre-Omicron studies identified chronic obstructive pulmonary disease",
    "entities": [
      {
        "text": "Pre-Omicron",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(COPD) as a significant risk factor for adverse COVID-19 outcomes. Given",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Omicron's altered pathogenicity and widespread population-level immunity, the",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "association between COPD and COVID-19 outcomes warrants reassessment in light of",
    "entities": [
      {
        "text": "COPD",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the variant's distinct clinical profile. We evaluated whether COPD remained a",
    "entities": [
      {
        "text": "COPD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk factor for poor clinical outcomes among hospitalized patients with",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 infection during Omicron predominance.",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We conducted a two-center retrospective cohort study of 1176 adults",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "1176",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hospitalized with confirmed Omicron infection between January 2022 and December",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      },
      {
        "text": "January 2022",
        "label": "DATE"
      },
      {
        "text": "December",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2023 in Northern China. Patients were stratified by pre-existing COPD status. To",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      },
      {
        "text": "Northern China",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "address confounding by treatment selection, inverse probability weighting (IPW)",
    "entities": []
  },
  {
    "text": "was applied based on the likelihood of receiving inhaled corticosteroids.",
    "entities": []
  },
  {
    "text": "Multivariable logistic regression models, adjusted for comorbidities, disease",
    "entities": []
  },
  {
    "text": "severity (as measured by the PSI), inflammatory markers (CRP, D-dimer, NLR,",
    "entities": [
      {
        "text": "PSI",
        "label": "ORG"
      },
      {
        "text": "CRP",
        "label": "ORG"
      },
      {
        "text": "NLR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "LDH), and treatment regimens, were used to evaluate the associations between",
    "entities": []
  },
  {
    "text": "COPD and in-hospital outcomes.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 1176 patients (337 COPD; 839 non-COPD), COPD patients had",
    "entities": [
      {
        "text": "1176",
        "label": "DATE"
      },
      {
        "text": "337",
        "label": "CARDINAL"
      },
      {
        "text": "839",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly lower PSI scores and lower levels of systemic inflammation despite",
    "entities": [
      {
        "text": "PSI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a higher prevalence of respiratory comorbidities. In unadjusted models, COPD was",
    "entities": []
  },
  {
    "text": "associated with reduced odds of mortality (OR 0.52), respiratory failure (OR",
    "entities": [
      {
        "text": "0.52",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.24), and ventilatory support. However, after IPW adjustment, these",
    "entities": [
      {
        "text": "0.24",
        "label": "CARDINAL"
      },
      {
        "text": "IPW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associations were no longer statistically significant (mortality: adjusted OR",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: COPD was not independently associated with increased risk of",
    "entities": []
  },
  {
    "text": "mortality, respiratory failure, or ventilatory support in hospitalized",
    "entities": []
  },
  {
    "text": "Omicron-infected patients after rigorous adjustment for confounding. These",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "findings suggest a shifting risk profile for COPD during Omicron predominance,",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "likely influenced by variant tropism, treatment effects, and altered",
    "entities": []
  },
  {
    "text": "inflammatory responses. Future prospective studies are warranted to validate",
    "entities": []
  },
  {
    "text": "these findings and explore the mechanisms underlying this observed shift.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). The Clinical Respiratory Journal published by John Wiley &",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Clinical Respiratory Journal",
        "label": "ORG"
      },
      {
        "text": "John Wiley &\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "PMID: 40665508 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665508",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "24. Disaster Med Public Health Prep. 2025 Jul 16;19:e185. doi:",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "Disaster Med Public Health Prep",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Journaling During a Disaster: Challenges and Opportunities for Data Collection.",
    "entities": []
  },
  {
    "text": "(1)https://ror.org/00b30xv10University of Pennsylvania, Department of Sociology,",
    "entities": [
      {
        "text": "1)https://ror.org/00b30xv10University",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Sociology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)https://ror.org/052w4zt36American University, Department of Sociology,",
    "entities": [
      {
        "text": "2)https://ror.org/052w4zt36American University, Department of Sociology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Washington DC, USA.",
    "entities": [
      {
        "text": "Washington DC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)https://ror.org/047s2c258University of Maryland, Department of African",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "Department of African\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "American and Africana Studies, Department of Sociology, College Park, MD, USA.",
    "entities": [
      {
        "text": "American",
        "label": "NORP"
      },
      {
        "text": "Africana Studies",
        "label": "ORG"
      },
      {
        "text": "Department of Sociology, College Park",
        "label": "ORG"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)https://ror.org/047s2c258University of Maryland, Department of Education,",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "Department of Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)https://ror.org/00y4zzh67George Washington University Miliken School of",
    "entities": [
      {
        "text": "5)https://ror.org/00y4zzh67George",
        "label": "CARDINAL"
      },
      {
        "text": "Washington University Miliken School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health, Department of Epidemiology, Washington DC, USA.",
    "entities": [
      {
        "text": "Public Health, Department of Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Washington DC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: This paper describes challenges and opportunities for data",
    "entities": []
  },
  {
    "text": "collection during a disaster, focusing on how young adults in the United States",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "navigated the initial period of the COVID-19 pandemic--a disaster which",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "introduced significant uncertainty and precarity both for individuals and the",
    "entities": []
  },
  {
    "text": "research process.",
    "entities": []
  },
  {
    "text": "METHODS: This paper draws on lessons from a small exploratory study which used",
    "entities": []
  },
  {
    "text": "RESULTS: Journaling addressed 3 key challenges to collecting data during a",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "public health crisis: 1) accessing respondents when preparation time and",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resources are limited; 2) ensuring protection for both participants and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "researchers in a context when human interaction is severely constrained; and 3)",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "needing both rapid response and flexibility in research design and data",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Journaling techniques are a feasible, efficient and effective tool",
    "entities": []
  },
  {
    "text": "that can be adapted and utilized in various disaster contexts, including other",
    "entities": []
  },
  {
    "text": "pandemics and extreme climate events.",
    "entities": []
  },
  {
    "text": "PMID: 40665496 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665496",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "25. Hum Vaccin Immunother. 2025 Dec;21(1):2533639. doi:",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "Hum Vaccin Immunother",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "From institutional trust to digital literacy: Socioeconomic and political",
    "entities": []
  },
  {
    "text": "determinants of COVID-19 vaccine hesitancy among Czech adults based on a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Czech",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of Public Health, Faculty of Medicine, Masaryk University, Brno,",
    "entities": [
      {
        "text": "Public Health, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Masaryk University",
        "label": "ORG"
      },
      {
        "text": "Brno",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Masaryk Centre for Global Health (MCGH), Department of Public Health, Faculty",
    "entities": [
      {
        "text": "Centre for Global Health",
        "label": "ORG"
      },
      {
        "text": "Department of Public Health, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Masaryk University, Brno, Czech Republic.",
    "entities": [
      {
        "text": "Medicine, Masaryk University",
        "label": "ORG"
      },
      {
        "text": "Brno",
        "label": "GPE"
      },
      {
        "text": "Czech Republic",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Vaccine hesitancy remains a significant public health challenge, particularly",
    "entities": [
      {
        "text": "Vaccine",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "during pandemics when high immunization rates are crucial. While individual",
    "entities": []
  },
  {
    "text": "psychological antecedents of vaccine hesitancy have been extensively studied,",
    "entities": []
  },
  {
    "text": "limited empirical evidence exists on how contextual determinants, such as",
    "entities": []
  },
  {
    "text": "socioeconomic status, political trust, and digital literacy, collectively shape",
    "entities": []
  },
  {
    "text": "vaccine-related behaviors, particularly in Central European populations. This",
    "entities": [
      {
        "text": "Central European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "study explores the key determinants of COVID-19 vaccine hesitancy among Czech",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Czech",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "adults. A cross-sectional study was conducted using data from the 48th wave of",
    "entities": [
      {
        "text": "the 48th",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the Czech national panel survey \u017divot b\u011bhem pandemie [Life During Pandemic],",
    "entities": [
      {
        "text": "Czech",
        "label": "NORP"
      },
      {
        "text": "\u017divot",
        "label": "CARDINAL"
      },
      {
        "text": "Life During Pandemic]",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "carried out in March 2023. The data were obtained via an online questionnaire",
    "entities": [
      {
        "text": "March 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "administered to a nationally representative sample of Czech adults (n = 1,708).",
    "entities": [
      {
        "text": "Czech",
        "label": "NORP"
      },
      {
        "text": "1,708",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Sociodemographic, socioeconomic, and anamnestic variables were examined",
    "entities": []
  },
  {
    "text": "alongside political attitudes. Psychological antecedents of vaccination were",
    "entities": []
  },
  {
    "text": "assessed using the 5C model (confidence, complacency, constraints, risk",
    "entities": []
  },
  {
    "text": "calculation, and collective responsibility), and digital vaccine literacy was",
    "entities": []
  },
  {
    "text": "measured using seven items covering trust in official sources, trust in social",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "media, and the ability to evaluate and apply vaccine information. Statistical",
    "entities": []
  },
  {
    "text": "analyses included bivariate tests and multivariable regression models to",
    "entities": []
  },
  {
    "text": "identify vaccine uptake and intent determinants. Higher trust in constitutional",
    "entities": []
  },
  {
    "text": "institutions, including the president (OR = 1.55; 95/ CI: 1.38-1.74), government",
    "entities": [
      {
        "text": "1.55",
        "label": "CARDINAL"
      },
      {
        "text": "95/ CI",
        "label": "PERSON"
      },
      {
        "text": "1.38-1.74",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(1.60; 1.38-1.85), Chamber of Deputies (1.73; 1.48-2.02), and Senate (1.47;",
    "entities": [
      {
        "text": "1.60",
        "label": "CARDINAL"
      },
      {
        "text": "1.38-1.85",
        "label": "CARDINAL"
      },
      {
        "text": "Chamber of Deputies",
        "label": "ORG"
      },
      {
        "text": "1.73",
        "label": "CARDINAL"
      },
      {
        "text": "1.48",
        "label": "CARDINAL"
      },
      {
        "text": "Senate",
        "label": "ORG"
      },
      {
        "text": "1.47",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.29-1.69), was significantly associated with higher vaccine uptake. Similarly,",
    "entities": [
      {
        "text": "1.29-1.69",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "positive attitudes toward the integration of Ukrainian refugees into Czech",
    "entities": [
      {
        "text": "Ukrainian",
        "label": "NORP"
      },
      {
        "text": "Czech",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "society - across domains such as work (1.63; 1.39-1.90), housing (1.59;",
    "entities": [
      {
        "text": "1.63",
        "label": "CARDINAL"
      },
      {
        "text": "1.39-1.90",
        "label": "CARDINAL"
      },
      {
        "text": "1.59",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.36-1.86), school (1.64; 1.41-1.92), language (1.57; 1.34-1.84), and culture",
    "entities": [
      {
        "text": "1.36",
        "label": "CARDINAL"
      },
      {
        "text": "1.64",
        "label": "CARDINAL"
      },
      {
        "text": "1.41",
        "label": "CARDINAL"
      },
      {
        "text": "1.57",
        "label": "CARDINAL"
      },
      {
        "text": "1.34",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1.74; 1.50-2.03) - were positively associated with uptake. Greater confidence",
    "entities": [
      {
        "text": "1.74",
        "label": "CARDINAL"
      },
      {
        "text": "1.50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in vaccine safety and effectiveness was also a significant predictor (1.51;",
    "entities": [
      {
        "text": "1.51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.44-1.58). In contrast, lower education (0.64; 0.56-0.73), lower income (0.91;",
    "entities": [
      {
        "text": "1.44-1.58",
        "label": "CARDINAL"
      },
      {
        "text": "0.64",
        "label": "CARDINAL"
      },
      {
        "text": "0.56-0.73",
        "label": "CARDINAL"
      },
      {
        "text": "0.91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.86-0.95), female sex (0.60; 0.47-0.76), and higher complacency (0.76;",
    "entities": [
      {
        "text": "0.86",
        "label": "CARDINAL"
      },
      {
        "text": "0.60",
        "label": "CARDINAL"
      },
      {
        "text": "0.47-0.76",
        "label": "CARDINAL"
      },
      {
        "text": "0.76",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.73-0.80) were associated with reduced uptake. Respondents with better digital",
    "entities": [
      {
        "text": "0.73",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccine literacy, particularly those more adept at identifying misinformation,",
    "entities": []
  },
  {
    "text": "showed significantly greater vaccine confidence (mean score: 3.62 vs. 3.30,",
    "entities": [
      {
        "text": "3.62",
        "label": "CARDINAL"
      },
      {
        "text": "3.30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p < .001). Beyond psychological antecedents, institutional trust, political",
    "entities": []
  },
  {
    "text": "orientation, and digital vaccine literacy significantly shape COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "vaccination behaviors. These findings underscore the importance of targeted",
    "entities": []
  },
  {
    "text": "interventions that address political and digital influences on vaccine",
    "entities": []
  },
  {
    "text": "hesitancy, and they highlight the need for future research to examine the causal",
    "entities": []
  },
  {
    "text": "pathways and longitudinal dynamics underlying these associations, particularly",
    "entities": []
  },
  {
    "text": "within Central and Eastern European contexts.",
    "entities": [
      {
        "text": "Central",
        "label": "ORG"
      },
      {
        "text": "Eastern European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "PMID: 40665470 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665470",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Mortality of severe pneumonia treated with methylprednisolone versus",
    "entities": []
  },
  {
    "text": "hydrocortisone: a propensity-matched analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency and Critical Care Medicine, The University of Tokyo",
    "entities": [
      {
        "text": "Emergency and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "The University of Tokyo",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Clinical Epidemiology and Health Economics, School of Public",
    "entities": [
      {
        "text": "Clinical Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Health Economics, School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 1138655, Japan.",
    "entities": [
      {
        "text": "The University of Tokyo",
        "label": "ORG"
      },
      {
        "text": "7-3-1",
        "label": "CARDINAL"
      },
      {
        "text": "Hongo",
        "label": "GPE"
      },
      {
        "text": "Bunkyo-Ku",
        "label": "GPE"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "1138655",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Emergency and Critical Care Medicine, The University of Tokyo",
    "entities": [
      {
        "text": "Emergency and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "The University of Tokyo",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Corticosteroids improve the outcomes of severe pneumonia; however,",
    "entities": []
  },
  {
    "text": "the most effective type remains unknown. In this study, we compared the",
    "entities": []
  },
  {
    "text": "mortality rates of patients with severe pneumonia who were treated with",
    "entities": []
  },
  {
    "text": "methylprednisolone versus those treated with hydrocortisone.",
    "entities": []
  },
  {
    "text": "METHODS: In this retrospective observational study, we utilized a nationwide",
    "entities": []
  },
  {
    "text": "Japanese Diagnosis Procedure Combination inpatient database to include adult",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "patients with severe pneumonia who were admitted to hospitals between April 2017",
    "entities": [
      {
        "text": "April 2017",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and March 2022 and received either methylprednisolone or hydrocortisone.",
    "entities": [
      {
        "text": "March 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Propensity score matching was used to adjust for measured confounders, with",
    "entities": []
  },
  {
    "text": "in-hospital mortality as the primary outcome.",
    "entities": []
  },
  {
    "text": "RESULTS: Among the 5,084 eligible patients, 623 matched pairs were analyzed.",
    "entities": [
      {
        "text": "5,084",
        "label": "CARDINAL"
      },
      {
        "text": "623",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "In-hospital mortality rates were 23.9% in the hydrocortisone group and 19.4% in",
    "entities": [
      {
        "text": "23.9%",
        "label": "PERCENT"
      },
      {
        "text": "19.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the methylprednisolone group (risk difference [RD], 4.5%; 95% confidence",
    "entities": [
      {
        "text": "the methylprednisolone group",
        "label": "ORG"
      },
      {
        "text": "RD",
        "label": "ORG"
      },
      {
        "text": "4.5%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "interval [CI] -0.082 to 9.1; p = 0.054). Subgroup analysis of patients with",
    "entities": [
      {
        "text": "CI] -0.082",
        "label": "PERSON"
      },
      {
        "text": "9.1",
        "label": "CARDINAL"
      },
      {
        "text": "0.054",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "shock demonstrated significantly higher mortality in the hydrocortisone group",
    "entities": []
  },
  {
    "text": "than in the methylprednisolone group (44.7% versus 30.1%; RD, 14.6%; 95% CI",
    "entities": [
      {
        "text": "44.7%",
        "label": "PERCENT"
      },
      {
        "text": "30.1%",
        "label": "PERCENT"
      },
      {
        "text": "RD",
        "label": "ORG"
      },
      {
        "text": "14.6%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: No significant difference in in-hospital mortality was observed",
    "entities": []
  },
  {
    "text": "between patients with severe pneumonia treated with methylprednisolone and those",
    "entities": []
  },
  {
    "text": "treated with hydrocortisone. Nevertheless, patients experiencing severe",
    "entities": []
  },
  {
    "text": "pneumonia-induced septic shock may derive benefits from methylprednisolone",
    "entities": [
      {
        "text": "methylprednisolone\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s40560-025-00810-1",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate: This study was approved by the Institutional Review Board of the",
    "entities": [
      {
        "text": "the Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Tokyo (approval number: 3501-5; May 19, 2021) for clinical",
    "entities": [
      {
        "text": "University of Tokyo",
        "label": "ORG"
      },
      {
        "text": "3501",
        "label": "CARDINAL"
      },
      {
        "text": "May 19, 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "epidemiological studies using DPC data. Given the unidentified nature of the",
    "entities": [
      {
        "text": "DPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "data, the requirement for informed consent was waived. Consent for publication:",
    "entities": []
  },
  {
    "text": "Given the unidentified nature of the data, the requirement for informed consent",
    "entities": []
  },
  {
    "text": "was waived. Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Preventive behaviors related to COVID-19 based on social cognitive integrative",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "model constructs among medical students: A cross-sectional study.",
    "entities": []
  },
  {
    "text": "(1)Student Research Committee, Babol University of Medical Sciences, Babol,",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Social Determinants of Health Research Center, Health Research Institute,",
    "entities": [
      {
        "text": "Determinants of Health Research Center",
        "label": "ORG"
      },
      {
        "text": "Health Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Babol University of Medical Sciences, Babol, Iran. Z.gholamnia@yahoo.com.",
    "entities": [
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Social Determinants of Health Research Center, Health Research Institute,",
    "entities": [
      {
        "text": "Determinants of Health Research Center",
        "label": "ORG"
      },
      {
        "text": "Health Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Babol University of Medical Sciences, Babol, Iran.",
    "entities": [
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Social Determinants of Health Research Center, Research Institute for",
    "entities": [
      {
        "text": "Determinants of Health Research Center",
        "label": "ORG"
      },
      {
        "text": "Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention Non-communicable Diseases, Qazvin University of Medical Sciences,",
    "entities": [
      {
        "text": "Diseases",
        "label": "ORG"
      },
      {
        "text": "Qazvin University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The COVID-19 outbreak in Iran has prompted the investigation of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "preventive behaviors in vulnerable and key groups. This descriptive and",
    "entities": []
  },
  {
    "text": "analytical cross-sectional study determined preventive behaviors for COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "among medical students using an integrated social cognition model and identified",
    "entities": []
  },
  {
    "text": "influencing factors.",
    "entities": []
  },
  {
    "text": "RESULTS: The study of 650 medical students with a mean age of 24.37 \u00b1 3.78 years",
    "entities": [
      {
        "text": "650",
        "label": "CARDINAL"
      },
      {
        "text": "24.37",
        "label": "CARDINAL"
      },
      {
        "text": "3.78 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "showed that the total scores of the integrated social cognition model and",
    "entities": []
  },
  {
    "text": "COVID-19 prevention behaviors were at the medium level, 85.44 \u00b1 8.70 out of 155",
    "entities": [
      {
        "text": "85.44",
        "label": "CARDINAL"
      },
      {
        "text": "8.70",
        "label": "CARDINAL"
      },
      {
        "text": "155",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 10.78 \u00b1 1.99 out of 20 scores, respectively. Univariate and multivariate",
    "entities": [
      {
        "text": "10.78",
        "label": "CARDINAL"
      },
      {
        "text": "1.99",
        "label": "CARDINAL"
      },
      {
        "text": "20 scores",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "regression analysis showed that the variables of marital status (\u03b2=-1.95",
    "entities": []
  },
  {
    "text": "[CI95%=-3.36 to -0.53], P = 0.007), maternal literacy (\u03b2 = 2.59 [CI95%=0.96 to",
    "entities": [
      {
        "text": "0.007",
        "label": "CARDINAL"
      },
      {
        "text": "2.59",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "4.21], P = 0.002), paternal literacy (\u03b2 = 2.47 [CI95%=0.89 to 4.04], P = 0.002),",
    "entities": [
      {
        "text": "4.21",
        "label": "CARDINAL"
      },
      {
        "text": "0.002",
        "label": "CARDINAL"
      },
      {
        "text": "2.47",
        "label": "CARDINAL"
      },
      {
        "text": "4.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "place of residence (\u03b2 = 3.46 [CI95%=2.14 to 4.79], P = < 0.001), being a native",
    "entities": [
      {
        "text": "3.46",
        "label": "CARDINAL"
      },
      {
        "text": "4.79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(\u03b2 = 1.70 [CI95%=0.21 to 3.19], P = 0.025), and educational level (\u03b2=-3.16",
    "entities": [
      {
        "text": "1.70",
        "label": "CARDINAL"
      },
      {
        "text": "3.19",
        "label": "CARDINAL"
      },
      {
        "text": "0.025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[CI95%=-1.64 to -4.68], P = < 0.001) are strong independent predictors of",
    "entities": []
  },
  {
    "text": "COVID-19 preventive behaviors. Single students, parents with university",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "education, were nondormitory and native, and at the basic science level earned",
    "entities": []
  },
  {
    "text": "higher scores for the model constructs (p < 0.05). These results can be used to",
    "entities": []
  },
  {
    "text": "design an educational intervention for COVID-19 preventive behaviors in medical",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665427 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665427",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: The code of ethics (IR.MUBABOL.HRI.REC.1400.144) was got from the",
    "entities": []
  },
  {
    "text": "Ethics Committee of Babol University of Medical Sciences, and informed consent",
    "entities": [
      {
        "text": "Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was got from the participants. Consent for publication: Not applicable.",
    "entities": []
  },
  {
    "text": "Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "28. BMC Med Educ. 2025 Jul 15;25(1):1061. doi: 10.1186/s12909-025-07386-2.",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Med Educ",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Remote online teaching beyond COVID-19 pandemic: a qualitative study across",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Physiotherapy programs in Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Experimental and Clinical Medicine, University of Florence,",
    "entities": [
      {
        "text": "Experimental",
        "label": "ORG"
      },
      {
        "text": "Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Florence",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Largo Brambilla, 3, Florence, 50134, Italy. mauro.dibari@unifi.it.",
    "entities": [
      {
        "text": "Largo Brambilla",
        "label": "PERSON"
      },
      {
        "text": "3",
        "label": "DATE"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "50134",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Unit of Geriatrics, Department of Medicine and Geriatrics, Azienda",
    "entities": [
      {
        "text": "Geriatrics, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Geriatrics",
        "label": "GPE"
      },
      {
        "text": "Azienda",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Medical, Surgical and Health Sciences, University of Trieste,",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Trieste",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Trieste, Italy.",
    "entities": [
      {
        "text": "Trieste",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Experimental and Clinical Medicine, University of Florence,",
    "entities": [
      {
        "text": "Experimental",
        "label": "ORG"
      },
      {
        "text": "Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Florence",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Largo Brambilla, 3, Florence, 50134, Italy.",
    "entities": [
      {
        "text": "Largo Brambilla",
        "label": "PERSON"
      },
      {
        "text": "3",
        "label": "DATE"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "50134",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Allied Health Professions, Azienda USL Toscana Centro,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Allied Health Professions",
        "label": "ORG"
      },
      {
        "text": "Azienda USL",
        "label": "PERSON"
      },
      {
        "text": "Toscana Centro",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Florence, Italy.",
    "entities": [
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Humanitas Clinical and Research Center - IRCCS, and Department of Biomedical",
    "entities": [
      {
        "text": "6)Humanitas",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical and Research Center - IRCCS",
        "label": "ORG"
      },
      {
        "text": "Department of Biomedical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Humanitas University, Milan, Italy.",
    "entities": [
      {
        "text": "Humanitas University",
        "label": "ORG"
      },
      {
        "text": "Milan",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: With the lockdown imposed by the Coronavirus Disease 2019 (COVID-19)",
    "entities": [
      {
        "text": "the Coronavirus Disease 2019",
        "label": "LOC"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic, remote online teaching (ROT) became pivotal in the rapid",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reorganization imposed on the healthcare professions' educational programs.",
    "entities": []
  },
  {
    "text": "Physiotherapy programs were particularly affected, as they are characterized by",
    "entities": []
  },
  {
    "text": "hard and soft skills that are hardly learned with ROT. The purpose of the",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "present study was to investigate the experiences and opinions on ROT by",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "faculties involved in the education and training of Physiotherapy students",
    "entities": []
  },
  {
    "text": "during the pandemic, and on its possible application thereafter.",
    "entities": []
  },
  {
    "text": "METHODS: Following accreditated checklists for qualitative research,",
    "entities": []
  },
  {
    "text": "semi-structured interviews were conducted by members of the National Directorate",
    "entities": [
      {
        "text": "the National Directorate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of the Physiotherapy programs in Italy. Academic directors (AD) and clinical",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "training coordinators (CTC) of Italian Physiotherapy programs were randomly",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "selected and interviewed, to collect their experiences and opinions on the use",
    "entities": []
  },
  {
    "text": "of ROT before, during, and after the COVID-19 pandemic. Iterative rounds of",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "readings and discussions were conducted to analyze the interviews.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 22 participants were interviewed, reaching a satisfactory",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "level of saturation. Before the COVID-19 pandemic, ROT was used sporadically in",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "academic activities; during the pandemic, participants familiarized themselves",
    "entities": []
  },
  {
    "text": "rapidly with this new approach, which was generally abandoned thereafter. After",
    "entities": []
  },
  {
    "text": "initial difficulties, most participants recognized the importance of ROT in",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "preserving education during the lockdown. A negative impact on Physiotherapy",
    "entities": [
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "students was occasionally reported, especially during their final exam and",
    "entities": []
  },
  {
    "text": "thesis dissertation. Despite the limitations of ROT in Physiotherapy education,",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      },
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "participants recognized its advantages in supporting administrative tasks,",
    "entities": []
  },
  {
    "text": "sharing lectures, and creating international programs. Its potential for",
    "entities": []
  },
  {
    "text": "pedagogical innovation and the opportunity for investments in Internet-based",
    "entities": []
  },
  {
    "text": "didactic approaches were also underlined.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: ROT was perceived as an important tool to preserve Physiotherapy",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      },
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "programs during the COVID-19 pandemic. Although it was in general discontinued",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "after the pandemic, many participants believed that it might contribute to",
    "entities": []
  },
  {
    "text": "establishing a \"new normal\" didactic paradigm in Physiotherapy education.",
    "entities": [
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PMID: 40665301 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: The study adheres to the Declaration of Helsinki. The study did not",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "require Ethics Committee review, according to the \u201cEthics and data protection\u201d",
    "entities": [
      {
        "text": "Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "regulations of the European advisory body and European Commission [29, 30].",
    "entities": [
      {
        "text": "European",
        "label": "NORP"
      },
      {
        "text": "European Commission",
        "label": "ORG"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Informed consent for registration and its use was obtained from each participant",
    "entities": []
  },
  {
    "text": "at the start of registration. Consent for publication: N.A. Competing interests:",
    "entities": []
  },
  {
    "text": "The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "29. BMC Public Health. 2025 Jul 15;25(1):2459. doi: 10.1186/s12889-025-23648-6.",
    "entities": [
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The optimal strategy for seasonal influenza vaccination to prevent",
    "entities": []
  },
  {
    "text": "high-intensity level of influenza epidemics in Zhejiang, China: an integrated",
    "entities": [
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "transmission-dynamic and health-economic modeling analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency Medicine, Second Affiliated Hospital, Department of",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Epidemiology and Biostatistics, School of Public Health, The Key Laboratory of",
    "entities": [
      {
        "text": "School of Public Health",
        "label": "ORG"
      },
      {
        "text": "The Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Intelligent Preventive Medicine of Zhejiang Province, Zhejiang University School",
    "entities": [
      {
        "text": "Intelligent Preventive Medicine",
        "label": "ORG"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "Zhejiang University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Hangzhou, China.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Quzhou People's Hospital, No.100 of Minjiang Street, Quzhou, 32400, Zhejiang,",
    "entities": [
      {
        "text": "2)Quzhou People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Minjiang Street",
        "label": "FAC"
      },
      {
        "text": "Quzhou",
        "label": "GPE"
      },
      {
        "text": "32400",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Public Health, Ningbo No.2 Hospital, Ningbo, China.",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Ningbo No.2 Hospital",
        "label": "ORG"
      },
      {
        "text": "Ningbo",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Communicable Disease Control and Prevention, Zhejiang",
    "entities": [
      {
        "text": "Communicable Disease Control and Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Provincial Center for Disease Control and Prevention, Hangzhou, China.",
    "entities": [
      {
        "text": "Provincial Center for Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Emergency Medicine, Second Affiliated Hospital, Department of",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Hangzhou, China. yangshigui@zju.edu.cn.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Although Seasonal Influenza Vaccination (SIV) is a crucial",
    "entities": [
      {
        "text": "Seasonal Influenza Vaccination",
        "label": "ORG"
      },
      {
        "text": "SIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "preventive measure, achieving sufficient coverage to completely control",
    "entities": []
  },
  {
    "text": "influenza epidemics poses a significant challenge. This study aims to evaluate",
    "entities": [
      {
        "text": "influenza",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "optimal strategies for SIV to prevent high-intensity level of influenza",
    "entities": [
      {
        "text": "SIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "epidemics in Zhejiang Province, China. High-intensity outbreaks were defined as",
    "entities": [
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "weekly incidence rates above 72.2 per 100,000.",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      },
      {
        "text": "72.2",
        "label": "CARDINAL"
      },
      {
        "text": "100,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: This study estimated the incidence of influenza from 2018 to 2023 in",
    "entities": [
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Zhejiang Province, China, using influenza weekly surveillance data. We developed",
    "entities": [
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "weekly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "a Susceptible-Vaccinated-Infectious-Recovered-Susceptible (SVIRS) model to",
    "entities": [
      {
        "text": "SVIRS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "simulate influenza transmission and used a decision tree to assess seven",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccination strategies aimed at preventing high-intensity influenza outbreaks.",
    "entities": []
  },
  {
    "text": "These strategies differed in vaccine coverage across the three age groups: 0-14",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years, 15-59 years, and 60 + years, despite having the same overall vaccination",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "15-59 years",
        "label": "DATE"
      },
      {
        "text": "60 + years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "coverage.",
    "entities": []
  },
  {
    "text": "RESULTS: Between 2018 and 2020, influenza incidence in Zhejiang Province",
    "entities": [
      {
        "text": "Between 2018 and 2020",
        "label": "DATE"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "followed typical seasonal patterns. However, during the COVID-19 pandemic, these",
    "entities": [
      {
        "text": "seasonal",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patterns became irregular, culminating in a high-intensity influenza season in",
    "entities": []
  },
  {
    "text": "2022-2023. Model simulations indicated that increasing population-wide",
    "entities": [
      {
        "text": "2022-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "vaccination coverage to 36.17% could effectively prevent outbreaks from",
    "entities": [
      {
        "text": "36.17%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "escalating to high-intensity levels. Among various allocation strategies for",
    "entities": []
  },
  {
    "text": "additional vaccines, targeting individuals aged 0-14 years and those aged 60",
    "entities": [
      {
        "text": "0-14 years",
        "label": "DATE"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years and older was found to be the most effective. This approach reduced the",
    "entities": []
  },
  {
    "text": "peak weekly incidence rate from the observed 182.83 to a predicted 42.28 per",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      },
      {
        "text": "182.83",
        "label": "CARDINAL"
      },
      {
        "text": "42.28",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "100,000, saved 23.45 CNY per capita, and yielded a health gain of 0.0102",
    "entities": [
      {
        "text": "100,000",
        "label": "CARDINAL"
      },
      {
        "text": "23.45",
        "label": "CARDINAL"
      },
      {
        "text": "0.0102",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "quality-adjusted life days (QALDs) per person.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Achieving a population-wide vaccination coverage beyond 36.17% is",
    "entities": [
      {
        "text": "36.17%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "projected to prevent high-intensity level of influenza epidemics. Targeting the",
    "entities": []
  },
  {
    "text": "0-14 years and 60 + years age groups proves to be the most cost-effective",
    "entities": [
      {
        "text": "0-14 years",
        "label": "DATE"
      },
      {
        "text": "60 + years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "strategy under constrained coverage conditions. These findings highlight the",
    "entities": []
  },
  {
    "text": "importance of age-prioritized vaccination policies to optimize resource",
    "entities": []
  },
  {
    "text": "allocation and mitigate the impact of influenza outbreaks, particularly in",
    "entities": []
  },
  {
    "text": "regions with limited healthcare capacity.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12889-025-23648-6",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665279 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: The study did not require ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate because it did not include individual-level information, ensuring no",
    "entities": []
  },
  {
    "text": "privacy concerns. Consent for publication: Not applicable. Competing interests:",
    "entities": []
  },
  {
    "text": "30. Int J Hematol. 2025 Jul 15. doi: 10.1007/s12185-025-04024-x. Online ahead of",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Hematol",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Intravenous umbilical cord-derived mesenchymal stromal cell therapy may improve",
    "entities": []
  },
  {
    "text": "overall survival in Japanese patients with idiopathic pneumonia syndrome after",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "hematopoietic stem cell transplantation: a multicenter, single-arm, phase II",
    "entities": [
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases",
    "entities": [
      {
        "text": "Division",
        "label": "ORG"
      },
      {
        "text": "Tokyo Metropolitan Cancer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Hematology and Oncology, Okayama University Hospital, Kita-Ku,",
    "entities": [
      {
        "text": "Hematology and Oncology",
        "label": "ORG"
      },
      {
        "text": "Okayama University Hospital",
        "label": "ORG"
      },
      {
        "text": "Kita-Ku",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Division of Hematology, Jichi Medical University Saitama Medical Center,",
    "entities": [
      {
        "text": "Hematology, Jichi Medical University Saitama Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Hematology, Chiba University Hospital, Chiba, Chiba, Japan.",
    "entities": [
      {
        "text": "Hematology",
        "label": "ORG"
      },
      {
        "text": "Chiba University Hospital",
        "label": "ORG"
      },
      {
        "text": "Chiba",
        "label": "ORG"
      },
      {
        "text": "Chiba",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Hematology, Department of Medicine, Jichi Medical University,",
    "entities": [
      {
        "text": "Hematology, Department of Medicine, Jichi Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Idiopathic pneumonia syndrome (IPS) is a serious complication of allogeneic",
    "entities": [
      {
        "text": "IPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hematopoietic stem cell transplantation (HSCT) and has a poor prognosis.",
    "entities": [
      {
        "text": "HSCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Although IPS is often treated with steroids, the disease can become resistant to",
    "entities": [
      {
        "text": "IPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "or dependent on steroid treatment, and there is no effective cure for patients",
    "entities": []
  },
  {
    "text": "with refractory or steroid-dependent IPS. This multicenter, open-label,",
    "entities": [
      {
        "text": "IPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "single-arm, phase II clinical trial investigated the efficacy and safety of",
    "entities": [
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "HLC-001 (allogeneic umbilical cord-derived mesenchymal stromal cells) in",
    "entities": []
  },
  {
    "text": "patients with progressive steroid-dependent or refractory IPS after HSCT. Seven",
    "entities": [
      {
        "text": "IPS",
        "label": "ORG"
      },
      {
        "text": "HSCT",
        "label": "ORG"
      },
      {
        "text": "Seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "male patients (all male; mean age: 43.3 years) received HLC-001 and three",
    "entities": [
      {
        "text": "43.3 years",
        "label": "DATE"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "completed the trial. The survival rate at day 56 (primary endpoint) was 71.4%",
    "entities": [
      {
        "text": "day 56",
        "label": "DATE"
      },
      {
        "text": "71.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(5/7 patients; 95% confidence interval: 29.0%-96.3%) and was sustained at day",
    "entities": [
      {
        "text": "5/7",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "29.0%-96.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "100, suggesting that HLC-001 was more effective than previously reported",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "HLC-001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment. Three of the five patients with \u2265 100 days of follow-up died. Five",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "100 days",
        "label": "DATE"
      },
      {
        "text": "Five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients experienced at least one adverse drug reaction, none of which were",
    "entities": [
      {
        "text": "at least one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "serious. These findings indicate that HLC-001 was potentially effective and",
    "entities": [
      {
        "text": "HLC-001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "generally well tolerated in Japanese patients with steroid-dependent or",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "refractory IPS after HSCT. Given there is no effective cure for",
    "entities": [
      {
        "text": "IPS",
        "label": "ORG"
      },
      {
        "text": "HSCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "steroid-dependent or refractory IPS, HLC-001 may be a promising treatment option",
    "entities": [
      {
        "text": "IPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and further clinical evaluation is warranted.Trial registration: Japan Registry",
    "entities": [
      {
        "text": "Japan Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Clinical Trials identifier: jRCT2063220014.",
    "entities": [
      {
        "text": "Clinical Trials",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: ND, NF, SK,",
    "entities": [
      {
        "text": "ND",
        "label": "ORG"
      },
      {
        "text": "NF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ES, and YK received support for medical writing, article processing charges,",
    "entities": [
      {
        "text": "YK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research funding, and advisory fees from Human Life CORD Japan Inc., related to",
    "entities": [
      {
        "text": "Human Life CORD Japan Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the submitted work. ND received research funding from The Japan Agency for",
    "entities": [
      {
        "text": "ND",
        "label": "ORG"
      },
      {
        "text": "The Japan Agency",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Research and Development (AMED) (24ek0510039h0003), and a Grant-in-Aid",
    "entities": [
      {
        "text": "Medical Research and Development",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for Scientific Research (KAKENHI) (23K06709); consulting fees from Janssen",
    "entities": [
      {
        "text": "Scientific Research",
        "label": "ORG"
      },
      {
        "text": "KAKENHI",
        "label": "ORG"
      },
      {
        "text": "Janssen",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pharmaceutical K.K.; and honoraria from AbbVie G.K., Asahi Kasei Pharma",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "AbbVie G.K.",
        "label": "PERSON"
      },
      {
        "text": "Asahi Kasei Pharma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Corporation, Astellas Pharma Inc., AstraZeneca K.K., Chugai Pharmaceutical Co.,",
    "entities": [
      {
        "text": "Astellas Pharma Inc.",
        "label": "ORG"
      },
      {
        "text": "AstraZeneca K.K.",
        "label": "ORG"
      },
      {
        "text": "Chugai Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Daiichi Sankyo Co., Ltd., Janssen Pharmaceutical K.K., Kyowa Kirin Co.,",
    "entities": [
      {
        "text": "Daiichi Sankyo Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Kyowa Kirin Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi K.K., Shionogi & Co., Ltd.,",
    "entities": [
      {
        "text": "Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      },
      {
        "text": "Sanofi K.K.",
        "label": "PERSON"
      },
      {
        "text": "Shionogi & Co., Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Takeda Pharmaceutical Co., Ltd., outside the submitted work. NF received",
    "entities": [
      {
        "text": "Takeda Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "NF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "honoraria from Asahi Kasei Pharma Corporation, Astellas Pharma Inc.,",
    "entities": [
      {
        "text": "Asahi Kasei Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Astellas Pharma Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co.,",
    "entities": [
      {
        "text": "Bristol-Myers Squibb K.K.",
        "label": "ORG"
      },
      {
        "text": "Chugai Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Daiichi Sankyo Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Gilead Sciences, Inc., Janssen Pharmaceutical K.K., Kyowa Kirin Co., Ltd.,",
    "entities": [
      {
        "text": "Gilead Sciences, Inc.",
        "label": "ORG"
      },
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Kyowa Kirin Co., Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MSD K.K., and Novartis Pharma K.K. SK received research funding from JSH",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Novartis Pharma K.K. SK",
        "label": "ORG"
      },
      {
        "text": "JSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kanto-Koshinetsu district; honoraria from AbbVie G.K., Amgen K.K., Asahi Kasei",
    "entities": [
      {
        "text": "Kanto",
        "label": "ORG"
      },
      {
        "text": "AbbVie G.K.",
        "label": "PERSON"
      },
      {
        "text": "Amgen K.K.",
        "label": "PERSON"
      },
      {
        "text": "Asahi Kasei",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharma Corporation, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai",
    "entities": [
      {
        "text": "Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Astellas Pharma Inc.",
        "label": "ORG"
      },
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co., Ltd., CSL Behring K.K., Daiichi Sankyo Co., Ltd., Eisai Co.,",
    "entities": [
      {
        "text": "Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "CSL Behring K.K.",
        "label": "ORG"
      },
      {
        "text": "Daiichi Sankyo Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Eisai Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical",
    "entities": [
      {
        "text": "Novartis Pharma K.K.",
        "label": "PERSON"
      },
      {
        "text": "Ono Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co., Ltd., Pfizer Japan Inc., Sanofi K.K., SymBio Pharmaceuticals Ltd., Taiho",
    "entities": [
      {
        "text": "Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      },
      {
        "text": "Sanofi K.K.",
        "label": "PERSON"
      },
      {
        "text": "SymBio Pharmaceuticals Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd.; and support for",
    "entities": [
      {
        "text": "Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co., Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "attending meetings from Pfizer Japan Inc., outside the submitted work. ES",
    "entities": [
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received research funding from Bristol-Myers Squibb K.K., The Japan Agency for",
    "entities": [
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "The Japan Agency",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Research and Development (AMED) (23808509), and a Grant-in-Aid for",
    "entities": [
      {
        "text": "Medical Research and Development",
        "label": "ORG"
      },
      {
        "text": "23808509",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Scientific Research (KAKENHI) (22K08471); honoraria from Amgen K.K., AbbVie",
    "entities": [
      {
        "text": "Scientific Research",
        "label": "ORG"
      },
      {
        "text": "KAKENHI",
        "label": "ORG"
      },
      {
        "text": "Amgen K.K.",
        "label": "ORG"
      },
      {
        "text": "AbbVie",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "G.K., Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Bristol-Myers Squibb",
    "entities": [
      {
        "text": "G.K.",
        "label": "PERSON"
      },
      {
        "text": "Asahi Kasei Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Astellas Pharma Inc.",
        "label": "ORG"
      },
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "K.K., Chugai Pharmaceutical Co., Ltd., CSL Behring K.K., Daiichi Sankyo Co.,",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Chugai Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "CSL Behring K.K.",
        "label": "ORG"
      },
      {
        "text": "Daiichi Sankyo Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co., Ltd., Nippon Kayaku Co., Ltd., Nihon Servier Co., Ltd., Nippon Shinyaku",
    "entities": [
      {
        "text": "Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nihon Servier Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nippon Shinyaku",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co., Ltd., Novartis Pharma K.K., Ohara Pharmaceutical Co., Ltd., Ono",
    "entities": [
      {
        "text": "Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Novartis Pharma K.K.",
        "label": "PERSON"
      },
      {
        "text": "Ohara Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Ono\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc.,",
    "entities": [
      {
        "text": "Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sanofi K.K., Taiho Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co.,",
    "entities": [
      {
        "text": "K.K., Taiho Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd.; fees for educational events from Kyowa Kirin Co., Ltd.; fees for advisory",
    "entities": [
      {
        "text": "Kyowa Kirin Co., Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "board participation from Bristol-Myers Squibb K.K., Nihon Servier Co., Ltd.,",
    "entities": [
      {
        "text": "Bristol-Myers Squibb K.K.",
        "label": "ORG"
      },
      {
        "text": "Nihon Servier Co., Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Novartis Pharma K.K., Ohara Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,",
    "entities": [
      {
        "text": "Novartis Pharma K.K.",
        "label": "PERSON"
      },
      {
        "text": "Ohara Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., and Pfizer Japan Inc.; and served as an unpaid vice director of the Japan",
    "entities": [
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Adult Leukemia Study Group (JALSG), outside the submitted work. YK received",
    "entities": [
      {
        "text": "Adult Leukemia Study Group",
        "label": "ORG"
      },
      {
        "text": "JALSG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research funding from Asahi Kasei Pharma Corporation, Chugai Pharmaceutical Co.,",
    "entities": [
      {
        "text": "Asahi Kasei Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Chugai Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Japan Blood Products Organization, Kyowa Kirin Co., Ltd., Nippon Kayaku",
    "entities": [
      {
        "text": "Japan Blood Products Organization",
        "label": "ORG"
      },
      {
        "text": "Kyowa Kirin Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Sumitomo Pharma Co., Ltd.; and",
    "entities": [
      {
        "text": "Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Sumitomo Pharma Co., Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "honoraria from Asahi Kasei Pharma Corporation, Astellas Pharma Inc., AstraZeneca",
    "entities": [
      {
        "text": "Asahi Kasei Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Astellas Pharma Inc.",
        "label": "ORG"
      },
      {
        "text": "AstraZeneca",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "K.K., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., CSL Behring",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "Chugai Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "CSL Behring",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "K.K., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K. GENOVA,",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Daiichi Sankyo Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Eisai Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      },
      {
        "text": "K.K. GENOVA",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Janssen Pharmaceutical K.K., Kowa Co., Ltd. Kyowa Kirin Co., Ltd., MSD K.K.,",
    "entities": [
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Kowa Co.",
        "label": "ORG"
      },
      {
        "text": "Kyowa Kirin Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "K.K.",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,",
    "entities": [
      {
        "text": "Novartis Pharma K.K.",
        "label": "PERSON"
      },
      {
        "text": "Ono Pharmaceutical Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Pfizer Japan Inc., Pharma Essentia Japan K.K., Research Organization of",
    "entities": [
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      },
      {
        "text": "Pharma Essentia",
        "label": "PERSON"
      },
      {
        "text": "K.K., Research Organization",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Information and Systems, PRECISION, R\u2019s park Incorporated, Sanofi K.K., Sumitomo",
    "entities": [
      {
        "text": "Information and Systems",
        "label": "ORG"
      },
      {
        "text": "Sanofi K.K.",
        "label": "PERSON"
      },
      {
        "text": "Sumitomo",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharma Co., Ltd., SymBio Pharmaceuticals Ltd., and Takeda Pharmaceutical Co.,",
    "entities": [
      {
        "text": "Pharma Co., Ltd.",
        "label": "ORG"
      },
      {
        "text": "SymBio Pharmaceuticals Ltd.",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., outside the submitted work. YK also serves as an Associate Editor for the",
    "entities": []
  },
  {
    "text": "International Journal of Hematology.",
    "entities": [
      {
        "text": "International Journal of Hematology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Emotional state in patients after COVID-19 in relation to comprehensive",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rehabilitation, Brain-Derived neurotrophic factor, Irisin levels, and selected",
    "entities": [
      {
        "text": "Brain",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical factors.",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian",
    "entities": [
      {
        "text": "Medical Rehabilitation and Clinical Physiotherapy",
        "label": "ORG"
      },
      {
        "text": "Pomeranian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medical University, Szczecin, 71-210, Poland. alicja.minko287@gmail.com.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Szczecin",
        "label": "GPE"
      },
      {
        "text": "71",
        "label": "CARDINAL"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian",
    "entities": [
      {
        "text": "Pomeranian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medical University, Szczecin, 71-210, Poland.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Szczecin",
        "label": "GPE"
      },
      {
        "text": "71",
        "label": "CARDINAL"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The outbreak of the COVID-19 epidemic is a breach of health protection",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "worldwide. Complications in people who limit the risk of COVID-19 can be",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with physical and mental health. Identification of states associated",
    "entities": []
  },
  {
    "text": "with anxiety and depression and threats that may occur in patients after",
    "entities": []
  },
  {
    "text": "COVID-19 is a very important aspect that occurs on the selection of therapeutic",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "methods, and thus recovery occurs. The aim of the study was to assess the",
    "entities": []
  },
  {
    "text": "penalty in the treatment of anxiety symptoms and depressiveness in a patient",
    "entities": []
  },
  {
    "text": "after COVID-19. The study includes the effects resulting from brain-derived",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neurotrophic factor, irisin and other problems related to problems and",
    "entities": []
  },
  {
    "text": "depressive symptoms in patients after COVID-19. included in the study",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "participation in the rehabilitation education program in stationary conditions.",
    "entities": []
  },
  {
    "text": "The Generalized Anxiety Disorder Questionnaire was used to solve anxiety",
    "entities": [
      {
        "text": "Questionnaire",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "problems. The Beck Depression Inventory was used to assess the effects of",
    "entities": [
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression. To assess the update of the irisin (ng/mL) and brain-derived",
    "entities": []
  },
  {
    "text": "neurotrophic factor (ng/mL) configuration on the day of treatment initiation",
    "entities": [
      {
        "text": "ng/mL",
        "label": "ORG"
      },
      {
        "text": "the day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "from each patient's blood was collected from a female venous sample. After",
    "entities": []
  },
  {
    "text": "rehabilitation, patients scored lower in both depression and anxiety",
    "entities": []
  },
  {
    "text": "assessments. Women had higher scores in the assessment of anxiety disorders and",
    "entities": []
  },
  {
    "text": "depression. The longer the period from the end of COVID-19 treatment to the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "start of rehabilitation, the higher the Generalized Anxiety Disorder",
    "entities": []
  },
  {
    "text": "Questionnaire and The Beck Depression Inventory scores. The higher the",
    "entities": [
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Generalized Anxiety Disorder Questionnaire and The Beck Depression Inventory",
    "entities": [
      {
        "text": "Generalized Anxiety",
        "label": "ORG"
      },
      {
        "text": "Questionnaire",
        "label": "PERSON"
      },
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "scores, the lower the handgrip strength values. With increasing irisin",
    "entities": []
  },
  {
    "text": "concentration, The Beck Depression Inventory values also increased.",
    "entities": [
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Comprehensive rehabilitation may be associated with a reduction in the severity",
    "entities": []
  },
  {
    "text": "of anxiety and depressive symptoms in patients after COVID-19. Earlier",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "initiation of rehabilitation may be associated with better emotional well-being",
    "entities": []
  },
  {
    "text": "in patients after COVID-19. The severity of anxiety and depressive symptoms may",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "be associated with gender, age, and hospitalization during COVID-19 treatment.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Increased irisin levels in patients after COVID-19 may be associated with",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inflammatory and metabolic complications after infection. However,",
    "entities": []
  },
  {
    "text": "interpretation of these relationships requires further studies taking into",
    "entities": []
  },
  {
    "text": "account additional biological variables and prospective analyses.",
    "entities": []
  },
  {
    "text": "PMID: 40665009 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665009",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Institutional review board statement: The study",
    "entities": []
  },
  {
    "text": "was conducted in accordance with the Declaration of Helsinki and approved by the",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Bioethics Committee of the Pomeranian Medical University (protocol code",
    "entities": [
      {
        "text": "Bioethics Committee",
        "label": "ORG"
      },
      {
        "text": "the Pomeranian Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "KB-0012/15/2021 of 28 June 2023). Informed consent Statement: Informed consent",
    "entities": [
      {
        "text": "28 June 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was obtained from all subjects involved in the study.",
    "entities": []
  },
  {
    "text": "Characterization of natural therapeutic compounds producing novel bacterial",
    "entities": []
  },
  {
    "text": "strains isolated from Hyderabad, India.",
    "entities": [
      {
        "text": "Hyderabad",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)In silico Research Laboratory, Eminent Biosciences, Indore, 452 010, Madhya",
    "entities": [
      {
        "text": "Research Laboratory",
        "label": "ORG"
      },
      {
        "text": "452 010",
        "label": "CARDINAL"
      },
      {
        "text": "Madhya",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Computer Aided Drug Design and Molecular Modelling Lab, Department of",
    "entities": [
      {
        "text": "Aided Drug Design",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)In silico Research Laboratory, Eminent Biosciences, Indore, 452 010, Madhya",
    "entities": [
      {
        "text": "Research Laboratory",
        "label": "ORG"
      },
      {
        "text": "452 010",
        "label": "CARDINAL"
      },
      {
        "text": "Madhya",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Computer Aided Drug Design and Molecular Modelling Lab, Department of",
    "entities": [
      {
        "text": "4)Computer",
        "label": "CARDINAL"
      },
      {
        "text": "Aided Drug Design",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Natural products (NPs) are secondary metabolites that exert their biological",
    "entities": [
      {
        "text": "NPs",
        "label": "GPE"
      },
      {
        "text": "secondary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "effects within and on other organisms. Bacteria are considered potent producers",
    "entities": []
  },
  {
    "text": "of bioactive natural compounds, due to their versatile biocatalytic activity.",
    "entities": []
  },
  {
    "text": "The present study aims to isolate, identify, and analyze four novel bacterial",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strains that have the potential to produce NPs. The novelty was determined via",
    "entities": [
      {
        "text": "NPs",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "screening assays. 16S rRNA molecular characterization and bioinformatics",
    "entities": [
      {
        "text": "16S",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analysis identified the isolates as Klebsiella pneumoniae strain ABSKSLAB01,",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "strain ABSKSLAB03, and Streptomyces peucetius strain ABSKSLAB04. Their bacterial",
    "entities": []
  },
  {
    "text": "sequences were deposited in the GenBank database with accession numbers",
    "entities": [
      {
        "text": "GenBank",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "'OP597532', 'OP597545', 'OQ061473', and 'PP086938', respectively. Among all the",
    "entities": [
      {
        "text": "OQ061473",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "bacterial strains, ABSKSLAB04 demonstrated the highest antagonistic activity and",
    "entities": [
      {
        "text": "ABSKSLAB04",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the potential to produce NPs. Further optimization studies using the OVAT",
    "entities": [
      {
        "text": "OVAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "approach and statistical investigations via Plackett-Burman, RSM-Box-Behnken",
    "entities": [
      {
        "text": "Plackett-Burman",
        "label": "ORG"
      },
      {
        "text": "RSM-Box-Behnken",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "design, and artificial neural network rendered the optimized culture conditions",
    "entities": []
  },
  {
    "text": "to produce NPs: pH 7 \u00b1 1.2, temperature 40 \u00b1 5 \u00b0C, and inositol concentration of",
    "entities": [
      {
        "text": "1.2",
        "label": "CARDINAL"
      },
      {
        "text": "40 \u00b1 5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "5.5 \u00b1 1.5, resulting in maximum antagonistic activity of 29.81 mm. The ANN model",
    "entities": [
      {
        "text": "5.5",
        "label": "CARDINAL"
      },
      {
        "text": "1.5",
        "label": "CARDINAL"
      },
      {
        "text": "29.81 mm",
        "label": "QUANTITY"
      },
      {
        "text": "ANN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reflected superior predictive capacity compared to the RSM model with enhanced",
    "entities": [
      {
        "text": "RSM",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "statistical metrics: R2 (92.23%), MSE (0.0277), and RMSE (0.1477). ANN optimized",
    "entities": [
      {
        "text": "R2",
        "label": "CARDINAL"
      },
      {
        "text": "92.23%",
        "label": "PERCENT"
      },
      {
        "text": "RMSE",
        "label": "ORG"
      },
      {
        "text": "0.1477",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "production yield was measured at 580 mg/L, reflecting a 1.57-fold enhancement",
    "entities": [
      {
        "text": "580 mg/L",
        "label": "QUANTITY"
      },
      {
        "text": "1.57-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "over the pre-optimized conditions (370 mg/L), and a 1.22-fold improvement",
    "entities": [
      {
        "text": "370 mg/L",
        "label": "QUANTITY"
      },
      {
        "text": "1.22-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compared to the RSM model (450 mg/L). This highlighted the ANN model's",
    "entities": [
      {
        "text": "RSM",
        "label": "PERSON"
      },
      {
        "text": "450",
        "label": "CARDINAL"
      },
      {
        "text": "ANN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "robustness in modeling complex nonlinear relationships and optimizing the",
    "entities": []
  },
  {
    "text": "bioprocess parameters with higher fidelity. Therefore, the results from the",
    "entities": []
  },
  {
    "text": "study conclude the potential of the designated bacterial strain (ABSKSLAB04) to",
    "entities": []
  },
  {
    "text": "produce NPs with enhanced antimicrobial and antineoplastic characteristics. The",
    "entities": [
      {
        "text": "produce NPs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "strain can further be utilized in biotechnological paradigms by scaling up in",
    "entities": []
  },
  {
    "text": "the pharmaceutical and industrial sectors for therapeutic applications.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-11615-5",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664890 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664890",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "declare no competing interests. Consent to participate: Informed consent was",
    "entities": []
  },
  {
    "text": "obtained from all individual participants included in the study. Consent to",
    "entities": []
  },
  {
    "text": "publish: The authors have consented to the submission of the case report to the",
    "entities": []
  },
  {
    "text": "Dysregulated type I/III interferon system in circulation from patients with",
    "entities": []
  },
  {
    "text": "(1)Department of Allergy and Rheumatology, Nippon Medical School Graduate School",
    "entities": [
      {
        "text": "Allergy and Rheumatology",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Graduate School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, 113-8602, Japan.",
    "entities": [
      {
        "text": "1-1-5",
        "label": "CARDINAL"
      },
      {
        "text": "Sendagi",
        "label": "NORP"
      },
      {
        "text": "Bunkyo-Ku",
        "label": "GPE"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "113-8602",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Scleroderma/Myositis Center of Excellence, Nippon Medical School Hospital,",
    "entities": [
      {
        "text": "Nippon Medical School Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Microbiology and Immunology, Nippon Medical School Graduate",
    "entities": [
      {
        "text": "Microbiology and Immunology",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Graduate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Tokyo, 113-8602, Japan.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "113-8602",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Emergency and Critical Care Medicine, Nippon Medical School",
    "entities": [
      {
        "text": "Emergency and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Graduate School of Medicine, Tokyo, 113-8602, Japan.",
    "entities": [
      {
        "text": "Graduate School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "113-8602",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Second Division, Department of Internal Medicine, Hamamatsu University School",
    "entities": [
      {
        "text": "Division, Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Hamamatsu University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Hamamatsu, 431-3192, Japan.",
    "entities": [
      {
        "text": "Hamamatsu",
        "label": "ORG"
      },
      {
        "text": "431-3192",
        "label": "CARDINAL"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Allergy and Rheumatology, Nippon Medical School Graduate School",
    "entities": [
      {
        "text": "Allergy and Rheumatology",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Graduate School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Scleroderma/Myositis Center of Excellence, Nippon Medical School Hospital,",
    "entities": [
      {
        "text": "7)Scleroderma/Myositis Center of Excellence",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(DM) is often complicated by rapidly progressive interstitial lung disease",
    "entities": []
  },
  {
    "text": "(RP-ILD), leading to early mortality. Previous studies on the pathogenesis of",
    "entities": []
  },
  {
    "text": "anti-MDA5-positive DM highlighted type I interferons (IFNs), while recent",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigations reported the significance of a type III IFN, IFN-\u03bb3. We",
    "entities": [
      {
        "text": "III IFN",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigated a range of cytokines, including type I/II/III IFNs, in serum",
    "entities": [
      {
        "text": "I/II/III",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "samples from anti-MDA5-positive DM patients collected at diagnosis before",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment introduction. Elevations of IFN-\u03b2 and \u03bb3 were identified as the",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hallmark of anti-MDA5-positive DM, in comparison with other myositis subtypes,",
    "entities": [
      {
        "text": "myositis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "systemic lupus erythematosus, and COVID-19 pneumonia. The elevation of IFN-\u03bb3",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was associated with decreased CD56dimCD16pos NK cells in circulation. The unique",
    "entities": []
  },
  {
    "text": "cytokine profile with type I/III IFN upregulation in anti-MDA5-positive DM was",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "replicated in independent validation cohorts. A cluster analysis using serum",
    "entities": []
  },
  {
    "text": "type I/III IFN levels identified three subgroups in anti-MDA5-positive DM: mild",
    "entities": [
      {
        "text": "I/III IFN",
        "label": "ORG"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "elevations of IFN-\u03b1/\u03b2 and \u03bb3; a marked increase in IFN-\u03bb3 alone; and pronounced",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elevations of IFN-\u03b1/\u03b2 with mild to moderate increase in IFN-\u03bb3. Patients in the",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cluster with a marked elevation of IFN-\u03bb3 alone tended to present with RP-ILD",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and decreased survival. The combination of serum type I/III IFN levels could",
    "entities": []
  },
  {
    "text": "serve as a prognostic biomarker in anti-MDA5-positive DM.",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41598-025-10895-1",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664875 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664875",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: T.G. has",
    "entities": [
      {
        "text": "T.G.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received speaking fees from Asahi Kasei Pharma, Astellas, Boehringer-Ingelheim,",
    "entities": [
      {
        "text": "Asahi Kasei Pharma",
        "label": "ORG"
      },
      {
        "text": "Astellas",
        "label": "PERSON"
      },
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bristol-Myers Squibb, Chugai, Eli Lily, Ono Pharmaceuticals, Pfizer, and",
    "entities": [
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "Chugai",
        "label": "PERSON"
      },
      {
        "text": "Eli Lily, Ono Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tanabe-Mitsubishi; M.K. has received royalties from MBL; speaking honoraria from",
    "entities": [
      {
        "text": "Tanabe-Mitsubishi",
        "label": "PERSON"
      },
      {
        "text": "M.K.",
        "label": "PERSON"
      },
      {
        "text": "MBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer-Ingelheim; consulting honoraria from Argenx, AstraZeneca,",
    "entities": [
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Argenx",
        "label": "LOC"
      },
      {
        "text": "AstraZeneca",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer-Ingelheim, GSK, and Novartis; and research grants from",
    "entities": [
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer-Ingelheim and MBL. The other authors have no conflicts of interest.",
    "entities": [
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "MBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 susceptibility, severity, and vaccine effectiveness in patients with",
    "entities": []
  },
  {
    "text": "psoriasis: a nationwide cohort study in South Korea.",
    "entities": [
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DA(1)(5), Lee YW(1)(5), Choe YB(6)(7).",
    "entities": [
      {
        "text": "DA(1)(5",
        "label": "GPE"
      },
      {
        "text": "Lee YW(1)(5",
        "label": "PERSON"
      },
      {
        "text": "Choe YB(6)(7",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Dermatology, Konkuk University School of Medicine, 120-1",
    "entities": [
      {
        "text": "Dermatology, Konkuk University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea.",
    "entities": [
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Public Health Sciences, Seoul National University, 1 Gwanak-ro,",
    "entities": [
      {
        "text": "Public Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Seoul National University",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Gwanak-gu, Seoul, 08826, Republic of Korea.",
    "entities": [
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "08826",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute of Health and Environment, Seoul National University, 1 Gwanak-ro,",
    "entities": [
      {
        "text": "Health and Environment",
        "label": "ORG"
      },
      {
        "text": "Seoul National University",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(4)RexSoft Inc, 542 Yeoksam-ro, Gangnam-gu, Seoul, 06187, Republic of Korea.",
    "entities": [
      {
        "text": "4)RexSoft Inc",
        "label": "ORG"
      },
      {
        "text": "542",
        "label": "CARDINAL"
      },
      {
        "text": "Gangnam",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "06187",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Research Institute of Medical Science, Konkuk University School of Medicine,",
    "entities": [
      {
        "text": "5)Research Institute of Medical Science, Konkuk University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "120-1 Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea.",
    "entities": [
      {
        "text": "120",
        "label": "CARDINAL"
      },
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Dermatology, Konkuk University School of Medicine, 120-1",
    "entities": [
      {
        "text": "Dermatology, Konkuk University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea. cyb@kuh.ac.kr.",
    "entities": [
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Research Institute of Medical Science, Konkuk University School of Medicine,",
    "entities": [
      {
        "text": "Institute of Medical Science, Konkuk University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "120-1 Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea. cyb@kuh.ac.kr.",
    "entities": [
      {
        "text": "120",
        "label": "CARDINAL"
      },
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Patients with psoriasis are vulnerable to infections due to dysregulated",
    "entities": []
  },
  {
    "text": "immunity, use of immunosuppressive drugs, and comorbid conditions. Despite",
    "entities": []
  },
  {
    "text": "ongoing concerns regarding coronavirus disease 2019 (COVID-19) vulnerability in",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with psoriasis, evidence remains limited. This nationwide,",
    "entities": []
  },
  {
    "text": "population-based, retrospective cohort study aimed to assess the risk and",
    "entities": []
  },
  {
    "text": "severity of COVID-19 and vaccine effectiveness in patients with psoriasis,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "including those receiving immunomodulatory therapy, using Korean National Health",
    "entities": [
      {
        "text": "Korean National Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Insurance Service claims data from 2018 to 2021. The primary analysis included",
    "entities": [
      {
        "text": "Insurance Service",
        "label": "ORG"
      },
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "167,746 patients with psoriasis and 866,582 controls, revealing no significant",
    "entities": [
      {
        "text": "167,746",
        "label": "CARDINAL"
      },
      {
        "text": "866,582",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations between psoriasis and COVID-19 (adjusted hazard ratio [aHR]: 0.99,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      },
      {
        "text": "0.99",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% confidence interval [CI]: 0.95-1.04). Conversely, the secondary analysis of",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.95-1.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "3,131 patients with psoriasis and 265,475 controls revealed significantly higher",
    "entities": [
      {
        "text": "3,131",
        "label": "CARDINAL"
      },
      {
        "text": "265,475",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rates of severe COVID-19 in patients with psoriasis (aHR: 1.33, 95% CI:",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "1.33",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.08-1.64). While some treatment subgroups - such as the cyclosporine and",
    "entities": [
      {
        "text": "1.08-1.64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "methotrexate subgroups - demonstrated higher incidences of COVID-19 than the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reference (nonsystemic) subgroup, these differences were not statistically",
    "entities": []
  },
  {
    "text": "significant. Furthermore, vaccine interaction effects between the duration of",
    "entities": []
  },
  {
    "text": "immunity and psoriasis or each treatment were insignificant (all P > 0.05).",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Patients with psoriasis exhibited a higher risk of severe COVID-19; however,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "their COVID-19 susceptibility and vaccine effectiveness resembled those of the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "control group. Additionally, the use of immunomodulatory agents did not impact",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 risk or vaccine effectiveness. These findings highlight the need for",
    "entities": []
  },
  {
    "text": "dermatologists to implement pre- and postinfection strategies tailored for",
    "entities": []
  },
  {
    "text": "patients with psoriasis.",
    "entities": []
  },
  {
    "text": "PMID: 40664730 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664730",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval: This study was",
    "entities": []
  },
  {
    "text": "reviewed and approved by the Konkuk University Medical Center IRB; approval",
    "entities": [
      {
        "text": "the Konkuk University Medical Center IRB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "number: 36 #KUMC 2021-12-033. Written consent was waived since this study used",
    "entities": [
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "2021-12-033",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "de-identified data. Competing interests: Y.B.C. has received research grants",
    "entities": [
      {
        "text": "Y.B.C.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from the the Konkuk University. The remaining authors have no conflict of",
    "entities": [
      {
        "text": "the the Konkuk University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Development and validation of a RP-HPLC method for simultaneous determination of",
    "entities": []
  },
  {
    "text": "five COVID-19 antiviral drugs in pharmaceutical formulations.",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-",
    "entities": [
      {
        "text": "Analytical Chemistry Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Azhar University, Nasr City, 11751, Cairo, Egypt.",
    "entities": [
      {
        "text": "Azhar University",
        "label": "ORG"
      },
      {
        "text": "Nasr City",
        "label": "GPE"
      },
      {
        "text": "11751",
        "label": "DATE"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-",
    "entities": [
      {
        "text": "Analytical Chemistry Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Azhar University, Nasr City, 11751, Cairo, Egypt. Ahmedserag777@azhar.edu.eg.",
    "entities": [
      {
        "text": "Azhar University",
        "label": "ORG"
      },
      {
        "text": "Nasr City",
        "label": "GPE"
      },
      {
        "text": "11751",
        "label": "DATE"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      },
      {
        "text": "Ahmedserag777@azhar.edu.eg",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "A rapid, sensitive, and selective reversed-phase high-performance liquid",
    "entities": []
  },
  {
    "text": "chromatography (RP-HPLC) method was developed and validated for the simultaneous",
    "entities": []
  },
  {
    "text": "determination of five COVID-19 antiviral drugs: favipiravir, molnupiravir,",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nirmatrelvir, remdesivir, and ritonavir. The chromatographic separation was",
    "entities": []
  },
  {
    "text": "achieved on a Hypersil BDS C18 column (4.5 \u00d7 150 mm, 5 \u03bcm particle size) using",
    "entities": [
      {
        "text": "Hypersil BDS C18",
        "label": "ORG"
      },
      {
        "text": "4.5",
        "label": "CARDINAL"
      },
      {
        "text": "5 \u03bcm",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "an isocratic mobile phase consisting of water and methanol (30:70 v/v, pH 3.0",
    "entities": [
      {
        "text": "30:70 v/v",
        "label": "QUANTITY"
      },
      {
        "text": "3.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "adjusted with 0.1% ortho-phosphoric acid) at a flow rate of 1 mL/min with UV",
    "entities": [
      {
        "text": "0.1%",
        "label": "PERCENT"
      },
      {
        "text": "1 mL/min",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "detection at 230 nm. The optimized method demonstrated good chromatographic",
    "entities": [
      {
        "text": "230",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resolution with retention times of 1.23, 1.79, 2.47, 2.86, and 4.34 min for",
    "entities": [
      {
        "text": "1.23",
        "label": "CARDINAL"
      },
      {
        "text": "1.79",
        "label": "CARDINAL"
      },
      {
        "text": "2.47",
        "label": "CARDINAL"
      },
      {
        "text": "2.86",
        "label": "CARDINAL"
      },
      {
        "text": "4.34",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respectively. The method was validated according to ICH guidelines, showing",
    "entities": []
  },
  {
    "text": "linearity in the concentration range of 10-50 \u00b5g/mL with correlation",
    "entities": [
      {
        "text": "10-50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "coefficients (r\u00b2) \u2265 0.9997 for all analytes. The limits of detection were",
    "entities": [
      {
        "text": "\u2265 0.9997",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "0.415-0.946 \u00b5g/mL, while the limits of quantification were 1.260-2.868 \u00b5g/mL.",
    "entities": [
      {
        "text": "0.415-0.946",
        "label": "CARDINAL"
      },
      {
        "text": "1.260",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The method demonstrated high trueness (99.59-100.08%) and precision",
    "entities": [
      {
        "text": "99.59-100.08%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(RSD < 1.1%). The validated method was successfully applied to the determination",
    "entities": [
      {
        "text": "RSD",
        "label": "ORG"
      },
      {
        "text": "1.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of these drugs in their pharmaceutical formulations, with recovery values",
    "entities": []
  },
  {
    "text": "ranging from 99.98 to 100.7% and no significant interference from excipients.",
    "entities": [
      {
        "text": "99.98",
        "label": "CARDINAL"
      },
      {
        "text": "100.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Comprehensive greenness and practicality evaluations using five assessment tools",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "yielded favorable scores: AGREE (0.70), AGREEprep (0.59), MoGAPI (70%), BAGI",
    "entities": [
      {
        "text": "AGREE",
        "label": "ORG"
      },
      {
        "text": "0.70",
        "label": "CARDINAL"
      },
      {
        "text": "AGREEprep",
        "label": "GPE"
      },
      {
        "text": "0.59",
        "label": "CARDINAL"
      },
      {
        "text": "MoGAPI",
        "label": "GPE"
      },
      {
        "text": "70%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(82.5), and CACI (79), indicating good environmental performance and excellent",
    "entities": [
      {
        "text": "82.5",
        "label": "CARDINAL"
      },
      {
        "text": "CACI",
        "label": "ORG"
      },
      {
        "text": "79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "practical applicability for routine pharmaceutical quality control analysis. The",
    "entities": []
  },
  {
    "text": "multi-tool assessment confirmed the method's environmental friendliness through",
    "entities": []
  },
  {
    "text": "strategic solvent selection and minimal sample preparation requirements, while",
    "entities": []
  },
  {
    "text": "demonstrating superior practical implementation characteristics including",
    "entities": []
  },
  {
    "text": "cost-effectiveness and accessibility in standard analytical laboratories.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-09904-0",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664729 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "applicable to this study. Consent for publication: Not applicable to this study.",
    "entities": []
  },
  {
    "text": "Pleural mesothelioma incidence and use of systemic treatment decreased during",
    "entities": [
      {
        "text": "Pleural",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the COVID-19 pandemic in The Netherlands.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The",
    "entities": [
      {
        "text": "Thoracic Oncology",
        "label": "ORG"
      },
      {
        "text": "Netherlands Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Netherlands. i.smesseim@nki.nl.",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pulmonary Medicine, Leiden University Medical Center, Leiden,",
    "entities": [
      {
        "text": "Pulmonary Medicine",
        "label": "PERSON"
      },
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The Netherlands. i.smesseim@nki.nl.",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The",
    "entities": [
      {
        "text": "Thoracic Oncology",
        "label": "ORG"
      },
      {
        "text": "Netherlands Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Research and Development, Association of Comprehensive Cancer",
    "entities": [
      {
        "text": "Research and Development, Association of Comprehensive Cancer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centres, Utrecht, The Netherlands.",
    "entities": [
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pleural mesothelioma (PM) is a lethal cancer often linked to asbestos exposure.",
    "entities": [
      {
        "text": "Pleural",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The COVID-19 pandemic caused a global health crisis, raising concerns about its",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "impact on cancer diagnoses and treatments. In response to the immense pressures",
    "entities": []
  },
  {
    "text": "on the healthcare system caused by the COVID-19 pandemic, many countries advised",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prioritizing essential healthcare services while postponing or suspending care",
    "entities": []
  },
  {
    "text": "considered non-emergent to prevent overburdening healthcare systems. This study",
    "entities": []
  },
  {
    "text": "assesses the impact of COVID-19 on the incidence, treatment, and overall",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "survival of PM patients in the Netherlands between 2018 and 2022. Data were",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      },
      {
        "text": "between 2018 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "collected from the Netherlands Cancer Registry for 2,629 PM patients. Incidence,",
    "entities": [
      {
        "text": "the Netherlands Cancer Registry",
        "label": "ORG"
      },
      {
        "text": "2,629 PM",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "treatment patterns, and survival rates were analyzed using statistical methods,",
    "entities": []
  },
  {
    "text": "including Kruskal-Wallis and log-rank tests. PM incidence dropped 13.2% in 2020",
    "entities": [
      {
        "text": "Kruskal-Wallis",
        "label": "PERSON"
      },
      {
        "text": "PM",
        "label": "ORG"
      },
      {
        "text": "13.2%",
        "label": "PERCENT"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during the pandemic, with a 58.8% increase in patients receiving best supportive",
    "entities": [
      {
        "text": "58.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "care and a decline in chemotherapy use (from 39.4% to 32.0%). In 2021, diagnoses",
    "entities": [
      {
        "text": "39.4%",
        "label": "PERCENT"
      },
      {
        "text": "32.0%",
        "label": "PERCENT"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "rebounded (+ 15.2%), and immunotherapy use rose following its approval. However,",
    "entities": [
      {
        "text": "+ 15.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "no significant difference in overall survival was found between 2018 and 2022.",
    "entities": [
      {
        "text": "between 2018 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19 led to a temporary decline in PM diagnoses and systemic treatments in",
    "entities": []
  },
  {
    "text": "2020, followed by recovery in 2021. Despite these changes, overall survival",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "rates remained stable.",
    "entities": []
  },
  {
    "text": "PMID: 40664720 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664720",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests. Ethical approval: This study was approved by the Ethics",
    "entities": [
      {
        "text": "Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Review Committee of the Netherlands Cancer Registry, under approval number",
    "entities": [
      {
        "text": "Review Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disinfection of medical devices with a steam machine that operates at",
    "entities": []
  },
  {
    "text": "atmospheric pressure and is suitable for home usage.",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Microbiology, University of Groningen, University",
    "entities": [
      {
        "text": "Medical Microbiology",
        "label": "ORG"
      },
      {
        "text": "University of Groningen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Microbiology, University of Groningen, University",
    "entities": [
      {
        "text": "Medical Microbiology",
        "label": "ORG"
      },
      {
        "text": "University of Groningen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical devices that come in direct contact with human skin or the oral cavity",
    "entities": []
  },
  {
    "text": "will inevitably be contaminated with microorganisms, including potential",
    "entities": []
  },
  {
    "text": "pathogens. Ensuring the microbiological safety of such devices is therefore",
    "entities": []
  },
  {
    "text": "crucial to prevent infections. Healthcare institutions usually have the",
    "entities": [
      {
        "text": "Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "facilities needed for effective sterilization of reusable medical devices.",
    "entities": []
  },
  {
    "text": "However, effective sterilization or disinfection of medical devices for usage at",
    "entities": []
  },
  {
    "text": "home has remained challenging both in terms of pathogen elimination and user",
    "entities": []
  },
  {
    "text": "safety. Preferably, this involves easy-to-operate equipment that works at",
    "entities": []
  },
  {
    "text": "relatively low temperatures and atmospheric pressure. In principle this need can",
    "entities": []
  },
  {
    "text": "be met by disinfection with steam. Therefore, the objective of the present study",
    "entities": []
  },
  {
    "text": "was to examine the efficacy of a simple electronic steam machine designed for",
    "entities": []
  },
  {
    "text": "home usage. Our results show that exposure to steam at 100 \u00b0C for 60 s resulted",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in complete eradication (100% reduction) of bacterial contaminants, including",
    "entities": [
      {
        "text": "100%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "methicillin-resistant Staphylococcus aureus (MRSA). Significant bacterial",
    "entities": [
      {
        "text": "methicillin",
        "label": "PERSON"
      },
      {
        "text": "Staphylococcus aureus",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reductions (ranging from ~ 90-100%) were also observed within shorter exposure",
    "entities": [
      {
        "text": "90-100%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "times (10-30 s), depending on the strain. Importantly, the applied steam",
    "entities": [
      {
        "text": "10-30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "disinfection approach is effective even against biofilm-embedded bacteria, or",
    "entities": []
  },
  {
    "text": "bacteria applied to a medical device for home usage, as exemplified with a",
    "entities": []
  },
  {
    "text": "nebulizer that is used by patients with asthma or chronic obstructive pulmonary",
    "entities": []
  },
  {
    "text": "disease (COPD). In conclusion, our results provide quantitative proof-of-concept",
    "entities": []
  },
  {
    "text": "evidence that portable steam-generating devices that operate at atmospheric",
    "entities": []
  },
  {
    "text": "pressure can be used for effective disinfection of reusable medical devices in",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-11509-6",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664706 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664706",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding",
    "entities": [
      {
        "text": "SARS-CoV-2 N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to RNA sequences engineered from the viral genome fragment.",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Landeras-Bueno S(1)(2), Hariharan C(3), Avalos RD(3), Norris AS(#)(4), Snyder",
    "entities": [
      {
        "text": "Landeras-Bueno",
        "label": "PERSON"
      },
      {
        "text": "Hariharan",
        "label": "GPE"
      },
      {
        "text": "Avalos RD(3",
        "label": "PERSON"
      },
      {
        "text": "Norris AS(#)(4",
        "label": "ORG"
      },
      {
        "text": "Snyder\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Olmedillas E(3), Miller R(3), Shresta S(3), Wysocki VH(4), Saphire EO(5)(6).",
    "entities": [
      {
        "text": "Miller",
        "label": "PERSON"
      },
      {
        "text": "Shresta S(3",
        "label": "PERSON"
      },
      {
        "text": "Wysocki",
        "label": "PERSON"
      },
      {
        "text": "Saphire EO(5)(6",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.",
    "entities": [
      {
        "text": "CEU Universities",
        "label": "ORG"
      },
      {
        "text": "Valencia",
        "label": "PERSON"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Chemistry and Biochemistry, The Ohio State University,",
    "entities": [
      {
        "text": "Chemistry and Biochemistry",
        "label": "ORG"
      },
      {
        "text": "The Ohio State University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Columbus, OH, USA.",
    "entities": [
      {
        "text": "Columbus",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Medicine, University of California, La Jolla, CA, USA.",
    "entities": [
      {
        "text": "Medicine, University of California",
        "label": "ORG"
      },
      {
        "text": "La Jolla",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The nucleocapsid N is one of four structural proteins of the coronaviruses. Its",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "essential role in genome encapsidation makes it a critical therapeutic target",
    "entities": []
  },
  {
    "text": "for COVID-19 and related diseases. However, the inherent disorder of full-length",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N hampers its structural analysis. Here, we describe a stepwise method using",
    "entities": []
  },
  {
    "text": "viral-derived RNAs to stabilize SARS-CoV-2 N for EM analysis. We identify pieces",
    "entities": [
      {
        "text": "SARS-CoV-2 N",
        "label": "ORG"
      },
      {
        "text": "EM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of RNA from the SARS-CoV-2 genome that promote the formation of structurally",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "homogeneous N dimers, intermediates of assembly, and filamentous capsid-like",
    "entities": []
  },
  {
    "text": "structures. Building on these results, we engineer a symmetric RNA to stabilize",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N protein dimers, the building block of high-order assemblies, for EM studies.",
    "entities": [
      {
        "text": "EM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We combine domain-specific monoclonal antibodies against N with chemical",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cross-linking mass spectrometry to validate the spatial arrangement of the N",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "domains within the dimer. Additionally, our cryo-EM analysis reveals novel",
    "entities": []
  },
  {
    "text": "antigenic sites on the N protein. Our findings provide insights into N protein\u00b4s",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      },
      {
        "text": "N",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "architectural and antigenic principles, which can guide design of",
    "entities": []
  },
  {
    "text": "pan-coronavirus therapeutics.",
    "entities": [
      {
        "text": "pan-coronavirus",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41467-025-61861-4",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664703 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "competing interests.",
    "entities": []
  },
  {
    "text": "Multilayer networks describing urban interactions for building the digital twins",
    "entities": [
      {
        "text": "Multilayer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of five cities in Spain.",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)CA UNED Illes Balears, Palma, Spain. jorgeprodriguezg@gmail.com.",
    "entities": [
      {
        "text": "2)CA",
        "label": "CARDINAL"
      },
      {
        "text": "Illes Balears",
        "label": "PERSON"
      },
      {
        "text": "Palma",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute for Biocomputation and Physics of Complex Systems (BIFI),",
    "entities": [
      {
        "text": "Biocomputation and Physics of Complex Systems",
        "label": "ORG"
      },
      {
        "text": "BIFI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Zaragoza, Zaragoza, Spain.",
    "entities": [
      {
        "text": "University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Zaragoza",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Theoretical Physics, University of Zaragoza, Zaragoza, Spain.",
    "entities": [
      {
        "text": "Theoretical Physics",
        "label": "ORG"
      },
      {
        "text": "University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Zaragoza",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Networks specifying who interacts with whom are crucial for mathematical models",
    "entities": []
  },
  {
    "text": "of epidemic spreading. In the context of emerging diseases, these networks have",
    "entities": []
  },
  {
    "text": "the potential to encode multiple interaction contexts where non-pharmaceutical",
    "entities": []
  },
  {
    "text": "interventions can be introduced, allowing for proper comparisons among different",
    "entities": []
  },
  {
    "text": "intervention strategies in a plethora of contexts. Consequently, a multilayer",
    "entities": []
  },
  {
    "text": "network describing interactions in a population and detailing their contexts in",
    "entities": []
  },
  {
    "text": "different layers constitutes an appropriate tool for such descriptions. These",
    "entities": []
  },
  {
    "text": "approaches however become challenging in large-scale systems such as cities,",
    "entities": []
  },
  {
    "text": "particularly in a framework where data protection policies are enhanced. In this",
    "entities": []
  },
  {
    "text": "work, we present a methodology to build such multilayer networks and make those",
    "entities": []
  },
  {
    "text": "corresponding to five Spanish cities available. Our work uses approaches",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "informed by multiple available datasets to create realistic digital twins of the",
    "entities": []
  },
  {
    "text": "citizens and their interactions and provides a playground to explore different",
    "entities": []
  },
  {
    "text": "pandemic scenario in realistic settings for better preparedness.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41597-025-05551-2",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664652 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664652",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: Authors declare no",
    "entities": []
  },
  {
    "text": "Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "self-controlled case series study.",
    "entities": []
  },
  {
    "text": "Pan Y(1)(2)(3), Han Y(4), Zhou C(5), Zhao L(6), Zheng J(2), Ye X(7)(8), He",
    "entities": [
      {
        "text": "Pan Y(1)(2)(3",
        "label": "PERSON"
      },
      {
        "text": "Han",
        "label": "NORP"
      },
      {
        "text": "Zhou C(5",
        "label": "PERSON"
      },
      {
        "text": "Zhao L(6",
        "label": "PERSON"
      },
      {
        "text": "Zheng J(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Collaborators: Chute CG.",
    "entities": [
      {
        "text": "Chute CG",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Radiology, People's Hospital of Guizhou Province, Guiyang,",
    "entities": [
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Unit for Laboratory Animal Medicine, University of Michigan Medical School,",
    "entities": [
      {
        "text": "Laboratory Animal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Guizhou University Medical College, Guiyang, Guizhou Province, China.",
    "entities": [
      {
        "text": "University Medical College",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine, Division of Nephrology, University of",
    "entities": [
      {
        "text": "Internal Medicine, Division of Nephrology, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Michigan, Medical School, Ann Arbor, MI, USA.",
    "entities": [
      {
        "text": "Michigan",
        "label": "GPE"
      },
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Radiology, University of Michigan, Medical School, Ann Arbor,",
    "entities": [
      {
        "text": "Radiology, University of Michigan,",
        "label": "ORG"
      },
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Preventive Medicine (Biostatistics Division), Northwestern",
    "entities": [
      {
        "text": "Preventive Medicine (Biostatistics Division",
        "label": "ORG"
      },
      {
        "text": "Northwestern\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Evanston, IL, USA.",
    "entities": [
      {
        "text": "Evanston",
        "label": "ORG"
      },
      {
        "text": "IL",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Guizhou University Medical College, Guiyang, Guizhou Province, China.",
    "entities": [
      {
        "text": "7)Guizhou University Medical College",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Respiratory and Critical Care Medicine and NHC Key Laboratory",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "NHC Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang,",
    "entities": [
      {
        "text": "Immunological Diseases",
        "label": "ORG"
      },
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Guizhou Province, China. yxw1205@163.com.",
    "entities": [
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Unit for Laboratory Animal Medicine, University of Michigan Medical School,",
    "entities": [
      {
        "text": "Laboratory Animal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Learning Health Sciences, University of Michigan Medical",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Learning Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Ann Arbor, MI, USA. yongqunh@med.umich.edu.",
    "entities": [
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "yongqunh@med.umich.edu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Center for Computational Medicine and Bioinformatics, University of Michigan",
    "entities": [
      {
        "text": "11)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Bioinformatics, University of Michigan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical School, Ann Arbor, MI, USA. yongqunh@med.umich.edu.",
    "entities": [
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "yongqunh@med.umich.edu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The safety of XBB.1.5-containing COVID-19 mRNA vaccines warrants investigation.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We assessed the relative risk of 15 adverse events following the XBB.1.5",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccination using a self-controlled case series study design with data from the",
    "entities": []
  },
  {
    "text": "National COVID Cohort Collaborative (N3C) from September 11, 2023, to June 1,",
    "entities": [
      {
        "text": "National COVID Cohort Collaborative",
        "label": "ORG"
      },
      {
        "text": "September 11, 2023",
        "label": "DATE"
      },
      {
        "text": "June 1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024 in the USA. Based on a baseline population of 244,494 patients, adverse",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "244,494",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "events included Guillain-Barr\u00e9 syndrome, seizure, non-hemorrhagic stroke and",
    "entities": []
  },
  {
    "text": "transient ischemic attack, hemorrhagic stroke, narcolepsy or cataplexy,",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anaphylaxis, acute myocardial infarction, myo/pericarditis, coagulopathy,",
    "entities": []
  },
  {
    "text": "multisystem inflammatory syndrome, Bell's palsy, transverse myelitis,",
    "entities": [
      {
        "text": "Bell",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "appendicitis, pulmonary embolism, and encephalitis. We found an association",
    "entities": [
      {
        "text": "appendicitis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "between vaccination and anaphylaxis (IRR [95% CI]: day 0-17.35 [9.32-30.03], day",
    "entities": [
      {
        "text": "IRR",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0-17.35",
        "label": "CARDINAL"
      },
      {
        "text": "9.32",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1-9.35 [5.12-15.95], day 2-6.20 [3.40-10.57], <20 patients in each risk period).",
    "entities": [
      {
        "text": "1-9.35",
        "label": "PERCENT"
      },
      {
        "text": "5.12-15.95",
        "label": "CARDINAL"
      },
      {
        "text": "2-6.20",
        "label": "DATE"
      },
      {
        "text": "3.40",
        "label": "CARDINAL"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "No other outcomes showed significantly increased risk following vaccination. Our",
    "entities": []
  },
  {
    "text": "results contribute to the safety profile evaluation for XBB.1.5-containing",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41467-025-61613-4",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664645 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664645",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Jul-Aug.",
    "entities": []
  },
  {
    "text": "Association between preoperative proton pump inhibitor use and postoperative",
    "entities": []
  },
  {
    "text": "infectious and renal complications following major elective surgery.",
    "entities": []
  },
  {
    "text": "Dubois L(1), McClure JA(2), Jones PM(2), Mrkobrada M(2), Flier S(2), Welk B(2),",
    "entities": [
      {
        "text": "McClure JA(2",
        "label": "PERSON"
      },
      {
        "text": "Jones PM(2",
        "label": "PERSON"
      },
      {
        "text": "Mrkobrada",
        "label": "ORG"
      },
      {
        "text": "M(2",
        "label": "CARDINAL"
      },
      {
        "text": "Flier S(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)From the Department of Surgery, Schulich School of Medicine and Dentistry,",
    "entities": [
      {
        "text": "the Department of Surgery",
        "label": "ORG"
      },
      {
        "text": "Schulich School of Medicine and Dentistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Western University, London, Ont. (Dubois, Mrkobrada, Welk, Vogt); London Health",
    "entities": [
      {
        "text": "Western University",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "Ont",
        "label": "PERSON"
      },
      {
        "text": "Dubois",
        "label": "NORP"
      },
      {
        "text": "Mrkobrada",
        "label": "GPE"
      },
      {
        "text": "London Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Vogt); ICES Western, London, Ont. (Dubois, Jones, Welk); the Department of",
    "entities": [
      {
        "text": "ICES Western",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "Ont",
        "label": "PERSON"
      },
      {
        "text": "Dubois",
        "label": "NORP"
      },
      {
        "text": "the Department of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry,",
    "entities": [
      {
        "text": "Schulich School of Medicine and Dentistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Western University, London, Ont. (Dubois, Jones, Welk); the Department of",
    "entities": [
      {
        "text": "Western University",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "Ont",
        "label": "PERSON"
      },
      {
        "text": "Dubois",
        "label": "NORP"
      },
      {
        "text": "the Department of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Anesthesia & Perioperative Medicine, Schulich School of Medicine and Dentistry,",
    "entities": [
      {
        "text": "Anesthesia & Perioperative Medicine",
        "label": "ORG"
      },
      {
        "text": "Schulich School of Medicine and Dentistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Western University, London, Ont. (Jones, Flier) luc.dubois@lhsc.on.ca.",
    "entities": [
      {
        "text": "Western University",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "Ont",
        "label": "PERSON"
      },
      {
        "text": "Jones, Flier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)From the Department of Surgery, Schulich School of Medicine and Dentistry,",
    "entities": [
      {
        "text": "the Department of Surgery",
        "label": "ORG"
      },
      {
        "text": "Schulich School of Medicine and Dentistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Western University, London, Ont. (Jones, Flier).",
    "entities": [
      {
        "text": "Western University",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "Ont",
        "label": "PERSON"
      },
      {
        "text": "Jones, Flier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Use of poton pump inhibitors (PPIs) is associated with increased",
    "entities": []
  },
  {
    "text": "risk of Clostridioides difficile-associated colitis, pneumonia, and acute kidney",
    "entities": [
      {
        "text": "Clostridioides",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "injury. Their effect on postoperative complications is unknown. The objective of",
    "entities": []
  },
  {
    "text": "this study was to investigate the association between PPIs and the risk of C.",
    "entities": [
      {
        "text": "C.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "difficile-associated colitis, pneumonia, and acute kidney injury following",
    "entities": []
  },
  {
    "text": "elective surgery.",
    "entities": []
  },
  {
    "text": "METHODS: In this population-based, matched cohort study, we identified patients",
    "entities": []
  },
  {
    "text": "who had filled a PPI prescription within 90 days before major elective surgery",
    "entities": [
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2010-2019). Study outcomes included C. difficile-associated colitis, pneumonia,",
    "entities": [
      {
        "text": "2010-2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "acute kidney injury, gastrointestinal bleeding, and death within 90 days of",
    "entities": [
      {
        "text": "acute kidney injury",
        "label": "PERSON"
      },
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "surgery. We matched patients 1-to-1 on the basis of age, sex, procedure, date of",
    "entities": [
      {
        "text": "1-to-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "surgery, and a propensity score predicting PPI exposure. We used logistic",
    "entities": []
  },
  {
    "text": "regression to evaluate between-group differences.",
    "entities": []
  },
  {
    "text": "RESULTS: Of 313 163 patients, 89 047 (28.4%) used PPIs; of those, 79 681 were",
    "entities": [
      {
        "text": "313 163",
        "label": "CARDINAL"
      },
      {
        "text": "89 047",
        "label": "CARDINAL"
      },
      {
        "text": "28.4%",
        "label": "PERCENT"
      },
      {
        "text": "79 681",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "successfully matched to patients who did not use PPIs. The risk of the composite",
    "entities": []
  },
  {
    "text": "outcome (acute kidney injury, pneumonia, C. difficile-associated colitis, and",
    "entities": [
      {
        "text": "C. difficile-",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "death) among the patients who used PPIs was slightly higher than among the",
    "entities": []
  },
  {
    "text": "patients who did not use PPIs (10.6% v. 10.2 4%), and was driven primarily by a",
    "entities": [
      {
        "text": "10.6%",
        "label": "PERCENT"
      },
      {
        "text": "10.2 4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "higher rate of pneumonia among those who used PPIs (4.0% v. 3.7%). There was a",
    "entities": [
      {
        "text": "4.0%",
        "label": "PERCENT"
      },
      {
        "text": "3.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "lower rate of gastrointestinal bleeding among the patients who used PPIs (1.6%",
    "entities": [
      {
        "text": "1.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "v. 1.8%). The risk of pneumonia was most pronounced in the subgroup undergoing",
    "entities": [
      {
        "text": "1.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "hip and knee replacement (odds ratio 1.21, 95% confidence interval 1.08-1.36; p",
    "entities": [
      {
        "text": "1.21",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "1.08",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "= 0.001). There were no significant differences between groups with regard to",
    "entities": [
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rates of C. difficile-associated colitis or acute kidney injury.",
    "entities": []
  },
  {
    "text": "CONCLUSION: We found that preoperative PPI use was associated with higher rates",
    "entities": []
  },
  {
    "text": "of pneumonia, particularly among patients undergoing hip and knee replacement",
    "entities": []
  },
  {
    "text": "surgery, and lower rates of gastrointestinal bleeding. Patients taking a PPI",
    "entities": []
  },
  {
    "text": "before surgery should be targeted for therapies aimed at reducing pneumonia",
    "entities": []
  },
  {
    "text": "risk, such as aggressive chest physiotherapy, following their operation.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 CMA Impact Inc. or its licensors.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PMID: 40664466 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664466",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests:: Kelly Vogt is an associate",
    "entities": [
      {
        "text": "Kelly Vogt",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "editor of CJS; she was not involved in the review or decision to accept this",
    "entities": [
      {
        "text": "CJS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "manuscript for publication. No other competing interests were declared.",
    "entities": []
  },
  {
    "text": "Impact of a community-based asynchronous review clinic on appointment attendance",
    "entities": []
  },
  {
    "text": "delays across an eye hospital network in London, UK: an interrupted time series",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "S(6), Alarc\u00f3n Garavito GA(6), Elphinstone H(6), Mills G(8), Scully P(9), Symons",
    "entities": [
      {
        "text": "Alarc\u00f3n Garavito GA(6",
        "label": "PERSON"
      },
      {
        "text": "Elphinstone",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foster PJ(2), Clarke CS(4); HERCULES Research Consortium.",
    "entities": [
      {
        "text": "Foster",
        "label": "PERSON"
      },
      {
        "text": "Clarke CS(4",
        "label": "GPE"
      },
      {
        "text": "HERCULES Research Consortium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Research Department of Primary Care and Population Health, University College",
    "entities": [
      {
        "text": "Department of Primary Care and Population Health, University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)National Institute for Health and Care Research (NIHR) Biomedical Research",
    "entities": [
      {
        "text": "Institute for Health and Care Research",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      },
      {
        "text": "Biomedical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute",
    "entities": [
      {
        "text": "BRC",
        "label": "ORG"
      },
      {
        "text": "Moorfields Eye Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "UCL Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Ophthalmology, London, UK.",
    "entities": [
      {
        "text": "Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Moorfields Eye Hospital NHS Foundation Trust, London, UK.",
    "entities": [
      {
        "text": "Eye Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Research Department of Primary Care and Population Health, University College",
    "entities": [
      {
        "text": "Department of Primary Care and Population Health, University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Research Department of Behavioural Science and Health, University College",
    "entities": [
      {
        "text": "6)Research Department of Behavioural Science and Health, University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Institute of Epidemiology and Health Care, University College London, London,",
    "entities": [
      {
        "text": "Epidemiology and Health Care, University College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)University College London The Bartlett School of Sustainable Construction,",
    "entities": [
      {
        "text": "College London",
        "label": "ORG"
      },
      {
        "text": "The Bartlett School of Sustainable Construction",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)University College London The Bartlett School of Architecture, London, UK.",
    "entities": [
      {
        "text": "College London",
        "label": "ORG"
      },
      {
        "text": "The Bartlett School of Architecture",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To assess the impact of opening a large community-based asynchronous",
    "entities": []
  },
  {
    "text": "review ophthalmic clinic on attendance delays among patients with stable chronic",
    "entities": []
  },
  {
    "text": "eye disease attending a London teaching eye hospital network.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DESIGN: Interrupted time-series analysis of routine electronic health records of",
    "entities": []
  },
  {
    "text": "SETTING: A large eye hospital network with facilities across London, UK, between",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "June 2018 and April 2023.",
    "entities": [
      {
        "text": "June 2018",
        "label": "DATE"
      },
      {
        "text": "April 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: We analysed 69 257 attendances from 39 357 patients, with glaucoma",
    "entities": [
      {
        "text": "69",
        "label": "CARDINAL"
      },
      {
        "text": "257",
        "label": "CARDINAL"
      },
      {
        "text": "39 357",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and medical retina accounting for 62% (n=42 982) and 38% (n=26 275) of visits,",
    "entities": [
      {
        "text": "62%",
        "label": "PERCENT"
      },
      {
        "text": "982",
        "label": "CARDINAL"
      },
      {
        "text": "38%",
        "label": "PERCENT"
      },
      {
        "text": "275",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respectively. Patients over 65 made up 54% (n=37 824) of attendances, while 53%",
    "entities": [
      {
        "text": "54%",
        "label": "PERCENT"
      },
      {
        "text": "824",
        "label": "CARDINAL"
      },
      {
        "text": "53%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(n=37 014) were from the more deprived half of the population, and 51%",
    "entities": [
      {
        "text": "014",
        "label": "CARDINAL"
      },
      {
        "text": "half",
        "label": "CARDINAL"
      },
      {
        "text": "51%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "INTERVENTION: An asynchronous review clinic opened in a shopping centre in",
    "entities": []
  },
  {
    "text": "London, in autumn 2021, following the COVID-19 lockdown in spring 2020.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "autumn 2021",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "spring 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "MAIN OUTCOME MEASURES: Average attendance delays (days), calculated as the",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "difference between follow-up attendance date and the latest clinically",
    "entities": []
  },
  {
    "text": "appropriate date determined at the preceding attendance.",
    "entities": []
  },
  {
    "text": "RESULTS: Pre-COVID-19, attendance delays for chronic eye disease monitoring were",
    "entities": []
  },
  {
    "text": "increasing by 0.9 days per week (95% CI, 0.8 to 0.9) on average, worsening to",
    "entities": [
      {
        "text": "0.9 days per week",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.8",
        "label": "DATE"
      },
      {
        "text": "0.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "2.0 days per week (95% CI, 2.0 to 2.0) after the first COVID-19 national",
    "entities": [
      {
        "text": "2.0 days per week",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.0",
        "label": "CARDINAL"
      },
      {
        "text": "2.0",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lockdown, mid-March 2020. Opening the asynchronous review clinic increased",
    "entities": [
      {
        "text": "mid-March 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "appointment capacity, with delays decreasing on average by 8.1 days per week",
    "entities": [
      {
        "text": "8.1 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(95% CI, 8.1 to 8.2) shortly after opening. The rate of decrease slowed to 0.3",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "8.1",
        "label": "CARDINAL"
      },
      {
        "text": "8.2",
        "label": "CARDINAL"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days per week (95% CI, 0.3 to 0.3) after 5 months. We found no significant",
    "entities": [
      {
        "text": "days per week",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      },
      {
        "text": "5 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "differences in average attendance delays by age, gender or level of deprivation.",
    "entities": []
  },
  {
    "text": "CONCLUSION: The asynchronous review clinic significantly reduced attendance",
    "entities": []
  },
  {
    "text": "delays across the hospital network, addressing pre-existing backlog for stable",
    "entities": []
  },
  {
    "text": "chronic eye diseases. The reduction appeared to be maintained after the initial",
    "entities": []
  },
  {
    "text": "backlog had been cleared.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664400 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664400",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: HB, JC, PJF, HJ and PTK",
    "entities": [
      {
        "text": "HB",
        "label": "ORG"
      },
      {
        "text": "JC",
        "label": "GPE"
      },
      {
        "text": "PJF",
        "label": "ORG"
      },
      {
        "text": "PTK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acknowledge salary support from the National Institute for Health and Care",
    "entities": [
      {
        "text": "the National Institute for Health and Care\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research (NIHR) through a grant for a Biomedical Research Centre (BRC) at",
    "entities": [
      {
        "text": "NIHR",
        "label": "ORG"
      },
      {
        "text": "Biomedical Research Centre",
        "label": "ORG"
      },
      {
        "text": "BRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.",
    "entities": [
      {
        "text": "Moorfields Eye Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "UCL Institute of Ophthalmology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Additionally, PJF reports personal fees from Abbvie, Allergan, AlphaSights, Carl",
    "entities": [
      {
        "text": "PJF",
        "label": "ORG"
      },
      {
        "text": "Abbvie",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "AlphaSights",
        "label": "ORG"
      },
      {
        "text": "Carl\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Zeiss, DeepMind, Google Health, GLG, Guidepoint, PwC and Santen, as well as a",
    "entities": [
      {
        "text": "Zeiss",
        "label": "ORG"
      },
      {
        "text": "DeepMind",
        "label": "PERSON"
      },
      {
        "text": "Google Health",
        "label": "ORG"
      },
      {
        "text": "GLG",
        "label": "GPE"
      },
      {
        "text": "Guidepoint",
        "label": "GPE"
      },
      {
        "text": "PwC",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Santen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "grant from Alcon, all outside the submitted work. HJ has consulted for Allergan,",
    "entities": [
      {
        "text": "Alcon",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ivantis, Scope Ophthalmics and Rebio; received honoraria for lectures and",
    "entities": [
      {
        "text": "Scope Ophthalmics",
        "label": "ORG"
      },
      {
        "text": "Rebio",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "educational events from Allergan, Laboratoires Th\u00e9a, and Santen; received",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Laboratoires Th\u00e9a",
        "label": "PERSON"
      },
      {
        "text": "Santen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "support to attend meetings from Allergan; participated on an Advisory Board for",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Advisory Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Allergan. SS reports receiving research grants from Novartis, Bayer, Allergan,",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "SS",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Roche, Boehringer, Ingelheim and Optos plc, travel grants from Novartis, Bayer,",
    "entities": [
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Boehringer,",
        "label": "ORG"
      },
      {
        "text": "Ingelheim",
        "label": "GPE"
      },
      {
        "text": "Optos plc",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "speaker fees from Novartis, Bayer and Optos plc, and attending advisory board",
    "entities": [
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "ORG"
      },
      {
        "text": "Optos plc",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "meetings for Novartis, Bayer, Allergan, Roche, Boehringer, Ingelheim, Optos plc,",
    "entities": [
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Boehringer, Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Optos plc",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Apellis, Oculis and Eyebiotech. Sir Peng T Khaw is also supported by the Helen",
    "entities": [
      {
        "text": "Apellis",
        "label": "PERSON"
      },
      {
        "text": "Oculis",
        "label": "GPE"
      },
      {
        "text": "Eyebiotech",
        "label": "GPE"
      },
      {
        "text": "Peng T Khaw",
        "label": "PERSON"
      },
      {
        "text": "Helen",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Hamlyn Trust, the Nolan Family, the Katz Foundation and reports consulting and",
    "entities": [
      {
        "text": "Hamlyn Trust",
        "label": "PERSON"
      },
      {
        "text": "the Nolan Family",
        "label": "ORG"
      },
      {
        "text": "the Katz Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lecturing at Aerie Pharmaceuticals and consulting for Novartis, Thea, Glaukos,",
    "entities": [
      {
        "text": "Aerie Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "Novartis, Thea, Glaukos",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Santen, Genentech, CMER Hospital Group, Hong Kong Alcon, ISA RNA Therapeutics",
    "entities": [
      {
        "text": "Genentech",
        "label": "ORG"
      },
      {
        "text": "CMER Hospital Group",
        "label": "ORG"
      },
      {
        "text": "Hong Kong",
        "label": "GPE"
      },
      {
        "text": "Alcon",
        "label": "GPE"
      },
      {
        "text": "ISA RNA Therapeutics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "GmbH; he is also on the Advisory Board of Novartis, DrugTech, Santen, CRICK",
    "entities": [
      {
        "text": "the Advisory Board of Novartis",
        "label": "ORG"
      },
      {
        "text": "DrugTech",
        "label": "ORG"
      },
      {
        "text": "Santen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Institute Translational Advisory Group, and Decisions on health Care to",
    "entities": [
      {
        "text": "Institute Translational Advisory Group",
        "label": "ORG"
      },
      {
        "text": "Decisions on health Care",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Introduce or Diffuse innovations using Evidence (DECIDE). NJF is an NIHR Senior",
    "entities": [
      {
        "text": "NJF",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Investigator. SN and CSC hold honorary research contracts from Moorfields Eye",
    "entities": [
      {
        "text": "SN",
        "label": "ORG"
      },
      {
        "text": "CSC",
        "label": "ORG"
      },
      {
        "text": "Moorfields Eye",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital to perform this work. PW reports receiving support from Ubisense",
    "entities": [
      {
        "text": "PW",
        "label": "GPE"
      },
      {
        "text": "Ubisense",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Limited in the form of equipment used for tracking participants as part of the",
    "entities": []
  },
  {
    "text": "HERCULES project. This equipment was loaned at a subsidised rate, primarily",
    "entities": [
      {
        "text": "HERCULES",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "covering initial installation and customisation costs. AIGR is a trustee at",
    "entities": [
      {
        "text": "AIGR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Services Research UK. NJF is an NIHR Senior Investigator and",
    "entities": [
      {
        "text": "Health Services Research",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "NJF",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Non-Executive Director at Covid-19 Bereaved Families for Justice UK. She was a",
    "entities": [
      {
        "text": "Non-Executive",
        "label": "ORG"
      },
      {
        "text": "Covid-19 Bereaved Families for",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Non-Executive Director at Whittington Health NHS Trust until October 2024 and a",
    "entities": [
      {
        "text": "Non-Executive",
        "label": "ORG"
      },
      {
        "text": "Whittington Health NHS Trust",
        "label": "ORG"
      },
      {
        "text": "October 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "trustee at Health Services Research UK until 2022; she was a member of the UKRI",
    "entities": [
      {
        "text": "Health Services Research",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "UKRI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and NIHR College of Experts for Covid-19 Research Funding (2020), the NIHR",
    "entities": [
      {
        "text": "NIHR College of Experts",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Services and Delivery Research (HS&DR) Programme Funding Committee",
    "entities": [
      {
        "text": "Health Services and",
        "label": "ORG"
      },
      {
        "text": "Delivery Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2013-2018), and the HS&DR Evidence Synthesis Sub Board (2016). NJF and AIGR are",
    "entities": [
      {
        "text": "2013-2018",
        "label": "DATE"
      },
      {
        "text": "the HS&DR Evidence Synthesis Sub Board",
        "label": "ORG"
      },
      {
        "text": "2016",
        "label": "DATE"
      },
      {
        "text": "NJF",
        "label": "ORG"
      },
      {
        "text": "AIGR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supported by the NIHR Central London Patient Safety Research Collaboration. All",
    "entities": [
      {
        "text": "the NIHR Central London Patient Safety Research Collaboration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "other authors have no competing interests to declare.",
    "entities": []
  },
  {
    "text": "43. Am J Trop Med Hyg. 2025 Jul 15:tpmd250191. doi: 10.4269/ajtmh.25-0191. Online",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "Med Hyg",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.4269",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Clinical Characteristics of Pediatric Pleuropulmonary Paragonimiasis with",
    "entities": [
      {
        "text": "Clinical Characteristics of Pediatric Pleuropulmonary Paragonimiasis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pleural Effusion: A Single-Center Retrospective Analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Pediatrics, Public Health Clinical Center of Chengdu, Chengdu,",
    "entities": [
      {
        "text": "Pediatrics, Public Health Clinical Center of Chengdu, Chengdu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "People's Republic of China.",
    "entities": []
  },
  {
    "text": "(2)School of Smart Healthcare Industry, Chongqing City Management College,",
    "entities": [
      {
        "text": "Smart Healthcare Industry",
        "label": "ORG"
      },
      {
        "text": "Chongqing City Management College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chongqing, People's Republic of China.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pediatrics, Chengdu Women's and Children's Central Hospital,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Chengdu Women's",
        "label": "ORG"
      },
      {
        "text": "Children's Central Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chengdu, People's Republic of China.",
    "entities": [
      {
        "text": "Chengdu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Pediatrics, Shanxi Children's Hospital, Taiyuan, People's",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "GPE"
      },
      {
        "text": "Taiyuan",
        "label": "GPE"
      },
      {
        "text": "People's\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Republic of China.",
    "entities": []
  },
  {
    "text": "Paragonimiasis, a cause of pleuropulmonary disease, is a neglected etiology of",
    "entities": []
  },
  {
    "text": "pediatric pleural effusion. We retrospectively analyzed children with",
    "entities": []
  },
  {
    "text": "paragonimiasis-induced pleural effusion admitted to our center, aiming to",
    "entities": []
  },
  {
    "text": "summarize their diagnosis, treatment, and prognosis. A total of 103 children",
    "entities": [
      {
        "text": "103",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were included, with a mean age of 8.2 years, and 87.4% resided in rural areas.",
    "entities": [
      {
        "text": "87.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "81/91 (89.0%) were initially misdiagnosed with other infectious diseases",
    "entities": [
      {
        "text": "81/91",
        "label": "CARDINAL"
      },
      {
        "text": "89.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "including community-acquired pneumonia (43.9%; 40/91) and tuberculosis (16.5%;",
    "entities": [
      {
        "text": "43.9%",
        "label": "PERCENT"
      },
      {
        "text": "40/91",
        "label": "CARDINAL"
      },
      {
        "text": "16.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "15/91). The predominant blood test findings included hypereosinophilia (98.1%),",
    "entities": [
      {
        "text": "15/91",
        "label": "CARDINAL"
      },
      {
        "text": "98.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "leukocytosis (95.1%), thrombocytosis (42.7%), hyperglobulinemia (78.6%), and",
    "entities": [
      {
        "text": "95.1%",
        "label": "PERCENT"
      },
      {
        "text": "42.7%",
        "label": "PERCENT"
      },
      {
        "text": "78.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "elevated immunoglobulin G levels (85.4%; 76/89). Multiple serous cavity",
    "entities": [
      {
        "text": "85.4%",
        "label": "PERCENT"
      },
      {
        "text": "76/89",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "effusions exhibited higher globulin levels (44.7 g/L versus 36.7 g/L) and lower",
    "entities": [
      {
        "text": "44.7",
        "label": "CARDINAL"
      },
      {
        "text": "36.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "albumin-globulin ratios (0.8 versus 1.0) than single pleural effusions, and",
    "entities": [
      {
        "text": "albumin-globulin",
        "label": "ORG"
      },
      {
        "text": "0.8",
        "label": "CARDINAL"
      },
      {
        "text": "1.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "loculation was more common in medium or large pleural effusions. After 3 days of",
    "entities": [
      {
        "text": "3 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "praziquantel treatment at a dosage of 75-90 mg/(kg\u00b7day), with a median of four",
    "entities": [
      {
        "text": "75-90",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "courses, all of the children improved, but no patients were cured with a single",
    "entities": []
  },
  {
    "text": "course of therapy. Almost half of the patients (44/99) continued to exhibit",
    "entities": [
      {
        "text": "Almost half",
        "label": "CARDINAL"
      },
      {
        "text": "44/99",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "medium or small residual effusion on chest computed tomography scans.",
    "entities": []
  },
  {
    "text": "Additionally, various types of lung lesions remained, and the incidence of",
    "entities": []
  },
  {
    "text": "pleural lesions increased during the follow-up period. Unexplained pediatric",
    "entities": [
      {
        "text": "pleural",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pleural effusion with eosinophilia requires paragonimiasis evaluation. Early",
    "entities": []
  },
  {
    "text": "diagnosis and accurate treatment critically improve clinical prognosis, whereas",
    "entities": []
  },
  {
    "text": "Online ahead of print.",
    "entities": []
  },
  {
    "text": "Critical exposure windows of PM2.5-Meteorological interactions triggering",
    "entities": []
  },
  {
    "text": "pediatric mycoplasma pneumoniae epidemics: An age-stratified distributed lag",
    "entities": []
  },
  {
    "text": "nonlinear modeling approach.",
    "entities": []
  },
  {
    "text": "(1)Department of Pediatrics, Shengjing Hospital of China Medical University,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Health Management, Shengjing Hospital of China Medical",
    "entities": [
      {
        "text": "Health Management",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Institute of Atmospheric Environment, China Meteorological Administration,",
    "entities": [
      {
        "text": "China Meteorological Administration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Laboratory Medicine, Shengjing Hospital of China Medical",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Liaoning Clinical Research Center for Laboratory Medicine, Shenyang,",
    "entities": [
      {
        "text": "University, Liaoning Clinical Research Center for Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Shenyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pediatrics, Shengjing Hospital of China Medical University,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shenyang, Liaoning, 110000, China. Electronic address: tomxu.123@163.com.",
    "entities": [
      {
        "text": "Shenyang",
        "label": "GPE"
      },
      {
        "text": "Liaoning",
        "label": "GPE"
      },
      {
        "text": "110000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Pediatrics, Shengjing Hospital of China Medical University,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shenyang, Liaoning, 110000, China. Electronic address: qcheng@cmu.edu.cn.",
    "entities": [
      {
        "text": "Shenyang",
        "label": "GPE"
      },
      {
        "text": "Liaoning",
        "label": "GPE"
      },
      {
        "text": "110000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The rising prevalence of Mycoplasma pneumoniae infection (MPI) in",
    "entities": [
      {
        "text": "Mycoplasma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "children, a leading cause of severe pneumonia and mortality, highlights the need",
    "entities": []
  },
  {
    "text": "to clarify impacts of air pollution and meteorological factors.",
    "entities": []
  },
  {
    "text": "METHODS: This study analyzed associations of PM2.5, temperature, and humidity",
    "entities": []
  },
  {
    "text": "with outpatient MPI, inpatient MPP, and severe MPP (SMPP). Data on 391,559",
    "entities": [
      {
        "text": "MPP",
        "label": "ORG"
      },
      {
        "text": "MPP",
        "label": "PERSON"
      },
      {
        "text": "SMPP",
        "label": "ORG"
      },
      {
        "text": "391,559",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "children from 15 Northeast China hospitals (2017-2023) were analyzed using a",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "Northeast China",
        "label": "LOC"
      },
      {
        "text": "2017-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "distributed lag nonlinear model, with sensitivity analysis after 2020 (COVID-19",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: PM2.5 (60-100 \u03bcg/m3) showed nonlinear associations with outpatient MPI",
    "entities": [
      {
        "text": "60-100",
        "label": "CARDINAL"
      },
      {
        "text": "MPI\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(7-15-day lag, RR = 2.28 at 100 \u03bcg/m3, 10-day lag), especially in preschoolers.",
    "entities": [
      {
        "text": "7-15-day",
        "label": "DATE"
      },
      {
        "text": "2.28",
        "label": "CARDINAL"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "10-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Temperature correlated positively with outpatient MPI (peaks at 20 \u00b0C/30 \u00b0C,",
    "entities": [
      {
        "text": "MPI",
        "label": "ORG"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "7-10-day lag; RR = 1.82 at 30 \u00b0C, 10-day lag), with high temperatures increasing",
    "entities": [
      {
        "text": "7-10-day",
        "label": "DATE"
      },
      {
        "text": "1.82",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "10-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "female MPP/SMPP risk. Humidity had a U-shaped association with outpatient MPI",
    "entities": [
      {
        "text": "MPP",
        "label": "ORG"
      },
      {
        "text": "MPI\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(20 %/100 % humidity increased risk 2.75/2.18-fold at 15-day lag), with high",
    "entities": [
      {
        "text": "20 %",
        "label": "PERCENT"
      },
      {
        "text": "2.75/2.18-fold",
        "label": "CARDINAL"
      },
      {
        "text": "15-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "humidity elevating female/school-age SMPP risk (RR = 5.32). Trends were",
    "entities": [
      {
        "text": "SMPP",
        "label": "ORG"
      },
      {
        "text": "5.32",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: High PM2.5, high temperature, and extreme humidity correlate with",
    "entities": []
  },
  {
    "text": "increased childhood MPI cases and severity, emphasizing targeted strategies for",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier Ltd. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest The authors",
    "entities": []
  },
  {
    "text": "declare that they have no known competing financial interests or personal",
    "entities": []
  },
  {
    "text": "relationships that could have appeared to influence the work reported in this",
    "entities": []
  },
  {
    "text": "Implementation of an automated, real-time mortality prediction tool in trauma",
    "entities": []
  },
  {
    "text": "patients: Can it do more than just predict mortality?",
    "entities": []
  },
  {
    "text": "Chowdhry V(2), Sanders D(3), Starr A(3), Park C(4).",
    "entities": [
      {
        "text": "Sanders D(3",
        "label": "PERSON"
      },
      {
        "text": "Starr",
        "label": "PERSON"
      },
      {
        "text": "Park C(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)University of Texas Southwestern Medical Center, Department of Surgery,",
    "entities": [
      {
        "text": "1)University",
        "label": "CARDINAL"
      },
      {
        "text": "Texas Southwestern Medical Center, Department of Surgery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Dallas, TX, USA.",
    "entities": [
      {
        "text": "Dallas",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Parkland Memorial Hospital, Dallas, TX, USA.",
    "entities": [
      {
        "text": "Memorial Hospital",
        "label": "ORG"
      },
      {
        "text": "Dallas",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)University of Texas Southwestern Medical Center, Department of Orthopedic",
    "entities": [
      {
        "text": "Texas Southwestern Medical Center, Department of Orthopedic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Surgery, Dallas, TX, USA.",
    "entities": [
      {
        "text": "Dallas",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)University of Texas Southwestern Medical Center, Department of Surgery,",
    "entities": [
      {
        "text": "Texas Southwestern Medical Center, Department of Surgery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Dallas, TX, USA. Electronic address: caroline.park@utsouthwestern.edu.",
    "entities": [
      {
        "text": "Dallas",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: The Parkland Trauma Index of Mortality (PTIM) is a validated",
    "entities": []
  },
  {
    "text": "machine learning tool for real-time prediction of 48-hour mortality in trauma",
    "entities": [
      {
        "text": "48-hour",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "METHODS: This retrospective study at a Level I Trauma center analyzed PTIM",
    "entities": [
      {
        "text": "PTIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "scores and their association with clinical outcomes in 171 patients from",
    "entities": [
      {
        "text": "171",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "December 2020 to August 2021. A PTIM score of 1.0 predicts 100 % mortality.",
    "entities": [
      {
        "text": "December 2020 to August 2021",
        "label": "DATE"
      },
      {
        "text": "PTIM",
        "label": "ORG"
      },
      {
        "text": "1.0",
        "label": "CARDINAL"
      },
      {
        "text": "100 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RESULTS: We included a total of 171 patients, with a mean PTIM score of 0.26",
    "entities": [
      {
        "text": "171",
        "label": "CARDINAL"
      },
      {
        "text": "0.26",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[median = 0.1825, range =0.89, IQR=0.37]. For every 0.1 increase in PTIM score,",
    "entities": [
      {
        "text": "0.1825",
        "label": "CARDINAL"
      },
      {
        "text": "0.89",
        "label": "CARDINAL"
      },
      {
        "text": "0.1",
        "label": "CARDINAL"
      },
      {
        "text": "PTIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ICU days increased by 0.966 days, ventilator days increased by 0.724 days,",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "0.966 days",
        "label": "DATE"
      },
      {
        "text": "0.724 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hospital stay increased by 1.668 days, and blood transfusion needs increased by",
    "entities": [
      {
        "text": "1.668 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "0.37 units. An increase in PTIM score was also associated with higher odds of",
    "entities": [
      {
        "text": "0.37",
        "label": "CARDINAL"
      },
      {
        "text": "PTIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "shock, pneumonia, and mortality. PTIM did not significantly impact time to the",
    "entities": [
      {
        "text": "PTIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: These findings demonstrate PTIM's utility in anticipating resource",
    "entities": [
      {
        "text": "PTIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "utilization and patient outcomes. Future research aims to validate PTIM",
    "entities": [
      {
        "text": "PTIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "externally and explore additional applications for this real-time prediction",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025. Published by Elsevier Ltd.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare the following financial interests/personal relationships which may be",
    "entities": []
  },
  {
    "text": "considered as potential competing interests: Caroline Park, Adam Starr, Vikas",
    "entities": [
      {
        "text": "Caroline Park",
        "label": "PERSON"
      },
      {
        "text": "Adam Starr",
        "label": "PERSON"
      },
      {
        "text": "Vikas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chowdhry reports a relationship with TraumaCare.AI that includes: consulting or",
    "entities": [
      {
        "text": "TraumaCare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "advisory. If there are other authors, they declare that they have no known",
    "entities": []
  },
  {
    "text": "competing financial interests or personal relationships that could have appeared",
    "entities": []
  },
  {
    "text": "to influence the work reported in this paper.",
    "entities": []
  },
  {
    "text": "46. Shock. 2025 Jun 26. doi: 10.1097/SHK.0000000000002656. Online ahead of print.",
    "entities": [
      {
        "text": "46",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "26",
        "label": "CARDINAL"
      },
      {
        "text": "10.1097/SHK.0000000000002656",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The Value of Heparin-Binding Protein (HBP) in Predicting Early Pneumonia in",
    "entities": [
      {
        "text": "The Value of Heparin-Binding Protein",
        "label": "ORG"
      },
      {
        "text": "Predicting",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Bethune Hospital",
        "label": "ORG"
      },
      {
        "text": "Shanxi Academy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Tongji Shanxi Hospital",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "University, Taiyuan, 030032, China.",
    "entities": [
      {
        "text": "University, Taiyuan, 030032",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Rehabilitation, The Second Hospital, Cheeloo College of",
    "entities": [
      {
        "text": "The Second Hospital",
        "label": "ORG"
      },
      {
        "text": "Cheeloo College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Shandong University, Jinan, 250033, China.",
    "entities": [
      {
        "text": "Shandong University",
        "label": "ORG"
      },
      {
        "text": "Jinan",
        "label": "GPE"
      },
      {
        "text": "250033",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurosurgery, Shandong Provincial Hospital Affiliated to",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Shandong Provincial Hospital Affiliated",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shandong First Medical University, Shandong Provincial Hospital, Jinan, 250021,",
    "entities": [
      {
        "text": "Shandong First Medical University",
        "label": "ORG"
      },
      {
        "text": "Shandong Provincial Hospital",
        "label": "ORG"
      },
      {
        "text": "Jinan",
        "label": "GPE"
      },
      {
        "text": "250021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan,",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Taiyuan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The high incidence of pneumonia in neurosurgical intensive care unit",
    "entities": []
  },
  {
    "text": "(NICU) patients significantly impacts their prognosis. Early identification of",
    "entities": [
      {
        "text": "NICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "high-risk individuals for pneumonia is crucial for timely intervention and",
    "entities": []
  },
  {
    "text": "personalized treatment. Heparin-binding protein (HBP), an early inflammatory",
    "entities": []
  },
  {
    "text": "marker, shows promise as a predictor for early-onset pneumonia.",
    "entities": []
  },
  {
    "text": "METHODS: This study enrolled a prospective cohort of 389 NICU patients. Logistic",
    "entities": [
      {
        "text": "389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "regression analysis was used to identify risk factors for early pneumonia while",
    "entities": []
  },
  {
    "text": "accounting for the potential confounding effects of other variables on HBP.",
    "entities": [
      {
        "text": "HBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Restricted cubic splines (RCS) were employed to explore the potential non-linear",
    "entities": [
      {
        "text": "Restricted",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "relationship between HBP and the risk of early pneumonia. Subgroup analyses were",
    "entities": [
      {
        "text": "HBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "conducted to evaluate the sensitivity of HBP as a risk factor. A nomogram",
    "entities": [
      {
        "text": "HBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "integrating HBP and four other independent risk factors was developed to predict",
    "entities": [
      {
        "text": "HBP",
        "label": "ORG"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "early pneumonia. The performance of the model was assessed using receiver",
    "entities": []
  },
  {
    "text": "operating characteristic (ROC) curves, calibration plots, and decision curve",
    "entities": [
      {
        "text": "ROC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 300 NICU patients were included, among whom 201 developed",
    "entities": [
      {
        "text": "300",
        "label": "CARDINAL"
      },
      {
        "text": "201",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "early pneumonia. Multivariate logistic regression confirmed HBP as an",
    "entities": [
      {
        "text": "HBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "independent risk factor for early pneumonia, with consistent results across all",
    "entities": []
  },
  {
    "text": "subgroups. The nomogram demonstrated excellent predictive performance, achieving",
    "entities": []
  },
  {
    "text": "high discrimination (AUC = 0.89) and calibration (Hosmer-Lemeshow test, P =",
    "entities": [
      {
        "text": "0.89",
        "label": "CARDINAL"
      },
      {
        "text": "Hosmer-Lemeshow",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.520). Additionally, the model showed significant clinical utility.",
    "entities": [
      {
        "text": "0.520",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Elevated HBP levels are independently associated with the risk of",
    "entities": []
  },
  {
    "text": "early pneumonia in NICU patients. The nomogram integrating HBP provides accurate",
    "entities": [
      {
        "text": "NICU",
        "label": "ORG"
      },
      {
        "text": "HBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "predictions for early pneumonia.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 by the Shock Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "the Shock Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflicts of Interest: The authors declare no",
    "entities": []
  },
  {
    "text": "conflict of interest.",
    "entities": []
  },
  {
    "text": "Genomic epidemiology of SARS-CoV-2 in Norfolk, UK, March 2020-December 2022.",
    "entities": [
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "March 2020-December 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Hayles EH(1)(2)(3), Page AJ(1)(4), Kingsley RA(1)(3)(5), Guitian J(6), The",
    "entities": [
      {
        "text": "Page AJ(1)(4",
        "label": "FAC"
      },
      {
        "text": "Kingsley RA(1)(3)(5",
        "label": "PERSON"
      },
      {
        "text": "Guitian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Covid-Genomics Uk Consortium, Langridge GC(1)(3).",
    "entities": [
      {
        "text": "Covid-Genomics Uk Consortium",
        "label": "PERSON"
      },
      {
        "text": "Langridge GC(1)(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.",
    "entities": [
      {
        "text": "1)Quadram Institute Bioscience",
        "label": "ORG"
      },
      {
        "text": "Norwich Research Park",
        "label": "ORG"
      },
      {
        "text": "Norwich",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Norwich Medical School, University of East Anglia, Norwich Research Park,",
    "entities": [
      {
        "text": "Medical School, University of East Anglia",
        "label": "ORG"
      },
      {
        "text": "Norwich Research Park",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Centre for Microbial Interactions, Norwich Research Park, Norwich, UK.",
    "entities": [
      {
        "text": "3)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Microbial Interactions",
        "label": "ORG"
      },
      {
        "text": "Norwich Research Park",
        "label": "ORG"
      },
      {
        "text": "Norwich",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Theiagen Genomics, 1745 Shea Center Drive, Highlands Ranch, Co, USA.",
    "entities": [
      {
        "text": "1745",
        "label": "DATE"
      },
      {
        "text": "Highlands Ranch",
        "label": "ORG"
      },
      {
        "text": "Co, USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)School of Biological Sciences, University of East Anglia, Norwich Research",
    "entities": [
      {
        "text": "5)School of",
        "label": "ORG"
      },
      {
        "text": "Biological Sciences",
        "label": "ORG"
      },
      {
        "text": "University of East Anglia",
        "label": "ORG"
      },
      {
        "text": "Norwich Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Pathobiology and Population Sciences, The Royal Veterinary",
    "entities": [
      {
        "text": "Pathobiology and Population Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "In the UK, the COVID-19 Genomics UK Consortium (COG-UK) established a real-time",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Genomics UK Consortium",
        "label": "ORG"
      },
      {
        "text": "COG-UK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "national genomic surveillance system during the COVID-19 pandemic, producing",
    "entities": [
      {
        "text": "national genomic surveillance system",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "centralized data for monitoring severe acute respiratory syndrome coronavirus 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(SARS-CoV-2). As a COG-UK partner, Quadram Institute Bioscience in Norfolk",
    "entities": [
      {
        "text": "COG",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Quadram Institute Bioscience",
        "label": "ORG"
      },
      {
        "text": "Norfolk",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "sequenced over 87,000 SARS-CoV-2 genomes as part of the national effort,",
    "entities": [
      {
        "text": "over 87,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "contributing to the region becoming densely sequenced. Retrospective analysis of",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 lineage dynamics in this region may contribute to preparedness for",
    "entities": []
  },
  {
    "text": "future pandemics. In total, 29,406 SARS-CoV-2 whole genome sequences and",
    "entities": [
      {
        "text": "29,406",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "corresponding metadata from Norfolk were extracted from the COG-UK dataset,",
    "entities": [
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "COG",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "sampled between March 2020 and December 2022, representing 9.9% of regional",
    "entities": [
      {
        "text": "between March 2020",
        "label": "DATE"
      },
      {
        "text": "December 2022",
        "label": "DATE"
      },
      {
        "text": "9.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "COVID-19 cases. Sequences were lineage typed using Pangolin, with subsequent",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Pangolin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "lineage analysis carried out in R using RStudio and related packages, including",
    "entities": [
      {
        "text": "RStudio",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "graphical analysis using ggplot2. In total, 401 global lineages were identified,",
    "entities": [
      {
        "text": "ggplot2",
        "label": "PERSON"
      },
      {
        "text": "401",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with 69.8% appearing more than once and 31.2% over ten times. Temporal",
    "entities": [
      {
        "text": "69.8%",
        "label": "PERCENT"
      },
      {
        "text": "31.2%",
        "label": "PERCENT"
      },
      {
        "text": "ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clustering identified six lineage communities based on first lineage emergence.",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Alpha, Delta and Omicron variants of concern (VOCs) accounted for 8.6, 34.9 and",
    "entities": [
      {
        "text": "Alpha",
        "label": "GPE"
      },
      {
        "text": "Delta",
        "label": "ORG"
      },
      {
        "text": "Omicron",
        "label": "ORG"
      },
      {
        "text": "8.6",
        "label": "CARDINAL"
      },
      {
        "text": "34.9",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "48.5% of sequences, respectively. These formed four regional epidemic waves",
    "entities": [
      {
        "text": "48.5%",
        "label": "PERCENT"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "alongside the remaining lineages which were observed in the early pandemic prior",
    "entities": []
  },
  {
    "text": "to VOC designation and were termed 'pre-VOC' lineages. Regional comparison",
    "entities": []
  },
  {
    "text": "highlighted variability in VOC epidemic wave dates dependent on location. This",
    "entities": [
      {
        "text": "VOC",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "study is the first to assess SARS-CoV-2 diversity in Norfolk across a large",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "Norfolk",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "timescale within the COVID-19 pandemic. SARS-CoV-2 was both highly diverse and",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dynamic throughout the Norfolk region between March 2020 and December 2022, with",
    "entities": [
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "March 2020",
        "label": "DATE"
      },
      {
        "text": "December 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "a strong VOC presence within the latter two-thirds of the study period. The",
    "entities": [
      {
        "text": "two-thirds",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "study also displays the utility of incorporating genomic epidemiological methods",
    "entities": []
  },
  {
    "text": "PMID: 40663468 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663468",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "'Vivaldi': an amplicon-based whole-genome sequencing method for the four",
    "entities": [
      {
        "text": "Vivaldi",
        "label": "PERSON"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "seasonal human coronaviruses, 229E, NL63, OC43 and HKU1, alongside SARS-CoV-2.",
    "entities": [
      {
        "text": "229E",
        "label": "CARDINAL"
      },
      {
        "text": "HKU1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "McClure CP(1)(2)(3), Tsoleridis T(1)(2)(4), Hill JD(1)(2), Holmes N(2)(5),",
    "entities": [
      {
        "text": "Tsoleridis T(1)(2)(4",
        "label": "PERSON"
      },
      {
        "text": "Hill",
        "label": "PERSON"
      },
      {
        "text": "Holmes N(2)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Clark G(6), Irving WL(1)(2)(3)(6), Tarr AW(1)(2)(3), Ball JK(1)(2)(3)(7),",
    "entities": [
      {
        "text": "Clark",
        "label": "PERSON"
      },
      {
        "text": "Irving WL(1)(2)(3)(6",
        "label": "PERSON"
      },
      {
        "text": "Tarr",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Astbury S(3)(8), Loose M(2)(5).",
    "entities": [
      {
        "text": "Astbury",
        "label": "GPE"
      },
      {
        "text": "Loose M(2)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Wolfson Centre for Global Virus Research, University of Nottingham,",
    "entities": [
      {
        "text": "Centre for Global Virus Research,",
        "label": "WORK_OF_ART"
      },
      {
        "text": "University of Nottingham",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nottingham, UK.",
    "entities": [
      {
        "text": "Nottingham",
        "label": "PERSON"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Life Sciences, University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Nottingham, Nottingham",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)National Institute for Health Research Nottingham Biomedical Research Centre,",
    "entities": [
      {
        "text": "3)National Institute for Health Research Nottingham Biomedical Research Centre",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Nottingham and Nottingham University Hospitals NHS Trust,",
    "entities": [
      {
        "text": "University of Nottingham and Nottingham University Hospitals NHS Trust",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)The Pirbright Institute, Ash Road, Pirbright, Woking, UK.",
    "entities": [
      {
        "text": "4)The Pirbright Institute",
        "label": "ORG"
      },
      {
        "text": "Woking",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Deep Seq, School of Life Sciences, University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "Seq",
        "label": "PERSON"
      },
      {
        "text": "School of Life Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Nottingham, Nottingham",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham,",
    "entities": [
      {
        "text": "6)Clinical Microbiology",
        "label": "ORG"
      },
      {
        "text": "Nottingham University Hospitals NHS Trust",
        "label": "ORG"
      },
      {
        "text": "Nottingham",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(7)Dept of Tropical Disease Biology, Liverpool School of Tropical Medicine,",
    "entities": [
      {
        "text": "Tropical Disease Biology",
        "label": "ORG"
      },
      {
        "text": "Liverpool School of Tropical Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Liverpool, UK.",
    "entities": [
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Nottingham Digestive Diseases Centre, Translational Medical Sciences, School",
    "entities": [
      {
        "text": "8)Nottingham",
        "label": "CARDINAL"
      },
      {
        "text": "Translational Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "Medicine, University of Nottingham, Nottingham",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Prior to the emergence of SARS-CoV-2 in 2019, alphacoronaviruses 229E and NL63",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "229E",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and betacoronaviruses OC43 and HKU1 were already established endemic 'common",
    "entities": [
      {
        "text": "HKU1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cold' viral infections. Despite their collective contribution towards global",
    "entities": []
  },
  {
    "text": "respiratory morbidity and mortality and potential to inform the future",
    "entities": []
  },
  {
    "text": "trajectory of SARS-CoV-2 endemicity, they are infrequently sequenced. We",
    "entities": []
  },
  {
    "text": "therefore developed a 1,200 bp amplicon whole-genome sequencing scheme targeting",
    "entities": [
      {
        "text": "1,200",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "all four seasonal coronaviruses and SARS-CoV-2. The 'Vivaldi' method was applied",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "Vivaldi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "retrospectively and prospectively using Oxford Nanopore Technology to ~400",
    "entities": [
      {
        "text": "Oxford Nanopore Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "seasonal coronavirus infections diagnosed in Nottingham, UK, from February 2016",
    "entities": [
      {
        "text": "Nottingham",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "February 2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to July 2023. We demonstrate that the amplicon multiplex strategy can be applied",
    "entities": [
      {
        "text": "July 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "agnostically to determine the complete genomes of five different species from",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "two coronaviral genera. Three hundred and four unique seasonal coronavirus",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Three hundred and four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "genomes of greater than 95% coverage were achieved: 64 for 229E, 85 for NL63,",
    "entities": [
      {
        "text": "greater than",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "229E",
        "label": "CARDINAL"
      },
      {
        "text": "85",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "128 for OC43 and 27 for HKU1. They collectively indicated a dynamic seasonal",
    "entities": [
      {
        "text": "128",
        "label": "CARDINAL"
      },
      {
        "text": "27",
        "label": "CARDINAL"
      },
      {
        "text": "HKU1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "coronavirus genomic landscape, with co-circulation of multiple variants emerging",
    "entities": []
  },
  {
    "text": "and declining over the UK winter respiratory infection season, with further",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "winter",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "geographical distinction when compared to a global dataset. Prolonged infection",
    "entities": []
  },
  {
    "text": "with concomitant intra-host evolution was also observed for both alpha- (NL63)",
    "entities": [
      {
        "text": "NL63",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and betacoronaviruses (OC43). This data represents the largest single cohort of",
    "entities": []
  },
  {
    "text": "seasonal coronavirus genomes to date and also a novel amplicon scheme for their",
    "entities": []
  },
  {
    "text": "future global surveillance suitable for widespread and easy adoption in the",
    "entities": []
  },
  {
    "text": "PMID: 40663464 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663464",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Analysing risk factors for foetal growth outcomes - the influence of maternal",
    "entities": []
  },
  {
    "text": "conditions and congenital cytomegalovirus infection.",
    "entities": []
  },
  {
    "text": "[Article in English]",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study aimed to analyse the risk factors differentiating small",
    "entities": []
  },
  {
    "text": "for gestational age (SGA) and appropriate for gestational age (AGA) neonates.",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: A retrospective-prospective cohort study was conducted",
    "entities": []
  },
  {
    "text": "from 2019 to 2024 at the 2nd Department of Obstetrics and Gynaecology,",
    "entities": [
      {
        "text": "2019 to 2024",
        "label": "DATE"
      },
      {
        "text": "2nd",
        "label": "ORDINAL"
      },
      {
        "text": "Department of Obstetrics and Gynaecology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital Bratislava. The study involved 174 term neonates from",
    "entities": [
      {
        "text": "University Hospital Bratislava",
        "label": "ORG"
      },
      {
        "text": "174",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "singleton pregnancies, including 125 SGA and 49 AGA infants. Various maternal,",
    "entities": [
      {
        "text": "125",
        "label": "CARDINAL"
      },
      {
        "text": "49",
        "label": "CARDINAL"
      },
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "foetal, and placental risk factors were analysed, with a particular focus on",
    "entities": []
  },
  {
    "text": "congenital cytomegalovirus infection (cCMV).",
    "entities": []
  },
  {
    "text": "RESULTS: Neonates' birth weights ranged from 1,480 to 4,470 grams. Of the risk",
    "entities": [
      {
        "text": "1,480",
        "label": "CARDINAL"
      },
      {
        "text": "4,470 grams",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "factors assessed, only maternal COVID-19 infection during pregnancy was",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly associated with AGA outcomes (P = 0.009). No significant",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      },
      {
        "text": "0.009",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations were found between common risk factors (e. g. hypertension,",
    "entities": [
      {
        "text": "associations",
        "label": "ORG"
      },
      {
        "text": "e. g. hypertension",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "diabetes mellitus) and foetal growth restriction. Congenital CMV infection was",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "not significantly associated with SGA. Logistic regression analysis confirmed",
    "entities": [
      {
        "text": "SGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the association of COVID-19 infection with foetal weight, while no significant",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effect was observed for CMV.",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Maternal COVID-19 infection was associated with AGA outcomes,",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potentially due to enhanced medical surveillance and immune responses. However,",
    "entities": []
  },
  {
    "text": "the study's small sample size limits the interpretation of these findings, and",
    "entities": []
  },
  {
    "text": "further research is required to fully understand the impacts of COVID-19 on",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pregnancy. No significant association between congenital CMV infection and",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "foetal growth restriction was found in this cohort, which was most likely due to",
    "entities": []
  },
  {
    "text": "the low prevalence of cCMV. Moreover, documented risk factors for foetal growth",
    "entities": []
  },
  {
    "text": "restriction, including hypertension and diabetes mellitus, were not",
    "entities": []
  },
  {
    "text": "statistically significant in our study population.",
    "entities": []
  },
  {
    "text": "PMID: 40663445 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Pediatric COVID-19 Hospitalization Trends by Race and Ethnicity, 2020-2023.",
    "entities": [
      {
        "text": "Race and Ethnicity",
        "label": "WORK_OF_ART"
      },
      {
        "text": "2020-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Anglin O(1), Patel K(1), Daily Kirley P(2), Sachdev D(3), Alden NB(4), Armistead",
    "entities": [
      {
        "text": "Daily Kirley",
        "label": "PERSON"
      },
      {
        "text": "Sachdev",
        "label": "PERSON"
      },
      {
        "text": "Alden",
        "label": "GPE"
      },
      {
        "text": "Armistead\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "I(4), Yousey-Hindes K(5), Meek J(5), Witt LS(6)(7), Openo KP(6)(7)(8), Monroe",
    "entities": [
      {
        "text": "Yousey-Hindes K(5",
        "label": "ORG"
      },
      {
        "text": "Meek",
        "label": "PERSON"
      },
      {
        "text": "Witt LS(6)(7",
        "label": "PERSON"
      },
      {
        "text": "Openo KP(6)(7)(8",
        "label": "PERSON"
      },
      {
        "text": "Monroe",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "ML(9), Kim S(10), Urlaub E(10), Como-Sabetti K(11), D'Heilly P(11), Ropp SL(12),",
    "entities": [
      {
        "text": "Kim S(10",
        "label": "PERSON"
      },
      {
        "text": "Urlaub",
        "label": "ORG"
      },
      {
        "text": "Como-Sabetti K(11",
        "label": "ORG"
      },
      {
        "text": "Ropp SL(12",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sutton M(16), Abdullah N(16), Schaffner W(17), Talbot HK(17), Chatelain R(18),",
    "entities": [
      {
        "text": "Sutton",
        "label": "GPE"
      },
      {
        "text": "Abdullah N(16",
        "label": "PERSON"
      },
      {
        "text": "Schaffner W(17",
        "label": "ORG"
      },
      {
        "text": "Talbot",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Price A(18), King H(1), Taylor CA(1), Patton ME(1)(19), Havers FP(1)(19).",
    "entities": [
      {
        "text": "Taylor",
        "label": "PERSON"
      },
      {
        "text": "Patton ME(1)(19",
        "label": "PERSON"
      },
      {
        "text": "Havers FP(1)(19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)National Center for Immunization and Respiratory Diseases, Centers for",
    "entities": [
      {
        "text": "Center for Immunization and Respiratory Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Control and Prevention, Atlanta, Georgia.",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)California Emerging Infections Program, Oakland.",
    "entities": [
      {
        "text": "Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Oakland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)California Department of Public Health, Richmond.",
    "entities": [
      {
        "text": "Department of Public Health",
        "label": "ORG"
      },
      {
        "text": "Richmond",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Colorado Department of Public Health & Environment, Denver.",
    "entities": [
      {
        "text": "4)Colorado Department of Public Health & Environment",
        "label": "ORG"
      },
      {
        "text": "Denver",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Connecticut Emerging Infections Program, Yale School of Public Health, New",
    "entities": [
      {
        "text": "Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Yale School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Division of Infectious Diseases, Emory University School of Medicine,",
    "entities": [
      {
        "text": "Emory University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Georgia Emerging Infections Program, Georgia Department of Public Health,",
    "entities": [
      {
        "text": "Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Georgia Department of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Research, Atlanta Veterans Affairs Medical Center, Decatur, Georgia.",
    "entities": [
      {
        "text": "Atlanta Veterans Affairs Medical Center",
        "label": "ORG"
      },
      {
        "text": "Decatur",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Maryland Department of Health, Baltimore.",
    "entities": [
      {
        "text": "9)Maryland Department of Health",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Michigan Department of Health and Human Services, Lansing.",
    "entities": [
      {
        "text": "10)Michigan Department of Health and Human Services",
        "label": "ORG"
      },
      {
        "text": "Lansing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Minnesota Department of Health, St Paul.",
    "entities": [
      {
        "text": "11)Minnesota",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Health",
        "label": "ORG"
      },
      {
        "text": "St Paul",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(12)New Mexico Department of Health, Santa Fe.",
    "entities": [
      {
        "text": "12)New Mexico Department of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)University of New Mexico Emerging Infections Program, Albuquerque.",
    "entities": [
      {
        "text": "13)University",
        "label": "CARDINAL"
      },
      {
        "text": "New Mexico Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Albuquerque",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(14)New York State Department of Health, Albany.",
    "entities": [
      {
        "text": "York State Department of Health",
        "label": "ORG"
      },
      {
        "text": "Albany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)University of Rochester School of Medicine and Dentistry, Rochester, New",
    "entities": [
      {
        "text": "15)University",
        "label": "CARDINAL"
      },
      {
        "text": "Rochester School of Medicine and Dentistry",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Public Health Division, Oregon Health Authority, Portland.",
    "entities": [
      {
        "text": "Health Division",
        "label": "ORG"
      },
      {
        "text": "Oregon Health Authority",
        "label": "ORG"
      },
      {
        "text": "Portland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Vanderbilt University Medical Center, Nashville, Tennessee.",
    "entities": [
      {
        "text": "17)Vanderbilt",
        "label": "CARDINAL"
      },
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Nashville",
        "label": "GPE"
      },
      {
        "text": "Tennessee",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Salt Lake County Health Department, Salt Lake City, Utah.",
    "entities": [
      {
        "text": "Lake County Health Department",
        "label": "ORG"
      },
      {
        "text": "Salt Lake City",
        "label": "GPE"
      },
      {
        "text": "Utah",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)United States Public Health Service, Rockville, Maryland.",
    "entities": [
      {
        "text": "19)United",
        "label": "CARDINAL"
      },
      {
        "text": "States Public Health Service",
        "label": "ORG"
      },
      {
        "text": "Rockville",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IMPORTANCE: Examining racial and ethnic disparities in pediatric COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hospitalizations is critical to inform public health efforts to reduce those",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To characterize trends in pediatric COVID-19 hospitalizations by race",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and ethnicity from March 2020 to September 2023, focusing on recent",
    "entities": [
      {
        "text": "March 2020 to September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "epidemiologic findings (October 2022 to September 2023).",
    "entities": [
      {
        "text": "October 2022 to September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the",
    "entities": []
  },
  {
    "text": "COVID-19 Hospitalization Surveillance Network (COVID-NET) including 13 555",
    "entities": [
      {
        "text": "COVID-19 Hospitalization Surveillance Network",
        "label": "ORG"
      },
      {
        "text": "13 555",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hospitalizations among patients aged 17 years or younger with a",
    "entities": [
      {
        "text": "17 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "laboratory-confirmed SARS-CoV-2 infection who are residents of the COVID-NET",
    "entities": []
  },
  {
    "text": "catchment area in 12 states, covering approximately 10% of the US population.",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "approximately 10%",
        "label": "PERCENT"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "EXPOSURE: Laboratory-confirmed SARS-CoV-2 infection within 14 days prior to or",
    "entities": [
      {
        "text": "14 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during hospitalization.",
    "entities": []
  },
  {
    "text": "MAIN OUTCOMES AND MEASURES: Pediatric COVID-19-associated hospitalization rates",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by race and ethnicity and characteristics associated with COVID-19-associated",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hospitalizations.",
    "entities": []
  },
  {
    "text": "RESULTS: Between March 2020 and September 2023, COVID-NET identified 13 555",
    "entities": [
      {
        "text": "Between March 2020 and September 2023",
        "label": "DATE"
      },
      {
        "text": "COVID-NET",
        "label": "ORG"
      },
      {
        "text": "13 555",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pediatric hospitalizations (median patient age, 3.3 years [IQR, 0.6-12.5 years];",
    "entities": [
      {
        "text": "3.3 years",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "0.6-12.5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "7110 boys [52.5%]; 780 non-Hispanic Asian or Pacific Islander children [5.8%],",
    "entities": [
      {
        "text": "7110",
        "label": "DATE"
      },
      {
        "text": "52.5%",
        "label": "PERCENT"
      },
      {
        "text": "780",
        "label": "CARDINAL"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      },
      {
        "text": "5.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "3837 non-Hispanic Black children [28.3%], 4131 Hispanic children [30.5%], and",
    "entities": [
      {
        "text": "3837",
        "label": "DATE"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "28.3%",
        "label": "PERCENT"
      },
      {
        "text": "4131",
        "label": "DATE"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "30.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "4807 non-Hispanic White children [35.5%]). Hospitalization rates were 2.15 (95%",
    "entities": [
      {
        "text": "4807",
        "label": "DATE"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "35.5%",
        "label": "PERCENT"
      },
      {
        "text": "2.15",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI, 2.01-2.34) times higher for Black children and 2.06 (95% CI, 1.91-2.23)",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.01",
        "label": "CARDINAL"
      },
      {
        "text": "2.06",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "times higher for Hispanic children compared with Asian or Pacific Islander",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "children, who had the lowest rates. Despite overall decreased pediatric",
    "entities": []
  },
  {
    "text": "hospitalization rates between October 2022 and September 2023, higher rates of",
    "entities": [
      {
        "text": "October 2022",
        "label": "DATE"
      },
      {
        "text": "September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "intensive care unit admissions among Black and Hispanic children persisted, at",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "1.88 (95% CI, 1.28-2.74) times higher for Black children and 2.13 (95% CI,",
    "entities": [
      {
        "text": "1.88",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.28-2.74",
        "label": "CARDINAL"
      },
      {
        "text": "2.13",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.47-3.10) times higher for Hispanic children compared with Asian or Pacific",
    "entities": [
      {
        "text": "1.47",
        "label": "CARDINAL"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Islander children. Among hospitalized children, 61.4% (95% CI, 57.0%-65.8%) of",
    "entities": [
      {
        "text": "61.4%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "57.0%-65.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Black patients and 45.5% (95% CI, 41.9%-49.3%) of Hispanic patients had 1 or",
    "entities": [
      {
        "text": "45.5%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "41.9%-49.3%",
        "label": "PERCENT"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "more underlying medical condition compared with 45.6% (95% CI, 42.1%-49.1%) of",
    "entities": [
      {
        "text": "45.6%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "42.1%-49.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "White children and 45.0% (95% CI, 41.9%-49.3%) of Asian or Pacific Islander",
    "entities": [
      {
        "text": "45.0%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "41.9%-49.3%",
        "label": "PERCENT"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "children. Obesity (17.8%; 95% CI, 15.3%-20.5%) and neurologic disorders (15.2%;",
    "entities": [
      {
        "text": "17.8%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "15.3%-20.5%",
        "label": "PERCENT"
      },
      {
        "text": "15.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "95% CI, 13.7%-16.8%) were the most common conditions overall; 11.9% (95% CI,",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "13.7%-16.8%",
        "label": "PERCENT"
      },
      {
        "text": "11.9%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "9.1%-15.1%) of Black children had sickle cell disease, the fourth most common",
    "entities": [
      {
        "text": "9.1%-15.1%",
        "label": "PERCENT"
      },
      {
        "text": "fourth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "condition in this group.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS AND RELEVANCE: This study found that among pediatric patients",
    "entities": [
      {
        "text": "CONCLUSIONS",
        "label": "ORG"
      },
      {
        "text": "RELEVANCE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "hospitalized with COVID-19, Black and Hispanic children were disproportionately",
    "entities": [
      {
        "text": "COVID-19, Black",
        "label": "ORG"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "more likely to be hospitalized for COVID-19 and experience severe disease",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compared with White and Asian or Pacific Islander children. A higher proportion",
    "entities": [
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "of hospitalized Black children had underlying medical conditions. This study",
    "entities": []
  },
  {
    "text": "underlines the need for targeted interventions, particularly for children with",
    "entities": []
  },
  {
    "text": "underlying medical conditions, and the need for equitable access and use of",
    "entities": []
  },
  {
    "text": "vaccines and therapeutics for disproportionately affected populations.",
    "entities": []
  },
  {
    "text": "PMID: 40663351 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663351",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul 1.",
    "entities": []
  },
  {
    "text": "Epidemiology of Community-Acquired Versus Hospital-Acquired Sepsis in Acute",
    "entities": [
      {
        "text": "Epidemiology of Community-Acquired",
        "label": "ORG"
      },
      {
        "text": "Versus Hospital",
        "label": "ORG"
      },
      {
        "text": "Acute",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospitals in Ireland, 2016-2022.",
    "entities": [
      {
        "text": "Ireland",
        "label": "GPE"
      },
      {
        "text": "2016-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Liddy EM(1), Amin DK(2), McKeown DJ(3), O'Dwyer MJ(4), Vellinga A(2).",
    "entities": [
      {
        "text": "Amin DK(2",
        "label": "PERSON"
      },
      {
        "text": "O'Dwyer MJ(4",
        "label": "PERSON"
      },
      {
        "text": "Vellinga A(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Public Health, Health Service Executive Dublin & South East and",
    "entities": [
      {
        "text": "Public Health, Health Service Executive",
        "label": "ORG"
      },
      {
        "text": "Dublin & South East",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Public Health, Physiotherapy and Sports Science, University College",
    "entities": [
      {
        "text": "School of Public Health",
        "label": "ORG"
      },
      {
        "text": "University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)CARA Network, School of Public Health, Physiotherapy and Sports Science,",
    "entities": [
      {
        "text": "2)CARA Network",
        "label": "MONEY"
      },
      {
        "text": "School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University College Dublin, Dublin, Ireland.",
    "entities": [
      {
        "text": "University College Dublin",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)National Health Intelligence Unit, Health Service Executive, Dublin, Ireland.",
    "entities": [
      {
        "text": "Health Intelligence Unit",
        "label": "ORG"
      },
      {
        "text": "Health Service Executive",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Anaesthesia and Critical Care, St Vincent's University",
    "entities": [
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Critical Care",
        "label": "ORG"
      },
      {
        "text": "St Vincent's",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hospital, Dublin and Clinical Lead, National Clinical Programme in Sepsis,",
    "entities": [
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "National Clinical Programme",
        "label": "ORG"
      },
      {
        "text": "Sepsis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Health Service Executive, Dublin, Ireland.",
    "entities": [
      {
        "text": "Health Service Executive",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IMPORTANCE: Sepsis is a leading cause of morbidity and mortality. Understanding",
    "entities": []
  },
  {
    "text": "sepsis epidemiology is crucial to enable clinicians to identify patients at",
    "entities": []
  },
  {
    "text": "highest risk of developing and dying from sepsis.",
    "entities": []
  },
  {
    "text": "OBJECTIVES: While community-acquired (CA) sepsis has been identified as more",
    "entities": [
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "common than hospital-acquired (HA) sepsis, HA sepsis has led to increased",
    "entities": []
  },
  {
    "text": "morbidity and mortality. Few studies, however, have analyzed CA and HA sepsis by",
    "entities": [
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "site of infection or by patient comorbidities. The aim of this analysis was to",
    "entities": []
  },
  {
    "text": "describe the epidemiology of patients with CA and HA sepsis diagnosed in",
    "entities": [
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ireland.",
    "entities": [
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study. The",
    "entities": []
  },
  {
    "text": "setting was all Irish acute public hospitals from 2016 to 2022. Data were",
    "entities": [
      {
        "text": "Irish",
        "label": "NORP"
      },
      {
        "text": "2016 to 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "extracted from the Hospital In-Patient Enquiry (HIPE) system recording all",
    "entities": [
      {
        "text": "the Hospital In-Patient Enquiry (HIPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "discharges from acute public hospitals, if a sepsis-related diagnostic code was",
    "entities": []
  },
  {
    "text": "included.",
    "entities": []
  },
  {
    "text": "MAIN OUTCOMES AND MEASURES: Univariate and multivariate analysis was conducted",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to compare CA and HA sepsis events and their association with sepsis-associated",
    "entities": [
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mortality.",
    "entities": []
  },
  {
    "text": "RESULTS: The number of CA vs. HA sepsis events in the database was 86,011",
    "entities": [
      {
        "text": "CA",
        "label": "PERSON"
      },
      {
        "text": "86,011",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in hospital compared with CA. Of diagnoses analyzed, severe acute respiratory",
    "entities": [
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "syndrome coronavirus 2 (SARS-CoV-2) was identified as the strongest risk factor",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "predictive of mortality (odds ratio [OR] = 2.4) followed by cardiac disease (OR,",
    "entities": [
      {
        "text": "2.4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.9) and influenza or pneumonia (OR, 1.9). Sepsis patients with a lower",
    "entities": [
      {
        "text": "1.9",
        "label": "CARDINAL"
      },
      {
        "text": "1.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "socioeconomic status had a 20% higher likelihood of death.",
    "entities": [
      {
        "text": "20%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS AND RELEVANCE: This analysis highlighted a significant increased",
    "entities": [
      {
        "text": "CONCLUSIONS",
        "label": "ORG"
      },
      {
        "text": "RELEVANCE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "risk of sepsis-associated mortality for patients diagnosed with sepsis as a",
    "entities": []
  },
  {
    "text": "result of a HA infection and key infection types and comorbidities including",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Authors. Published by Wolters Kluwer Health, Inc. on behalf",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of the Society of Critical Care Medicine.",
    "entities": [
      {
        "text": "the Society of Critical Care Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1097/CCE.0000000000001289",
    "entities": [
      {
        "text": "10.1097",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40663158 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663158",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors have disclosed that they do not have",
    "entities": []
  },
  {
    "text": "any potential conflicts of interest.",
    "entities": []
  },
  {
    "text": "52. Intensive Care Med. 2025 Jul 15. doi: 10.1007/s00134-025-08014-9. Online",
    "entities": [
      {
        "text": "52",
        "label": "CARDINAL"
      },
      {
        "text": "Intensive Care Med",
        "label": "ORG"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic",
    "entities": [
      {
        "text": "PCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exposure in critically ill patients with community-acquired pneumonia: the",
    "entities": []
  },
  {
    "text": "MULTI-CAP randomized controlled trial.",
    "entities": []
  },
  {
    "text": "B\u00e9rard L(4), Rousseau A(4), Tabassome S(4), Fartoukh M(#)(26), Timsit JF(#)(27);",
    "entities": [
      {
        "text": "Rousseau A(4",
        "label": "PERSON"
      },
      {
        "text": "Fartoukh",
        "label": "PERSON"
      },
      {
        "text": "Timsit",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "MULTI-CAP collaborative trial group.",
    "entities": []
  },
  {
    "text": "Collaborators: Siaha BFN, Turpin M, Gibelin A, de Montmollin N, Desnos C,",
    "entities": [
      {
        "text": "BFN",
        "label": "ORG"
      },
      {
        "text": "Turpin M",
        "label": "ORG"
      },
      {
        "text": "Gibelin A",
        "label": "PERSON"
      },
      {
        "text": "de Montmollin N",
        "label": "PERSON"
      },
      {
        "text": "Desnos C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bouadma L, de Montmollin E, Doman M, Thy M, Sonneville R, Lamara F, Eczenberg M,",
    "entities": [
      {
        "text": "de Montmollin",
        "label": "PERSON"
      },
      {
        "text": "Doman M",
        "label": "ORG"
      },
      {
        "text": "Thy M",
        "label": "PERSON"
      },
      {
        "text": "Sonneville R",
        "label": "PERSON"
      },
      {
        "text": "Lamara F",
        "label": "PERSON"
      },
      {
        "text": "Eczenberg M",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Recherche Saint-Antoine UMRS_938 Team 5PMed, Paris, France.",
    "entities": [
      {
        "text": "Recherche Saint-Antoine UMRS_938 Team",
        "label": "PERSON"
      },
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Universitaire Gabriel Montpied, Clermont-Ferrand, France.",
    "entities": [
      {
        "text": "Universitaire Gabriel Montpied",
        "label": "PERSON"
      },
      {
        "text": "Clermont-Ferrand",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Intensive Care Medicine Department, Lapeyronie University Hospital,",
    "entities": [
      {
        "text": "Care Medicine Department",
        "label": "ORG"
      },
      {
        "text": "Lapeyronie University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Department of Medical and Toxicological Critical Care, Lariboisi\u00e8re",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(19)Intensive Care Unit, Research Center for Respiratory Diseases, Tours",
    "entities": [
      {
        "text": "19)Intensive",
        "label": "CARDINAL"
      },
      {
        "text": "Care Unit",
        "label": "ORG"
      },
      {
        "text": "Research Center for Respiratory Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital, INSERM U1100, University of Tours, Tours, France.",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "University of Tours",
        "label": "ORG"
      },
      {
        "text": "Tours",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "5-DeSCID: Decision Sciences in Infectious Diseases Control and Care, Universit\u00e9",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "Decision Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE: Multiplex polymerase chain reaction (mPCR) testing has the potential to",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "Multiplex",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "rapidly and accurately identify causative microorganisms in patients with",
    "entities": []
  },
  {
    "text": "community-acquired pneumonia (CAP). Its use in a management strategy, along with",
    "entities": [
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "biomarkers, may reduce antibiotic exposure and improve clinical outcomes.",
    "entities": []
  },
  {
    "text": "METHODS: The MULTI-CAP trial was a multicenter (n = 20), parallel-group,",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "superiority, open-label, randomized trial. Subjects were non-immunocompromised",
    "entities": []
  },
  {
    "text": "adult patients (\u2265 18 years) admitted to the intensive care unit (ICU) for CAP",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "18 years",
        "label": "DATE"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and randomly assigned in a 1:1 ratio. In the intervention group, the",
    "entities": [
      {
        "text": "1:1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "microbiological diagnosis combined a broad-spectrum respiratory mPCR and",
    "entities": []
  },
  {
    "text": "conventional microbiological investigations. An algorithm for early",
    "entities": []
  },
  {
    "text": "discontinuation or de-escalation of antibiotics was applied, based on mPCR",
    "entities": []
  },
  {
    "text": "results and serum procalcitonin. In the control group, only conventional",
    "entities": []
  },
  {
    "text": "microbiological investigations were performed. In both groups, antibiotic",
    "entities": []
  },
  {
    "text": "discontinuation was considered on Day 3 and day after day until Day 7, based on",
    "entities": [
      {
        "text": "Day 3 and day after day",
        "label": "DATE"
      },
      {
        "text": "Day 7",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "procalcitonin values and kinetics. The primary endpoint was defined as the",
    "entities": []
  },
  {
    "text": "number of days alive without any antibiotic from the time of enrollment to Day",
    "entities": [
      {
        "text": "days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: From October 4, 2018, to March 3, 2022, 406 patients were randomized,",
    "entities": [
      {
        "text": "October 4, 2018",
        "label": "DATE"
      },
      {
        "text": "March 3, 2022",
        "label": "DATE"
      },
      {
        "text": "406",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 385 were evaluable in the intention-to-treat analysis. The median number of",
    "entities": [
      {
        "text": "385",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days alive without antibiotics on Day 28 was 19.0 (0.0; 24.0) days in the",
    "entities": [
      {
        "text": "days",
        "label": "DATE"
      },
      {
        "text": "Day 28",
        "label": "DATE"
      },
      {
        "text": "19.0",
        "label": "CARDINAL"
      },
      {
        "text": "0.0",
        "label": "CARDINAL"
      },
      {
        "text": "24.0) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "intervention group and 19.0 (7.0; 22.0) days in the control group (difference,",
    "entities": [
      {
        "text": "19.0",
        "label": "CARDINAL"
      },
      {
        "text": "7.0",
        "label": "CARDINAL"
      },
      {
        "text": "22.0) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "0.0 (95% CI, - 4.0 to 4.0). However, the antibiotic cumulative duration on day",
    "entities": [
      {
        "text": "0.0",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "4.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "28 was 3 days shorter (95% CI, - 5.1 to - 0.9) in the intervention group.",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "3 days",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: In ICU patients with CAP, a management strategy combining a mPCR and",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "serum procalcitonin failed to reduce antibiotic exposure or improve outcomes on",
    "entities": [
      {
        "text": "serum procalcitonin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Day 28, compared to usual care.",
    "entities": [
      {
        "text": "Day 28",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "TRIAL REGISTRATION NUMBER: NCT03452826 (March 2018), EudraCT 2017-A01615-48.",
    "entities": [
      {
        "text": "March 2018",
        "label": "DATE"
      },
      {
        "text": "2017-A01615-48",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "\u00a9 2025. Springer-Verlag GmbH Germany, part of Springer Nature.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer-Verlag GmbH Germany",
        "label": "ORG"
      },
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflicts of interest: Laurence",
    "entities": []
  },
  {
    "text": "Armand-Lef\u00e8vre received consulting fees from Shionogi and Viatris, and honoraria",
    "entities": [
      {
        "text": "Armand-Lef\u00e8vre",
        "label": "ORG"
      },
      {
        "text": "Shionogi",
        "label": "ORG"
      },
      {
        "text": "Viatris",
        "label": "PERSON"
      },
      {
        "text": "honoraria\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "for lectures from Advanz, Shionogi and Pfizer. In addition, she performed unpaid",
    "entities": [
      {
        "text": "Advanz",
        "label": "GPE"
      },
      {
        "text": "Shionogi",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lectures for BioM\u00e9rieux and Qiagen. Julien Dessajan received honoraria for",
    "entities": [
      {
        "text": "BioM\u00e9rieux",
        "label": "ORG"
      },
      {
        "text": "Qiagen",
        "label": "ORG"
      },
      {
        "text": "Julien Dessajan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Bristol Myers Squibb, MSD, Sanofi, Pfizer and Roche. Muriel Fartoukh reported",
    "entities": [
      {
        "text": "Bristol Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "MSD",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Muriel Fartoukh",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Oxygene and Fisher and Paykel. Tabassome Simon reported support for research",
    "entities": [
      {
        "text": "Oxygene",
        "label": "PERSON"
      },
      {
        "text": "Fisher",
        "label": "PERSON"
      },
      {
        "text": "Tabassome Simon",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "from BioM\u00e9rieux, research grants from Astra Zeneca, Bayer, Boehringer, Daiichi",
    "entities": [
      {
        "text": "BioM\u00e9rieux",
        "label": "ORG"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Bayer",
        "label": "ORG"
      },
      {
        "text": "Boehringer",
        "label": "PERSON"
      },
      {
        "text": "Daiichi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sankyo, Ili-Lilly, GSK, Novartis and Sanofi, and honoraria for lectures from",
    "entities": [
      {
        "text": "Sankyo",
        "label": "GPE"
      },
      {
        "text": "Ili-Lilly",
        "label": "ORG"
      },
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Servier and Novartis. In addition, she reported participation in Data Safety",
    "entities": [
      {
        "text": "Servier",
        "label": "PERSON"
      },
      {
        "text": "Novartis",
        "label": "PERSON"
      },
      {
        "text": "Data Safety",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Monitoring Board for Ablative Solutions, Air Liquide, Astra Zeneca, Sanofi,",
    "entities": [
      {
        "text": "Monitoring Board for Ablative Solutions",
        "label": "ORG"
      },
      {
        "text": "Air Liquide",
        "label": "ORG"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Novartis and 4Living Biotech. Jean-Francois Timsit Simon reported support for",
    "entities": [
      {
        "text": "4Living Biotech",
        "label": "PRODUCT"
      },
      {
        "text": "Jean-Francois Timsit Simon",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "research from BioM\u00e9rieux, and consulting fees from Advanz, Menarini, Pfizer and",
    "entities": [
      {
        "text": "BioM\u00e9rieux",
        "label": "ORG"
      },
      {
        "text": "Advanz",
        "label": "GPE"
      },
      {
        "text": "Menarini",
        "label": "GPE"
      },
      {
        "text": "Pfizer",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Merck. In addition, he reported honoraria for lectures from BioM\u00e9rieux,",
    "entities": [
      {
        "text": "Merck",
        "label": "ORG"
      },
      {
        "text": "BioM\u00e9rieux",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MundiPharma and Merck. Guillaume Voiriot reported research grants from",
    "entities": [
      {
        "text": "MundiPharma",
        "label": "NORP"
      },
      {
        "text": "Merck",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BioM\u00e9rieux and SOS Oxygene, and support for attending meetings from Oxyvie.",
    "entities": [
      {
        "text": "BioM\u00e9rieux",
        "label": "ORG"
      },
      {
        "text": "SOS Oxygene",
        "label": "PERSON"
      },
      {
        "text": "Oxyvie",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Francois Vandenesch reported been founder and shareholder of Weezion.",
    "entities": [
      {
        "text": "Francois Vandenesch",
        "label": "PERSON"
      },
      {
        "text": "Weezion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Metabolic and fermentation engineering of Klebsiella Pneumoniae for high-level",
    "entities": [
      {
        "text": "Metabolic",
        "label": "ORG"
      },
      {
        "text": "Klebsiella Pneumoniae",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "production of 3-hydroxypropionic acid.",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Laboratory of Biosystems and Microanalysis, State Key Laboratory of",
    "entities": [
      {
        "text": "Biosystems",
        "label": "NORP"
      },
      {
        "text": "Microanalysis",
        "label": "NORP"
      },
      {
        "text": "State Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bioreactor Engineering, East China University of Science and Technology,",
    "entities": [
      {
        "text": "Bioreactor Engineering",
        "label": "ORG"
      },
      {
        "text": "East China University of Science and Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Laboratory of Biosystems and Microanalysis, State Key Laboratory of",
    "entities": [
      {
        "text": "2)Laboratory",
        "label": "CARDINAL"
      },
      {
        "text": "Biosystems",
        "label": "NORP"
      },
      {
        "text": "Microanalysis",
        "label": "NORP"
      },
      {
        "text": "State Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Laboratory of Biosystems and Microanalysis, State Key Laboratory of",
    "entities": [
      {
        "text": "Biosystems",
        "label": "NORP"
      },
      {
        "text": "Microanalysis",
        "label": "NORP"
      },
      {
        "text": "State Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: The authors",
    "entities": []
  },
  {
    "text": "54. South Med J. 2025 Jul;118(7):389-393. doi: 10.14423/SMJ.0000000000001845.",
    "entities": [
      {
        "text": "54",
        "label": "CARDINAL"
      },
      {
        "text": "Jul;118(7):389-393",
        "label": "CARDINAL"
      },
      {
        "text": "10.14423",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Access and Use of Green and Blue Spaces for Memory and Physical Health.",
    "entities": [
      {
        "text": "Blue Spaces for",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Wolf JK(1), Cossman JS(1).",
    "entities": [
      {
        "text": "Wolf JK(1",
        "label": "PERSON"
      },
      {
        "text": "Cossman JS(1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(1)From the Department of Sociology and Demography, College for Health,",
    "entities": [
      {
        "text": "the Department of Sociology and Demography, College for Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Community and Policy, University of Texas at San Antonio, San Antonio.",
    "entities": [
      {
        "text": "Policy, University of Texas",
        "label": "ORG"
      },
      {
        "text": "San Antonio",
        "label": "GPE"
      },
      {
        "text": "San Antonio",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: The coronavirus disease 2019 pandemic exacerbated mental and",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "physical health issues in the United States. Due to various lockdown procedures",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "to curb the spread of the virus, indoor gatherings were severely restricted,",
    "entities": []
  },
  {
    "text": "intensifying stress and anxiety.",
    "entities": []
  },
  {
    "text": "METHODS: We used nationally representative data from the 2021 Crime, Health, and",
    "entities": [
      {
        "text": "the 2021 Crime, Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Politics Survey sampled from the National Opinion Research Center's AmeriSpeak",
    "entities": [
      {
        "text": "the National Opinion Research Center's",
        "label": "ORG"
      },
      {
        "text": "AmeriSpeak",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "panel. To explore pandemic-safe options to relieve negative health outcomes, we",
    "entities": []
  },
  {
    "text": "studied how access to and use of green and blue spaces were related to",
    "entities": []
  },
  {
    "text": "self-rated physical and mental health (ie, memory) during the pandemic.",
    "entities": []
  },
  {
    "text": "RESULTS: Most of the logistic regressions show no relationships between access",
    "entities": []
  },
  {
    "text": "to green or blue spaces and the health outcomes (except for access to blue",
    "entities": []
  },
  {
    "text": "spaces and physical health), but we find positive associations between use of",
    "entities": []
  },
  {
    "text": "green and blue spaces with overall physical health and memory.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Access to green or blue spaces is not necessarily enough to create",
    "entities": []
  },
  {
    "text": "a relationship with overall physical health and memory-actually using these",
    "entities": []
  },
  {
    "text": "areas is a key component to their association with positive health outcomes.",
    "entities": []
  },
  {
    "text": "PMID: 40663126 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663126",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Overlooked Pneumonia-Like Lung Cancer with Elevated Neutrophils and Typical",
    "entities": [
      {
        "text": "Lung Cancer",
        "label": "PERSON"
      },
      {
        "text": "Elevated Neutrophils",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Pneumonia-type lung cancer is a specific type of lung cancer with",
    "entities": []
  },
  {
    "text": "low incidence, lack of clinical specificity, and strong imaging similarity to",
    "entities": []
  },
  {
    "text": "pneumonia, which can be easily misdiagnosed as a lung infection.",
    "entities": []
  },
  {
    "text": "METHODS: We report a special case of a patient who was misdiagnosed as",
    "entities": []
  },
  {
    "text": "Mycoplasma pneumonia by routine blood tests, bronchoscopy, NGS of alveolar",
    "entities": [
      {
        "text": "NGS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lavage fluid and combined with the patient's lung CT imaging features, and then",
    "entities": [
      {
        "text": "lavage fluid",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "was definitively diagnosed as lung adenocarcinoma by percutaneous lung puncture.",
    "entities": []
  },
  {
    "text": "RESULTS: The patient's solid shadow in the right lower lung remained unabsorbed",
    "entities": []
  },
  {
    "text": "after aggressive anti-infection, and finally the diagnosis of lung",
    "entities": []
  },
  {
    "text": "adenocarcinoma was finally clarified by percutaneous lung puncture.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: In middle-aged and elderly patients with a first diagnosis of lung",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "infection, if the exudate shadow remains unabsorbed after aggressive empirical",
    "entities": []
  },
  {
    "text": "anti-infective treatment, the infection should be aggressively investigated for",
    "entities": []
  },
  {
    "text": "specific pathogens such as Mycobacterium tuberculosis, nontuberculous",
    "entities": []
  },
  {
    "text": "mycobacteria, fungi, adenoviruses, etc., and in addition to that, malignant",
    "entities": []
  },
  {
    "text": "lesions should also be investigated.",
    "entities": []
  },
  {
    "text": "PMID: 40663072 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663072",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Oral Manifestations in the Post COVID-19 Condition: A Systematic Review With",
    "entities": []
  },
  {
    "text": "(1)Department of Microbiology and Immunology, Georgetown University School of",
    "entities": [
      {
        "text": "Microbiology and Immunology",
        "label": "ORG"
      },
      {
        "text": "Georgetown University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Washington, District of Columbia, USA.",
    "entities": [
      {
        "text": "Washington",
        "label": "GPE"
      },
      {
        "text": "District of Columbia",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Graduate Program in Dentistry, State University of Ponta Grossa (UEPG), Ponta",
    "entities": [
      {
        "text": "2)Graduate Program in Dentistry",
        "label": "ORG"
      },
      {
        "text": "State University of Ponta Grossa",
        "label": "ORG"
      },
      {
        "text": "UEPG",
        "label": "GPE"
      },
      {
        "text": "Ponta",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)University of Joinville (UNIVILLE), Joinville, Brazil.",
    "entities": [
      {
        "text": "Joinville",
        "label": "PERSON"
      },
      {
        "text": "UNIVILLE",
        "label": "GPE"
      },
      {
        "text": "Joinville",
        "label": "GPE"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Dentistry, State University of Ponta Grossa, Ponta Grossa,",
    "entities": [
      {
        "text": "State University of Ponta Grossa",
        "label": "ORG"
      },
      {
        "text": "Ponta Grossa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(5)Department of Medicine, State University of Ponta Grossa, Ponta Grossa,",
    "entities": [
      {
        "text": "Medicine, State University of Ponta Grossa",
        "label": "ORG"
      },
      {
        "text": "Ponta Grossa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(6)Department of Epidemiology, College of Public Health, University of S\u00e3o",
    "entities": [
      {
        "text": "Epidemiology, College of Public Health",
        "label": "ORG"
      },
      {
        "text": "University of S\u00e3o",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Public Health, State University of Ponta Grossa, Ponta Grossa,",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "State University of Ponta Grossa",
        "label": "ORG"
      },
      {
        "text": "Ponta Grossa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Post-COVID-19 condition, or Long COVID, is characterised by symptoms persisting",
    "entities": []
  },
  {
    "text": "or emerging beyond 12 weeks after acute infection. Among over 200 reported",
    "entities": [
      {
        "text": "12 weeks",
        "label": "DATE"
      },
      {
        "text": "200",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "symptoms, oral manifestations such as taste loss and dry mouth have been",
    "entities": []
  },
  {
    "text": "identified. This systematic review reports the frequency and characteristics of",
    "entities": []
  },
  {
    "text": "these symptoms. Registered in PROSPERO and following PRISMA guidelines, the",
    "entities": [
      {
        "text": "PROSPERO",
        "label": "ORG"
      },
      {
        "text": "PRISMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "review included observational studies on COVID-19-positive adults presenting",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "oral symptoms in the post-COVID-19 condition. A search in six databases",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(Medline/PubMed, Embase, Web of Science, Cochrane, SCOPUS, and LILACS) was",
    "entities": [
      {
        "text": "Medline/PubMed",
        "label": "ORG"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "conducted in January 2024. Risk of bias was assessed using Joanna Briggs",
    "entities": [
      {
        "text": "January 2024",
        "label": "DATE"
      },
      {
        "text": "Joanna Briggs",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Institute's critical appraisal tools, and certainty of evidence via GRADE. A",
    "entities": [
      {
        "text": "Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "meta-analysis using the inverse variance method estimated oral symptom",
    "entities": []
  },
  {
    "text": "prevalence. Of 4552 articles, 107 were included. Taste dysfunction persisted in",
    "entities": [
      {
        "text": "4552",
        "label": "DATE"
      },
      {
        "text": "107",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "8% (95% CI 6%-10%) of patients beyond 12 weeks. Combined taste and smell",
    "entities": [
      {
        "text": "8%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "6%-10%",
        "label": "PERCENT"
      },
      {
        "text": "12 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "alterations had a prevalence of 17% (95% CI 13%-21%). Less frequent symptoms",
    "entities": [
      {
        "text": "17%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "13%-21%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "included hyposalivation, periodontitis, mouth ulcers, tongue mucosal changes,",
    "entities": []
  },
  {
    "text": "facial tingling, sensitivity in the trigeminal nerve, difficulty swallowing, and",
    "entities": []
  },
  {
    "text": "lesions in the hard palate. Taste alterations were the most commonly reported",
    "entities": []
  },
  {
    "text": "symptom, underscoring the need for clinical recognition and appropriate",
    "entities": []
  },
  {
    "text": "management by oral health professionals. Additionally, the wide range of other",
    "entities": []
  },
  {
    "text": "oral manifestations highlights the necessity for further research to better",
    "entities": []
  },
  {
    "text": "understand their prevalence, underlying mechanisms, and clinical implications in",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Reviews in Medical Virology published by John Wiley & Sons",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Medical Virology",
        "label": "ORG"
      },
      {
        "text": "John Wiley & Sons",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40663038 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "57. Cytotherapy. 2025 Jun 4:S1465-3249(25)00722-4. doi:",
    "entities": [
      {
        "text": "57",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1016/j.jcyt.2025.05.011. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Clinical trial assessing the safety and efficacy of human bone marrow-derived",
    "entities": []
  },
  {
    "text": "allogeneic mesenchymal stem cell therapy for chronic active antibody-mediated",
    "entities": []
  },
  {
    "text": "rejection in kidney transplant recipients.",
    "entities": []
  },
  {
    "text": "(1)Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's",
    "entities": [
      {
        "text": "Nephrology, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, The Catholic University of Korea, Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "The Catholic University of Korea",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Transplantation Research Center, College of Medicine, The Catholic University",
    "entities": [
      {
        "text": "2)Transplantation Research Center, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "The Catholic University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Korea, Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Transplantation Research Center, College of Medicine, The Catholic University",
    "entities": [
      {
        "text": "Research Center, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "The Catholic University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Korea, Seoul, Republic of Korea; Division of Nephrology, Department of",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      },
      {
        "text": "Division of Nephrology, Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Internal Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Eunpyeong St. Mary's Hospital",
        "label": "PERSON"
      },
      {
        "text": "The Catholic University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Korea, Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, The Catholic University of Korea, Seoul, Republic of Korea.",
    "entities": [
      {
        "text": "The Catholic University of Korea",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Transplantation Research Center, College of Medicine, The Catholic University",
    "entities": [
      {
        "text": "5)Transplantation Research Center, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "The Catholic University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Korea, Seoul, Republic of Korea. Electronic address: scamph@catholic.ac.kr.",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's",
    "entities": [
      {
        "text": "Nephrology, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, The Catholic University of Korea, Seoul, Republic of Korea;",
    "entities": [
      {
        "text": "The Catholic University of Korea",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Transplantation Research Center, College of Medicine, The Catholic University of",
    "entities": [
      {
        "text": "Transplantation Research Center",
        "label": "ORG"
      },
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "The Catholic University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Korea, Seoul, Republic of Korea. Electronic address: chungbh@catholic.ac.kr.",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND AIMS: This study evaluated the safety and efficacy of allogenic human",
    "entities": [
      {
        "text": "allogenic human\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bone marrow-derived mesenchymal stem cell (hBM-MSC) therapy in kidney transplant",
    "entities": []
  },
  {
    "text": "recipients (KTR) with chronic active antibody-mediated rejection (cABMR).",
    "entities": [
      {
        "text": "KTR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Seven cABMR patients received four infusions of hBM-MSC (1 \u00d7 10\u2076",
    "entities": [
      {
        "text": "Seven",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cells/kg), one every other week. The primary outcome was clinical safety,",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "focusing on short-term adverse events. Secondary outcomes included changes in",
    "entities": [
      {
        "text": "Secondary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "allograft function, mean fluorescence intensity (MFI) of donor-specific",
    "entities": []
  },
  {
    "text": "determined by ELISPOT, lymphocyte subset analysis, infection-free survival, and",
    "entities": [
      {
        "text": "ELISPOT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "graft survival compared to 18 historical controls via propensity score matching.",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: Seven patients received hBM-MSC therapy at a median of 5.4 years",
    "entities": [
      {
        "text": "Seven",
        "label": "CARDINAL"
      },
      {
        "text": "5.4 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(range, 1.6-15.3) after KT and 8.5 months (range, 1.2-20.6) after the diagnosis",
    "entities": [
      {
        "text": "1.6-15.3",
        "label": "CARDINAL"
      },
      {
        "text": "KT",
        "label": "ORG"
      },
      {
        "text": "8.5 months",
        "label": "DATE"
      },
      {
        "text": "1.2-20.6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of cABMR. Six patients completed treatment, and one patient received two doses.",
    "entities": [
      {
        "text": "Six",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "No immediate side effects were observed. One patient developed Pneumocystis",
    "entities": [
      {
        "text": "One",
        "label": "CARDINAL"
      },
      {
        "text": "Pneumocystis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "post-treatment. Among those who completed therapy, the eGFR slope shifted from",
    "entities": []
  },
  {
    "text": "-\u039416.6% to -\u03942.4% over the 6 month periods before and after treatment,",
    "entities": [
      {
        "text": "-\u039416.6%",
        "label": "PERCENT"
      },
      {
        "text": "the 6 month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "suggesting a stabilization of eGFR decline, proteinuria decreased, and MFI of",
    "entities": [
      {
        "text": "proteinuria decreased",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "HLA-DSA declined. T-cell subset analysis showed increased CD8+CD45RA+CCR7- T",
    "entities": [
      {
        "text": "HLA-DSA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cells and CD4+CD25+CD127low T cells with decreased CD8+CCR7+CD45RO+/CD45RA+ T",
    "entities": []
  },
  {
    "text": "cells. Kaplan-Meier analysis demonstrated no significant difference in",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "infection-free survival or death-censored graft survival compared to those of",
    "entities": []
  },
  {
    "text": "the propensity score-matched control group. No significant difference in",
    "entities": []
  },
  {
    "text": "the propensity score-matched control group.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: hBM-MSC therapy was generally well tolerated for KTR with cABMR and",
    "entities": [
      {
        "text": "KTR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "demonstrated favorable immunomodulatory effects. Larger, controlled trials with",
    "entities": []
  },
  {
    "text": "extended period are required to validate these findings and better define the",
    "entities": []
  },
  {
    "text": "role of hBM-MSC therapy for cABMR.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 International Society for Cell & Gene Therapy. Published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare no potential conflicts of interest.",
    "entities": []
  },
  {
    "text": "Chronic behavioral and seizure outcomes following experimental traumatic brain",
    "entities": []
  },
  {
    "text": "injury and comorbid Klebsiella pneumoniae lung infection in mice.",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Neuroscience, The School of Translational Medicine, Monash",
    "entities": [
      {
        "text": "Neuroscience",
        "label": "ORG"
      },
      {
        "text": "The School of Translational Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Melbourne, Victoria, Australia.",
    "entities": [
      {
        "text": "Melbourne",
        "label": "GPE"
      },
      {
        "text": "Victoria",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Alfred Health, Melbourne, Victoria, Australia.",
    "entities": [
      {
        "text": "Melbourne",
        "label": "GPE"
      },
      {
        "text": "Victoria",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Microbiology, Monash Biomedical Discovery Institute, Monash",
    "entities": [
      {
        "text": "Microbiology, Monash Biomedical Discovery Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Clayton, Victoria, Australia.",
    "entities": [
      {
        "text": "Clayton",
        "label": "GPE"
      },
      {
        "text": "Victoria",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Medicine (Royal Melbourne Hospital), University of Melbourne,",
    "entities": [
      {
        "text": "Medicine (Royal Melbourne Hospital",
        "label": "ORG"
      },
      {
        "text": "University of Melbourne",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Parkville, Victoria, Australia.",
    "entities": [
      {
        "text": "Parkville",
        "label": "GPE"
      },
      {
        "text": "Victoria",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Traumatic brain injury (TBI) is a leading cause of long-term",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disability, and infections such as pneumonia represent a common and serious",
    "entities": []
  },
  {
    "text": "complication for patients with TBI in the acute and subacute post-injury period.",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Although the acute effects of infections have been documented, their long-term",
    "entities": []
  },
  {
    "text": "consequences on neurological and behavioral recovery as well as the potential",
    "entities": []
  },
  {
    "text": "precipitation of seizures after TBI remain unclear. This study aimed to",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigate the chronic effects of Klebsiella pneumoniae infection following",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "TBI, focusing on post-traumatic seizure development and neurobehavioral changes.",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Using a mouse model, we assessed the long-term effects of TBI and K.",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      },
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "pneumoniae infection both in isolation and in combination.",
    "entities": []
  },
  {
    "text": "RESULTS: We found that, although infection with K. pneumoniae resulted in loss",
    "entities": [
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "of body weight and increased mortality compared to vehicle-inoculated mice,",
    "entities": []
  },
  {
    "text": "there was no additional mortality in TBI animals. Furthermore, although TBI",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      },
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "alone induced chronic hyperactivity and reduced anxiety-like behaviors, K.",
    "entities": [
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "pneumoniae lung infection had no lasting effect on these long-term outcomes.",
    "entities": [
      {
        "text": "pneumoniae lung infection",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Third, although TBI resulted in both spontaneous and evoked seizures long-term",
    "entities": [
      {
        "text": "Third",
        "label": "ORDINAL"
      },
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "post-injury, early post-injury K. pneumoniae infection did not affect late-onset",
    "entities": [
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "SIGNIFICANCE: Together with recent findings on acute outcomes in this combined",
    "entities": []
  },
  {
    "text": "insult model of TBI and K. pneumoniae infection, this study suggests that K.",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      },
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "pneumoniae does not significantly alter long-term neurobehavioral outcomes or",
    "entities": []
  },
  {
    "text": "the development of post-traumatic epilepsy. This research highlights the need to",
    "entities": []
  },
  {
    "text": "further explore the interplay between additional immune insults such as",
    "entities": []
  },
  {
    "text": "infection that may influence long-term recovery.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Epilepsia published by Wiley Periodicals LLC on behalf of",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Epilepsia",
        "label": "GPE"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "International League Against Epilepsy.",
    "entities": [
      {
        "text": "International League Against Epilepsy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.1093/bioinformatics/btaf212.",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Ultrafast and ultralarge multiple sequence alignments using TWILIGHT.",
    "entities": []
  },
  {
    "text": "(1)Department of Electrical and Computer Engineering, University of California",
    "entities": [
      {
        "text": "Electrical and Computer Engineering",
        "label": "ORG"
      },
      {
        "text": "University of California\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MOTIVATION: Multiple sequence alignment (MSA) is a fundamental operation in",
    "entities": [
      {
        "text": "MSA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bioinformatics, yet existing MSA tools are struggling to keep up with the speed",
    "entities": [
      {
        "text": "MSA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and volume of incoming data. This is because the runtimes and memory",
    "entities": []
  },
  {
    "text": "requirements of current MSA tools become untenable when processing large numbers",
    "entities": [
      {
        "text": "MSA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of long input sequences, and they also fail to fully harness the parallelism",
    "entities": []
  },
  {
    "text": "provided by modern CPUs and GPUs.",
    "entities": []
  },
  {
    "text": "RESULTS: We present Tall and Wide Alignments at High Throughput (TWILIGHT), a",
    "entities": [
      {
        "text": "Tall",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "novel MSA tool optimized for speed, accuracy, scalability, and memory",
    "entities": []
  },
  {
    "text": "constraints, with both CPU and GPU support. TWILIGHT incorporates innovative",
    "entities": [
      {
        "text": "CPU",
        "label": "ORG"
      },
      {
        "text": "GPU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "parallelization and memory-efficiency strategies that enable it to build",
    "entities": []
  },
  {
    "text": "ultralarge alignments at high speed even on memory-constrained devices. On",
    "entities": []
  },
  {
    "text": "challenging datasets, TWILIGHT outperformed all other tools in speed and",
    "entities": []
  },
  {
    "text": "accuracy. It scaled beyond the limits of existing tools and performed an",
    "entities": []
  },
  {
    "text": "alignment of 1 million RNASim sequences within 30 min while utilizing <16 GB of",
    "entities": [
      {
        "text": "1 million",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "GB",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "memory. TWILIGHT is the first tool to align over 8 million publicly available",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "8 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 sequences, setting a new standard for large-scale genomic alignment",
    "entities": []
  },
  {
    "text": "AVAILABILITY AND IMPLEMENTATION: TWILIGHT's code is freely available under the",
    "entities": [
      {
        "text": "AVAILABILITY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MIT license at https://github.com/TurakhiaLab/TWILIGHT. The test datasets and",
    "entities": [
      {
        "text": "MIT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "experimental results, including our alignment of 8 million SARS-CoV-2 sequences,",
    "entities": [
      {
        "text": "8 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1093/bioinformatics/btaf212",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662833 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662833",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1093/bioinformatics/btaf210.",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Recovering time-varying networks from single-cell data.",
    "entities": []
  },
  {
    "text": "(1)Machine Learning Department, Carnegie Mellon University, Pittsburgh, PA",
    "entities": [
      {
        "text": "Learning Department",
        "label": "ORG"
      },
      {
        "text": "Carnegie Mellon University",
        "label": "ORG"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "15213, United States.",
    "entities": [
      {
        "text": "15213",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Computational Biology Department, Carnegie Mellon University, Pittsburgh, PA",
    "entities": [
      {
        "text": "2)Computational",
        "label": "CARDINAL"
      },
      {
        "text": "Biology Department",
        "label": "ORG"
      },
      {
        "text": "Carnegie Mellon University",
        "label": "ORG"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "MOTIVATION: Gene regulation is a dynamic process that underlies all aspects of",
    "entities": []
  },
  {
    "text": "human development, disease response, and other biological processes. The",
    "entities": []
  },
  {
    "text": "reconstruction of temporal gene regulatory networks has conventionally relied on",
    "entities": []
  },
  {
    "text": "regression analysis, graphical models, or other types of relevance networks.",
    "entities": []
  },
  {
    "text": "With the large increase in time series single-cell data, new approaches are",
    "entities": []
  },
  {
    "text": "needed to address the unique scale and nature of these data for reconstructing",
    "entities": []
  },
  {
    "text": "such networks.",
    "entities": []
  },
  {
    "text": "RESULTS: Here, we develop a deep neural network, Marlene, to infer dynamic",
    "entities": [
      {
        "text": "Marlene",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "directed gene networks using a self-attention mechanism where the weights evolve",
    "entities": []
  },
  {
    "text": "over time using recurrent units. By employing meta learning, the model is able",
    "entities": []
  },
  {
    "text": "to recover accurate temporal networks even for rare cell types. In addition,",
    "entities": []
  },
  {
    "text": "Marlene can identify gene interactions relevant to specific biological",
    "entities": [
      {
        "text": "Marlene",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "responses, including COVID-19 immune response, fibrosis, and aging, paving the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "way for potential treatments.",
    "entities": []
  },
  {
    "text": "AVAILABILITY AND IMPLEMENTATION: The code used to train Marlene is available at",
    "entities": [
      {
        "text": "AVAILABILITY",
        "label": "ORG"
      },
      {
        "text": "Marlene",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DOI: 10.1093/bioinformatics/btaf210",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662830 [Indexed for MEDLINE]61. Bioinformatics. 2025 Jul 1;41(Supplement_1):i391-i400. doi:",
    "entities": [
      {
        "text": "40662830",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "10.1093/bioinformatics/btaf245.",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Dai N(1), Zhou T(1), Tang WY(1), Mathews DH(2)(3)(4), Huang L(1)(5).",
    "entities": [
      {
        "text": "Dai N(1",
        "label": "PERSON"
      },
      {
        "text": "Zhou T(1",
        "label": "PERSON"
      },
      {
        "text": "Tang",
        "label": "PERSON"
      },
      {
        "text": "Mathews",
        "label": "ORG"
      },
      {
        "text": "Huang L(1)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)School of Electrical Engineering and Computer Science, Oregon State",
    "entities": [
      {
        "text": "1)School of Electrical Engineering and Computer Science",
        "label": "ORG"
      },
      {
        "text": "Oregon State",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Corvallis, OR 97330, United States.",
    "entities": [
      {
        "text": "Corvallis",
        "label": "PERSON"
      },
      {
        "text": "97330",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Biochemistry and Biophysics, University of Rochester Medical",
    "entities": [
      {
        "text": "Biochemistry and Biophysics,",
        "label": "ORG"
      },
      {
        "text": "University of Rochester Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Rochester, NY 14642, United States.",
    "entities": [
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "ORG"
      },
      {
        "text": "14642",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Center for RNA Biology, University of Rochester Medical Center, Rochester, NY",
    "entities": [
      {
        "text": "RNA Biology",
        "label": "ORG"
      },
      {
        "text": "University of Rochester Medical Center",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "14642, United States.",
    "entities": [
      {
        "text": "14642",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Biostatistics and Computational Biology, University of",
    "entities": [
      {
        "text": "Biostatistics and Computational Biology, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Rochester Medical Center, Rochester, NY 14642, United States.",
    "entities": [
      {
        "text": "Rochester Medical Center",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "ORG"
      },
      {
        "text": "14642",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Biochemistry and Biophysics, Oregon State University,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biochemistry and Biophysics",
        "label": "ORG"
      },
      {
        "text": "Oregon State University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Corvallis, OR 97330, United States.",
    "entities": [
      {
        "text": "Corvallis",
        "label": "PERSON"
      },
      {
        "text": "97330",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "MOTIVATION: The task of designing optimized messenger RNA (mRNA) sequences has",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received much attention in recent years, thanks to breakthroughs in mRNA",
    "entities": [
      {
        "text": "recent years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "vaccines during the COVID-19 pandemic. Because most previous work aimed to",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "minimize the minimum free energy (MFE) of the mRNA in order to improve stability",
    "entities": []
  },
  {
    "text": "and protein expression, which only considers one particular structure per mRNA",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sequence, millions of alternative conformations in equilibrium are neglected.",
    "entities": [
      {
        "text": "millions",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "More importantly, we prefer an mRNA to populate multiple stable structures and",
    "entities": []
  },
  {
    "text": "be flexible among them during translation when the ribosome unwinds it.",
    "entities": []
  },
  {
    "text": "RESULTS: Therefore, we consider a new objective to minimize the ensemble free",
    "entities": []
  },
  {
    "text": "energy of an mRNA, which includes all possible structures in its Boltzmann",
    "entities": []
  },
  {
    "text": "ensemble. However, this new problem is much harder to solve than the original",
    "entities": []
  },
  {
    "text": "MFE optimization. To address the increased complexity of this problem, we",
    "entities": []
  },
  {
    "text": "introduce EnsembleDesign, a novel algorithm that employs continuous relaxation",
    "entities": [
      {
        "text": "EnsembleDesign",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to optimize the expected ensemble free energy over a distribution of candidate",
    "entities": []
  },
  {
    "text": "sequences. EnsembleDesign extends both the lattice representation of the design",
    "entities": []
  },
  {
    "text": "space and the dynamic programming algorithm from LinearDesign to their",
    "entities": [
      {
        "text": "LinearDesign",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "probabilistic counterparts. Our algorithm consistently outperforms LinearDesign",
    "entities": [
      {
        "text": "LinearDesign",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in terms of ensemble free energy, especially on long sequences. Interestingly,",
    "entities": []
  },
  {
    "text": "as byproducts, our designs also enjoy lower average unpaired probabilities",
    "entities": []
  },
  {
    "text": "(which correlates with degradation) and flatter Boltzmann ensembles (more",
    "entities": [
      {
        "text": "Boltzmann",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "flexibility between conformations).",
    "entities": []
  },
  {
    "text": "DOI: 10.1093/bioinformatics/btaf245",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662826 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662826",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "10.1093/bioinformatics/btaf228.",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CATH-ddG: towards robust mutation effect prediction on protein-protein",
    "entities": []
  },
  {
    "text": "interactions out of CATH homologous superfamily.",
    "entities": [
      {
        "text": "CATH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)School of Computer Science and Engineering, Central South University,",
    "entities": [
      {
        "text": "1)School of Computer Science and Engineering",
        "label": "ORG"
      },
      {
        "text": "Central South University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Hunan Provincial Key Lab on Bioinformatics, Central South University,",
    "entities": [
      {
        "text": "Central South University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)College of Medical Engineering and Technology, Xinjiang Medical University,",
    "entities": [
      {
        "text": "Medical Engineering and Technology",
        "label": "ORG"
      },
      {
        "text": "Xinjiang Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Computer Science, Old Dominion University, Norfolk, VA 23529,",
    "entities": [
      {
        "text": "Computer Science, Old Dominion University",
        "label": "ORG"
      },
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "23529",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "United States.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "MOTIVATION: Protein-protein interactions (PPIs) are fundamental aspects in",
    "entities": []
  },
  {
    "text": "understanding biological processes. Accurately predicting the effects of",
    "entities": []
  },
  {
    "text": "mechanistic studies. Recently, deep learning models using protein 3D structures",
    "entities": []
  },
  {
    "text": "have become predominant for predicting mutation effects. However, significant",
    "entities": []
  },
  {
    "text": "challenges remain in practical applications, in part due to the considerable",
    "entities": []
  },
  {
    "text": "disparity in generalization capabilities between easy and hard mutations.",
    "entities": []
  },
  {
    "text": "Specifically, a hard mutation is defined as one with its maximum TM-score <0.6",
    "entities": [
      {
        "text": "TM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "when compared to the training set. Additionally, compared to physics-based",
    "entities": []
  },
  {
    "text": "approaches, deep learning models may overestimate performance due to potential",
    "entities": []
  },
  {
    "text": "RESULTS: We propose new training/test splits that mitigate data leakage",
    "entities": []
  },
  {
    "text": "according to the CATH homologous superfamily. Under the constraints of physical",
    "entities": [
      {
        "text": "CATH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "energy, protein 3D structures, and CATH domain objectives, we employ a hybrid",
    "entities": []
  },
  {
    "text": "named CATH-ddG, to represent the mutational microenvironment differences between",
    "entities": []
  },
  {
    "text": "wild-type and mutated protein complexes. Additionally, we fine-tune ESM2",
    "entities": []
  },
  {
    "text": "representations by incorporating a lightweight nonlinear module to achieve the",
    "entities": []
  },
  {
    "text": "transferability of sequence co-evolutionary information. Finally, our study",
    "entities": []
  },
  {
    "text": "demonstrates that CATH-ddG framework provides enhanced generalization by",
    "entities": []
  },
  {
    "text": "outperforming other baselines on non-superfamily leakage splits, which plays a",
    "entities": []
  },
  {
    "text": "crucial role in exploring robust mutation effect regression prediction.",
    "entities": []
  },
  {
    "text": "Independent case studies demonstrate successful enhancement of binding affinity",
    "entities": []
  },
  {
    "text": "on 419 antibody variants to human epidermal growth factor receptor 2 (HER2) and",
    "entities": [
      {
        "text": "419",
        "label": "CARDINAL"
      },
      {
        "text": "2 (HER2",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "285 variants in the receptor-binding domain (RBD) of SARS-CoV-2 to",
    "entities": [
      {
        "text": "285",
        "label": "CARDINAL"
      },
      {
        "text": "RBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "angiotensin-converting enzyme 2 (ACE2) receptor.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "AVAILABILITY AND IMPLEMENTATION: CATH-ddG is available at",
    "entities": [
      {
        "text": "AVAILABILITY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1093/bioinformatics/btaf228",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662779 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "10.1093/bioinformatics/btaf211.",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CREMSA: compressed indexing of (ultra) large multiple sequence alignments.",
    "entities": []
  },
  {
    "text": "Y(2), Marchet C(1), Pan N(4), Will S(4), Ponty Y(4).",
    "entities": [
      {
        "text": "Marchet",
        "label": "PERSON"
      },
      {
        "text": "Pan N(4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MOTIVATION: Recent viral outbreaks motivate the systematic collection of",
    "entities": []
  },
  {
    "text": "pathogenic genomes in order to accelerate their study and monitor the",
    "entities": []
  },
  {
    "text": "apparition/spread of variants. Due to their limited length and temporal",
    "entities": []
  },
  {
    "text": "proximity of their sequencing, viral genomes are usually organized, and analyzed",
    "entities": []
  },
  {
    "text": "as oversized Multiple Sequence Alignments (MSAs). Such MSAs are largely",
    "entities": [
      {
        "text": "Multiple Sequence Alignments",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ungapped, and mostly homogeneous on a column-wise level but not at a sequential",
    "entities": []
  },
  {
    "text": "level due to local variations, hindering the performances of sequential",
    "entities": []
  },
  {
    "text": "compression algorithms.",
    "entities": []
  },
  {
    "text": "RESULTS: In order to enable an efficient handling of MSAs, including subsequent",
    "entities": []
  },
  {
    "text": "statistical analyses, we introduce CREMSA (Column-wise Run-length Encoding for",
    "entities": []
  },
  {
    "text": "MSAs), a new index that builds on sparse bitvector representations to compress",
    "entities": []
  },
  {
    "text": "an existing or streamed MSA, all the while allowing for an expressive set of",
    "entities": [
      {
        "text": "MSA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "accelerated requests to query the alignment without prior decompression. Using",
    "entities": []
  },
  {
    "text": "CREMSA, a 65 GB MSA consisting of 1.9M SARS-CoV 2 genomes could be compressed",
    "entities": [
      {
        "text": "CREMSA",
        "label": "ORG"
      },
      {
        "text": "65",
        "label": "CARDINAL"
      },
      {
        "text": "GB",
        "label": "GPE"
      },
      {
        "text": "1.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "into 22 MB using less than half a gigabyte of main memory, while executing",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "MB",
        "label": "ORG"
      },
      {
        "text": "less than half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "access requests in the order of 100 ns. Such a speed up enables a comprehensive",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analysis of covariation over this very large MSA. We further assess the impact",
    "entities": []
  },
  {
    "text": "of the sequence ordering on the compressibility of MSAs and propose a resorting",
    "entities": []
  },
  {
    "text": "strategy that, despite the proven NP-hardness of an optimal sort, induces",
    "entities": [
      {
        "text": "NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "greatly increased compression ratios at a marginal computational cost.",
    "entities": []
  },
  {
    "text": "AVAILABILITY AND IMPLEMENTATION: CREMSA is freely accessible at",
    "entities": [
      {
        "text": "AVAILABILITY",
        "label": "ORG"
      },
      {
        "text": "CREMSA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "https://gitlab.univ-lille.fr/cremsa/cremsa. The Snakemake workflow for the",
    "entities": []
  },
  {
    "text": "benchmarks is available at: https://gitlab.univ-lille.fr/cremsa/bench. The data",
    "entities": []
  },
  {
    "text": "used in the paper is on Zenodo at https://zenodo.org/records/14698859 and",
    "entities": [
      {
        "text": "Zenodo",
        "label": "ORG"
      },
      {
        "text": "https://zenodo.org/records/14698859",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1093/bioinformatics/btaf211",
    "entities": [
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662774 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662774",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "64. HIV Med. 2025 Jul 15. doi: 10.1111/hiv.70074. Online ahead of print.",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Impact of three different interventions designed to improve the implementation",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of an opt-in targeted strategy of HIV testing in emergency departments.",
    "entities": []
  },
  {
    "text": "R(11), Caba\u00f1as J(12), Manzanares J\u00c1(13), Mir\u00f3 \u00d2(14); Emergency HIV Network",
    "entities": [
      {
        "text": "Caba\u00f1as J(12",
        "label": "PERSON"
      },
      {
        "text": "Mir\u00f3",
        "label": "GPE"
      },
      {
        "text": "Emergency HIV Network",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Emergency Department, IdISSC, Universidad Complutense, Madrid, Spain.",
    "entities": [
      {
        "text": "Department",
        "label": "GPE"
      },
      {
        "text": "IdISSC",
        "label": "GPE"
      },
      {
        "text": "Universidad Complutense",
        "label": "GPE"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Emergency Department, Hospital Universitario Dr. Negr\u00edn, Gran Canaria, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario Dr.",
        "label": "ORG"
      },
      {
        "text": "Negr\u00edn",
        "label": "PERSON"
      },
      {
        "text": "Gran Canaria",
        "label": "PERSON"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Emergency Department, Hospital Universitario de Galdakao, Bilbao, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario de Galdakao",
        "label": "ORG"
      },
      {
        "text": "Bilbao",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Emergency Department, Hospital Universitario San Cecilio, Granada, Spain.",
    "entities": [
      {
        "text": "Department, Hospital Universitario San Cecilio",
        "label": "ORG"
      },
      {
        "text": "Granada",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IDISCAM, Toledo, Spain.",
    "entities": [
      {
        "text": "Toledo",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Emergency Department, Hospital Universitario Rio Hortega, Valladolid, Spain.",
    "entities": [
      {
        "text": "13)Emergency Department",
        "label": "ORG"
      },
      {
        "text": "Hospital Universitario",
        "label": "FAC"
      },
      {
        "text": "Rio Hortega",
        "label": "GPE"
      },
      {
        "text": "Valladolid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Undiagnosed HIV infection remains the main driver of new HIV cases",
    "entities": []
  },
  {
    "text": "in Western countries. Emergency Departments (EDs) offer a key opportunity for",
    "entities": []
  },
  {
    "text": "detection. In 2020, Spanish emergency and infectious diseases societies",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "recommended an opt-in strategy for targeted conditions for HIV testing in EDs.",
    "entities": []
  },
  {
    "text": "This study evaluates the efficacy of three strategies for targeted HIV testing.",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: Twelve Spanish EDs, selected based on predefined structural criteria,",
    "entities": [
      {
        "text": "Twelve",
        "label": "CARDINAL"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "assessed HIV testing from April to June 2024. Hospitals applied: no strategy",
    "entities": [
      {
        "text": "April to June 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(control, three EDs), an educational programme (strategy A, three EDs), strategy",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A plus preconfigured electronic orders (strategy B, three EDs) or strategy B",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "plus electronic alerts in medical records (strategy C, three EDs). The impact on",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "HIV testing was measured overall and by targeted condition, using absolute",
    "entities": []
  },
  {
    "text": "differences with 95% confidence intervals (CIs).",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RESULTS: Of the 612 909 ED visits, 210 039 occurred in control hospitals (1232",
    "entities": [
      {
        "text": "612 909",
        "label": "CARDINAL"
      },
      {
        "text": "210",
        "label": "CARDINAL"
      },
      {
        "text": "1232",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients [0.59%] had targeted conditions), 172 806 in hospitals applying",
    "entities": [
      {
        "text": "0.59%",
        "label": "PERCENT"
      },
      {
        "text": "172 806",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strategy A (1497 [0.87%]), 132 835 in strategy B hospitals (1761 [1.33%]) and",
    "entities": [
      {
        "text": "1497",
        "label": "DATE"
      },
      {
        "text": "0.87%",
        "label": "PERCENT"
      },
      {
        "text": "132 835",
        "label": "CARDINAL"
      },
      {
        "text": "1761",
        "label": "DATE"
      },
      {
        "text": "1.33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "97 229 in hospitals applying strategy C (1269 [1.31%]). Testing rates were",
    "entities": [
      {
        "text": "97 229",
        "label": "CARDINAL"
      },
      {
        "text": "1269",
        "label": "CARDINAL"
      },
      {
        "text": "1.31%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "0.16%, 0.38%, 1.17% and 2.16% in the control, and strategy A, B and C EDs.,",
    "entities": [
      {
        "text": "0.16%",
        "label": "PERCENT"
      },
      {
        "text": "0.38%",
        "label": "PERCENT"
      },
      {
        "text": "1.17%",
        "label": "PERCENT"
      },
      {
        "text": "2.16%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "respectively. Among patients with targeted conditions, testing reached 13.1%,",
    "entities": [
      {
        "text": "13.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "22.9%, 30.7% and 78.1%. Compared to no strategy, testing increased by 0.22% (95%",
    "entities": [
      {
        "text": "22.9%",
        "label": "PERCENT"
      },
      {
        "text": "30.7%",
        "label": "PERCENT"
      },
      {
        "text": "78.1%",
        "label": "PERCENT"
      },
      {
        "text": "0.22%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 0.18-0.25) with strategy A, 0.79% (95% CI = 0.73-0.86) with B, and 0.98%",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.18-0.25",
        "label": "CARDINAL"
      },
      {
        "text": "0.79%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.73",
        "label": "CARDINAL"
      },
      {
        "text": "0.98%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(95% CI = 0.88-1.09) with C. In targeted conditions, testing rose by 9.8%, 7.8%",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.88-1.09",
        "label": "CARDINAL"
      },
      {
        "text": "C.",
        "label": "NORP"
      },
      {
        "text": "9.8%",
        "label": "PERCENT"
      },
      {
        "text": "7.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and 47.5% for strategies A, B and C, respectively. All strategies improved",
    "entities": [
      {
        "text": "47.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "testing in sexually transmitted infections (STI), meningitis/neurological",
    "entities": [
      {
        "text": "STI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "syndromes and community-acquired pneumonia (CAP); strategy C also increased",
    "entities": [
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "testing in herpes zoster (HZ) and post-exposure prophylaxis.",
    "entities": []
  },
  {
    "text": "CONCLUSION: All the strategies evaluated enhanced targeted HIV testing,",
    "entities": []
  },
  {
    "text": "especially strategy C (electronic alerts), which was associated with the highest",
    "entities": []
  },
  {
    "text": "testing rates observed, particularly in STI, CAP and HZ.",
    "entities": [
      {
        "text": "STI",
        "label": "ORG"
      },
      {
        "text": "CAP",
        "label": "ORG"
      },
      {
        "text": "HZ",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "\u00a9 2025 British HIV Association.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "British HIV Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shifts in bla genes and Class 1 integron prevalence in beta-lactamase-producing",
    "entities": []
  },
  {
    "text": "bacteria before and after the COVID-19 pandemic in Mendoza, Argentina.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Mendoza",
        "label": "GPE"
      },
      {
        "text": "Argentina",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Dominguez S(3), Secotaro A(3), Rathour VS(1)(2), Damiani MT(1)(2), Contreras",
    "entities": [
      {
        "text": "Dominguez S(3",
        "label": "PERSON"
      },
      {
        "text": "Secotaro A(3",
        "label": "PERSON"
      },
      {
        "text": "Rathour VS(1)(2",
        "label": "PERSON"
      },
      {
        "text": "Damiani MT(1)(2",
        "label": "PERSON"
      },
      {
        "text": "Contreras",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "This study analyzes the molecular epidemiology of bla genes and Class 1 integron",
    "entities": []
  },
  {
    "text": "in broad-spectrum beta-lactamase (BSBL) and extended-spectrum beta-lactamase",
    "entities": []
  },
  {
    "text": "(ESBL) producing strains of bacteria isolated from clinical samples of",
    "entities": [
      {
        "text": "ESBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hospitalized and ambulatory patients before and after the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Isolates obtained in two periods were compared: the first corresponding to the",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "years November 2019-March 2020, and the second to the years November 2021-April",
    "entities": [
      {
        "text": "years November 2019-March 2020",
        "label": "DATE"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "2021-April",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2022. We evaluate changes in resistance patterns of antibiotics associated with",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pressures on the healthcare system and social lockdowns. A total of 156 isolates",
    "entities": [
      {
        "text": "156",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were analyzed: 78 from the first period (61 hospitalized, 17 ambulatory) and 78",
    "entities": [
      {
        "text": "78",
        "label": "CARDINAL"
      },
      {
        "text": "the first period",
        "label": "DATE"
      },
      {
        "text": "61",
        "label": "CARDINAL"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "78",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "from the second period (47 hospitalized, 31 ambulatory). Escherichia coli and",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "31",
        "label": "CARDINAL"
      },
      {
        "text": "Escherichia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Klebsiella pneumoniae were the predominant bacterial species, representing 85%",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "PERSON"
      },
      {
        "text": "85%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of the isolates in both periods. The frequency of ambulatory ESBL-producing",
    "entities": [
      {
        "text": "ESBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "isolates increased significantly, from 22% (17/78) to 40% (31/78; P < 0.01) in",
    "entities": [
      {
        "text": "22%",
        "label": "PERCENT"
      },
      {
        "text": "17/78",
        "label": "CARDINAL"
      },
      {
        "text": "40%",
        "label": "PERCENT"
      },
      {
        "text": "31/78",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the second period. The prevalence of blaSHV increased from 24% (19/78) to 72%",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "blaSHV",
        "label": "PERSON"
      },
      {
        "text": "24%",
        "label": "PERCENT"
      },
      {
        "text": "19/78",
        "label": "CARDINAL"
      },
      {
        "text": "72%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(56/78; P < 0.01) in the second period, while the blaCTX-M-2 group, absent in",
    "entities": [
      {
        "text": "56/78",
        "label": "CARDINAL"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "blaCTX-M-2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the first period, was detected in 43% (34/78) of isolates from the second",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "43%",
        "label": "PERCENT"
      },
      {
        "text": "34/78",
        "label": "CARDINAL"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "period. Strains from the second period exhibited greater genetic complexity,",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "with an increased prevalence of combinations involving three or more bla genes,",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "including isolates carrying up to five of such genes. Class 1 integron showed a",
    "entities": [
      {
        "text": "up to five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strong correlation with resistance to ciprofloxacin and",
    "entities": []
  },
  {
    "text": "trimethoprim-sulfamethoxazole. The gene blaOXA-1, previously associated with",
    "entities": []
  },
  {
    "text": "resistance to beta-lactamase inhibitors, did not show a clear pattern in the",
    "entities": []
  },
  {
    "text": "second period.IMPORTANCEAntimicrobial resistance associated with the production",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "of extended-spectrum beta-lactamase (ESBL) represents a critical global health",
    "entities": [
      {
        "text": "ESBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "challenge, particularly due to the limited development of new antibiotics. This",
    "entities": []
  },
  {
    "text": "is the first report from Argentina's central-west region examining the",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "Argentina",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "prevalence of beta-lactamase-encoding genes, providing a framework for future",
    "entities": []
  },
  {
    "text": "research. Our findings reveal a significant increase in bacteria with the ESBL",
    "entities": [
      {
        "text": "ESBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "phenotype, particularly among ambulatory populations post-pandemic, suggesting a",
    "entities": []
  },
  {
    "text": "concerning spread of multidrug-resistant bacteria outside hospital environments.",
    "entities": []
  },
  {
    "text": "This could compromise empirical antibiotic treatments for ambulatory patients,",
    "entities": []
  },
  {
    "text": "increasing the risk of severe complications. Our results highlight the urgent",
    "entities": []
  },
  {
    "text": "need for ongoing surveillance to detect virulent strains before clonal spread or",
    "entities": []
  },
  {
    "text": "horizontal gene transfer occurs in the community. They also emphasize the",
    "entities": []
  },
  {
    "text": "importance of strategies to ensure the prudent use of antimicrobials and",
    "entities": []
  },
  {
    "text": "mitigate the increasing prevalence of resistance genes, which threatens the",
    "entities": []
  },
  {
    "text": "effectiveness of current therapeutic options.",
    "entities": []
  },
  {
    "text": "Online Tool for Predicting Severe Cases of Childhood Community-Acquired",
    "entities": []
  },
  {
    "text": "Pneumonia Based on the PIRO Concept.",
    "entities": []
  },
  {
    "text": "(1)Department of Otolaryngology, Children's Hospital of Chongqing Medical",
    "entities": [
      {
        "text": "Otolaryngology, Children's Hospital of Chongqing Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, National Clinical Research Center for Child Health and Disorders,",
    "entities": [
      {
        "text": "National Clinical Research Center for Child Health and Disorders",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ministry of Education Key Laboratory of Child Development and Disorders,",
    "entities": [
      {
        "text": "Ministry of Education Key Laboratory of Child Development and Disorders",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Chongqing Key Laboratory of Child Rare Disease in Infection and Immunity,",
    "entities": [
      {
        "text": "2)Chongqing",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory of Child Rare Disease in",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Respiratory Medicine, Children's Hospital of Chongqing Medical",
    "entities": [
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Key Laboratory of Children's Vital Organ Development and Diseases of",
    "entities": [
      {
        "text": "4)Key Laboratory of Children's Vital Organ Development and Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chongqing Health Commission, Chongqing, China.",
    "entities": [
      {
        "text": "Chongqing Health Commission",
        "label": "ORG"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Chongqing Engineering Research Center of Stem Cell Therapy, Chongqing, China.",
    "entities": [
      {
        "text": "Engineering Research Center of Stem Cell Therapy",
        "label": "ORG"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Big Data Center for Children's Medical Care, Children's Hospital of Chongqing",
    "entities": [
      {
        "text": "6)Big",
        "label": "CARDINAL"
      },
      {
        "text": "Data Center for Children's Medical Care, Children's Hospital of Chongqing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical University, National Clinical Research Center for Child Health and",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "National Clinical Research Center for Child Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disorders, Ministry of Education Key Laboratory of Child Development and",
    "entities": [
      {
        "text": "Disorders, Ministry of Education Key Laboratory of Child Development",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disorders, Chongqing, China.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Chongqing Higher Institution Engineering Research Center of Children's",
    "entities": [
      {
        "text": "Higher Institution Engineering Research Center of Children's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Big Data Intelligent Application, Chongqing, China.",
    "entities": [
      {
        "text": "Medical Big Data Intelligent Application",
        "label": "ORG"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Pneumonia remains a leading cause of mortality among children under",
    "entities": [
      {
        "text": "Pneumonia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "5 years of age. This study aimed to compare existing prognostic scoring systems",
    "entities": [
      {
        "text": "5 years of age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and identify the most effective tool for assessing outcomes in children with",
    "entities": []
  },
  {
    "text": "community-acquired pneumonia (CAP).",
    "entities": [
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: The Predisposition, Insult, Response, and Organ Dysfunction score for",
    "entities": [
      {
        "text": "Insult",
        "label": "ORG"
      },
      {
        "text": "Response",
        "label": "ORG"
      },
      {
        "text": "Organ Dysfunction",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CAP (PIRO-CAP) was modified to create the Ch-online PIRO score based on a",
    "entities": [
      {
        "text": "PIRO-CAP",
        "label": "ORG"
      },
      {
        "text": "PIRO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "comprehensive cohort study. This new scoring system was validated in a cohort of",
    "entities": []
  },
  {
    "text": "75,965 children under the age of 5 years with CAP, treated at the Children's",
    "entities": [
      {
        "text": "75,965",
        "label": "CARDINAL"
      },
      {
        "text": "the age of 5 years",
        "label": "DATE"
      },
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital of Chongqing Medical University between 2016 and 2021. Effectiveness in",
    "entities": [
      {
        "text": "between 2016 and 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "predicting severe cases was then compared against the Pediatric Critical Illness",
    "entities": [
      {
        "text": "the Pediatric Critical Illness",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Score (PCIS), Pneumonia Etiology Research for Child Health (PERCH) score, and",
    "entities": [
      {
        "text": "Pneumonia Etiology Research for Child Health (PERCH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The Ch-online PIRO score retained most of the original PIRO-CAP",
    "entities": [
      {
        "text": "PIRO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "factors, including age under 6 months, comorbidities, SpO2 below 90%, multilobar",
    "entities": [
      {
        "text": "age under 6 months",
        "label": "DATE"
      },
      {
        "text": "90%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "or complicated pneumonia, kidney or liver dysfunction, and respiratory failure,",
    "entities": []
  },
  {
    "text": "but replaced hypotension and bacteremia with delayed capillary refill time",
    "entities": []
  },
  {
    "text": "(> 3 s) and procalcitonin > 0.5 ng/mL. When predicting severe CAP cases, the",
    "entities": [
      {
        "text": "3 s",
        "label": "CARDINAL"
      },
      {
        "text": "0.5",
        "label": "CARDINAL"
      },
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(AUC = 0.85, 95% CI: 0.85-0.86) compared to the PCIS (AUC = 0.67, 95% CI:",
    "entities": [
      {
        "text": "0.85",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.85",
        "label": "CARDINAL"
      },
      {
        "text": "0.67",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "0.66-0.69), PERCH score (AUC = 0.64, 95% CI: 0.64-0.65), and PIRO-CAP score",
    "entities": [
      {
        "text": "0.66",
        "label": "CARDINAL"
      },
      {
        "text": "0.64",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.64-0.65",
        "label": "CARDINAL"
      },
      {
        "text": "PIRO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(AUC = 0.68, 95% CI: 0.64-0.71).",
    "entities": [
      {
        "text": "0.68",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: The Ch-online PIRO score shows promise as an effective prognostic",
    "entities": [
      {
        "text": "PIRO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "tool for assessing the severity of CAP in young children.",
    "entities": [
      {
        "text": "CAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Pediatric Pulmonology",
        "label": "ORG"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40662510 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Assessing the Impact of Nirsevimab Immunization on RSV Bronchiolitis Hospital",
    "entities": [
      {
        "text": "RSV Bronchiolitis Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Admissions and Their Severity: A Case-Control Study and Comparison With Pre- and",
    "entities": [
      {
        "text": "Admissions and Their Severity",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Post-COVID-19 Seasons in a Tertiary Pediatric Hospital.",
    "entities": [
      {
        "text": "Tertiary Pediatric Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Paediatrics at the Malaga Mother-and-Child Hospital, Hospital",
    "entities": [
      {
        "text": "Paediatrics",
        "label": "ORG"
      },
      {
        "text": "the Malaga Mother-and-Child Hospital",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "INTRODUCTION: This study evaluates nirsevimab's real-world effectiveness in",
    "entities": [
      {
        "text": "nirsevimab",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "preventing respiratory syncytial virus (RSV) bronchiolitis hospitalizations",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "after its introduction in Andalusia's immunization schedule, compares clinical",
    "entities": [
      {
        "text": "Andalusia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "outcomes between immunized and non-immunized infants (2023-2024), and examines",
    "entities": [
      {
        "text": "2023-2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RSV seasonality pre- and post-COVID-19.",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Retrospective single-center case-control study conducted at a tertiary",
    "entities": []
  },
  {
    "text": "pediatric hospital (Malaga Regional University Hospital). Infants hospitalized",
    "entities": [
      {
        "text": "Malaga Regional University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for PCR-confirmed RSV bronchiolitis during the first season after nirsevimab",
    "entities": [
      {
        "text": "PCR",
        "label": "ORG"
      },
      {
        "text": "RSV",
        "label": "ORG"
      },
      {
        "text": "the first season",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "introduction were matched with two controls born on the same day. Immunization",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "the same day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "status, demographic data, and clinical outcomes were analyzed. As a secondary",
    "entities": []
  },
  {
    "text": "analysis, clinical characteristics and adverse outcomes of immunized and",
    "entities": []
  },
  {
    "text": "non-immunized RSV bronchiolitis cases from the 2023-2024 season were compared",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      },
      {
        "text": "2023-2024 season",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with four previous periods: pre-pandemic decade (04/2010-03/2020), first",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "04/2010-03/2020",
        "label": "DATE"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "pandemic season (04/2020-03/2021), second pandemic season (04/2021-03/2022) and",
    "entities": [
      {
        "text": "04/2020-03/2021",
        "label": "DATE"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "third pandemic season (04/2022-03/2023).",
    "entities": [
      {
        "text": "third pandemic season",
        "label": "DATE"
      },
      {
        "text": "04/2022-03/2023",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Nirsevimab showed 91.5% effectiveness (95% CI: 71.8%-97.4%) in reducing",
    "entities": [
      {
        "text": "91.5%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "71.8%-97.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RSV bronchiolitis hospitalizations, which decreased 72.4% from the pre-pandemic",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      },
      {
        "text": "72.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "average and 82.4% from 04/2022-03/2023. Intensive-care-unit admissions were",
    "entities": [
      {
        "text": "82.4%",
        "label": "PERCENT"
      },
      {
        "text": "04/2022-03/2023",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly higher in non-immunized infants (60.0% vs. 26.1%, p = 0.04), with",
    "entities": [
      {
        "text": "60.0%",
        "label": "PERCENT"
      },
      {
        "text": "26.1%",
        "label": "PERCENT"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "no differences in bacterial superinfection, oxygen requirement and",
    "entities": []
  },
  {
    "text": "length-of-stay.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Nirsevimab significantly reduced RSV bronchiolitis hospitalizations",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "during its first season of use. The study also highlights shifts in RSV",
    "entities": [
      {
        "text": "its first season",
        "label": "DATE"
      },
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "seasonality trends influenced by the COVID-19 pandemic, highlighting the need",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for ongoing surveillance to adapt public health strategies.",
    "entities": []
  },
  {
    "text": "PMID: 40662491 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662491",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "68. J Intellect Disabil Res. 2025 Jul 15. doi: 10.1111/jir.70013. Online ahead of",
    "entities": [
      {
        "text": "68",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Oral Health and Pneumonia in Adults With Intellectual and Developmental",
    "entities": [
      {
        "text": "Adults With Intellectual and Developmental",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Disabilities: A Scoping Review.",
    "entities": []
  },
  {
    "text": "(1)School of Dental Science, Trinity College, University of Dublin, Dublin,",
    "entities": [
      {
        "text": "Dental Science",
        "label": "ORG"
      },
      {
        "text": "Trinity College",
        "label": "ORG"
      },
      {
        "text": "University of Dublin",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Trinity College Dublin",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Nursing and Healthcare Sciences, Munster Technological",
    "entities": [
      {
        "text": "Nursing and Healthcare Sciences",
        "label": "ORG"
      },
      {
        "text": "Munster Technological",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University - Kerry Campus, Tralee, Co. Kerry, Ireland.",
    "entities": [
      {
        "text": "University - Kerry Campus",
        "label": "ORG"
      },
      {
        "text": "Tralee",
        "label": "ORG"
      },
      {
        "text": "Kerry",
        "label": "PERSON"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Dublin Dental University Hospital & School of Dental Science, Trinity",
    "entities": [
      {
        "text": "4)Dublin",
        "label": "CARDINAL"
      },
      {
        "text": "Dental University Hospital & School of Dental Science",
        "label": "ORG"
      },
      {
        "text": "Trinity",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, University of Dublin, Dublin, Ireland.",
    "entities": [
      {
        "text": "University of Dublin",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)School of Social Work, Temple University, Philadelphia, Pennsylvania, USA.",
    "entities": [
      {
        "text": "5)School of",
        "label": "ORG"
      },
      {
        "text": "Social Work, Temple University",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "Pennsylvania",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Pneumonia is a leading cause of death for people with intellectual",
    "entities": [
      {
        "text": "Pneumonia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and developmental disabilities (IDD), who also have increased risk of oral",
    "entities": []
  },
  {
    "text": "disease. Given the known relationship between oral disease and pneumonia in",
    "entities": []
  },
  {
    "text": "similar populations, this review aims to explore what is known about the",
    "entities": []
  },
  {
    "text": "association between oral health and pneumonia among people with IDD.",
    "entities": [
      {
        "text": "IDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This systematic scoping review was carried out in accordance with the",
    "entities": []
  },
  {
    "text": "Joanna Briggs Institute methods and the Preferred Reporting Items for Systematic",
    "entities": [
      {
        "text": "Joanna Briggs Institute",
        "label": "PERSON"
      },
      {
        "text": "the Preferred Reporting Items for Systematic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Reviews and Meta-Analyses Extension for Scoping Reviews checklist (PRISMA-ScR).",
    "entities": [
      {
        "text": "Meta-Analyses Extension",
        "label": "ORG"
      },
      {
        "text": "PRISMA-ScR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A systematic search of Medline (Ovid), Embase, Cochrane Trials, Cochrane Review,",
    "entities": [
      {
        "text": "Medline (Ovid",
        "label": "ORG"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      },
      {
        "text": "Cochrane Trials",
        "label": "ORG"
      },
      {
        "text": "Cochrane Review",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CINAHL and PubMed was conducted, guided by a registered protocol. The PCC",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "PCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "framework informed the search and inclusion criteria. Titles and abstracts were",
    "entities": []
  },
  {
    "text": "independently screened by two reviewers, with full texts assessed for relevance",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "to oral health and pneumonia in adults with IDD.",
    "entities": [
      {
        "text": "IDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Following a protocol and defined criteria, (2544) articles were",
    "entities": [
      {
        "text": "2544",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "abstract screened; a further (31) reached full-text review, with (7) included in",
    "entities": [
      {
        "text": "31",
        "label": "CARDINAL"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "this review. Study designs included cross-sectional studies (2), retrospective",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cohorts (2), prospective cohorts (2) and one RCT pilot (1). Six studies reported",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "oral carriage of respiratory pathogens such as Streptococcus pneumoniae,",
    "entities": []
  },
  {
    "text": "predictive relationships between oral pathogens and pneumonia, with increased",
    "entities": []
  },
  {
    "text": "odds of respiratory illness associated with positive PCR results for specific",
    "entities": [
      {
        "text": "PCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathogens (OR 9.0, 95% confidence interval [CI] 2.3-38.8). Two studies",
    "entities": [
      {
        "text": "9.0",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.3-38.8",
        "label": "CARDINAL"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "identified poor oral health as a predictor of pneumonia, using validated tools",
    "entities": []
  },
  {
    "text": "such as the ROAG (OR 1.6, 95% CI 1.1-2.5). Mediating factors included enteral",
    "entities": [
      {
        "text": "ROAG",
        "label": "ORG"
      },
      {
        "text": "1.6,",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.1-2.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "feeding, level of IDD, and history of oral disease.",
    "entities": [
      {
        "text": "IDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Research consistently finds carriage of potential respiratory",
    "entities": []
  },
  {
    "text": "pathogens in the oral microbiome of people with IDD. Despite this, there is a",
    "entities": [
      {
        "text": "IDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant lack of research into the relationship between the oral microbiome,",
    "entities": []
  },
  {
    "text": "poor oral health, and pneumonia in this population, though the latter two are",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "both prevalent and consequential. There is an urgent need for further research",
    "entities": []
  },
  {
    "text": "exploring the role that oral health and the oral microbiome play in pneumonia",
    "entities": []
  },
  {
    "text": "among people with IDD.",
    "entities": [
      {
        "text": "IDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Journal of Intellectual Disability Research published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Journal of Intellectual Disability Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MENCAP and John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "MENCAP",
        "label": "ORG"
      },
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.3389/fcimb.2025.1480123. eCollection 2025.",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Effect of prone positioning on inflammatory markers in blood and lungs: a",
    "entities": []
  },
  {
    "text": "retrospective cohort study in COVID-19-related ARDS.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Pulmonary and Critical Medicine, Xiangtan Central Hospital,",
    "entities": [
      {
        "text": "Pulmonary and Critical Medicine",
        "label": "ORG"
      },
      {
        "text": "Xiangtan Central Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Oncology, Xiangtan Central Hospital, Xiangtan, Hunan, China.",
    "entities": [
      {
        "text": "Oncology",
        "label": "ORG"
      },
      {
        "text": "Xiangtan Central Hospital",
        "label": "ORG"
      },
      {
        "text": "Xiangtan",
        "label": "GPE"
      },
      {
        "text": "Hunan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Hematology, Xiangtan Central Hospital, Xiangtan, Hunan, China.",
    "entities": [
      {
        "text": "Hematology",
        "label": "ORG"
      },
      {
        "text": "Xiangtan Central Hospital",
        "label": "ORG"
      },
      {
        "text": "Xiangtan",
        "label": "GPE"
      },
      {
        "text": "Hunan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Prone positioning is a commonly recommended intervention in",
    "entities": []
  },
  {
    "text": "clinical practice to enhance oxygenation in COVID-19 patients with ARDS, but its",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effects on inflammatory markers in the blood and lungs have not been thoroughly",
    "entities": []
  },
  {
    "text": "investigated.",
    "entities": []
  },
  {
    "text": "METHODS: This retrospective study examined COVID-19-related ARDS patients",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "admitted to the ICU of a tertiary hospital between January 2020 and November",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "tertiary",
        "label": "ORDINAL"
      },
      {
        "text": "between January 2020 and",
        "label": "DATE"
      },
      {
        "text": "November",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2023. The analysis focused on measuring cytokines and lymphocyte subsets in both",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "blood and bronchoalveolar lavage fluid (BALF) to evaluate the impact of prone",
    "entities": [
      {
        "text": "BALF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "positioning on inflammatory markers in the lungs and systemic circulation.",
    "entities": []
  },
  {
    "text": "RESULTS: Of the 86 intubated patients, 44 were included in the study, with 30",
    "entities": [
      {
        "text": "86",
        "label": "CARDINAL"
      },
      {
        "text": "44",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "undergoing prone positioning. Compared to the supine position, prone positioning",
    "entities": []
  },
  {
    "text": "was associated with elevated plasma levels of IL-12p70 and IL-4, as well as",
    "entities": [
      {
        "text": "IL-12p70",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "increased expression of IFN-\u03b1 and TNF-\u03b1 in BALF. With increased frequency of",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      },
      {
        "text": "TNF",
        "label": "ORG"
      },
      {
        "text": "BALF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prone positioning, oxygenation progressively improved, accompanied by a rise in",
    "entities": []
  },
  {
    "text": "plasma IL-4 levels. No significant differences in peripheral blood lymphocyte",
    "entities": [
      {
        "text": "plasma IL-4 levels",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "levels were observed between the supine and prone groups.",
    "entities": []
  },
  {
    "text": "CONCLUSION: This study sheds light on the potential mechanisms of prone",
    "entities": []
  },
  {
    "text": "positioning in both local and systemic circulation, particularly in the context",
    "entities": []
  },
  {
    "text": "of inflammatory markers. In COVID-19-related ARDS, prone positioning may",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "strengthen the immune response by modulating inflammatory markers in the lungs",
    "entities": []
  },
  {
    "text": "and bloodstream.",
    "entities": []
  },
  {
    "text": "PMID: 40661964 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Single-cell RNA-sequencing highlights a curtailed NK cell function in",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      },
      {
        "text": "NK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Women's Health, Research Institute for Women's Health,",
    "entities": [
      {
        "text": "Women's Health, Research Institute for Women's Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of T\u00fcbingen, T\u00fcbingen, Germany.",
    "entities": [
      {
        "text": "University of T\u00fcbingen",
        "label": "ORG"
      },
      {
        "text": "T\u00fcbingen",
        "label": "ORG"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Universiti",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Biology, Ineos Oxford Institute of Antimicrobial Research,",
    "entities": [
      {
        "text": "Biology",
        "label": "ORG"
      },
      {
        "text": "Ineos Oxford Institute of Antimicrobial Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Oxford, Oxford, United Kingdom.",
    "entities": [
      {
        "text": "University of Oxford",
        "label": "ORG"
      },
      {
        "text": "Oxford",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Intitute for Medical Virology and Epidemiology of Viral Diseases, University",
    "entities": [
      {
        "text": "Medical Virology and Epidemiology of Viral Diseases",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Institute of Medical Genetics and Applied Genomics, University of T\u00fcbingen,",
    "entities": [
      {
        "text": "Applied Genomics, University of T\u00fcbingen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Next Generation Sequencing (NGS) Competence Centre T\u00fcbingen (NCCT),",
    "entities": [
      {
        "text": "Generation Sequencing (NGS) Competence Centre T\u00fcbingen",
        "label": "WORK_OF_ART"
      },
      {
        "text": "NCCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Obstetrics and Gynaecology, Sungai Buloh Hospital,",
    "entities": [
      {
        "text": "Obstetrics and Gynaecology, Sungai Buloh Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: During gestation the immune system undergoes dramatic remodelling",
    "entities": []
  },
  {
    "text": "to protect the maternal-fetal dyad from infections whilst also preventing fetal",
    "entities": []
  },
  {
    "text": "rejection. We investigated how SARS-CoV-2 modifies the immune landscape during",
    "entities": []
  },
  {
    "text": "infection and in recovered pregnant women.",
    "entities": []
  },
  {
    "text": "METHODS: We immunophenotyped our two independent geographical cohorts using a",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "14-colour flow cytometry panel (surface and intracellular staining). We",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "estimated cytokines and SARS-CoV-2 IgG antibodies in validation cohort using a",
    "entities": []
  },
  {
    "text": "multiplexd flow cytometry panel. Single-cell RNA sequencing (scRNA-seq) was",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "performed using a Chromium Single Cell 3' Gel Bead Chip and Library Kit from 10x",
    "entities": [
      {
        "text": "3'",
        "label": "DATE"
      },
      {
        "text": "Library Kit",
        "label": "PERSON"
      },
      {
        "text": "10x",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Genomics (Drop-seq method). Furthermore, we estimated the cytotoxic functions of",
    "entities": []
  },
  {
    "text": "natural killer (NK) cells by flow cytometry using surface and intracellular",
    "entities": []
  },
  {
    "text": "RESULTS: Using two independent geographical cohorts, we identified that NK cells",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "had a sustained reduction during active infection and after recovery. Further,",
    "entities": []
  },
  {
    "text": "scRNA-seq data revealed that infection with SARS-CoV-2 rewired the gene",
    "entities": []
  },
  {
    "text": "expression profile of NK, monocytes, CD4+, CD8+ effector T cells and antibody",
    "entities": [
      {
        "text": "NK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "producing B cells in convalescent pregnant women. Several gene pathways",
    "entities": []
  },
  {
    "text": "associated with cytotoxic function, interferon signalling type I & II, and pro-",
    "entities": [
      {
        "text": "I & II",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "and anti-inflammatory functions in NK and CD8+ cytotoxic T cells were attenuated",
    "entities": [
      {
        "text": "NK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "in recovered pregnant patients compared with healthy pregnancies. We validated",
    "entities": []
  },
  {
    "text": "our scRNA-seq of NK cells from convalescent pregnant women and confirmed that NK",
    "entities": []
  },
  {
    "text": "cells had diminished levels of cytotoxic proteins; perforin, CD122 and granzyme",
    "entities": [
      {
        "text": "CD122",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "DISCUSSION: Overall, our study uncovers that SARS-CoV-2 infection deranges the",
    "entities": []
  },
  {
    "text": "adaptive immune response in pregnant women even after recovery and may",
    "entities": []
  },
  {
    "text": "contribute to post-COVID19 sequalae of symptoms.",
    "entities": []
  },
  {
    "text": "PMID: 40661959 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest. The author(s) declared that",
    "entities": []
  },
  {
    "text": "they were an editorial board member of Frontiers, at the time of submission.",
    "entities": [
      {
        "text": "Frontiers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "This had no impact on the peer review process and the final decision.",
    "entities": []
  },
  {
    "text": "circ-0001875 downregulation is associated with M1 macrophage activation and lung",
    "entities": [
      {
        "text": "circ-0001875",
        "label": "DATE"
      },
      {
        "text": "M1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "inflammation in severe asthma.",
    "entities": []
  },
  {
    "text": "(1)Department of Respiratory and Critical Care Medicine, Affiliated Hospital of",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guangdong Medical University, Zhanjiang, China.",
    "entities": [
      {
        "text": "Guangdong Medical University",
        "label": "ORG"
      },
      {
        "text": "Zhanjiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Asthma is a heterogeneous group of diseases. The mechanism by which",
    "entities": []
  },
  {
    "text": "dysregulated circRNAs affect severe asthma by regulating macrophage polarization",
    "entities": []
  },
  {
    "text": "METHODS: High-throughput RNA sequencing technology was used to analyze circRNA",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "expression in peripheral blood mononuclear cells (PBMCs) from patients with",
    "entities": []
  },
  {
    "text": "severe asthma. RT-qPCR and ELISA were used to analyze the expression of",
    "entities": [
      {
        "text": "RT-qPCR",
        "label": "PERSON"
      },
      {
        "text": "ELISA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inflammatory factors in a mouse model of severe asthma induced by",
    "entities": []
  },
  {
    "text": "ovalbumin-lipopolysaccharide. The effect of circ-0001875 on macrophage",
    "entities": [
      {
        "text": "circ-0001875",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "activation and the underlying mechanism were analyzed by RT-qPCR, Western blot,",
    "entities": [
      {
        "text": "RT-qPCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and ELISA. Subsequently, the regulatory relationships among circ-0001875,",
    "entities": [
      {
        "text": "ELISA",
        "label": "ORG"
      },
      {
        "text": "circ-0001875",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "miR-31-5p, and SP1 were examined through dual luciferase reporter gene assay,",
    "entities": []
  },
  {
    "text": "and the mechanism by which they regulate macrophage polarization was analyzed by",
    "entities": []
  },
  {
    "text": "RESULTS: Compared with the healthy control group, 420 circRNAs were",
    "entities": [
      {
        "text": "420",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "differentially expressed in PBMCs from patients with severe asthma. Among them,",
    "entities": []
  },
  {
    "text": "circ-0001875, which was mainly expressed in the cytoplasm of monocytes, was",
    "entities": [
      {
        "text": "circ-0001875",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "significantly downregulated in asthmatics, especially those with severe disease.",
    "entities": []
  },
  {
    "text": "circ-0001875 overexpression inhibited M1 macrophage activation in vitro and",
    "entities": [
      {
        "text": "circ-0001875",
        "label": "DATE"
      },
      {
        "text": "M1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "alleviated lung inflammation in a mouse model of severe asthma. Mechanistically,",
    "entities": []
  },
  {
    "text": "circ-0001875 promoted SP1 translation by competitively binding to miR-31-5p,",
    "entities": [
      {
        "text": "circ-0001875",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "thereby reducing its inhibitory effect on SP1 translation; SP1 then inhibited M1",
    "entities": [
      {
        "text": "M1\n",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "macrophage polarization, which is associated with severe asthma, through the",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: We found that circ-0001875 plays an important role in regulating M1",
    "entities": [
      {
        "text": "circ-0001875",
        "label": "DATE"
      },
      {
        "text": "M1\n",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "macrophage polarization, which is associated with a severe pro-inflammatory",
    "entities": []
  },
  {
    "text": "PMID: 40661956 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40661956",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Clinical significance of respiratory bacteria and mycobacteria isolates in adult",
    "entities": []
  },
  {
    "text": "bronchiectasis in Taiwan.",
    "entities": [
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "SF(7)(26)(27), Cheng MH(3)(28), Chen YF(29)(30), Cheng WC(8), Peng CK(11), Chan",
    "entities": [
      {
        "text": "Cheng",
        "label": "PERSON"
      },
      {
        "text": "Chen YF(29)(30",
        "label": "PERSON"
      },
      {
        "text": "Cheng WC(8",
        "label": "PERSON"
      },
      {
        "text": "Peng CK(11",
        "label": "PERSON"
      },
      {
        "text": "Chan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "National Taiwan University Hospital Hsin-Chu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan",
    "entities": [
      {
        "text": "2)Graduate Institute of Clinical Medicine, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Taipei, Taiwan.",
    "entities": [
      {
        "text": "Taipei",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Pulmonary and Critical Care Medicine, Department of Internal",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine, Department of Internal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.",
    "entities": [
      {
        "text": "Kaohsiung Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Kaohsiung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine, School of Medicine, College of Medicine,",
    "entities": [
      {
        "text": "Internal Medicine, School of Medicine, College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Division of Thoracic Medicine, Far Eastern Memorial Hospital, New Taipei",
    "entities": [
      {
        "text": "Thoracic Medicine",
        "label": "ORG"
      },
      {
        "text": "New Taipei",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "City, Taiwan.",
    "entities": [
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Thoracic Medicine, Chang Gung Memorial Hospital at Linkou,",
    "entities": [
      {
        "text": "Thoracic Medicine",
        "label": "ORG"
      },
      {
        "text": "Chang Gung Memorial Hospital",
        "label": "PERSON"
      },
      {
        "text": "Linkou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)College of Medicine, Chang Gung University, Taoyuan, Taiwan.",
    "entities": [
      {
        "text": "Chang Gung University",
        "label": "PERSON"
      },
      {
        "text": "Taoyuan",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Division of Pulmonary and Critical Care Medicine, Department of Internal",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine, Department of Internal\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, China Medical University Hospital, Taichung, Taiwan.",
    "entities": [
      {
        "text": "China Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Critical Medical Center, China Medical University Hospital, Taichung, Taiwan.",
    "entities": [
      {
        "text": "9)Critical Medical Center",
        "label": "ORG"
      },
      {
        "text": "China Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)School of Medicine, China Medical University, Taichung, Taiwan.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "China Medical University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Division of Pulmonary and Critical Care Medicine, Department of Internal",
    "entities": [
      {
        "text": "11)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Internal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Division of Chest Medicine, Department of Internal Medicine, Taichung",
    "entities": [
      {
        "text": "12)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Chest Medicine",
        "label": "ORG"
      },
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Division of Chest Medicine, Department of Internal Medicine, E-Da Cancer",
    "entities": [
      {
        "text": "13)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Chest Medicine",
        "label": "ORG"
      },
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, I-Shou University, Kaohsiung, Taiwan.",
    "entities": [
      {
        "text": "I-Shou University",
        "label": "ORG"
      },
      {
        "text": "Kaohsiung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)School of Medicine for International Students, College of Medicine, I-Shou",
    "entities": [
      {
        "text": "14)School",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine for International Students",
        "label": "ORG"
      },
      {
        "text": "College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Kaohsiung, Taiwan.",
    "entities": [
      {
        "text": "Kaohsiung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)Division of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial",
    "entities": [
      {
        "text": "Chang Gung Memorial",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(16)Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Tzu",
    "entities": [
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Taipei Tzu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.",
    "entities": [
      {
        "text": "Chi Hospital",
        "label": "ORG"
      },
      {
        "text": "Buddhist Tzu Chi Medical Foundation",
        "label": "ORG"
      },
      {
        "text": "New Taipei City",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Department of Internal Medicine, Cardinal Tien Hospital and School of",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Tien Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City,",
    "entities": [
      {
        "text": "Medicine, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Fu Jen Catholic University",
        "label": "ORG"
      },
      {
        "text": "New Taipei City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Division of Pulmonary Medicine, Department of Internal Medicine, Hualien Tzu",
    "entities": [
      {
        "text": "18)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Hualien Tzu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.",
    "entities": [
      {
        "text": "Chi Hospital",
        "label": "ORG"
      },
      {
        "text": "Buddhist Tzu Chi Medical Foundation",
        "label": "ORG"
      },
      {
        "text": "Hualien",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)School of Medicine, Tzu Chi University, Hualien, Taiwan.",
    "entities": [
      {
        "text": "Tzu Chi University",
        "label": "ORG"
      },
      {
        "text": "Hualien",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Division of Pulmonary Medicine, Department of Internal Medicine, Chia-Yi",
    "entities": [
      {
        "text": "20)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Chia-Yi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Christian Hospital, Chia-Yi, Taiwan.",
    "entities": [
      {
        "text": "Christian Hospital",
        "label": "ORG"
      },
      {
        "text": "Chia-Yi",
        "label": "ORG"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(21)Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan",
    "entities": [
      {
        "text": "21)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Chung Shan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Medical University Hospital, Taichung, Taiwan.",
    "entities": [
      {
        "text": "Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)School of Medicine, Chung Shan Medical University, Taichung, Taiwan.",
    "entities": [
      {
        "text": "22)School",
        "label": "CARDINAL"
      },
      {
        "text": "Chung Shan Medical University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Department of Internal Medicine, Division of Chest Medicine, Changhua",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine,",
        "label": "ORG"
      },
      {
        "text": "Division of Chest Medicine",
        "label": "ORG"
      },
      {
        "text": "Changhua",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Institute of Genomics and Bioinformatics, National Chung Hsing University,",
    "entities": [
      {
        "text": "24)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Genomics and Bioinformatics",
        "label": "ORG"
      },
      {
        "text": "National Chung Hsing University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(25)PhD Program in Translational Medicine, National Chung Hsing University,",
    "entities": [
      {
        "text": "Translational Medicine",
        "label": "ORG"
      },
      {
        "text": "National Chung Hsing University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(26)Division of Pulmonary and Critical Care Medicine, Department of Internal",
    "entities": [
      {
        "text": "Department of Internal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(27)Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital,",
    "entities": [
      {
        "text": "27)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory Therapy",
        "label": "PERSON"
      },
      {
        "text": "Kaohsiung Chang Gung Memorial Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(28)Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical",
    "entities": [
      {
        "text": "28)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory Therapy",
        "label": "PERSON"
      },
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kaohsiung Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(29)Department of Internal Medicine, National Taiwan University Hospital, Yunlin",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "National Taiwan University Hospital",
        "label": "ORG"
      },
      {
        "text": "Yunlin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Thoracic Medicine Center, Department of Medicine and Surgery, National",
    "entities": [
      {
        "text": "Department of Medicine and Surgery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan.",
    "entities": [
      {
        "text": "Taiwan University Hospital Yunlin Branch",
        "label": "ORG"
      },
      {
        "text": "Yunlin County",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(31)School of Post Baccalaureate Medicine, College of Medicine, National Chung",
    "entities": [
      {
        "text": "31)School",
        "label": "CARDINAL"
      },
      {
        "text": "Post Baccalaureate Medicine, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "National Chung",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hsing University, Taichung, Taiwan.",
    "entities": [
      {
        "text": "Hsing University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(32)Medical Research Center, Cardinal Tien Hospital and School of Medicine,",
    "entities": [
      {
        "text": "32)Medical Research Center",
        "label": "ORG"
      },
      {
        "text": "Tien Hospital and",
        "label": "ORG"
      },
      {
        "text": "School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Fu Jen Catholic University",
        "label": "ORG"
      },
      {
        "text": "New Taipei City",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)Department of Pulmonary Medicine, Lee's Clinic, Pingtung, Taiwan.",
    "entities": [
      {
        "text": "33)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Lee's Clinic",
        "label": "ORG"
      },
      {
        "text": "Pingtung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Department of Chemical Engineering and Materials Science, Yuan Ze",
    "entities": [
      {
        "text": "34)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Chemical Engineering and Materials Science",
        "label": "ORG"
      },
      {
        "text": "Yuan Ze\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Taoyuan City, Taiwan.",
    "entities": [
      {
        "text": "Taoyuan City",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(35)Department of Respiratory Therapy, Chang Gung Memorial Hospital at Linkou,",
    "entities": [
      {
        "text": "35)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory Therapy",
        "label": "PERSON"
      },
      {
        "text": "Chang Gung Memorial Hospital",
        "label": "PERSON"
      },
      {
        "text": "Linkou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(36)Department of Internal Medicine, National Taiwan University Hospital,",
    "entities": [
      {
        "text": "36)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "National Taiwan University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "National Taiwan University College of Medicine, Taipei, Taiwan.",
    "entities": [
      {
        "text": "National Taiwan University College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Taipei",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(37)J-Y. Chien and H-C. Wang contributed equally to this article as lead authors",
    "entities": [
      {
        "text": "37)J-Y. Chien",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and supervised the work.",
    "entities": []
  },
  {
    "text": "(38)Department of Medicine National Taiwan University Cancer Center, National",
    "entities": [
      {
        "text": "38)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine National Taiwan University Cancer Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Taiwan University College of Medicine, Taipei, Taiwan.",
    "entities": [
      {
        "text": "Taiwan University College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Taipei",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The clinical impact of bacterial and mycobacterial isolates on",
    "entities": []
  },
  {
    "text": "METHODS: Patients with bronchiectasis at 16 hospitals in Taiwan were recruited",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "with a 1-year follow-up. The patients were classified into six groups: Group 1,",
    "entities": [
      {
        "text": "1-year",
        "label": "DATE"
      },
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "Group 1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pseudomonas aeruginosa; Group 2, Klebsiella pneumoniae; Group 3, other bacteria;",
    "entities": [
      {
        "text": "Group 2",
        "label": "ORG"
      },
      {
        "text": "Klebsiella",
        "label": "ORG"
      },
      {
        "text": "Group 3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Group 4, non-tuberculous mycobacteria (NTM); Group 5, daily sputum without",
    "entities": [
      {
        "text": "Group 4",
        "label": "ORG"
      },
      {
        "text": "NTM",
        "label": "ORG"
      },
      {
        "text": "Group 5",
        "label": "ORG"
      },
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "bacterial or NTM colonisation; and Group 6, dry bronchiectasis.",
    "entities": [
      {
        "text": "NTM",
        "label": "ORG"
      },
      {
        "text": "Group 6",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: In total, 1416 patients (mean age 67 years; 43% males) were included.",
    "entities": [
      {
        "text": "1416",
        "label": "DATE"
      },
      {
        "text": "age 67 years",
        "label": "DATE"
      },
      {
        "text": "43%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "The mean modified Reiff score was 5 (range 1-18). 59% (829 patients) had sputum,",
    "entities": [
      {
        "text": "5",
        "label": "DATE"
      },
      {
        "text": "59%",
        "label": "PERCENT"
      },
      {
        "text": "829",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "whereas the remaining did not. The proportions of bacteria and NTM cultured from",
    "entities": [
      {
        "text": "NTM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sputum within 1 year of observation were 27% (381/1416) and 15% (202/1416),",
    "entities": [
      {
        "text": "1 year",
        "label": "DATE"
      },
      {
        "text": "27%",
        "label": "PERCENT"
      },
      {
        "text": "381/1416",
        "label": "CARDINAL"
      },
      {
        "text": "15%",
        "label": "PERCENT"
      },
      {
        "text": "202/1416",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respectively. The most common bacterial isolate was P. aeruginosa (13%),",
    "entities": [
      {
        "text": "13%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "followed by K. pneumoniae (7%). 26% of the patients experienced severe",
    "entities": [
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "7%",
        "label": "PERCENT"
      },
      {
        "text": "26%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "exacerbations at least once within the year. The 1-year all-cause mortality rate",
    "entities": [
      {
        "text": "the year",
        "label": "DATE"
      },
      {
        "text": "1-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was 3%. Patients with sputum exhibited a higher rate of severe exacerbations",
    "entities": [
      {
        "text": "3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "compared to patients with dry bronchiectasis, regardless of the presence of",
    "entities": []
  },
  {
    "text": "bacteria or NTM (p<0.001). Patients with bacterial colonisation had a higher",
    "entities": [
      {
        "text": "NTM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mortality rate (p<0.001). Further, the highest mortality rate was observed among",
    "entities": []
  },
  {
    "text": "those with K. pneumoniae colonisation (hazard ratio (HR) 8.39 (95% CI",
    "entities": [
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "8.39",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "2.39-29.49)), followed by individuals colonised with other bacteria (HR 8.04",
    "entities": [
      {
        "text": "2.39-29.49",
        "label": "CARDINAL"
      },
      {
        "text": "8.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Additionally, old age was an independent risk factor (HR 2.72 (95% CI",
    "entities": [
      {
        "text": "2.72",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONCLUSION: K. pneumoniae was more frequently isolated from patients with",
    "entities": []
  },
  {
    "text": "bronchiectasis in Taiwan compared to Western countries and was associated with",
    "entities": [
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9The authors 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflict of interest: The authors declare no",
    "entities": []
  },
  {
    "text": "Exploring the Efficacy of Benralizumab in Chronic Eosinophilic Pneumonia",
    "entities": []
  },
  {
    "text": "Following Corticosteroid Therapeutic Failure: A Case Report.",
    "entities": []
  },
  {
    "text": "University of Chihuahua, Chihuahua, MEX.",
    "entities": [
      {
        "text": "University of Chihuahua, Chihuahua, MEX",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Pulmonology, Christus Muguerza Chihuahua / University of Monterrey,",
    "entities": [
      {
        "text": "Christus",
        "label": "ORG"
      },
      {
        "text": "Muguerza Chihuahua / University of Monterrey",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chronic eosinophilic pneumonia is a rare idiopathic disease characterized by",
    "entities": []
  },
  {
    "text": "eosinophilic infiltrates in the alveoli and interstitial lung spaces. There are",
    "entities": []
  },
  {
    "text": "no specific diagnostic tests for this condition, but it is suspected in patients",
    "entities": []
  },
  {
    "text": "presenting with dyspnea, cough, a tomographic pattern of consolidations,",
    "entities": []
  },
  {
    "text": "peripheral ground-glass opacities, and peripheral eosinophilia. This report",
    "entities": []
  },
  {
    "text": "presents the case of a male patient with chronic eosinophilic pneumonia that was",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Human subjects: Consent for treatment and open",
    "entities": []
  },
  {
    "text": "access publication was obtained or waived by all participants in this study.",
    "entities": []
  },
  {
    "text": "Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors declare the following: Payment/services info: All authors have declared",
    "entities": []
  },
  {
    "text": "that no financial support was received from any organization for the submitted",
    "entities": []
  },
  {
    "text": "work. Financial relationships: All authors have declared that they have no",
    "entities": []
  },
  {
    "text": "financial relationships at present or within the previous three years with any",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "Postoperative pneumonia in patients with non-small cell lung cancer undergoing",
    "entities": []
  },
  {
    "text": "thoracoscopic surgery: What should we care about?",
    "entities": []
  },
  {
    "text": "(1)Department of Thoracic Surgery, The Affiliated Suqian Hospital of Xuzhou",
    "entities": [
      {
        "text": "Thoracic",
        "label": "ORG"
      },
      {
        "text": "The Affiliated Suqian Hospital",
        "label": "ORG"
      },
      {
        "text": "Xuzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University, Suqian, Jiangsu, China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Suqian",
        "label": "GPE"
      },
      {
        "text": "Jiangsu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Gastroenterology, The Affiliated Suqian First People's Hospital",
    "entities": []
  },
  {
    "text": "of Nanjing Medical University, Suqian, Jiangsu, China.",
    "entities": [
      {
        "text": "Nanjing Medical University",
        "label": "ORG"
      },
      {
        "text": "Suqian",
        "label": "GPE"
      },
      {
        "text": "Jiangsu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The prevention of postoperative pneumonia in patients with non-small",
    "entities": []
  },
  {
    "text": "cell lung cancer (NSCLC) undergoing thoracoscopic surgery holds significant",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical importance. This study aimed to evaluate the status quo and influencing",
    "entities": []
  },
  {
    "text": "factors of postoperative pneumonia in patients with NSCLC.",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Patients with NSCLC undergoing thoracoscopic surgery at our hospital",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from January 2023 to October 2024 were included. The characteristics of patients",
    "entities": [
      {
        "text": "January 2023 to October 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with and without postoperative pneumonia were analyzed. A logistic regression",
    "entities": []
  },
  {
    "text": "model was employed to analyze the influencing factors of postoperative",
    "entities": []
  },
  {
    "text": "pneumonia, and a corresponding predictive model was constructed. The predictive",
    "entities": []
  },
  {
    "text": "performance of the model was evaluated using receiver operating characteristic",
    "entities": []
  },
  {
    "text": "(ROC) curve analysis.",
    "entities": [
      {
        "text": "ROC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 226 patients with NSCLC were included, the incidence of",
    "entities": [
      {
        "text": "226",
        "label": "CARDINAL"
      },
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "postoperative pneumonia in patients with NSCLC was 31.86%. Correlation analyses",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      },
      {
        "text": "31.86%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "showed that age(r=0.570), scope of the surgical procedure(r=0.618),",
    "entities": []
  },
  {
    "text": "COPD(r=0.562), history of smoking(r=0.516) and hypoproteinemia(r=0.587) were",
    "entities": []
  },
  {
    "text": "associated with the occurrence of postoperative pneumonia. Logistic regression",
    "entities": []
  },
  {
    "text": "analysis revealed that age (OR=2.146, 95%CI: 1.439~3.045), scope of the surgical",
    "entities": [
      {
        "text": "1.439~3.045",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "procedure (OR=3.009, 95%CI: 2.813~3.543), COPD (OR=2.312, 95%CI: 1.605~3.008),",
    "entities": [
      {
        "text": "2.813~3.543",
        "label": "CARDINAL"
      },
      {
        "text": "1.605~3.008",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "history of smoking (OR=2.445, 95%CI: 2.117~2.821) and hypoproteinemia(OR=1.997,",
    "entities": [
      {
        "text": "2.117~2.821",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95%CI: 1.533~2.580) were the independent influencing factors of postoperative",
    "entities": [
      {
        "text": "1.533~2.580",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pneumonia in patient with NSCLC. The area under the ROC curve (AUC) was 0.830.",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      },
      {
        "text": "ROC",
        "label": "GPE"
      },
      {
        "text": "0.830",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: The incidence of postoperative pneumonia in patients with NSCLC is",
    "entities": [
      {
        "text": "NSCLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "relatively high and is influenced by a multitude of factors. The postoperative",
    "entities": []
  },
  {
    "text": "pneumonia risk prediction model developed in this study has demonstrated",
    "entities": []
  },
  {
    "text": "promising predictive performance. However, given the single-center design and",
    "entities": []
  },
  {
    "text": "limited sample size, additional clinical validation is necessary to confirm its",
    "entities": []
  },
  {
    "text": "practical applicability and reliability in real-world clinical settings.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 You, Chen, Liu, Zhang and Zheng.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Chen",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Zhang",
        "label": "PERSON"
      },
      {
        "text": "Zheng",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "75. Can Respir J. 2025 Jul 7;2025:7790381. doi: 10.1155/carj/7790381. eCollection",
    "entities": [
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "Respir J. 2025",
        "label": "PERSON"
      },
      {
        "text": "10.1155",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Postinfectious Bronchiolitis Obliterans in Children.",
    "entities": [
      {
        "text": "Obliterans",
        "label": "NORP"
      },
      {
        "text": "Children",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Pediatrics, First People's Hospital of Jingzhou, Jingzhou,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "First People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Jingzhou",
        "label": "GPE"
      },
      {
        "text": "Jingzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Bronchiolitis obliterans is a rare form of chronic obstructive lung disease,",
    "entities": [
      {
        "text": "Bronchiolitis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "with postinfectious bronchiolitis obliterans being particularly prevalent in",
    "entities": []
  },
  {
    "text": "pediatric populations. The pathogenic investigations of pediatric postinfectious",
    "entities": []
  },
  {
    "text": "bronchiolitis obliterans predominantly center on adenovirus and Mycoplasma",
    "entities": [
      {
        "text": "obliterans",
        "label": "NORP"
      },
      {
        "text": "Mycoplasma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pneumoniae. Following the illness, children's lung function is impacted to",
    "entities": []
  },
  {
    "text": "varying extents; however, a definitive diagnosis relies on lung biopsy, which is",
    "entities": []
  },
  {
    "text": "not conducive to early detection and timely intervention. Consequently, there",
    "entities": []
  },
  {
    "text": "remains a need for novel research methodologies. This article synthesizes the",
    "entities": []
  },
  {
    "text": "2023 China Reformulation of the Expert Consensus on the Diagnosis and Treatment",
    "entities": []
  },
  {
    "text": "of Bronchiolitis Obliterans in Children along with recent studies, providing a",
    "entities": [
      {
        "text": "Bronchiolitis",
        "label": "NORP"
      },
      {
        "text": "Obliterans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "comprehensive overview of early diagnosis, treatment modalities, and preventive",
    "entities": []
  },
  {
    "text": "strategies for postinfectious bronchiolitis obliterans in children.",
    "entities": []
  },
  {
    "text": "Additionally, it outlines future research directions aimed at enhancing",
    "entities": []
  },
  {
    "text": "pediatricians' understanding of this complex disease.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Linfang Wan and Zhonghong Wang. Canadian Respiratory Journal",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Linfang Wan",
        "label": "PERSON"
      },
      {
        "text": "Zhonghong Wang",
        "label": "PERSON"
      },
      {
        "text": "Canadian Respiratory Journal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "published by John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40661670 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40661670",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Exploring the Impact of Oral Health and Vaccination on Pneumonia-causing",
    "entities": [
      {
        "text": "the Impact of Oral Health and Vaccination",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Pneumonia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Bacteria: Insights from Predictive Modeling.",
    "entities": []
  },
  {
    "text": "Ramirez K, Bolduc C, Ross A, Pearson T, Fofanov VY.",
    "entities": [
      {
        "text": "Ramirez K",
        "label": "PERSON"
      },
      {
        "text": "Bolduc C",
        "label": "ORG"
      },
      {
        "text": "Ross A",
        "label": "PERSON"
      },
      {
        "text": "Fofanov VY",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nursing home acquired pneumonia (NHAP) is a leading cause of mortality in",
    "entities": [
      {
        "text": "NHAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "long-term care facilities (LTCFs). The primary mechanism of infection in older",
    "entities": []
  },
  {
    "text": "individuals is macro-aspiration of opportunistic pathogens colonizing the oral",
    "entities": []
  },
  {
    "text": "and nasal cavities. Pneumococcal vaccination is the primary preventative",
    "entities": []
  },
  {
    "text": "measure, but oral hygiene is increasingly explored as a strategy for reducing",
    "entities": []
  },
  {
    "text": "oral colonization. While promising, oral health interventions have shown mixed",
    "entities": []
  },
  {
    "text": "results, likely due to variation in the way that different NHAP-associated",
    "entities": [
      {
        "text": "NHAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathogens respond to these interventions. To test this, we analyzed oral health",
    "entities": []
  },
  {
    "text": "to identify factors linked to carriage of each pathogen. We found that oral",
    "entities": []
  },
  {
    "text": "hygiene impacted carriage of bacteria which more frequently colonized the oral",
    "entities": []
  },
  {
    "text": "cavity ( Haemophilus influenzae and Streptococcus pneumoniae ), but had limited",
    "entities": [
      {
        "text": "Streptococcus",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "effect on bacteria that were more prevalent in the anterior nares (",
    "entities": []
  },
  {
    "text": "reduced oral colonization by both S. pneumoniae and H. influenzae , suggesting",
    "entities": [
      {
        "text": "S.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "community level interactions. Our results suggest that oral hygiene",
    "entities": []
  },
  {
    "text": "interventions are likely to only be effective against pathogens that primarily",
    "entities": []
  },
  {
    "text": "colonize the oral cavity, underscoring the importance of identifying the primary",
    "entities": []
  },
  {
    "text": "reservoirs of NHAP-associated pathogens when developing effective intervention",
    "entities": [
      {
        "text": "NHAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Antimicrobial Effect of Common Bacterial Pigments on Clinically Significant",
    "entities": [
      {
        "text": "Antimicrobial Effect of Common Bacterial Pigments on Clinically Significant",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Microorganisms.",
    "entities": []
  },
  {
    "text": "(1)Department of Microbiology, Kasturba Medical College Mangalore, Manipal",
    "entities": [
      {
        "text": "Microbiology, Kasturba Medical College Mangalore",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Academy of Higher Education, Manipal, India.",
    "entities": [
      {
        "text": "Academy of Higher Education",
        "label": "ORG"
      },
      {
        "text": "Manipal",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Community Medicine, Kasturba Medical College Mangalore, Manipal",
    "entities": [
      {
        "text": "Community Medicine",
        "label": "ORG"
      },
      {
        "text": "Kasturba Medical College Mangalore",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The aim of this research is to investigate the antimicrobial characteristics of",
    "entities": []
  },
  {
    "text": "bacterial pigments. Pigments are vibrant metabolites generated by bacteria,",
    "entities": []
  },
  {
    "text": "offering defence against radiation, sunlight, stress and competing",
    "entities": []
  },
  {
    "text": "microorganisms. Bacterial pigments have various applications in cosmetics,",
    "entities": []
  },
  {
    "text": "pharmaceuticals and food sectors due to their antimicrobial, anticancer and",
    "entities": []
  },
  {
    "text": "antioxidant properties. In this cross-sectional in vitro study, we used 30",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "isolates each of Enterococcus faecalis, Klebsiella spp. and Candida spp.",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "NORP"
      },
      {
        "text": "Candida",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "isolated from human urine, blood and pus samples to study the antimicrobial",
    "entities": []
  },
  {
    "text": "effect of pigments produced by Serratia marcescens (prodigiosin),",
    "entities": [
      {
        "text": "Serratia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the suitable pH and temperature, pigment-producing bacteria were mass-cultured",
    "entities": []
  },
  {
    "text": "in nutrient broth. Pigments were extracted from S. marcescens and C. violaceum",
    "entities": [
      {
        "text": "S.",
        "label": "ORG"
      },
      {
        "text": "C.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "cultures using acetone and methanol. Pyocyanin from P. aeruginosa was extracted",
    "entities": [
      {
        "text": "P.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "by using hydrochloric acid and chloroform. Extracted pigments were dried and",
    "entities": []
  },
  {
    "text": "characterised by mass spectrometry. The antimicrobial activity of the crude",
    "entities": []
  },
  {
    "text": "pigments was determined by the agar dilution method using Muller Hinton agar",
    "entities": [
      {
        "text": "Muller Hinton",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(MHA) plates for bacterial isolates, and Sabouraud's Dextrose agar (SDA) for",
    "entities": [
      {
        "text": "Sabouraud",
        "label": "ORG"
      },
      {
        "text": "SDA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Candida spp. E. faecalis ATCC 29212, K. pneumonia ATCC 700603 and C. albicans",
    "entities": [
      {
        "text": "29212",
        "label": "DATE"
      },
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "C.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "ATCC 14053 were used as standards. The minimum concentration of the pigment that",
    "entities": [
      {
        "text": "14053",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "supressed the growth of microorganism on the MHA/SDA agar plate was considered",
    "entities": [
      {
        "text": "agar plate",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "as minimum inhibitory concentration (MIC). Data were analysed using the",
    "entities": [
      {
        "text": "MIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chi-square statistical method. E. faecalis, which were resistant to teicoplanin,",
    "entities": [
      {
        "text": "Chi-square",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "vancomycin, norfloxacin and penicillin, were found susceptible to pyocyanin (p <",
    "entities": [
      {
        "text": "penicillin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "0.05). Multidrug-resistant Klebsiella spp. were susceptible to pyocyanin,",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "Klebsiella",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "micafungin, showed susceptibility to prodigiosin, and those isolates resistant",
    "entities": []
  },
  {
    "text": "to amphotericin B showed susceptibility to pyocyanin (p < 0.05). Among all",
    "entities": []
  },
  {
    "text": "clinical isolates, Klebsiella spp. from urine exhibited the highest resistance",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "to the pigments studied. Among the pigments studied, violacein and prodigiosin",
    "entities": []
  },
  {
    "text": "exhibited superior antimicrobial and antifungal properties. Therefore, violacein",
    "entities": []
  },
  {
    "text": "and prodigiosin could serve as an alternative antimicrobial substance for",
    "entities": []
  },
  {
    "text": "addressing multidrug-resistant pathogenic microorganisms.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Afroz Salman et al. Scientifica published by John Wiley & Sons",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Afroz Salman",
        "label": "PERSON"
      },
      {
        "text": "John Wiley & Sons",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "[Molecular epidemiological characteristics and risk factors analysis of",
    "entities": []
  },
  {
    "text": "Carbapenem-resistant Enterobacterales intestines colonization of neonates in",
    "entities": [
      {
        "text": "Carbapenem",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "[Article in Chinese; Abstract available in Chinese from the publisher]",
    "entities": [
      {
        "text": "Article in Chinese; Abstract",
        "label": "LAW"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)The First School of Clinical Medicine,Guangdong Medical University, Zhanjiang",
    "entities": [
      {
        "text": "First School of Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "Guangdong Medical University",
        "label": "ORG"
      },
      {
        "text": "Zhanjiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "524001, China Department of Laboratory Medicine, Longgang District Maternity &",
    "entities": [
      {
        "text": "524001",
        "label": "DATE"
      },
      {
        "text": "China Department of Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Longgang District Maternity &",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child",
    "entities": [
      {
        "text": "Child Healthcare Hospital",
        "label": "ORG"
      },
      {
        "text": "Child",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Institute of Shantou University Medical College), Shenzhen 518172, China.",
    "entities": [
      {
        "text": "Institute of Shantou University Medical College",
        "label": "ORG"
      },
      {
        "text": "Shenzhen",
        "label": "GPE"
      },
      {
        "text": "518172",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Laboratory Medicine, Shenzhen Children's Hospital, Shenzhen",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Shenzhen",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Laboratory Medicine, Longgang District Maternity & Child",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Longgang District Maternity & Child",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of",
    "entities": [
      {
        "text": "Healthcare Hospital",
        "label": "ORG"
      },
      {
        "text": "Child Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shantou University Medical College), Shenzhen 518172, China.",
    "entities": [
      {
        "text": "Shantou University Medical College",
        "label": "ORG"
      },
      {
        "text": "Shenzhen",
        "label": "GPE"
      },
      {
        "text": "518172",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Laboratory Medicine, Beijing University of Chinese Medicine",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Beijing University of Chinese Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Laboratory Medicine, Longgang District People's Hospital of",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "District People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)The First School of Clinical Medicine,Guangdong Medical University, Zhanjiang",
    "entities": [
      {
        "text": "First School of Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "Guangdong Medical University",
        "label": "ORG"
      },
      {
        "text": "Zhanjiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "524001, China Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen",
    "entities": [
      {
        "text": "524001",
        "label": "DATE"
      },
      {
        "text": "China Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "Sun Yat-Sen Memorial Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Guangzhou 510120, China.",
    "entities": [
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "510120",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Objective: To study the risk factors and the molecular epidemiology",
    "entities": []
  },
  {
    "text": "characteristics for Carbapenem-resistant Enterobacteriaceae(CRE) colonization in",
    "entities": [
      {
        "text": "Carbapenem",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "neonatal inpatients in Shenzhen region, China, which provide reference for the",
    "entities": [
      {
        "text": "Shenzhen",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "prevention and control of clinical CRE infection. Methods: This study is a",
    "entities": [
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prospective case-control study.Anal samples from inpatients between January 2023",
    "entities": [
      {
        "text": "January 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and December 2023 at Longgang Maternity and Child Institute of Shantou",
    "entities": [
      {
        "text": "December 2023",
        "label": "DATE"
      },
      {
        "text": "Longgang Maternity and Child Institute of Shantou\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical College and Shenzhen Children's Hospital were collected for",
    "entities": [
      {
        "text": "University Medical College",
        "label": "ORG"
      },
      {
        "text": "Shenzhen Children's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "screening CRE strain. Drug susceptibility test, modified Carbapenem Inactivation",
    "entities": [
      {
        "text": "CRE",
        "label": "ORG"
      },
      {
        "text": "Carbapenem Inactivation",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Method (mCIM) test, drug resistance-related gene sequencing and multilocus",
    "entities": []
  },
  {
    "text": "sequence typing (MLST) were performed for isolated CRE strains.Meanwhile, the",
    "entities": [
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical data were collected for analyzing the risk factors of CRE intestinal",
    "entities": [
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "colonization by multivariate regression analysis. Results: A total of 1 517",
    "entities": [
      {
        "text": "1 517",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients were screened, 26 CRE(1.7%, 26/1 517) were identified which including",
    "entities": [
      {
        "text": "26 CRE(1.7%",
        "label": "PERCENT"
      },
      {
        "text": "26/1 517",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Enterobacter cloacae(3.9%, 1/26). The predominant carbapenemase gene was New",
    "entities": [
      {
        "text": "1/26",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Delhi Metallo(NDM) (92.4%, 24/26), followed by Imipenem (IMP) (3.8%, 1/26) and",
    "entities": [
      {
        "text": "Delhi Metallo(NDM",
        "label": "PERSON"
      },
      {
        "text": "92.4%",
        "label": "PERCENT"
      },
      {
        "text": "24/26",
        "label": "CARDINAL"
      },
      {
        "text": "Imipenem",
        "label": "GPE"
      },
      {
        "text": "IMP",
        "label": "ORG"
      },
      {
        "text": "3.8%",
        "label": "PERCENT"
      },
      {
        "text": "1/26",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Guiana extended spectrum gene (GES) (3.8%, 1/26).Among the carried NDM",
    "entities": [
      {
        "text": "Guiana",
        "label": "PERSON"
      },
      {
        "text": "GES",
        "label": "ORG"
      },
      {
        "text": "3.8%",
        "label": "PERCENT"
      },
      {
        "text": "1/26).Among",
        "label": "CARDINAL"
      },
      {
        "text": "NDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resistance genes, New Delhi Metallo 5 (NDM5) was the main one, accounting for",
    "entities": [
      {
        "text": "New Delhi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "84.6% (22/26).The MLST typing of Escherichia coli was mainly Sequence Type 48",
    "entities": [
      {
        "text": "84.6%",
        "label": "PERCENT"
      },
      {
        "text": "Escherichia",
        "label": "PERSON"
      },
      {
        "text": "Sequence Type",
        "label": "ORG"
      },
      {
        "text": "48",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(ST48) (6/14), while that of Klebsiella pneumoniae was mainly Sequence Type 35",
    "entities": [
      {
        "text": "6/14",
        "label": "CARDINAL"
      },
      {
        "text": "Klebsiella",
        "label": "ORG"
      },
      {
        "text": "Sequence Type",
        "label": "ORG"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(ST35) (10/11). All CRE isolates were resistant to penicillin, penicillinase",
    "entities": [
      {
        "text": "10/11",
        "label": "CARDINAL"
      },
      {
        "text": "CRE",
        "label": "ORG"
      },
      {
        "text": "penicillin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "inhibitors, cephalosporins, ertapenem and imipenem.The resistance rates of",
    "entities": []
  },
  {
    "text": "Escherichia coli to amikacin, levofloxacin was 1/14, 4/14, respectively. All",
    "entities": [
      {
        "text": "Escherichia",
        "label": "PERSON"
      },
      {
        "text": "1/14",
        "label": "DATE"
      },
      {
        "text": "4/14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "isolates of Klebsiella pneumoniae were sensitive to amikacin, and the resistance",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rate to levofloxacin is 1/11. Risk factors for CRE colonization include the",
    "entities": [
      {
        "text": "1/11",
        "label": "CARDINAL"
      },
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "older age, length of hospital stay, tracheal intubation, invasive respiration,",
    "entities": []
  },
  {
    "text": "lumbar puncture, Apgar <7 score, and exposure to antibiotics. Conclusions: NDM5",
    "entities": []
  },
  {
    "text": "is the predominant resistant gene in CRE isolated from neonatal patients feces",
    "entities": [
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in Shenzhen region.It is necessary to strengthen the screening of CRE",
    "entities": [
      {
        "text": "Shenzhen",
        "label": "GPE"
      },
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "colonization in neonate for prevention and control of CRE infection.",
    "entities": [
      {
        "text": "CRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40661009 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40661009",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "[Association of capsular types with antibiotic resistance and clinical prognosis",
    "entities": []
  },
  {
    "text": "(1)Institute of Medical Technology, Peking University Health Science Center,",
    "entities": [
      {
        "text": "Medical Technology",
        "label": "ORG"
      },
      {
        "text": "Peking University Health Science Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Beijing 100191, China Department of Clinical Laboratory, Peking University",
    "entities": [
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100191",
        "label": "DATE"
      },
      {
        "text": "China Department of Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "Peking University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "People's Hospital, Beijing 100044, China.",
    "entities": [
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100044",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Clinical Laboratory, Peking University People's Hospital,",
    "entities": [
      {
        "text": "Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "Peking University People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Objective: Analysis of antimicrobial resistance and clinical outcomes in",
    "entities": []
  },
  {
    "text": "patients infected with different KL types of Acinetobacter baumannii. Methods:",
    "entities": []
  },
  {
    "text": "This is a cross-sectional study. From 2011 to 2021, 675 non-repetitive A.",
    "entities": [
      {
        "text": "2011 to 2021",
        "label": "DATE"
      },
      {
        "text": "675",
        "label": "CARDINAL"
      },
      {
        "text": "A.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "baumannii strains were isolated from patients with bloodstream infection (BSI,",
    "entities": [
      {
        "text": "baumannii",
        "label": "PERSON"
      },
      {
        "text": "BSI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infection (IAI, 17 cases) and urinary tract infection (UTI, 1 case) in 10",
    "entities": [
      {
        "text": "IAI",
        "label": "ORG"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "UTI",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hospitals across 8 provinces of China. KL types and resistance genes were",
    "entities": [
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "KL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "identified using bioinformatics methods. The minimum inhibitory concentrations",
    "entities": []
  },
  {
    "text": "of different antibiotics against 675 A.baumannii strains were determined by agar",
    "entities": [
      {
        "text": "675",
        "label": "CARDINAL"
      },
      {
        "text": "agar\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "or microbroth dilution method. Ten strains were randomly selected from each KL",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      },
      {
        "text": "KL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "type using simple random sampling for whole blood survival experiments.",
    "entities": []
  },
  {
    "text": "Differences in hospitalization duration and clinical outcomes were analyzed",
    "entities": []
  },
  {
    "text": "among patients infected with different KL types. Results: The 675 patients were",
    "entities": [
      {
        "text": "675",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "aged (59\u00b120) years, including 460 males. The predominant KL types included KL2",
    "entities": [
      {
        "text": "59\u00b120) years",
        "label": "DATE"
      },
      {
        "text": "460",
        "label": "PRODUCT"
      },
      {
        "text": "KL2",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22.0%, 149 strains), KL3 (17.5%, 118 strains), KL210 (7.0%, 47 strains) and",
    "entities": [
      {
        "text": "22.0%",
        "label": "PERCENT"
      },
      {
        "text": "149",
        "label": "CARDINAL"
      },
      {
        "text": "KL3",
        "label": "ORG"
      },
      {
        "text": "17.5%",
        "label": "PERCENT"
      },
      {
        "text": "118",
        "label": "CARDINAL"
      },
      {
        "text": "KL210",
        "label": "ORG"
      },
      {
        "text": "7.0%",
        "label": "PERCENT"
      },
      {
        "text": "47",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "KL160 (7.0%, 47 strains), while non-predominant KL types accounted for 314",
    "entities": [
      {
        "text": "KL160",
        "label": "PERSON"
      },
      {
        "text": "7.0%",
        "label": "PERCENT"
      },
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "314",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strains (46.5%). The four predominant KL types showed higher overall resistance",
    "entities": [
      {
        "text": "46.5%",
        "label": "PERCENT"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "KL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "rates to most antibiotics compared with non-predominant KL types (all P<0.05).",
    "entities": []
  },
  {
    "text": "KL2 (92.6%, 113 strains) showed higher resistance to",
    "entities": [
      {
        "text": "92.6%",
        "label": "PERCENT"
      },
      {
        "text": "113",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sulfamethoxazole-trimethoprim than KL3 (55.9%, 66 strains) (P<0.05). KL2 (87.2%,",
    "entities": [
      {
        "text": "KL3",
        "label": "ORG"
      },
      {
        "text": "55.9%",
        "label": "PERCENT"
      },
      {
        "text": "66",
        "label": "CARDINAL"
      },
      {
        "text": "KL2",
        "label": "PERSON"
      },
      {
        "text": "87.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "130 strains) and KL210 (91.5%, 43 strains) showed higher resistance to",
    "entities": [
      {
        "text": "130",
        "label": "CARDINAL"
      },
      {
        "text": "KL210",
        "label": "ORG"
      },
      {
        "text": "91.5%",
        "label": "PERCENT"
      },
      {
        "text": "43",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "minocycline than KL3 (67.8%, 80 strains) and KL160 (66.0%, 31 strains) (all",
    "entities": [
      {
        "text": "KL3",
        "label": "ORG"
      },
      {
        "text": "67.8%",
        "label": "PERCENT"
      },
      {
        "text": "80",
        "label": "CARDINAL"
      },
      {
        "text": "KL160",
        "label": "PERSON"
      },
      {
        "text": "66.0%",
        "label": "PERCENT"
      },
      {
        "text": "31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "P<0.05). KL2 exhibited stronger whole blood survival capacity [(58.36\u00b120.33)%]",
    "entities": [
      {
        "text": "KL2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "than other KL types (all P<0.05). The fatality rate of KL2-infected patients was",
    "entities": [
      {
        "text": "KL2",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "30.9% (46 cases), higher than that of patients infected with KL3 (11.9%, 14",
    "entities": [
      {
        "text": "30.9%",
        "label": "PERCENT"
      },
      {
        "text": "46",
        "label": "CARDINAL"
      },
      {
        "text": "KL3",
        "label": "ORG"
      },
      {
        "text": "11.9%",
        "label": "PERCENT"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cases) and KL210 (6.4%, 3 cases) (all P<0.05). The hospitalization duration",
    "entities": [
      {
        "text": "KL210",
        "label": "ORG"
      },
      {
        "text": "6.4%",
        "label": "PERCENT"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[M(Q1,Q3)] of KL2-infected patients was 46.00 (26.50, 74.00) days, longer than",
    "entities": [
      {
        "text": "KL2",
        "label": "GPE"
      },
      {
        "text": "46.00",
        "label": "CARDINAL"
      },
      {
        "text": "26.50",
        "label": "CARDINAL"
      },
      {
        "text": "74.00) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "that of patients infected with KL3 [30.00 (15.25, 40.75) days], KL210 [27.00",
    "entities": [
      {
        "text": "KL3",
        "label": "ORG"
      },
      {
        "text": "30.00",
        "label": "CARDINAL"
      },
      {
        "text": "15.25",
        "label": "CARDINAL"
      },
      {
        "text": "40.75",
        "label": "CARDINAL"
      },
      {
        "text": "KL210",
        "label": "PRODUCT"
      },
      {
        "text": "27.00",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(21.00, 44.00) days], KL160 [27.00 (20.00, 34.00) days] and non-predominant KL",
    "entities": [
      {
        "text": "21.00",
        "label": "CARDINAL"
      },
      {
        "text": "44.00) days",
        "label": "DATE"
      },
      {
        "text": "KL160",
        "label": "PRODUCT"
      },
      {
        "text": "27.00",
        "label": "CARDINAL"
      },
      {
        "text": "20.00",
        "label": "CARDINAL"
      },
      {
        "text": "34.00) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "types [25.00 (12.00, 40.00) days] (all P<0.05). Conclusions: Different KL types",
    "entities": [
      {
        "text": "25.00",
        "label": "CARDINAL"
      },
      {
        "text": "12.00",
        "label": "CARDINAL"
      },
      {
        "text": "40.00) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of A.baumannii show variations in antimicrobial resistance and clinical outcomes",
    "entities": []
  },
  {
    "text": "of infected patients. KL2 demonstrates higher resistance rates and is associated",
    "entities": [
      {
        "text": "KL2",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "with poorer clinical prognosis.",
    "entities": []
  },
  {
    "text": "PMID: 40660976 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660976",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Discrimination of Klebsiella pneumoniae and Klebsiella quasipneumoniae by",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "NORP"
      },
      {
        "text": "Klebsiella",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "MALDI-TOF Mass Spectrometry Coupled With Machine Learning.",
    "entities": [
      {
        "text": "MALDI-TOF Mass Spectrometry Coupled With Machine Learning",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Faculty of Natural Sciences, Department of Life Sciences, Centre for",
    "entities": [
      {
        "text": "Natural Sciences",
        "label": "ORG"
      },
      {
        "text": "Department of Life Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bacterial Resistance Biology, Imperial College London, UK.",
    "entities": [
      {
        "text": "Bacterial Resistance Biology",
        "label": "ORG"
      },
      {
        "text": "Imperial College London",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Faculty of Natural Sciences, Department of Mathematics, Imperial College",
    "entities": [
      {
        "text": "2)Faculty",
        "label": "CARDINAL"
      },
      {
        "text": "Natural Sciences",
        "label": "ORG"
      },
      {
        "text": "Department of Mathematics",
        "label": "ORG"
      },
      {
        "text": "Imperial College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Bruker Daltonics GmbH&Co. KG, Bremen, Germany.",
    "entities": [
      {
        "text": "KG",
        "label": "PERSON"
      },
      {
        "text": "Bremen",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)NIHR Health Protection Research Unit in Healthcare Associated Infections and",
    "entities": [
      {
        "text": "4)NIHR Health Protection Research Unit",
        "label": "ORG"
      },
      {
        "text": "Healthcare Associated Infections",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Antimicrobial Resistance, Department of Infectious Disease, Imperial College",
    "entities": [
      {
        "text": "Antimicrobial Resistance, Department of Infectious Disease",
        "label": "ORG"
      },
      {
        "text": "Imperial College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Imperial College Healthcare NHS Trust, London, UK.",
    "entities": [
      {
        "text": "5)Imperial College Healthcare NHS Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Microbiology, North West London Pathology, London, UK.",
    "entities": [
      {
        "text": "Microbiology",
        "label": "GPE"
      },
      {
        "text": "North West",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "their genetic similarity, which complicates accurate species identification",
    "entities": []
  },
  {
    "text": "using established methods, including matrix-assisted laser",
    "entities": []
  },
  {
    "text": "desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) on the",
    "entities": []
  },
  {
    "text": "protein/peptide level. Although the treatment choice for infections caused by",
    "entities": []
  },
  {
    "text": "these pathogens is often similar, precise species characterization enhances our",
    "entities": []
  },
  {
    "text": "epidemiological understanding. While whole-genome sequencing can accurately",
    "entities": []
  },
  {
    "text": "distinguish Klebsiella species accurately, those analyses are time-consuming,",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "requiring specialized expertise, and are not currently used in routine clinical",
    "entities": []
  },
  {
    "text": "laboratories. Therefore, developing a timely and accurate pathogen",
    "entities": []
  },
  {
    "text": "characterization method is essential for effective treatment, management, and",
    "entities": []
  },
  {
    "text": "infection control measures. This study combined MALDI-TOF MS in negative ion",
    "entities": [
      {
        "text": "MALDI-TOF MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mode with machine learning techniques to identify potential lipid biomarkers as",
    "entities": []
  },
  {
    "text": "a novel method to distinguish between K. pneumoniae and K. quasipneumoniae.",
    "entities": [
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Using this method, we identified discriminative features between the species,",
    "entities": []
  },
  {
    "text": "with peaks at m/z 2157, m/z 1931, m/z 1964, m/z 2042, and m/z 1407 highlighted",
    "entities": [
      {
        "text": "m/z 2157",
        "label": "ORG"
      },
      {
        "text": "1931",
        "label": "DATE"
      },
      {
        "text": "2042",
        "label": "DATE"
      },
      {
        "text": "1407",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "as potential biomarkers for species identification. Our findings suggest that",
    "entities": []
  },
  {
    "text": "the lipid profiles of the species obtained from MALDI-TOF MS can serve as",
    "entities": [
      {
        "text": "MALDI-TOF MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effective biomarkers for distinguishing Klebsiella species. Further research",
    "entities": [
      {
        "text": "Klebsiella",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "should focus on the structural identification of these biomarkers and expand the",
    "entities": []
  },
  {
    "text": "data set to include more isolates for each of the species. This approach holds",
    "entities": []
  },
  {
    "text": "promise for developing more cost-effective and rapid diagnostic tools in",
    "entities": []
  },
  {
    "text": "clinical microbiology, ultimately improving patient outcomes and infection",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). MicrobiologyOpen published by John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40660849 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660849",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "81. Nephrology (Carlton). 2025 Jul;30(7):e70093. doi: 10.1111/nep.70093.",
    "entities": [
      {
        "text": "81",
        "label": "CARDINAL"
      },
      {
        "text": "Carlton",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Coronavirus Disease 2019 Vaccination Booster Effectiveness Based on the 2022",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Japanese Dialysis Registry.",
    "entities": [
      {
        "text": "Japanese Dialysis Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo,",
    "entities": [
      {
        "text": "Nephrology and Endocrinology",
        "label": "ORG"
      },
      {
        "text": "The University of Tokyo",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Health Services Research, Institute of Medicine, University of",
    "entities": [
      {
        "text": "Health Services Research",
        "label": "ORG"
      },
      {
        "text": "Institute of Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Division of Nephrology, Shimoochiai Clinic, Tokyo, Japan.",
    "entities": [
      {
        "text": "Nephrology, Shimoochiai Clinic",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "AIM: To evaluate the effectiveness of the third, fourth, and fifth booster doses",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      },
      {
        "text": "fourth",
        "label": "ORDINAL"
      },
      {
        "text": "fifth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "(rolled out in December 2021, June 2022, and October 2022, respectively) of the",
    "entities": [
      {
        "text": "December 2021, June 2022",
        "label": "DATE"
      },
      {
        "text": "October 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "coronavirus disease 2019 (COVID-19) vaccine in Japanese haemodialysis patients",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "during the Omicron era.",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We analysed the Japanese Society for Dialysis Therapy Renal Data",
    "entities": [
      {
        "text": "the Japanese",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Registry (JRDR) year-end survey data from 2021 to 2022, which included",
    "entities": [
      {
        "text": "JRDR",
        "label": "ORG"
      },
      {
        "text": "year-end",
        "label": "DATE"
      },
      {
        "text": "2021 to 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "information on the number of vaccinations and the most recent vaccination and",
    "entities": []
  },
  {
    "text": "infection months. For each month of 2022, the COVID-19 infection and related",
    "entities": [
      {
        "text": "months",
        "label": "DATE"
      },
      {
        "text": "each month of 2022",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mortality risks were calculated by vaccination status, followed by logistic",
    "entities": []
  },
  {
    "text": "regression analyses to estimate adjusted odds ratios (aORs).",
    "entities": []
  },
  {
    "text": "RESULTS: Overall, 225 887 patients were analysed, including 13 440 (5.9%),",
    "entities": [
      {
        "text": "225 887",
        "label": "CARDINAL"
      },
      {
        "text": "13 440",
        "label": "CARDINAL"
      },
      {
        "text": "5.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "25 547 (11.3%), 64 242 (28.4%), and 122 658 (54.3%) with \u2264 2, 3, 4, and 5 doses",
    "entities": [
      {
        "text": "25 547",
        "label": "CARDINAL"
      },
      {
        "text": "11.3%",
        "label": "PERCENT"
      },
      {
        "text": "64 242",
        "label": "CARDINAL"
      },
      {
        "text": "28.4%",
        "label": "PERCENT"
      },
      {
        "text": "122 658",
        "label": "CARDINAL"
      },
      {
        "text": "54.3%",
        "label": "PERCENT"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "DATE"
      },
      {
        "text": "4",
        "label": "DATE"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at the end of 2022, respectively. The third dose was significantly correlated",
    "entities": [
      {
        "text": "the end of 2022",
        "label": "DATE"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "with a lower risk of COVID-19 infection in early 2022 (March: aOR 0.53",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "early 2022",
        "label": "DATE"
      },
      {
        "text": "March",
        "label": "DATE"
      },
      {
        "text": "0.53",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[0.43-0.64]; April: 0.77 [0.63-0.95]) but was associated with a higher risk",
    "entities": [
      {
        "text": "0.43-0.64",
        "label": "CARDINAL"
      },
      {
        "text": "April",
        "label": "DATE"
      },
      {
        "text": "0.77",
        "label": "CARDINAL"
      },
      {
        "text": "0.63-0.95",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "during mid-2022, coinciding with the BA.1/2 to BA.5 transition (July: 1.65",
    "entities": [
      {
        "text": "mid-2022",
        "label": "DATE"
      },
      {
        "text": "July",
        "label": "DATE"
      },
      {
        "text": "1.65",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[1.39-1.95]; August: 2.37 [2.06-2.71]). The third dose consistently correlated",
    "entities": [
      {
        "text": "1.39",
        "label": "CARDINAL"
      },
      {
        "text": "August",
        "label": "DATE"
      },
      {
        "text": "2.37",
        "label": "CARDINAL"
      },
      {
        "text": "2.06",
        "label": "CARDINAL"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "with reduced COVID-19-related mortality. The fourth and fifth doses correlated",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "fourth",
        "label": "ORDINAL"
      },
      {
        "text": "fifth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "with lower infection risk and COVID-19-related mortality throughout the period.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Among Japanese haemodialysis patients, the third to fifth COVID-19",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      },
      {
        "text": "fifth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "vaccine doses were associated with reduced infection risk (except in July and",
    "entities": [
      {
        "text": "July",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "August for third doses) and mortality.",
    "entities": [
      {
        "text": "August",
        "label": "DATE"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Nephrology published by John Wiley & Sons Australia, Ltd",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Australia, Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "on behalf of Asian Pacific Society of Nephrology.",
    "entities": [
      {
        "text": "Asian Pacific Society of Nephrology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40660740 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Study on rehabilitation effect of continuous nursing on patients with dysphagia",
    "entities": [
      {
        "text": "dysphagia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Wuhan Fourth Hospital, Wuhan, Hubei Province, China.",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Wuhan Fourth Hospital",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "Hubei Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Emergency Department, Wuhan Fourth Hospital, Wuhan, Hubei Province, China.",
    "entities": [
      {
        "text": "Department",
        "label": "ORG"
      },
      {
        "text": "Wuhan Fourth Hospital",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "Hubei Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study aims to investigate the impact of continuous care on the",
    "entities": []
  },
  {
    "text": "rehabilitation outcomes of patients with acute cerebral infarction accompanied",
    "entities": []
  },
  {
    "text": "by dysphagia. This retrospective study involved 119 patients with acute cerebral",
    "entities": [
      {
        "text": "dysphagia",
        "label": "GPE"
      },
      {
        "text": "119",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "infarction and dysphagia admitted to Wuhan No. 4 Hospital from June 2022 to",
    "entities": [
      {
        "text": "dysphagia",
        "label": "PERSON"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "June 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "December 2023. Patients were divided into an experimental group (n = 56)",
    "entities": [
      {
        "text": "December 2023",
        "label": "DATE"
      },
      {
        "text": "56",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "receiving standard care plus continuous care, and a control group (n = 63)",
    "entities": [
      {
        "text": "63",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "receiving standard care alone. Continuous care included follow-up calls, home",
    "entities": []
  },
  {
    "text": "visits, health education, and personalized rehabilitation. Outcomes assessed",
    "entities": []
  },
  {
    "text": "included swallowing function, Barthel Index, quality of life (SF-36,",
    "entities": [
      {
        "text": "Barthel Index",
        "label": "PERSON"
      },
      {
        "text": "SF-36",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Stroke-Specific Quality of Life), medication adherence, mental health,",
    "entities": [
      {
        "text": "Stroke-Specific Quality of Life",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "complications, and readmission rates. In the experimental group, swallowing",
    "entities": []
  },
  {
    "text": "function scores increased from 3.1 \u00b1 1.2 at baseline to 5.0 \u00b1 0.7 at 6 months,",
    "entities": [
      {
        "text": "3.1",
        "label": "CARDINAL"
      },
      {
        "text": "1.2",
        "label": "CARDINAL"
      },
      {
        "text": "5.0",
        "label": "CARDINAL"
      },
      {
        "text": "6 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "while the control group increased from 3.4 \u00b1 1.3 to 4.2 \u00b1 0.8 (P < .05). The",
    "entities": [
      {
        "text": "3.4",
        "label": "CARDINAL"
      },
      {
        "text": "0.8",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Barthel Index in the experimental group improved from 40.5 \u00b1 10.3 to 85.3 \u00b1 10.7",
    "entities": [
      {
        "text": "Barthel Index",
        "label": "PERSON"
      },
      {
        "text": "40.5",
        "label": "CARDINAL"
      },
      {
        "text": "10.3",
        "label": "CARDINAL"
      },
      {
        "text": "85.3",
        "label": "CARDINAL"
      },
      {
        "text": "10.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at 6 months, compared to an increase from 41.2 \u00b1 9.8 to 78.5 \u00b1 12.3 in the",
    "entities": [
      {
        "text": "6 months",
        "label": "DATE"
      },
      {
        "text": "41.2",
        "label": "CARDINAL"
      },
      {
        "text": "9.8",
        "label": "CARDINAL"
      },
      {
        "text": "12.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "control group (P < .05). SF-36 scores in the experimental group rose from",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "60.5 \u00b1 8.1 to 75.0 \u00b1 6.5, while the control group increased from 61.2 \u00b1 7.9 to",
    "entities": [
      {
        "text": "60.5",
        "label": "CARDINAL"
      },
      {
        "text": "8.1",
        "label": "CARDINAL"
      },
      {
        "text": "6.5",
        "label": "CARDINAL"
      },
      {
        "text": "61.2",
        "label": "CARDINAL"
      },
      {
        "text": "7.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "68.0 \u00b1 6.8 (P < .05). The Stroke-Specific Quality of Life scores in the",
    "entities": [
      {
        "text": "68.0",
        "label": "CARDINAL"
      },
      {
        "text": "6.8",
        "label": "CARDINAL"
      },
      {
        "text": "The Stroke-Specific Quality of Life",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "experimental group increased from 100.5 \u00b1 15.3 to 130.2 \u00b1 10.9 at 6 months,",
    "entities": [
      {
        "text": "100.5",
        "label": "CARDINAL"
      },
      {
        "text": "15.3",
        "label": "DATE"
      },
      {
        "text": "130.2",
        "label": "CARDINAL"
      },
      {
        "text": "10.9",
        "label": "DATE"
      },
      {
        "text": "6 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "whereas the control group increased from 101.2 \u00b1 14.9 to 120.5 \u00b1 12.5 (P < .05).",
    "entities": [
      {
        "text": "101.2",
        "label": "CARDINAL"
      },
      {
        "text": "120.5",
        "label": "CARDINAL"
      },
      {
        "text": "12.5",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Medication adherence significantly improved in the experimental group, with the",
    "entities": []
  },
  {
    "text": "proportion of highly adherent patients increasing from 42.9% to 80.4%",
    "entities": [
      {
        "text": "42.9%",
        "label": "PERCENT"
      },
      {
        "text": "80.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(P < .001), compared to an increase from 41.1% to 62.5% in the control group",
    "entities": [
      {
        "text": "41.1%",
        "label": "PERCENT"
      },
      {
        "text": "62.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(P = .02). The incidence of aspiration pneumonia significantly lower than the",
    "entities": []
  },
  {
    "text": "control group (P = .02). The readmission rate was 14.3% in the experimental",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      },
      {
        "text": "14.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "group, significantly lower than 30.4% in the control group (P = .002).",
    "entities": [
      {
        "text": "30.4%",
        "label": "PERCENT"
      },
      {
        "text": ".002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Additionally, anxiety and depression scores in the experimental group were",
    "entities": []
  },
  {
    "text": "significantly reduced (P < .001). Continuous care significantly improves",
    "entities": []
  },
  {
    "text": "swallowing function, activities of daily living, and mental health in patients",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with acute cerebral infarction and dysphagia. It also reduces complications and",
    "entities": [
      {
        "text": "dysphagia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 the Author(s). Published by Wolters Kluwer Health, Inc.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40660601 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660601",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors have no funding and conflicts of",
    "entities": []
  },
  {
    "text": "Successful treatment of long-COVID postural tachycardia syndrome with",
    "entities": []
  },
  {
    "text": "epipharyngeal abrasive therapy in an adolescent patient: A case report.",
    "entities": []
  },
  {
    "text": "RATIONALE: Postural orthostatic tachycardia syndrome (POTS) is a type of",
    "entities": [
      {
        "text": "RATIONALE",
        "label": "PERSON"
      },
      {
        "text": "POTS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "autonomic dysfunction that can occur following coronavirus disease (COVID-19)",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infection, particularly in adolescents. Treatment options are limited and often",
    "entities": []
  },
  {
    "text": "ineffective. We report a case of long COVID-associated POTS that responded",
    "entities": [
      {
        "text": "POTS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "favorably to epipharyngeal abrasive therapy (EAT), a treatment targeting chronic",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inflammation in the epipharynx.",
    "entities": []
  },
  {
    "text": "PATIENT CONCERNS: A previously healthy adolescent developed persistent fatigue,",
    "entities": []
  },
  {
    "text": "headache, dizziness, insomnia, and orthostatic intolerance lasting over 3 months",
    "entities": [
      {
        "text": "3 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "after a COVID-19 infection. The symptoms severely impaired daily functioning,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DIAGNOSES: Based on clinical symptoms and a positive orthostatic test showing",
    "entities": []
  },
  {
    "text": "excessive postural tachycardia without hypotension, the patient was diagnosed",
    "entities": []
  },
  {
    "text": "with POTS associated with long COVID. Chronic epipharyngitis was also noted upon",
    "entities": [
      {
        "text": "POTS",
        "label": "ORG"
      },
      {
        "text": "Chronic epipharyngitis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "INTERVENTIONS: The patient underwent weekly sessions of EAT for a total of 120",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      },
      {
        "text": "EAT",
        "label": "ORG"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days. No additional pharmacologic treatment was provided during this period.",
    "entities": []
  },
  {
    "text": "OUTCOMES: The patient showed marked improvement in symptoms, including increased",
    "entities": []
  },
  {
    "text": "tolerance to standing, reduced fatigue, and improved sleep quality. Objective",
    "entities": []
  },
  {
    "text": "improvement was confirmed through repeat orthostatic testing. The patient",
    "entities": []
  },
  {
    "text": "resumed school attendance and daily activities without limitation.",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "LESSONS: This case highlights the potential effectiveness of EAT in treating",
    "entities": [
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "long COVID-related POTS in adolescents. EAT may offer a nonpharmacological",
    "entities": [
      {
        "text": "POTS",
        "label": "ORG"
      },
      {
        "text": "EAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment option by addressing underlying chronic epipharyngeal inflammation, a",
    "entities": []
  },
  {
    "text": "possible contributor to autonomic dysfunction.",
    "entities": []
  },
  {
    "text": "PMID: 40660536 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The author has no funding and conflicts of",
    "entities": []
  },
  {
    "text": "COVID-19 vaccination status and the risk of developing lung diseases: A",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mendelian randomization study.",
    "entities": [
      {
        "text": "Mendelian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of Respiratory Medicine, Nantong Third People's Hospital,",
    "entities": [
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Nantong Third People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China.",
    "entities": [
      {
        "text": "Nantong Hospital 3",
        "label": "ORG"
      },
      {
        "text": "Nantong University",
        "label": "ORG"
      },
      {
        "text": "Nantong",
        "label": "GPE"
      },
      {
        "text": "Jiangsu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Emergency Medicine, Shanghai Eighth People's Hospital,",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Shanghai Eighth People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Respiratory and Critical Care Medicine, Shanghai Sixth People's",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,",
    "entities": [
      {
        "text": "Hospital Affiliated",
        "label": "FAC"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Tong University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Eye Institute, Affiliated Hospital of Nantong University, Medical School of",
    "entities": [
      {
        "text": "4)Eye Institute",
        "label": "ORG"
      },
      {
        "text": "Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Nantong University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Recent studies have suggested an increased incidence of various lung diseases",
    "entities": []
  },
  {
    "text": "following COVID-19 vaccination. However, causal relationships have not been",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "definitively established. We conducted a two-sample Mendelian randomization (MR)",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Mendelian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "study using publicly available genome-wide association study data to investigate",
    "entities": []
  },
  {
    "text": "potential causal relationships between COVID-19 vaccination status as the",
    "entities": [
      {
        "text": "potential causal",
        "label": "PERSON"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exposure and 14 different lung diseases as outcomes. The analytical methods",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included random-effects inverse-variance weighting, MR Egger, and weighted",
    "entities": [
      {
        "text": "Egger",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "median, with additional heterogeneity and sensitivity analyses. Seven",
    "entities": [
      {
        "text": "Seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "instrumental variables for exposure were selected (P < 5 \u00d7 10-8). MR analyses",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "revealed that COVID-19 vaccination status was not associated with an increased",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk of developing overall lung cancer (P = .78), lung adenocarcinoma",
    "entities": []
  },
  {
    "text": "(P = .173), asthma (P = .905), chronic obstructive pulmonary disease,",
    "entities": [
      {
        "text": ".173",
        "label": "CARDINAL"
      },
      {
        "text": ".905",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "bronchiectasis (P = .669), forced vital capacity (FVC), forced expiratory volume",
    "entities": [
      {
        "text": ".669",
        "label": "CARDINAL"
      },
      {
        "text": "FVC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in 1 second/FVC (P = .794), pneumonia (P = .282), idiopathic pulmonary fibrosis",
    "entities": [
      {
        "text": "1 second",
        "label": "TIME"
      },
      {
        "text": ".794",
        "label": "CARDINAL"
      },
      {
        "text": ".282",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(P = .486), pulmonary embolism (P = .267), pneumothorax (P = .73), or",
    "entities": [
      {
        "text": ".486",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sarcoidosis (P = .732). Evidence of heterogeneity was observed in the",
    "entities": [
      {
        "text": ".732",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "inverse-variance weighting model for overall lung cancer, chronic obstructive",
    "entities": []
  },
  {
    "text": "pulmonary disease, and FVC, whereas no indications of horizontal pleiotropy or",
    "entities": [
      {
        "text": "FVC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant heterogeneity were noted for other lung diseases. COVID-19",
    "entities": []
  },
  {
    "text": "vaccination does not appear to increase the risk of developing various lung",
    "entities": []
  },
  {
    "text": "diseases. These findings support the safety of COVID-19 vaccines in terms of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respiratory health, reinforcing their role in public health interventions and",
    "entities": []
  },
  {
    "text": "PMID: 40660535 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660535",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Severe pneumonia caused by Legionella pneumophila associated with Tropheryma",
    "entities": [
      {
        "text": "Tropheryma\n",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "whipplei: A case report.",
    "entities": []
  },
  {
    "text": "(1)Department of Pharmacy, Chengdu Sixth People's Hospital, Chengdu, China.",
    "entities": [
      {
        "text": "Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pulmonology, Chengdu Sixth People's Hospital, Chengdu, China.",
    "entities": [
      {
        "text": "Pulmonology",
        "label": "GPE"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RATIONALE: Legionella pneumophila (LP) and Tropheryma whipplei (TW) have been",
    "entities": [
      {
        "text": "RATIONALE",
        "label": "PERSON"
      },
      {
        "text": "Tropheryma",
        "label": "NORP"
      },
      {
        "text": "TW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "identified as pathogens that can coexist in sewage environments, which can both",
    "entities": []
  },
  {
    "text": "cause pneumophila and can impact various organs, leading to extrapulmonary",
    "entities": []
  },
  {
    "text": "manifestations. It is rare to find literature on pneumonia caused by atypical",
    "entities": []
  },
  {
    "text": "pathogens, such as the combination of LP and TW. There are no reports on",
    "entities": [
      {
        "text": "LP",
        "label": "GPE"
      },
      {
        "text": "TW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "specific drug treatments for such combined infections.",
    "entities": []
  },
  {
    "text": "PATIENT CONCERNS: A 55-year-old male with no underlying diseases developed",
    "entities": [
      {
        "text": "55-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "community-acquired pneumonia. His condition worsened after empirical treatment",
    "entities": []
  },
  {
    "text": "with piperacillin/tazobactam. He subsequently experienced adverse drug reactions",
    "entities": []
  },
  {
    "text": "after using moxifloxacin.",
    "entities": []
  },
  {
    "text": "DIAGNOSES: Pulmonary infection, pulmonary bullae.",
    "entities": []
  },
  {
    "text": "INTERVENTIONS: After admission, the patient was treated with",
    "entities": []
  },
  {
    "text": "piperacillin/tazobactam and moxifloxacin for anti-infection. He also underwent a",
    "entities": []
  },
  {
    "text": "bronchoscopy of the lungs, and the alveolar lavage fluid was tested using",
    "entities": []
  },
  {
    "text": "targeted next-generation sequencing. The results identified pathogens such as LP",
    "entities": []
  },
  {
    "text": "and TW. The anti-infection regimen was then adjusted to a combination of",
    "entities": [
      {
        "text": "TW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ceftriaxone and levofloxacin. Symptomatic treatments were also provided,",
    "entities": []
  },
  {
    "text": "including expectorant therapy, liver protection, and nutritional support.",
    "entities": []
  },
  {
    "text": "OUTCOMES: The patient was discharged after showing signs of improvement and was",
    "entities": []
  },
  {
    "text": "subsequently monitored at an outpatient clinic.",
    "entities": []
  },
  {
    "text": "LESSONS: When empirical antibiotic therapy for pneumonia is ineffective,",
    "entities": []
  },
  {
    "text": "infections caused by atypical pathogens should be considered. To prevent",
    "entities": []
  },
  {
    "text": "progression to severe pneumonia and even patient death, the precise use of",
    "entities": []
  },
  {
    "text": "antibiotics is beneficial for improving patient outcomes. However, the diagnosis",
    "entities": []
  },
  {
    "text": "of atypical pathogens is challenging, and the selection of drugs also needs to",
    "entities": []
  },
  {
    "text": "be considered from multiple aspects.",
    "entities": []
  },
  {
    "text": "PMID: 40660514 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660514",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "86. Hereditas. 2025 Jul 14;162(1):128. doi: 10.1186/s41065-025-00500-w.",
    "entities": [
      {
        "text": "86",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "14;162(1):128",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Insight into the shared pathogenic link between COVID-19 and pterygium: a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "systematic bioinformatics analysis with experimental validation.",
    "entities": []
  },
  {
    "text": "(1)Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao",
    "entities": [
      {
        "text": "Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Shanghai Ninth People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Shanghai Jiao",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Tong University School of Medicine, 639 Zhi-Zao-Ju Road, Huangpu District,",
    "entities": [
      {
        "text": "Tong University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "639",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(2)Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai,",
    "entities": [
      {
        "text": "2)Shanghai",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory of Orbital Diseases",
        "label": "ORG"
      },
      {
        "text": "Ocular Oncology",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's",
    "entities": [
      {
        "text": "Plastic",
        "label": "NORP"
      },
      {
        "text": "Shanghai Ninth People's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhi-Zao-Ju Road,",
    "entities": [
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Tong University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "639",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(4)Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao",
    "entities": [
      {
        "text": "Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Shanghai Ninth People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Shanghai Jiao",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai,",
    "entities": [
      {
        "text": "5)Shanghai",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory of Orbital Diseases",
        "label": "ORG"
      },
      {
        "text": "Ocular Oncology",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's",
    "entities": [
      {
        "text": "Plastic",
        "label": "NORP"
      },
      {
        "text": "Shanghai Ninth People's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The outbreak of coronavirus disease 2019 (COVID-19) has resulted in a remarkable",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "threat to global public health over the past few years. Despite the tremendous",
    "entities": [
      {
        "text": "the past few years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "studies of COVID-19 ongoing, few have focused on the viral impact on the ocular",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "surface. As one of the most common inflammatory diseases of the ocular surface,",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pterygium could be triggered under multiple environmental exposures. In the",
    "entities": []
  },
  {
    "text": "present work, we aimed at investigating the potential interactions between",
    "entities": []
  },
  {
    "text": "pterygium and COVID-19. Based on bioinformatic tools, we compared databases of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 and pterygium and screened for common differentially expressed genes",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(DEGs). Multifactor regulatory network and co-expression network of the common",
    "entities": []
  },
  {
    "text": "DEGs were analyzed. In vitro experiments, including siRNA knockdown using human",
    "entities": []
  },
  {
    "text": "conjunctival fibroblasts (HConFs) confirmed the bioinformatics results. Gene",
    "entities": [
      {
        "text": "HConFs",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment",
    "entities": [
      {
        "text": "Kyoto Encyclopedia of",
        "label": "ORG"
      },
      {
        "text": "Genes and Genomes",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysis implied that immune response was associated with COVID-19-induced",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ocular events. We then identified five common DEGs, including ERP27, SYTL5,",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "ERP27, SYTL5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "STXBP6, EXTL1 and DIO2, which was further validated by in vitro experiments.",
    "entities": [
      {
        "text": "STXBP6",
        "label": "ORG"
      },
      {
        "text": "EXTL1",
        "label": "PRODUCT"
      },
      {
        "text": "DIO2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Three hub genes were further extracted which included SYTL5, STXBP6 and ERP27",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "SYTL5",
        "label": "ORG"
      },
      {
        "text": "STXBP6",
        "label": "ORG"
      },
      {
        "text": "ERP27",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "through protein-protein interactions (PPI) network. Furthermore, we illustrated",
    "entities": []
  },
  {
    "text": "a regulatory network consisting of eight transcription factors (STAT6B, GATA1,",
    "entities": [
      {
        "text": "eight transcription",
        "label": "CARDINAL"
      },
      {
        "text": "GATA1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "POU2F2, PGR, RBPJ, STAT3, CRTC1 and HMGA1) and one microRNA (hsa-miR-384).",
    "entities": [
      {
        "text": "PGR",
        "label": "ORG"
      },
      {
        "text": "STAT3",
        "label": "ORG"
      },
      {
        "text": "CRTC1",
        "label": "GPE"
      },
      {
        "text": "HMGA1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Overall, we investigated the common link between SARS-CoV-2 and pterygium in the",
    "entities": []
  },
  {
    "text": "modulation of gene profiles on the ocular surface. Our study proposed a novel",
    "entities": []
  },
  {
    "text": "insight into the common pathogenic mechanisms between COVID-19 and pterygium,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "which are associated with immune dysregulation and pathological proliferation,",
    "entities": []
  },
  {
    "text": "indicating a viral impact on pterygium susceptibility. This innovative",
    "entities": []
  },
  {
    "text": "perspective may enable a more comprehensive understanding and advance towards",
    "entities": []
  },
  {
    "text": "improved clinical prevention and treatment.",
    "entities": []
  },
  {
    "text": "PMID: 40660393 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660393",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate: Not applicable. Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "87. Eur J Med Res. 2025 Jul 14;30(1):619. doi: 10.1186/s40001-025-02896-7.",
    "entities": [
      {
        "text": "87",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Optimization of pathogen detection in abscess specimens: a 6-year retrospective",
    "entities": [
      {
        "text": "6-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Department of Clinical Laboratory, the 940Th Hospital of Joint Logistics",
    "entities": [
      {
        "text": "Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "the 940Th Hospital of Joint Logistics",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Support Force of People's Liberation Army, Lanzhou, 730050, China.",
    "entities": [
      {
        "text": "Lanzhou",
        "label": "GPE"
      },
      {
        "text": "730050",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine-Cardiovascular, the 940Th Hospital of Joint",
    "entities": [
      {
        "text": "Internal Medicine-Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "the 940Th Hospital of Joint",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Logistics Support Force of People's Liberation Army, Lanzhou, 730050, China.",
    "entities": [
      {
        "text": "Lanzhou",
        "label": "GPE"
      },
      {
        "text": "730050",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Clinical Laboratory, the 940Th Hospital of Joint Logistics",
    "entities": [
      {
        "text": "Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "the 940Th Hospital of Joint Logistics",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine-Cardiovascular, the 940Th Hospital of Joint",
    "entities": [
      {
        "text": "Internal Medicine-Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "the 940Th Hospital of Joint",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "BACKGROUND: This study aimed to evaluate the impact of optimized diagnostic",
    "entities": []
  },
  {
    "text": "protocols on pathogen detection rates in abscess specimens.",
    "entities": []
  },
  {
    "text": "METHODS: Our retrospective study analyzed 1,297 abscess specimens collected",
    "entities": [
      {
        "text": "1,297",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "between 2018 and 2024 using an enhanced diagnostic protocol combining four key",
    "entities": [
      {
        "text": "between 2018 and 2024",
        "label": "DATE"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "acid-fast bacilli staining, and blood culture bottle enrichment techniques.",
    "entities": []
  },
  {
    "text": "RESULTS: The implementation of optimized diagnostic protocols significantly",
    "entities": []
  },
  {
    "text": "enhanced pathogen detection efficacy (P < 0.001, \u03c7 = 9.663), achieving an",
    "entities": [
      {
        "text": "9.663",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "overall positivity rate of 81.9% (1,062/1,297)-a 20.1 percentage point",
    "entities": [
      {
        "text": "81.9%",
        "label": "PERCENT"
      },
      {
        "text": "1,062/1,297)-a 20.1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "improvement over conventional methods. Among culture-positive specimens,",
    "entities": []
  },
  {
    "text": "polymicrobial infections were identified in 27.6% of cases (293/1,062). A total",
    "entities": [
      {
        "text": "27.6%",
        "label": "PERCENT"
      },
      {
        "text": "293/1,062",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of 1,651 microbial isolates were recovered, dominated by gram-negative bacteria",
    "entities": [
      {
        "text": "1,651",
        "label": "CARDINAL"
      },
      {
        "text": "gram",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(50.6%, 836/1,651) with Escherichia coli (55.0%), Klebsiella pneumoniae (23.0%),",
    "entities": [
      {
        "text": "50.6%",
        "label": "PERCENT"
      },
      {
        "text": "Escherichia",
        "label": "PERSON"
      },
      {
        "text": "55.0%",
        "label": "PERCENT"
      },
      {
        "text": "Klebsiella",
        "label": "PERSON"
      },
      {
        "text": "23.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and Acinetobacter baumannii (4.0%) as predominant species. Gram-positive cocci",
    "entities": [
      {
        "text": "4.0%",
        "label": "PERCENT"
      },
      {
        "text": "Gram",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "accounted for 33.7% (557/1,651), primarily Streptococcus spp.",
    "entities": [
      {
        "text": "33.7%",
        "label": "PERCENT"
      },
      {
        "text": "557/1,651",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(45.0%), Staphylococcus aureus (19.0%), and Enterococcus faecium (6.0%).",
    "entities": [
      {
        "text": "45.0%",
        "label": "PERCENT"
      },
      {
        "text": "Staphylococcus aureus",
        "label": "PERSON"
      },
      {
        "text": "19.0%",
        "label": "PERCENT"
      },
      {
        "text": "Enterococcus",
        "label": "ORG"
      },
      {
        "text": "6.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Enhanced methodology detected 261 additional pathogens (20.1% of total yield),",
    "entities": [
      {
        "text": "261",
        "label": "CARDINAL"
      },
      {
        "text": "20.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "including anaerobes (33.7%), smear-positive organisms (32.2%), acid-fast bacilli",
    "entities": [
      {
        "text": "33.7%",
        "label": "PERCENT"
      },
      {
        "text": "32.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(6.9%), and Brucella melitensis (1.5%). Anatomic distribution analysis revealed",
    "entities": [
      {
        "text": "6.9%",
        "label": "PERCENT"
      },
      {
        "text": "Brucella",
        "label": "PERSON"
      },
      {
        "text": "1.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "perianal abscesses (358 cases, 407 isolates) predominantly associated with E.",
    "entities": [
      {
        "text": "358",
        "label": "CARDINAL"
      },
      {
        "text": "407",
        "label": "CARDINAL"
      },
      {
        "text": "E.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "coli (51.8%), K. pneumoniae (14.7%), and Streptococcus spp. (15.7%), followed by",
    "entities": [
      {
        "text": "51.8%",
        "label": "PERCENT"
      },
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "14.7%",
        "label": "PERCENT"
      },
      {
        "text": "Streptococcus",
        "label": "ORG"
      },
      {
        "text": "15.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "maxillofacial infections (244 cases, 297 isolates; 18.0%). Other significant",
    "entities": [
      {
        "text": "244",
        "label": "CARDINAL"
      },
      {
        "text": "297",
        "label": "CARDINAL"
      },
      {
        "text": "18.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "sites included abdominal abscesses/peritonitis (17.0%), hepatic abscesses",
    "entities": [
      {
        "text": "17.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(5.2%), and Periappendicular abscess (5.5%).",
    "entities": [
      {
        "text": "5.2%",
        "label": "PERCENT"
      },
      {
        "text": "Periappendicular",
        "label": "PRODUCT"
      },
      {
        "text": "5.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Systematic optimization of diagnostic protocols significantly",
    "entities": []
  },
  {
    "text": "enhanced pathogen detection in abscess specimens, demonstrating substantial",
    "entities": []
  },
  {
    "text": "clinical utility for infectious disease management. These findings support the",
    "entities": []
  },
  {
    "text": "adoption of comprehensive, standardized approaches for abscess specimen",
    "entities": []
  },
  {
    "text": "processing.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s40001-025-02896-7",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40660369 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660369",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate: The study was approved by the 940th Hospital Committee for Medical",
    "entities": [
      {
        "text": "the 940th Hospital Committee for Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Health Research Ethics. The Ethics Committee waived the need for informed",
    "entities": [
      {
        "text": "Health Research Ethics",
        "label": "ORG"
      },
      {
        "text": "The Ethics Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consent, as this was an observational study, the treatment of the patients was",
    "entities": []
  },
  {
    "text": "standard, and no samples were taken for the study. Consent for publication: All",
    "entities": []
  },
  {
    "text": "authors agree to publish articles in the journal. Competing interests: The",
    "entities": []
  },
  {
    "text": "authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Association of meteorological factors with childhood pneumonia incidence in",
    "entities": []
  },
  {
    "text": "Central Gondar Zone, Northwest Ethiopia: a time-series study (2013-2022).",
    "entities": [
      {
        "text": "Central Gondar Zone",
        "label": "PERSON"
      },
      {
        "text": "Northwest Ethiopia",
        "label": "LOC"
      },
      {
        "text": "2013-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Department of Environmental and Occupational Health and Safety, Institute of",
    "entities": [
      {
        "text": "Environmental and Occupational Health and Safety, Institute of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health, College of Medicine and Health Sciences, University of Gondar,",
    "entities": [
      {
        "text": "Public Health, College of Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Gondar",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Environmental and Occupational Health and Safety, Institute of",
    "entities": [
      {
        "text": "Environmental and Occupational Health and Safety, Institute of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Gondar, Ethiopia.",
    "entities": [
      {
        "text": "Gondar",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Childhood pneumonia remains a significant clinical and public health",
    "entities": [
      {
        "text": "Childhood",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "challenge, contributing to substantial morbidity and mortality in under five",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years of age, including Ethiopia. Despite efforts to reduce its impact,",
    "entities": [
      {
        "text": "years of age",
        "label": "DATE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "childhood pneumonia persists as a leading cause of death in young children,",
    "entities": []
  },
  {
    "text": "particularly in low-resource settings. This study investigates the association",
    "entities": []
  },
  {
    "text": "between childhood pneumonia incidence and meteorological factors in the Central",
    "entities": []
  },
  {
    "text": "Gondar Zone, northwest Ethiopia, from January 2013 to December 2022.",
    "entities": [
      {
        "text": "Gondar Zone",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      },
      {
        "text": "January 2013 to December 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: Institution based time-series cross-sectional study design was",
    "entities": []
  },
  {
    "text": "conducted in Central Gondar Zone, Northwest Ethiopia. Data on childhood",
    "entities": [
      {
        "text": "Central Gondar Zone",
        "label": "GPE"
      },
      {
        "text": "Northwest Ethiopia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pneumonia cases were obtained from the Central Gondar Zone Health Department and",
    "entities": [
      {
        "text": "the Central Gondar Zone Health Department",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Gondar Administrative Health Department. Meteorological data, including",
    "entities": [
      {
        "text": "Gondar Administrative Health Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "temperature, rainfall, and relative humidity, were sourced from the West Amhara",
    "entities": [
      {
        "text": "West Amhara",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Meteorology Agency. Spearman correlation, bivariate negative binomial, and",
    "entities": [
      {
        "text": "Meteorology Agency",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "multivariable negative binomial regressions were employed to analyze the",
    "entities": []
  },
  {
    "text": "relationship between childhood pneumonia incidence and meteorological factors.",
    "entities": []
  },
  {
    "text": "RESULTS: The findings reveal a consistent increase in childhood pneumonia",
    "entities": []
  },
  {
    "text": "incidence during the study period. Specifically, there is a significant inverse",
    "entities": []
  },
  {
    "text": "association between mean monthly temperature and the incidence of childhood",
    "entities": [
      {
        "text": "monthly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pneumonia, indicating a higher incidence during the cooler month. In contrast,",
    "entities": [
      {
        "text": "the cooler month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mean monthly rainfall demonstrates a positive association with childhood",
    "entities": [
      {
        "text": "monthly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pneumonia incidence, suggesting increased incidence following periods of higher",
    "entities": []
  },
  {
    "text": "rainfall. However, no significant association was observed between relative",
    "entities": []
  },
  {
    "text": "humidity and childhood pneumonia incidence.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: These results underscore the complex interplay between",
    "entities": []
  },
  {
    "text": "meteorological factors and childhood pneumonia incidence, with implications for",
    "entities": []
  },
  {
    "text": "public health interventions and climate adaptation strategies in Ethiopia.",
    "entities": [
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Understanding these associations can inform targeted interventions to mitigate",
    "entities": []
  },
  {
    "text": "the impact of childhood pneumonia, particularly in climate-vulnerable regions.",
    "entities": []
  },
  {
    "text": "PMID: 40660351 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660351",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: Ethical clearance was obtained from research and ethical review",
    "entities": []
  },
  {
    "text": "committee of Institution of Public Health, College of Medicine and Health",
    "entities": [
      {
        "text": "committee of Institution of Public Health, College of Medicine and Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Gondar on April 06, 2023 (Ref No/IPH/2707/2023). A",
    "entities": [
      {
        "text": "University of Gondar",
        "label": "ORG"
      },
      {
        "text": "April 06, 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "support letter was obtained from the Department of Environmental and",
    "entities": [
      {
        "text": "the Department of Environmental",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Occupational Health and Safety for the required data to Central Gondar Zone",
    "entities": [
      {
        "text": "Occupational Health and Safety",
        "label": "ORG"
      },
      {
        "text": "Central Gondar",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "health department and Ethiopia Statistical Service. To ensure the",
    "entities": [
      {
        "text": "health department",
        "label": "ORG"
      },
      {
        "text": "Ethiopia Statistical Service",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "confidentiality of data, it was kept secure and the data was not used for other",
    "entities": []
  },
  {
    "text": "purposes. Consent for publication: This manuscript does not contain any",
    "entities": []
  },
  {
    "text": "individual person\u2019s data. Competing Interests: The authors declare that the",
    "entities": []
  },
  {
    "text": "research was conducted in the absence of any commercial or financial",
    "entities": []
  },
  {
    "text": "relationships that could be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "Patient and public involvement: There was no patient and public involvement in",
    "entities": []
  },
  {
    "text": "this study.",
    "entities": []
  },
  {
    "text": "10.1186/s12963-025-00390-0.",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Socio-economic inequalities in all-cause mortality during the COVID-19 period in",
    "entities": [
      {
        "text": "Socio",
        "label": "NORP"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "north-western Tanzania, 2018-2021.",
    "entities": [
      {
        "text": "Tanzania",
        "label": "GPE"
      },
      {
        "text": "2018-2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Mwanza Research Centre, National Institute for Medical Research, Mwanza,",
    "entities": [
      {
        "text": "1)Mwanza Research Centre",
        "label": "ORG"
      },
      {
        "text": "National Institute for Medical Research",
        "label": "ORG"
      },
      {
        "text": "Mwanza",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Epidemiology and Biostatistics, Catholic University of Health",
    "entities": [
      {
        "text": "Epidemiology and Biostatistics, Catholic University of Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Mwanza Research Centre, National Institute for Medical Research, Mwanza,",
    "entities": [
      {
        "text": "3)Mwanza Research Centre",
        "label": "ORG"
      },
      {
        "text": "National Institute for Medical Research",
        "label": "ORG"
      },
      {
        "text": "Mwanza",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Epidemiology and Biostatistics, Catholic University of Health",
    "entities": [
      {
        "text": "Epidemiology and Biostatistics, Catholic University of Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Population Health, London School of Hygiene and Tropical",
    "entities": [
      {
        "text": "Population Health",
        "label": "ORG"
      },
      {
        "text": "London School of Hygiene and Tropical\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)MRC/Wits Rural Public Health and Health Transitions Research Unit",
    "entities": [
      {
        "text": "Health Transitions Research Unit",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(Agincourt), Faculty of Health Sciences, School of Public Health, University of",
    "entities": [
      {
        "text": "Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Community Health Science, University of Manitoba, Winnipeg, Canada.",
    "entities": [
      {
        "text": "Health Science, University of Manitoba",
        "label": "ORG"
      },
      {
        "text": "Winnipeg",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Evidence suggests that the COVID-19 pandemic has exacerbated social",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and demographic inequalities in the communities through pathways of unequal",
    "entities": []
  },
  {
    "text": "exposure, vulnerability, and susceptibility. In Tanzania, evidence on",
    "entities": [
      {
        "text": "Tanzania",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "COVID-19-related mortality is limited to health facility data, with little to no",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "information on the mortality patterns in the general population. This study",
    "entities": []
  },
  {
    "text": "assessed sociodemographic inequalities in all-cause mortality during the",
    "entities": []
  },
  {
    "text": "COVID-19 period in north-western Tanzania.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Tanzania",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: We utilized available longitudinal data from the Magu Health and",
    "entities": [
      {
        "text": "the Magu Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Demographic Surveillance System (HDSS) from January 2018 to December 2021. We",
    "entities": [
      {
        "text": "Demographic Surveillance System",
        "label": "ORG"
      },
      {
        "text": "HDSS",
        "label": "ORG"
      },
      {
        "text": "January 2018 to December 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "compared the crude death rates between subgroups of age, sex, area of residence,",
    "entities": []
  },
  {
    "text": "and wealth index for a period before (2018/2019) and during (2020/2021) the",
    "entities": [
      {
        "text": "2018/2019",
        "label": "DATE"
      },
      {
        "text": "2020/2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19 pandemic. To quantify how mortality risk varies across the subgroups we",
    "entities": []
  },
  {
    "text": "fitted a Cox proportional hazard model with an interaction of the COVID-19",
    "entities": [
      {
        "text": "Cox",
        "label": "NORP"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Overall mortality declined from 5.9 in 2018/2019 to 5.4 and 5.5 deaths",
    "entities": [
      {
        "text": "5.9",
        "label": "CARDINAL"
      },
      {
        "text": "2018/2019",
        "label": "DATE"
      },
      {
        "text": "5.4",
        "label": "CARDINAL"
      },
      {
        "text": "5.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "per 1000 person-years in 2020 and 2021, respectively. We observed an increase in",
    "entities": [
      {
        "text": "1000",
        "label": "CARDINAL"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "differences in crude death rates by age groups, area of residence, and wealth",
    "entities": []
  },
  {
    "text": "quintiles during the COVID-19 period. In the Cox proportional hazards model,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Cox",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compared to adults aged 15-49, we observed greater mortality risk in children",
    "entities": [
      {
        "text": "15-49",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "under five (AHR:2.9; 95%CI: 2.2-3.9), older individuals aged 50-64 years",
    "entities": [
      {
        "text": "under five",
        "label": "DATE"
      },
      {
        "text": "2.2-3.9",
        "label": "CARDINAL"
      },
      {
        "text": "50-64 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(AHR:3.02; 95%CI:2.11-4.33) and 65 + (AHR:18.65; 95%CI:14.28-24.35) during",
    "entities": [
      {
        "text": "95%CI:2.11-4.33",
        "label": "CARDINAL"
      },
      {
        "text": "65 +",
        "label": "DATE"
      },
      {
        "text": "95%CI:14.28-24.35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "COVID-19 period. Males were also at greater risk of death compared to females",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(AHR:1.30; 95%CI:1.06-1.59).",
    "entities": [
      {
        "text": "95%CI:1.06",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Despite the overall mortality decline during the pandemic, we",
    "entities": []
  },
  {
    "text": "observed an increased risk of mortality among vulnerable subgroups",
    "entities": []
  },
  {
    "text": "(aged < 5 years and > 60 years) in the population. This highlights the need to",
    "entities": [
      {
        "text": "5 years",
        "label": "DATE"
      },
      {
        "text": "60 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "take into account vulnerable subpopulations when addressing major public health",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12963-025-00390-0",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40660241 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660241",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: Permission to conduct this study was obtained from the Medical",
    "entities": [
      {
        "text": "the Medical\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Coordinating Committee in Tanzania with ethical clearance number",
    "entities": [
      {
        "text": "Research Coordinating Committee",
        "label": "ORG"
      },
      {
        "text": "Tanzania",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "NIMR/HQ/R.8c/Vol. I/1496 and from Catholic University of Health of Health and",
    "entities": [
      {
        "text": "Catholic University of Health of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Allied Sciences Bugando Research and Ethical Committee (CREC) with ethical",
    "entities": [
      {
        "text": "Allied Sciences Bugando Research and Ethical Committee",
        "label": "ORG"
      },
      {
        "text": "CREC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clearance number CREC/580/2022. Informed consent was obtained for participants",
    "entities": [
      {
        "text": "CREC/580/2022",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "aged 18 and above, and assent was obtained from minors. Unique identification",
    "entities": [
      {
        "text": "18",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "numbers were used to identify study participants. Confidentiality was adhered to",
    "entities": []
  },
  {
    "text": "during the data process and analysis. Competing interests: The authors declare",
    "entities": []
  },
  {
    "text": "that they have no competing interests.",
    "entities": []
  },
  {
    "text": "90. BMC Public Health. 2025 Jul 14;25(1):2448. doi: 10.1186/s12889-025-23597-0.",
    "entities": [
      {
        "text": "90",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Association between Adverse Childhood Events (ACEs) and long-term COVID-19",
    "entities": [
      {
        "text": "Adverse Childhood Events",
        "label": "PERSON"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "symptoms: evidence from the 2022 behavioral risk factor surveillance system.",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Elkefi S(1)(2), Steffen A(3), Matthews AK(4).",
    "entities": [
      {
        "text": "Matthews",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)School of Nursing, Columbia University, New York, USA.",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Columbia University",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Systems Science and Industrial Engineering, Watson College, Binghamton",
    "entities": [
      {
        "text": "Watson College",
        "label": "ORG"
      },
      {
        "text": "Binghamton",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, New York, USA. safaelkefi.research@gmail.com.",
    "entities": [
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)School of Nursing, University of Illinois Chicago, Chicago, USA.",
    "entities": [
      {
        "text": "Nursing, University of Illinois Chicago",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)School of Nursing, Columbia University, New York, USA.",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Columbia University",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study investigated the association between Adverse Childhood",
    "entities": [
      {
        "text": "Adverse Childhood",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Events (ACEs) and long-term COVID-19 symptoms.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We used data from the 2022 Behavioral Risk Factor Surveillance System.",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "Behavioral Risk Factor Surveillance System",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Multivariable logistic regression was used to assess the association between",
    "entities": []
  },
  {
    "text": "long-term COVID symptoms and ACEs, adjusting for demographic characteristics",
    "entities": []
  },
  {
    "text": "(race/ethnicity, age, and sex). Survey weights were applied.",
    "entities": []
  },
  {
    "text": "RESULTS: Of the 14,560 participants, 46.73% experienced 1-3 ACEs, and 26.81%",
    "entities": [
      {
        "text": "14,560",
        "label": "CARDINAL"
      },
      {
        "text": "46.73%",
        "label": "PERCENT"
      },
      {
        "text": "1-3",
        "label": "CARDINAL"
      },
      {
        "text": "26.81%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "experienced 4 + ACEs-23.38% experienced long-term COVID-19 symptoms. Blacks",
    "entities": [
      {
        "text": "4 + ACEs-23.38%",
        "label": "PERCENT"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR = 0.76, P =.002) and Asians (OR = 0.56, P =.009) were less likely than",
    "entities": [
      {
        "text": "0.76",
        "label": "CARDINAL"
      },
      {
        "text": ".002",
        "label": "CARDINAL"
      },
      {
        "text": "Asians",
        "label": "NORP"
      },
      {
        "text": "0.56",
        "label": "CARDINAL"
      },
      {
        "text": ".009",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Whites to experience long-term COVID-19, but American Indians (OR = 1.72) were",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "American Indians",
        "label": "NORP"
      },
      {
        "text": "1.72",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "more likely. Adults aged 35-69 had a higher likelihood of long-term symptoms",
    "entities": [
      {
        "text": "35-69",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "than younger adults (OR = 1.24), whereas those aged 70 or older did not differ",
    "entities": [
      {
        "text": "1.24",
        "label": "CARDINAL"
      },
      {
        "text": "70",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "from younger adults. Females were also more likely to experience them",
    "entities": []
  },
  {
    "text": "(OR = 1.61). Exposure to ACEs was positively associated with long-term COVID-19",
    "entities": [
      {
        "text": "1.61",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "symptoms. The more adverse events individuals were exposed to, the more risk of",
    "entities": []
  },
  {
    "text": "long-term COVID-19. Specifically, experience of household substance abuse",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR = 1.14, 95%, P =.008), physical abuse (OR = 1.18, 95%, P =.001), emotional",
    "entities": [
      {
        "text": "1.14",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": ".008",
        "label": "CARDINAL"
      },
      {
        "text": "1.18",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": ".001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "abuse (OR = 1.13, 95%, P =.014), sexual abuse (OR = 1.43, 95%, P <.001), and",
    "entities": [
      {
        "text": "1.13",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": ".014",
        "label": "CARDINAL"
      },
      {
        "text": "1.43",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "P <.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "household mental illness (OR = 1.35, 95%, P <.001) were positively associated",
    "entities": [
      {
        "text": "1.35",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "P <.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with the long-term COVID-19 experience.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Study findings contribute to the extensive literature demonstrating",
    "entities": []
  },
  {
    "text": "the negative health consequences of childhood adversities. More adverse events",
    "entities": []
  },
  {
    "text": "resulted in more risk to experience long term COVID-19 symptoms. Additional",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research is needed to better understand and intervene in the biological",
    "entities": []
  },
  {
    "text": "vulnerabilities associated with childhood adversities.",
    "entities": []
  },
  {
    "text": "PMID: 40660201 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: This is a secondary data analysis so no IRB is needed in accordance",
    "entities": [
      {
        "text": "IRB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with the Declaration of Helsinki. Consent for publication: Not applicable.",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "91. BMC Public Health. 2025 Jul 14;25(1):2444. doi: 10.1186/s12889-025-23591-6.",
    "entities": [
      {
        "text": "91",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Post-COVID gambling habits of adolescents and young adults in Aragon, Spain: a",
    "entities": [
      {
        "text": "Aragon",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "cross-sectional study.",
    "entities": []
  },
  {
    "text": "(1)Department of Psychology and Sociology, University of Zaragoza, Saragossa,",
    "entities": [
      {
        "text": "University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Saragossa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS),",
    "entities": []
  },
  {
    "text": "(3)Institute of Health Research of Aragon, Saragossa, Spain.",
    "entities": [
      {
        "text": "Health Research of Aragon",
        "label": "ORG"
      },
      {
        "text": "Saragossa",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Faculty of Medicine, University of Zaragoza, Saragossa, Spain.",
    "entities": [
      {
        "text": "Medicine, University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Saragossa",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Clinical and Health Psychology, Universitat Aut\u00f2noma de",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical and Health Psychology",
        "label": "ORG"
      },
      {
        "text": "Universitat Aut\u00f2noma de\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(6)CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.",
    "entities": [
      {
        "text": "6)CIBER",
        "label": "CARDINAL"
      },
      {
        "text": "Epidemiology and Public Health",
        "label": "ORG"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Psychology and Sociology, University of Zaragoza, Saragossa,",
    "entities": [
      {
        "text": "Psychology and Sociology, University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Saragossa",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(8)Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS),",
    "entities": []
  },
  {
    "text": "(9)Institute of Health Research of Aragon, Saragossa, Spain. yolandal@unizar.es.",
    "entities": [
      {
        "text": "Health Research of Aragon",
        "label": "ORG"
      },
      {
        "text": "Saragossa",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Gambling has become increasingly normalized in Spain, with 49.3% of",
    "entities": [
      {
        "text": "Spain",
        "label": "GPE"
      },
      {
        "text": "49.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the population participating and high engagement among youth, particularly",
    "entities": []
  },
  {
    "text": "online. Despite legal restrictions, some studies have reported that over 20% of",
    "entities": [
      {
        "text": "over 20%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "adolescents aged 14-19 reported gambling in 2022. These findings raise concerns",
    "entities": [
      {
        "text": "14-19",
        "label": "DATE"
      },
      {
        "text": "2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "about gambling disorder, which affects 4.7% of Spanish youth and is linked to",
    "entities": [
      {
        "text": "4.7%",
        "label": "PERCENT"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "other mental health problems. Factors such as advertising and the COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic may have contributed to this trend. This study, part of the GAMBL-OUT",
    "entities": []
  },
  {
    "text": "project, examines gambling behaviors among young people in Aragon, Spain,",
    "entities": [
      {
        "text": "Aragon",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "focusing on prevalence, advertising exposure, post-COVID vs. pre-pandemic",
    "entities": []
  },
  {
    "text": "comparisons, and factors associated with problem gambling, while comparing high",
    "entities": []
  },
  {
    "text": "school and university students.",
    "entities": []
  },
  {
    "text": "METHODS: A cross-sectional study was conducted between November 2023 and March",
    "entities": [
      {
        "text": "between November 2023 and March\n",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024 with 617 participants aged 16-25 from high schools, vocational centers, and",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "617",
        "label": "CARDINAL"
      },
      {
        "text": "16-25",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "universities. Measures included sociodemographic variables, gambling behaviors,",
    "entities": []
  },
  {
    "text": "advertising exposure, and psychological constructs. Standardized tools included",
    "entities": []
  },
  {
    "text": "the Problem Gambling Severity Index, Gambling Related Cognitions Scale, Gambling",
    "entities": [
      {
        "text": "the Problem Gambling Severity Index",
        "label": "ORG"
      },
      {
        "text": "Gambling Related Cognitions Scale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Motives Questionnaire, and UPPS-P Impulsive Behavior Scale.",
    "entities": [
      {
        "text": "Questionnaire",
        "label": "PERSON"
      },
      {
        "text": "UPPS-P Impulsive Behavior Scale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Nearly 60% of participants had gambled, 78.4% of whom had done so in",
    "entities": [
      {
        "text": "Nearly 60%",
        "label": "PERCENT"
      },
      {
        "text": "78.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the past 12 months. The overall prevalence of problem gambling in our sample was",
    "entities": [
      {
        "text": "the past 12 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "3.5%. Among university students, 64.6% had gambled and 3.4% showed signs of",
    "entities": [
      {
        "text": "3.5%",
        "label": "PERCENT"
      },
      {
        "text": "64.6%",
        "label": "PERCENT"
      },
      {
        "text": "3.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "problem gambling, which does not represent a significant increase compared to",
    "entities": []
  },
  {
    "text": "2019 data. University students post-COVID reported significantly lower exposure",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to gambling advertisements and less knowledge of betting venues and websites,",
    "entities": []
  },
  {
    "text": "despite stable levels of preventive information. Although lifetime gambling",
    "entities": []
  },
  {
    "text": "increased (65.3% vs. 58.1%), riskier behaviors such as sports betting, online",
    "entities": [
      {
        "text": "65.3%",
        "label": "PERCENT"
      },
      {
        "text": "58.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "gambling, and microtransactions decreased. University students showed greater",
    "entities": []
  },
  {
    "text": "gambling participation and online awareness, while high school students showed",
    "entities": []
  },
  {
    "text": "higher impulsivity and stronger gambling intentions. Regression analyses",
    "entities": []
  },
  {
    "text": "identified enhancement motives, predictive control, negative urgency, and peer",
    "entities": []
  },
  {
    "text": "influence as factors associated with problem gambling.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Gambling remains a prevalent issue among youth in Aragon, with",
    "entities": [
      {
        "text": "Aragon",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "problem gambling rates stable over time. Despite reduced advertising exposure,",
    "entities": []
  },
  {
    "text": "the normalization of gambling persists. Findings support the need for",
    "entities": []
  },
  {
    "text": "age-specific, psychologically informed interventions addressing both individual",
    "entities": []
  },
  {
    "text": "vulnerabilities and social contexts.",
    "entities": []
  },
  {
    "text": "PMID: 40660173 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660173",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: The Research Ethics Committee of the Autonomous Community of Arag\u00f3n",
    "entities": [
      {
        "text": "The Research Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "the Autonomous Community of Arag\u00f3n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(CEICA) evaluated and approved the study protocol in June 2023 (PI22/406). All",
    "entities": [
      {
        "text": "June 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "study participants signed an informed consent. Consent for publication: Not",
    "entities": []
  },
  {
    "text": "applicable. Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "92. BMC Public Health. 2025 Jul 14;25(1):2457. doi: 10.1186/s12889-025-23411-x.",
    "entities": [
      {
        "text": "92",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The promotion mechanism of physical and mental health of the elderly in China:",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the impact of the digital divide and social capital.",
    "entities": []
  },
  {
    "text": "(1)School of Law, Hohai University, Nanjing, 211100, China. jiaxiang@hhu.edu.cn.",
    "entities": [
      {
        "text": "1)School of Law",
        "label": "ORG"
      },
      {
        "text": "Hohai University",
        "label": "ORG"
      },
      {
        "text": "Nanjing",
        "label": "GPE"
      },
      {
        "text": "211100",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "jiaxiang@hhu.edu.cn",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)School of Law, Hohai University, Nanjing, 211100, China.",
    "entities": [
      {
        "text": "Law, Hohai University",
        "label": "ORG"
      },
      {
        "text": "Nanjing",
        "label": "GPE"
      },
      {
        "text": "211100",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "With the deep integration of population aging and digital transformation, the",
    "entities": []
  },
  {
    "text": "society has benefit from digital dividend, while also giving rise to the issue",
    "entities": []
  },
  {
    "text": "of the aging population's digital divide.This study is based on the three-level",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "digital divide theory analysis framework, concentrating on the impact of the",
    "entities": []
  },
  {
    "text": "digital divide on elderly people's health during the Covid-19 pandemic in China,",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "conducts multiple regression analysis, and uses the instrumental variable method",
    "entities": []
  },
  {
    "text": "and PSM propensity matching for robustness testing. Constructs a multiple",
    "entities": []
  },
  {
    "text": "mediation model of digital skill-social capital-elderly health, and applies",
    "entities": []
  },
  {
    "text": "Bootstrap-based structural equation model(SEM) to analyze and examine the",
    "entities": []
  },
  {
    "text": "influencing mechanism and pathway of digital skill on elderly people's physical",
    "entities": []
  },
  {
    "text": "and mental health. The research results indicate that: (1) From self-rated",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "health, physical health, and mental health three aspects, digital skill",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly promotes elderly people's health, moreover, the elderly health is",
    "entities": []
  },
  {
    "text": "negatively impacted by the digital divide. (2) Among the elderly, their physical",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and psychological health are linked by a \"cyclic cumulative causal effect\". (3)",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The effect of digital skill on elderly people's health exists urban-rural",
    "entities": []
  },
  {
    "text": "difference. (4) A mediating effect of social capital in the connection between",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "digital skill and elderly people's health. Digital skill enhances the state of",
    "entities": [
      {
        "text": "digital",
        "label": "ORG"
      },
      {
        "text": "Digital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elderly people's health by enriching relational and structural social capital,",
    "entities": []
  },
  {
    "text": "and aged adults' health is negatively impacted by a reduction in cognitive",
    "entities": []
  },
  {
    "text": "social capital. Therefore, in the future, it is necessary to fully leverage the",
    "entities": []
  },
  {
    "text": "health promotion function of digital skill, broaden senior citizens' social",
    "entities": [
      {
        "text": "health promotion function",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "network, promote their social participation, bridge the senior citizens' digital",
    "entities": []
  },
  {
    "text": "divide, so then realize healthy aging and sustainable development.",
    "entities": []
  },
  {
    "text": "PMID: 40660167 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660167",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: Research ethics approval for data collection in the Chinese General",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Social Survey (CGSS) dataset was granted by the Institutional Review Board of",
    "entities": [
      {
        "text": "Social Survey",
        "label": "ORG"
      },
      {
        "text": "the Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Renmin University, PR China. Prior to conducting the study, a voluntary informed",
    "entities": [
      {
        "text": "Renmin University",
        "label": "ORG"
      },
      {
        "text": "PR China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consent form has been obtained from the study participants. The research content",
    "entities": []
  },
  {
    "text": "and purpose are within the scope of standardized informed consent.This study",
    "entities": []
  },
  {
    "text": "conducted research using anonymized information data. This study does not cause",
    "entities": []
  },
  {
    "text": "harm to the human body and does not involve sensitive personal information or",
    "entities": []
  },
  {
    "text": "commercial interests. Based on this, this study complies with the basic",
    "entities": []
  },
  {
    "text": "principles of the Helsinki Declaration and meets the ethical exemption",
    "entities": [
      {
        "text": "the Helsinki Declaration",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "requirements of the \u201cEthical Review Measures for Research Involving Human Life",
    "entities": [
      {
        "text": "the \u201cEthical Review Measures for Research Involving Human Life",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences and Medical Sciences\u201d issued by China, which can exempt ethical review.",
    "entities": [
      {
        "text": "Sciences and Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "We used the public data of CGSS, no additional ethics approval was needed.",
    "entities": [
      {
        "text": "CGSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Consent for publication: Not applicable. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "Enhanced crisis resilience of general practitioner-centred care: a retrospective",
    "entities": []
  },
  {
    "text": "cohort study of patients with coronary artery disease during the COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic in Germany.",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Institute of General Practice, Goethe University Frankfurt, Theodor-Stern-Kai",
    "entities": [
      {
        "text": "General Practice",
        "label": "ORG"
      },
      {
        "text": "Goethe University Frankfurt",
        "label": "ORG"
      },
      {
        "text": "Theodor-Stern-Kai",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "7, Frankfurt, 60590, Germany. c.friedmacher@allgemeinmedizin.uni-frankfurt.de.",
    "entities": [
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "Frankfurt",
        "label": "GPE"
      },
      {
        "text": "60590",
        "label": "DATE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      },
      {
        "text": "c.friedmacher@allgemeinmedizin.uni-frankfurt.de",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Institute of General Practice, Goethe University Frankfurt, Theodor-Stern-Kai",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "General Practice",
        "label": "ORG"
      },
      {
        "text": "Goethe University Frankfurt",
        "label": "ORG"
      },
      {
        "text": "Theodor-Stern-Kai",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "7, Frankfurt, 60590, Germany.",
    "entities": [
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "Frankfurt",
        "label": "GPE"
      },
      {
        "text": "60590",
        "label": "DATE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Informatics, Biometry and Epidemiology, Ruhr University",
    "entities": [
      {
        "text": "Medical Informatics, Biometry and Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Ruhr University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Structured, comprehensive provision of primary care services has",
    "entities": [
      {
        "text": "Structured",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "been shown to provide better outcomes in chronic disease management. In 2004,",
    "entities": [
      {
        "text": "2004",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Germany introduced a programme of general practitioner (GP)-centred healthcare",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "to strengthen the primary care sector. Crises such as pandemics, world conflict",
    "entities": []
  },
  {
    "text": "and climate events can result in significant challenges for the provision of",
    "entities": []
  },
  {
    "text": "routine healthcare requiring rapid reorganisation of existing models of care",
    "entities": [
      {
        "text": "routine healthcare",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "provision. The objective of this study was to assess the impact of the COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic on the provision of chronic disease surveillance services and the",
    "entities": []
  },
  {
    "text": "treatment of patients with coronary artery disease (CAD) by GPs in the federal",
    "entities": []
  },
  {
    "text": "state of Baden-W\u00fcrttemberg, Germany over the years 2019-2020 to examine if the",
    "entities": [
      {
        "text": "Baden-W\u00fcrttemberg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      },
      {
        "text": "the years 2019-2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "previously demonstrated benefits of GPCC participation were maintained",
    "entities": [
      {
        "text": "GPCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "throughout the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Retrospective cohort study monitoring 170,466 CAD patients, conducted",
    "entities": [
      {
        "text": "170,466",
        "label": "CARDINAL"
      },
      {
        "text": "CAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "using biannually aggregated German insurance claims data (AOK-BaW\u00fc), comparing",
    "entities": [
      {
        "text": "German",
        "label": "NORP"
      },
      {
        "text": "AOK-BaW\u00fc",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2019 (pre-pandemic) with 2020 (COVID-19 pandemic), examining access (contacts),",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "therapy (e.g. statin therapy), and clinical outcomes (acute myocardial",
    "entities": [
      {
        "text": "statin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "infarction, angina pectoris, stroke, invasive procedures and",
    "entities": [
      {
        "text": "angina pectoris",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: Patients enrolled in the GP-centred care programme (GPCC) had more",
    "entities": [
      {
        "text": "GP",
        "label": "ORG"
      },
      {
        "text": "GPCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "frequent cohort-specific contacts, increasing during the pandemic, compared to",
    "entities": []
  },
  {
    "text": "those receiving standard care. Statin prescriptions were higher in the GPCC",
    "entities": [
      {
        "text": "Statin",
        "label": "NORP"
      },
      {
        "text": "GPCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group and appear to be maintained over the study period. GPCC participation has",
    "entities": [
      {
        "text": "GPCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "demonstrated lower risks of all listed clinical outcomes in comparison to",
    "entities": []
  },
  {
    "text": "standard care and these established advantages of GPCC participation with",
    "entities": [
      {
        "text": "GPCC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respect to clinical outcomes were maintained during 2020 despite the challenges",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Structured, comprehensive GP-centred care in Germany demonstrated",
    "entities": [
      {
        "text": "Structured",
        "label": "ORG"
      },
      {
        "text": "GP",
        "label": "ORG"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "resilience the challenges of the COVID-19 pandemic and was associated with",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "better continuity of care for patients with coronary artery disease (CAD) and a",
    "entities": []
  },
  {
    "text": "maintained lower risk of CAD complications. These differences could be explained",
    "entities": [
      {
        "text": "CAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by the structured and comprehensive provision of primary care services and",
    "entities": []
  },
  {
    "text": "enhanced coordination with secondary care, allowing practices to maintain care",
    "entities": []
  },
  {
    "text": "effectively despite the challenges of the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40660135 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660135",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: This study was submitted to the Ethics Committee of the Faculty of",
    "entities": [
      {
        "text": "the Ethics Committee of the Faculty of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine at the Goethe University, Frankfurt am Main under the reference number",
    "entities": [
      {
        "text": "the Goethe University",
        "label": "ORG"
      },
      {
        "text": "Frankfurt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "470/13. The waiver is based on the principles outlined in the Declaration of",
    "entities": [
      {
        "text": "470/13",
        "label": "CARDINAL"
      },
      {
        "text": "the Declaration of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Helsinki and the German Professional Code for Physicians (\u00a7 15). According to",
    "entities": [
      {
        "text": "the German Professional Code for Physicians",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the ethics committee, an approval is not required for studies that exclusively",
    "entities": []
  },
  {
    "text": "rely on fully anonymized secondary data from health insurance records. As this",
    "entities": []
  },
  {
    "text": "study does not involve direct patient contact or identifiable personal data, the",
    "entities": []
  },
  {
    "text": "Ethics Committee of the Faculty of Medicine at the Goethe University, Frankfurt",
    "entities": [
      {
        "text": "Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "the Goethe University",
        "label": "ORG"
      },
      {
        "text": "Frankfurt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "am Main determined that a formal ethics vote is unnecessary and that consent to",
    "entities": []
  },
  {
    "text": "participate is not applicable in this case. Consent for publication: Not",
    "entities": []
  },
  {
    "text": "94. Clin Exp Med. 2025 Jul 15;25(1):249. doi: 10.1007/s10238-025-01787-9.",
    "entities": [
      {
        "text": "94",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Exp Med",
        "label": "ORG"
      },
      {
        "text": "Jul 15;25(1):249",
        "label": "PERSON"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Second allogeneic stem cell transplantation using different donors as the",
    "entities": [
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "salvage treatment for acute myeloid leukemia relapsed after allogeneic",
    "entities": [
      {
        "text": "myeloid",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hematopoietic stem cell transplantation.",
    "entities": []
  },
  {
    "text": "(1)Department of Hematopoietic Stem Cell Transplant, Beijing GoBroad Boren",
    "entities": [
      {
        "text": "Beijing GoBroad Boren",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Hematopoietic Stem Cell Transplant, Beijing GoBroad Boren",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Beijing GoBroad Boren",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Hematopoietic Stem Cell Transplant, Beijing GoBroad Boren",
    "entities": [
      {
        "text": "Beijing GoBroad Boren",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Patients with acute myeloid leukemia (AML) who relapse after the first",
    "entities": [
      {
        "text": "myeloid",
        "label": "ORG"
      },
      {
        "text": "AML",
        "label": "ORG"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "with an extremely poor prognosis, primarily due to the dearth of effective",
    "entities": []
  },
  {
    "text": "treatment strategies. In light of this critical clinical challenge, we embarked",
    "entities": []
  },
  {
    "text": "on an in-depth analysis of second salvage allo-HSCT in this high-risk patient",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "population. Between 2019 and 2023, a total of 20 patients diagnosed with",
    "entities": [
      {
        "text": "Between 2019 and 2023",
        "label": "DATE"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "relapsed or refractory (r/r) AML received second salvage allo-HSCT at our",
    "entities": [
      {
        "text": "AML",
        "label": "ORG"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "center. Among these patients, 14 had a mean leukemic cell load of 44.2% (ranging",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "44.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "from 5.5 to 97%) in the bone marrow, while the remaining 6 presented with",
    "entities": [
      {
        "text": "5.5 to 97%",
        "label": "PERCENT"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "extramedullary lesions. With a median follow-up period of 14.5 months (ranging",
    "entities": [
      {
        "text": "14.5 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "from 1 to 36 months), 9 patients managed to survive in a leukemia-free state.",
    "entities": [
      {
        "text": "1 to 36 months",
        "label": "DATE"
      },
      {
        "text": "9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The expected 2-year overall survival (OS) and leukemia-free survival (LFS) rates",
    "entities": [
      {
        "text": "2-year",
        "label": "DATE"
      },
      {
        "text": "LFS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were both (45.5 \u00b1 14.0)%. Among the 11 patients who succumbed to the disease,",
    "entities": [
      {
        "text": "45.5 \u00b1 14.0)%",
        "label": "DATE"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the causes of death were as follows: 1 case of implant failure, 2 cases of",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "severe pneumonia, 1 case of pulmonary graft-versus-host disease (GVHD), and 7",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cases of leukemia progression. Our research clearly demonstrates that second",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "allo-HSCT serves as an effective salvage therapy for r/r AML patients following",
    "entities": [
      {
        "text": "HSCT",
        "label": "ORG"
      },
      {
        "text": "AML",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the first transplantation. Moreover, its safety profile is relatively",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "manageable, suggesting its potential value in the clinical treatment of such",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s10238-025-01787-9",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40660037 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40660037",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "have stated that they have no conflicts of interest and other Ethics Statement.",
    "entities": [
      {
        "text": "Ethics Statement",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "95. J Antibiot (Tokyo). 2025 Jul 14. doi: 10.1038/s41429-025-00850-7. Online",
    "entities": [
      {
        "text": "95",
        "label": "CARDINAL"
      },
      {
        "text": "Antibiot",
        "label": "PERSON"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The effect of exogenous glutathione on meropenem susceptibility in Klebsiella",
    "entities": [
      {
        "text": "meropenem",
        "label": "ORG"
      },
      {
        "text": "Klebsiella",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Natural and Life Sciences, Long Island University, Brooklyn,",
    "entities": [
      {
        "text": "Natural and Life Sciences",
        "label": "ORG"
      },
      {
        "text": "Long Island University",
        "label": "ORG"
      },
      {
        "text": "Brooklyn",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Natural and Life Sciences, Long Island University, Brooklyn,",
    "entities": [
      {
        "text": "Natural and Life Sciences",
        "label": "ORG"
      },
      {
        "text": "Long Island University",
        "label": "ORG"
      },
      {
        "text": "Brooklyn",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pseudomonas aeruginosa, associated with systemic and hospital-acquired",
    "entities": []
  },
  {
    "text": "infections, have spread globally and pose a significant public health concern.",
    "entities": []
  },
  {
    "text": "Glutathione is a multifunctional thiol-antioxidant compound synthesized in most",
    "entities": []
  },
  {
    "text": "Gram-negative bacteria and crucial in maintaining intracellular redox",
    "entities": [
      {
        "text": "Gram-negative",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "homeostasis. Exogenous glutathione exhibits antibiotic properties and has",
    "entities": []
  },
  {
    "text": "differential effects on conventional antibiotics. Therefore, its effect on",
    "entities": []
  },
  {
    "text": "specific antibiotics needs to be clarified in bacterial species. In this study,",
    "entities": []
  },
  {
    "text": "we investigated the antibacterial activity of glutathione and its effect on",
    "entities": []
  },
  {
    "text": "meropenem susceptibility in KPC-producing bacteria. Two major KPC-encoding genes",
    "entities": [
      {
        "text": "meropenem",
        "label": "ORG"
      },
      {
        "text": "KPC",
        "label": "ORG"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "KPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cloned from two different clinical KPC-producing K. pneumoniae were introduced",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "KPC",
        "label": "ORG"
      },
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "into E. coli and P. aeruginosa. Then, the KPC-producing K. pneumoniae, E. coli,",
    "entities": [
      {
        "text": "P.",
        "label": "NORP"
      },
      {
        "text": "KPC",
        "label": "ORG"
      },
      {
        "text": "K.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "and P. aeruginosa were used for minimum inhibitory concentration (MIC),",
    "entities": [
      {
        "text": "P.",
        "label": "NORP"
      },
      {
        "text": "MIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "population analysis, checkerboard, and time-killing assays. The results showed",
    "entities": [
      {
        "text": "assays",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "that glutathione exhibited antibacterial activity at >10 mM in K. pneumoniae, E.",
    "entities": [
      {
        "text": "mM",
        "label": "PERSON"
      },
      {
        "text": "K.",
        "label": "NORP"
      },
      {
        "text": "E.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "coli, and P. aeruginosa. MIC levels of meropenem combined with 10 mM of",
    "entities": [
      {
        "text": "P.",
        "label": "NORP"
      },
      {
        "text": "MIC",
        "label": "ORG"
      },
      {
        "text": "meropenem",
        "label": "ORG"
      },
      {
        "text": "10 mM",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "glutathione were synergistically decreased by 8- to \u2265 256-fold in KPC-producing",
    "entities": [
      {
        "text": "\u2265",
        "label": "GPE"
      },
      {
        "text": "256-fold",
        "label": "CARDINAL"
      },
      {
        "text": "KPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bacteria. Furthermore, this combination killed 100% of the KPC-producing",
    "entities": [
      {
        "text": "100%",
        "label": "PERCENT"
      },
      {
        "text": "KPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bacteria at 2 to 4 \u03bcg mL-1 of meropenem. These findings suggest that exogenous",
    "entities": [
      {
        "text": "2 to 4",
        "label": "CARDINAL"
      },
      {
        "text": "meropenem",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "glutathione may be applicable in fighting infections caused by KPC-producing",
    "entities": [
      {
        "text": "KPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to the Japan Antibiotics Research",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "the Japan Antibiotics Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Association.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41429-025-00850-7",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Compliance with ethical standards. Conflict of",
    "entities": []
  },
  {
    "text": "interest: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "96. J Gen Intern Med. 2025 Jul 14. doi: 10.1007/s11606-025-09660-x. Online ahead",
    "entities": [
      {
        "text": "96",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of print.",
    "entities": []
  },
  {
    "text": "Derivation and Validation of a New Score for Predicting In-Hospital Mortality in",
    "entities": []
  },
  {
    "text": "Exacerbations of Chronic Obstructive Pulmonary Disease.",
    "entities": []
  },
  {
    "text": "C(12), Zhou H(13); MAGNET ECOPD Registry Investigators.",
    "entities": [
      {
        "text": "Zhou H(13",
        "label": "ORG"
      },
      {
        "text": "MAGNET ECOPD Registry Investigators",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Respiratory and Critical Care Medicine, West China Hospital,",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "West China Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sichuan University, Chengdu, Sichuan Province, China.",
    "entities": [
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Sichuan Cancer Hospital, University of Electronic Science and Technology of",
    "entities": [
      {
        "text": "Cancer Hospital",
        "label": "ORG"
      },
      {
        "text": "University of Electronic Science and Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "China,, Chengdu, Sichuan Province, China.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)State Key Laboratory of Respiratory Disease, Guangzhou Medical University,",
    "entities": [
      {
        "text": "Key Laboratory of Respiratory Disease",
        "label": "ORG"
      },
      {
        "text": "Guangzhou Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Respiratory and Critical Care Medicine, People's Hospital of",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Leshan, Leshan, Sichuan Province, China.",
    "entities": [
      {
        "text": "Leshan",
        "label": "GPE"
      },
      {
        "text": "Leshan",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Respiratory and Critical Care Medicine, Sir Run Run Shaw",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Run Run Shaw",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province,",
    "entities": [
      {
        "text": "Zhejiang University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Tongji Hospital",
        "label": "ORG"
      },
      {
        "text": "Tongji",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",
    "entities": [
      {
        "text": "Medical College",
        "label": "ORG"
      },
      {
        "text": "Huazhong University of Science and Technology",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "Hubei",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province, China.",
    "entities": [
      {
        "text": "Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine, Union Hospital",
        "label": "ORG"
      },
      {
        "text": "Tongji",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Respiratory and Critical Care Medicine, the First People's",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "First",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Hospital of Neijiang City, Neijiang, Sichuan Province, China.",
    "entities": [
      {
        "text": "Neijiang City",
        "label": "GPE"
      },
      {
        "text": "Neijiang",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Respiratory and Critical Care Medicine, Xiangya Hospital,",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Xiangya Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Central South University, Changsha, Hunan Province, China.",
    "entities": [
      {
        "text": "Central South University",
        "label": "ORG"
      },
      {
        "text": "Changsha",
        "label": "GPE"
      },
      {
        "text": "Hunan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Emergency, First People's Hospital of Jiujiang, Jiujiang,",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "First People's Hospital of Jiujiang",
        "label": "ORG"
      },
      {
        "text": "Jiujiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Jiangxi Province, China.",
    "entities": [
      {
        "text": "Jiangxi Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Respiratory and Critical Care Medicine, The Affiliated",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Affiliated",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Hospital of Chengdu University, Chengdu, Sichuan Province, China.",
    "entities": [
      {
        "text": "Chengdu University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Center of Infectious Diseases, Division of Infectious Diseases in State Key",
    "entities": [
      {
        "text": "Division of Infectious Diseases",
        "label": "ORG"
      },
      {
        "text": "State Key",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu,",
    "entities": [
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of Respiratory and Critical Care Medicine, West China Hospital,",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "West China Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sichuan University, Chengdu, Sichuan Province, China. zhouhaixia@wchscu.cn.",
    "entities": [
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND AND OBJECTIVE: Since exacerbation of chronic obstructive pulmonary",
    "entities": []
  },
  {
    "text": "disease (ECOPD) is both common and often fatal, accurate prognostication of",
    "entities": []
  },
  {
    "text": "patients hospitalized for ECOPD is critical. We aimed to develop and validate a",
    "entities": []
  },
  {
    "text": "new score for predicting hospital mortality.",
    "entities": []
  },
  {
    "text": "METHODS: Independent predictors of in-hospital mortality were identified from a",
    "entities": []
  },
  {
    "text": "large prospective cohort of ECOPD from 10 medical centers in China between",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "September 2017 and July 2021, and incorporated into a clinical prediction score.",
    "entities": [
      {
        "text": "September 2017 and July 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Application of this score was then prospectively evaluated in an external",
    "entities": []
  },
  {
    "text": "validation cohort. The prognostic value of the scores was assessed by the area",
    "entities": []
  },
  {
    "text": "under the receiver operating characteristic curve (AUC).",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 14,007 patients were included in the derivation cohort, and",
    "entities": [
      {
        "text": "14,007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "201 patients (1.43%) died in the hospital. The 11 strongest independent",
    "entities": [
      {
        "text": "201",
        "label": "CARDINAL"
      },
      {
        "text": "1.43%",
        "label": "PERCENT"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "predictors were combined to form the Chronic Heart failure, Age \u2265 75, altered",
    "entities": [
      {
        "text": "75",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pressure \u2264 70 mmHg, Neutrophil ratio > 85 (%), Anemia, Long-term bed rest, hEart",
    "entities": [
      {
        "text": "70",
        "label": "CARDINAL"
      },
      {
        "text": "Neutrophil",
        "label": "PERSON"
      },
      {
        "text": "85 (%",
        "label": "PERCENT"
      },
      {
        "text": "Anemia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Rate > 100 (beats/minute), and blood urea niTrogen > 7.3 mmol/L, CHAMPION-ALERT",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "7.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Score, which enabled patients to be stratified according to increasing risk of",
    "entities": []
  },
  {
    "text": "in-hospital mortality: score 0-5, 0.3%; score 6-9, 4.4%; score 10-16, 25.9%. The",
    "entities": [
      {
        "text": "0-5",
        "label": "CARDINAL"
      },
      {
        "text": "0.3%",
        "label": "PERCENT"
      },
      {
        "text": "6-9",
        "label": "CARDINAL"
      },
      {
        "text": "4.4%",
        "label": "PERCENT"
      },
      {
        "text": "10-16",
        "label": "CARDINAL"
      },
      {
        "text": "25.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "score displayed excellent predictive value for mortality with an AUC of 0.89",
    "entities": [
      {
        "text": "0.89",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(95% CI 0.87-0.92), which was reproduced in the validation cohort of 3048",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.87",
        "label": "CARDINAL"
      },
      {
        "text": "3048",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients. The discrimination of the new score was superior to or comparable to",
    "entities": []
  },
  {
    "text": "that of existing prognostic scores (DECAF, BAP-65, and CURB-65).",
    "entities": [
      {
        "text": "CURB-65",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CONCLUSION: A new scoring system composes of 11 routinely available clinical",
    "entities": [
      {
        "text": "11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "variables on admission can accurately predict in-hospital mortality in ECOPD and",
    "entities": []
  },
  {
    "text": "shows a trend toward better performance compared to previous prognostic scores.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to Society of General Internal",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Society of General Internal\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations:. Human/Animal Ethics Approval::",
    "entities": [
      {
        "text": "Human/Animal Ethics Approval",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The Ethics Committee of each participating academic medical center approved the",
    "entities": [
      {
        "text": "The Ethics Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study based on the ethical approval obtained from the Ethics Committee of the",
    "entities": [
      {
        "text": "the Ethics Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "coordinating center, West China Hospital of Sichuan University (No: 2019\u20131056).",
    "entities": [
      {
        "text": "West China Hospital of Sichuan University",
        "label": "LOC"
      },
      {
        "text": "2019\u20131056",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of Interest:: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "97. Eur Phys J E Soft Matter. 2025 Jul 14;48(6-7):39. doi:",
    "entities": [
      {
        "text": "97",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "On degree-dependent topological study of line graph of some antiviral COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Mathematics, Institute of Science, Banaras Hindu University,",
    "entities": [
      {
        "text": "Mathematics, Institute of Science, Banaras Hindu University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Mathematics, Institute of Science, Banaras Hindu University,",
    "entities": [
      {
        "text": "Mathematics, Institute of Science, Banaras Hindu University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A topological index is a numerical value that correlates with a chemical",
    "entities": []
  },
  {
    "text": "structure. A degree-based topological index of drug molecular structures is",
    "entities": []
  },
  {
    "text": "beneficial for researchers investigating in the fields of medicals and",
    "entities": []
  },
  {
    "text": "pharmaceuticals because it is significant for testing the physicochemical",
    "entities": []
  },
  {
    "text": "properties of drugs. Graph theory has proven to be quite useful in this field of",
    "entities": []
  },
  {
    "text": "study. Graph analysis reveals insights into chemical structures. In physical",
    "entities": []
  },
  {
    "text": "chemistry, a line graph has multiple applications. This article focuses on the",
    "entities": []
  },
  {
    "text": "topological characterization of a line graph for antiviral COVID-19 drugs,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "namely Nirmatrelvir, Molnupiravir, Thalidomide, Theaflavin, Remdesivir,",
    "entities": [
      {
        "text": "Nirmatrelvir",
        "label": "ORG"
      },
      {
        "text": "Molnupiravir",
        "label": "PERSON"
      },
      {
        "text": "Thalidomide",
        "label": "PERSON"
      },
      {
        "text": "Theaflavin",
        "label": "PERSON"
      },
      {
        "text": "Remdesivir",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Ritonavir, Chloroquine, Hydroxychloroquine, Arbidol and Lopinavir. The",
    "entities": [
      {
        "text": "Ritonavir",
        "label": "PERSON"
      },
      {
        "text": "Chloroquine",
        "label": "GPE"
      },
      {
        "text": "Hydroxychloroquine",
        "label": "PERSON"
      },
      {
        "text": "Arbidol",
        "label": "PERSON"
      },
      {
        "text": "Lopinavir",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "computation of degree-based topological indices is carried out using their",
    "entities": []
  },
  {
    "text": "M-polynomials. Numerical values of topological indices of line graphs and",
    "entities": []
  },
  {
    "text": "geometric representations of the polynomials are shown graphically. A",
    "entities": []
  },
  {
    "text": "comparative study between the obtained values of the line graph and the values",
    "entities": []
  },
  {
    "text": "of an actual graph is presented through numerical and graphical representation.",
    "entities": []
  },
  {
    "text": "Furthermore, we conduct a QSPR analysis between the degree-based topological",
    "entities": [
      {
        "text": "QSPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "indices of the line graph of certain COVID-19 drugs and their physicochemical",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "properties using curvilinear regression models. A comparison is made between the",
    "entities": []
  },
  {
    "text": "squared correlation coefficients derived from our curvilinear regression models",
    "entities": []
  },
  {
    "text": "and those obtained from earlier research. These findings may aid the",
    "entities": []
  },
  {
    "text": "applicability of newly developed drugs of similar kind, in predicting their",
    "entities": []
  },
  {
    "text": "physicochemical properties and in improving the associated QSPR studies and",
    "entities": [
      {
        "text": "QSPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hence pave a way to improve treatments against the COVID-19 disease.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to EDP Sciences, SIF and",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "EDP Sciences",
        "label": "ORG"
      },
      {
        "text": "SIF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Springer-Verlag GmbH Germany, part of Springer Nature.",
    "entities": [
      {
        "text": "Springer-Verlag GmbH Germany",
        "label": "ORG"
      },
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PMID: 40659960 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659960",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: No Conflict",
    "entities": []
  },
  {
    "text": "of interest statement and potential Conflict of interest was reported by the",
    "entities": []
  },
  {
    "text": "authors.",
    "entities": []
  },
  {
    "text": "98. Surg Endosc. 2025 Jul 14. doi: 10.1007/s00464-025-11924-w. Online ahead of",
    "entities": [
      {
        "text": "98",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Restoration of normal anatomy without fundoplication in non-elective",
    "entities": []
  },
  {
    "text": "incarcerated giant paraesophageal hernia repair.",
    "entities": []
  },
  {
    "text": "Alicuben ET(1), Luketich JD(2), Levy RM(2), Kelsom C(2), Lloyd G(2), Witek T(2),",
    "entities": [
      {
        "text": "Luketich JD(2",
        "label": "PERSON"
      },
      {
        "text": "Levy",
        "label": "PERSON"
      },
      {
        "text": "Kelsom C(2",
        "label": "PERSON"
      },
      {
        "text": "Lloyd G(2",
        "label": "PERSON"
      },
      {
        "text": "Witek T(2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Cardiothoracic Surgery, University of Pittsburgh, 5200 Centre",
    "entities": [
      {
        "text": "Cardiothoracic Surgery",
        "label": "ORG"
      },
      {
        "text": "University of Pittsburgh",
        "label": "ORG"
      },
      {
        "text": "5200",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Avenue, Suite 715, Pittsburgh, PA, 15232, USA. alicubenet@upmc.edu.",
    "entities": [
      {
        "text": "Suite",
        "label": "GPE"
      },
      {
        "text": "715",
        "label": "CARDINAL"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "15232",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiothoracic Surgery, University of Pittsburgh, 5200 Centre",
    "entities": [
      {
        "text": "Cardiothoracic Surgery",
        "label": "ORG"
      },
      {
        "text": "University of Pittsburgh",
        "label": "ORG"
      },
      {
        "text": "5200",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical",
    "entities": [
      {
        "text": "Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Thoracic Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Center, Dallas, TX, USA.",
    "entities": [
      {
        "text": "Dallas",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Cardiovascular and Thoracic Surgery, WVU Heart and Vascular",
    "entities": [
      {
        "text": "Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Thoracic Surgery",
        "label": "PERSON"
      },
      {
        "text": "WVU Heart",
        "label": "ORG"
      },
      {
        "text": "Vascular",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Institute, Morgantown, WV, USA.",
    "entities": [
      {
        "text": "Morgantown",
        "label": "GPE"
      },
      {
        "text": "WV",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The purpose of our study was to examine outcomes following a novel",
    "entities": []
  },
  {
    "text": "approach to management of incarcerated giant paraesophageal hernia in a",
    "entities": []
  },
  {
    "text": "non-elective setting. Surgical dogma has dictated performing a fundoplication,",
    "entities": []
  },
  {
    "text": "but we have hypothesized that this is unnecessary in patients without",
    "entities": []
  },
  {
    "text": "significant reflux presenting with predominantly obstructive symptoms.",
    "entities": []
  },
  {
    "text": "METHODS: Patients who presented to the emergency room between January 2010 and",
    "entities": [
      {
        "text": "January 2010",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "June 2024 with symptomatic giant incarcerated paraesophageal hernia with",
    "entities": [
      {
        "text": "June 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "operative repair performed during the same hospitalization were included. An",
    "entities": []
  },
  {
    "text": "absence of pre-operative reflux symptoms was required. Operative steps included",
    "entities": []
  },
  {
    "text": "hernia sac reduction, mediastinal mobilization with vagal and crural lining",
    "entities": []
  },
  {
    "text": "preservation and primary crural closure. An Angle of His reconstruction was",
    "entities": []
  },
  {
    "text": "performed, and the fundus was sutured to the left hemidiaphragm immediately",
    "entities": []
  },
  {
    "text": "anterior to the spleen. Objective follow-up was obtained via esophagram,",
    "entities": []
  },
  {
    "text": "endoscopy, and CT scan.",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: There were 255 patients with a median age of 81 years. All operations",
    "entities": [
      {
        "text": "255",
        "label": "CARDINAL"
      },
      {
        "text": "age of 81 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "were performed with minimally invasive techniques. The median post-operative",
    "entities": []
  },
  {
    "text": "length of stay was 6 days. The 30-day mortality was 3.5%, mostly related to",
    "entities": [
      {
        "text": "6 days",
        "label": "DATE"
      },
      {
        "text": "30-day",
        "label": "DATE"
      },
      {
        "text": "3.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "complications of pneumonia. Objective follow-up was available in 230 patients at",
    "entities": [
      {
        "text": "230",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "a median of 13 months. There were 13 hiatal hernia recurrences (5.7%): 7 medium",
    "entities": [
      {
        "text": "13 months",
        "label": "DATE"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "5.7%",
        "label": "PERCENT"
      },
      {
        "text": "7",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3-4 cm), and 6 large. There were 7 patients that had any heartburn at last",
    "entities": [
      {
        "text": "3-4 cm",
        "label": "TIME"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "follow-up and all were well controlled with medication. Reoperation was",
    "entities": []
  },
  {
    "text": "performed in 2 patients due to recurrent obstructive symptoms following vomiting",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Meticulous hiatal hernia repair with crural closure and restoration",
    "entities": []
  },
  {
    "text": "of normal anatomy is a safe and effective option in patients presenting in",
    "entities": []
  },
  {
    "text": "non-elective settings without a significant reflux history. Given increased",
    "entities": []
  },
  {
    "text": "morbidity with urgent operations, elective repair of giant paraesophageal hernia",
    "entities": []
  },
  {
    "text": "should be considered in all patients.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Disclosures: Dr. Alicuben, Dr.",
    "entities": [
      {
        "text": "Alicuben",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Dr. Christie and Dr. Awais have no conflicts of interest to disclose.",
    "entities": [
      {
        "text": "Christie",
        "label": "PERSON"
      },
      {
        "text": "Awais",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "99. Behav Res Methods. 2025 Jul 14;57(8):223. doi: 10.3758/s13428-025-02743-x.",
    "entities": [
      {
        "text": "99",
        "label": "CARDINAL"
      },
      {
        "text": "Behav Res Methods",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.3758",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Collecting behavioural data across countries during pandemics: Development of",
    "entities": []
  },
  {
    "text": "the COVID-19 Risk Assessment Tool.",
    "entities": [
      {
        "text": "the COVID-19 Risk Assessment Tool",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chan AHY(6), Chan SS(6), Cipolletta S(16), DeSmet A(17)(18), Dewi TK(19), Dima",
    "entities": [
      {
        "text": "Chan SS(6",
        "label": "ORG"
      },
      {
        "text": "Cipolletta S(16",
        "label": "FAC"
      },
      {
        "text": "DeSmet",
        "label": "ORG"
      },
      {
        "text": "Dewi TK(19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Open University of the Netherlands, Heerlen, Netherlands.",
    "entities": [
      {
        "text": "University of the Netherlands",
        "label": "ORG"
      },
      {
        "text": "Heerlen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)University of Melbourne, Parkville, Australia.",
    "entities": [
      {
        "text": "2)University",
        "label": "CARDINAL"
      },
      {
        "text": "Melbourne",
        "label": "GPE"
      },
      {
        "text": "Parkville",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Maastricht University, Maastricht, The Netherlands.",
    "entities": [
      {
        "text": "University",
        "label": "GPE"
      },
      {
        "text": "Maastricht",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Maastricht University, Maastricht, The Netherlands.",
    "entities": [
      {
        "text": "4)Maastricht University",
        "label": "ORG"
      },
      {
        "text": "Maastricht",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)MSB Medical School Berlin, Berlin, Germany.",
    "entities": [
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)The University of Auckland, Auckland, New Zealand.",
    "entities": [
      {
        "text": "University of Auckland, Auckland,",
        "label": "ORG"
      },
      {
        "text": "New Zealand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "Faisal Specialist Hospital",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Addis Ababa University, Addis Ababa, Ethiopia.",
    "entities": [
      {
        "text": "Ababa University",
        "label": "ORG"
      },
      {
        "text": "Addis Ababa",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)University of Otago, Dunedin, New Zealand.",
    "entities": [
      {
        "text": "9)University",
        "label": "CARDINAL"
      },
      {
        "text": "Otago",
        "label": "GPE"
      },
      {
        "text": "Dunedin",
        "label": "PERSON"
      },
      {
        "text": "New Zealand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Cerrehpa\u015fa University Faculty of Medicine, \u0130stanbul, Turkey.",
    "entities": [
      {
        "text": "11)Cerrehpa\u015fa University Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "\u0130stanbul",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Queen's University Belfast, Belfast, UK.",
    "entities": [
      {
        "text": "12)Queen",
        "label": "CARDINAL"
      },
      {
        "text": "University Belfast",
        "label": "FAC"
      },
      {
        "text": "Belfast",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "13)University",
        "label": "CARDINAL"
      },
      {
        "text": "Nottingham",
        "label": "PERSON"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)University of Gloucestershire, Cheltenham, UK.",
    "entities": [
      {
        "text": "15)University",
        "label": "CARDINAL"
      },
      {
        "text": "Gloucestershire",
        "label": "GPE"
      },
      {
        "text": "Cheltenham",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)University of Padua, Padova, Italy.",
    "entities": [
      {
        "text": "16)University",
        "label": "CARDINAL"
      },
      {
        "text": "Padua",
        "label": "GPE"
      },
      {
        "text": "Padova",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)University of Antwerp, Antwerp, Belgium.",
    "entities": [
      {
        "text": "18)University",
        "label": "CARDINAL"
      },
      {
        "text": "Antwerp",
        "label": "GPE"
      },
      {
        "text": "Antwerp",
        "label": "GPE"
      },
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Avedis Donabedian Research Institute (FAD), Barcelona, Spain.",
    "entities": [
      {
        "text": "20)Avedis Donabedian Research Institute",
        "label": "ORG"
      },
      {
        "text": "FAD",
        "label": "ORG"
      },
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Public Health (CIBERESP), Madrid, Spain.",
    "entities": [
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(25)University of Manchester, Manchester, UK.",
    "entities": [
      {
        "text": "25)University",
        "label": "CARDINAL"
      },
      {
        "text": "Manchester",
        "label": "GPE"
      },
      {
        "text": "Manchester",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(28)University Savoie Mont Blanc, Chamb\u00e9ry, France.",
    "entities": [
      {
        "text": "28)University",
        "label": "CARDINAL"
      },
      {
        "text": "Mont Blanc",
        "label": "PERSON"
      },
      {
        "text": "Chamb\u00e9ry",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)University of Toronto, Toronto, Canada.",
    "entities": [
      {
        "text": "30)University",
        "label": "CARDINAL"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(32)University of Limerick, Limerick, Ireland.",
    "entities": [
      {
        "text": "32)University",
        "label": "CARDINAL"
      },
      {
        "text": "Limerick",
        "label": "GPE"
      },
      {
        "text": "Limerick",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)University of Galway, Galway, Ireland.",
    "entities": [
      {
        "text": "33)University",
        "label": "CARDINAL"
      },
      {
        "text": "Galway",
        "label": "GPE"
      },
      {
        "text": "Galway",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Istanbul Technical University, \u0130stanbul, Turkey.",
    "entities": [
      {
        "text": "34)Istanbul Technical University",
        "label": "ORG"
      },
      {
        "text": "\u0130stanbul",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(36)Radboud University Medical Centre, Nijmegen, Netherlands.",
    "entities": [
      {
        "text": "36)Radboud University Medical Centre",
        "label": "ORG"
      },
      {
        "text": "Nijmegen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(37)University of Bern, Bern, Switzerland.",
    "entities": [
      {
        "text": "37)University",
        "label": "CARDINAL"
      },
      {
        "text": "Bern",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(38)Cyprus University of Technology, Limassol, Cyprus.",
    "entities": [
      {
        "text": "38)Cyprus University of Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(39)University College London, London, UK.",
    "entities": [
      {
        "text": "39)University College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)University of Vienna, Vienna, Austria.",
    "entities": [
      {
        "text": "42)University",
        "label": "CARDINAL"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(44)SWPS University, Warszawa, Poland.",
    "entities": [
      {
        "text": "44)SWPS University",
        "label": "ORG"
      },
      {
        "text": "Warszawa",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)National School of Public Health, Comprehensive Health Research Centre, NOVA",
    "entities": [
      {
        "text": "45)National School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Comprehensive Health Research Centre",
        "label": "ORG"
      },
      {
        "text": "NOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Lisbon, Lisbon, Portugal.",
    "entities": [
      {
        "text": "University of Lisbon, Lisbon",
        "label": "ORG"
      },
      {
        "text": "Portugal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(46)The Kids Research Institute Australia, Perth, Australia.",
    "entities": [
      {
        "text": "46)The Kids Research Institute Australia",
        "label": "ORG"
      },
      {
        "text": "Perth",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(47)University of Helsinki, Helsinki, Finland.",
    "entities": [
      {
        "text": "47)University",
        "label": "CARDINAL"
      },
      {
        "text": "Helsinki",
        "label": "GPE"
      },
      {
        "text": "Helsinki",
        "label": "GPE"
      },
      {
        "text": "Finland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(48)University of Cambridge, Cambridge, UK.",
    "entities": [
      {
        "text": "48)University",
        "label": "CARDINAL"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(50)Bilkent University, Ankara, Turkey.",
    "entities": [
      {
        "text": "Ankara",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(51)The Kids Research Institute, University of Western Australia, Perth,",
    "entities": [
      {
        "text": "51)The Kids Research Institute",
        "label": "ORG"
      },
      {
        "text": "University of Western Australia",
        "label": "ORG"
      },
      {
        "text": "Perth",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(52)Ghent University, Ghent, Belgium.",
    "entities": [
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(53)University of Exeter, Exeter, UK.",
    "entities": [
      {
        "text": "Exeter",
        "label": "PRODUCT"
      },
      {
        "text": "Exeter",
        "label": "PRODUCT"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(55)Holy House of Mercy of Piracicaba, Piracicaba, Brazil.",
    "entities": [
      {
        "text": "House of Mercy of Piracicaba",
        "label": "ORG"
      },
      {
        "text": "Piracicaba",
        "label": "GPE"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(56)French Institute of Sport (INSEP), Paris, France.",
    "entities": [
      {
        "text": "56)French Institute of Sport",
        "label": "ORG"
      },
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(57)LimeSurvey GmbH, Hamburg, Germany.",
    "entities": [
      {
        "text": "57)LimeSurvey GmbH",
        "label": "MONEY"
      },
      {
        "text": "Hamburg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(58)University of Zurich, Z\u00fcrich, Switzerland.",
    "entities": [
      {
        "text": "58)University",
        "label": "CARDINAL"
      },
      {
        "text": "Zurich",
        "label": "GPE"
      },
      {
        "text": "Z\u00fcrich",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(62)Trinity College Dublin, Dublin 2, Ireland.",
    "entities": [
      {
        "text": "62)Trinity College Dublin",
        "label": "ORG"
      },
      {
        "text": "Dublin 2",
        "label": "PERSON"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(64)Fastgen Corporation, San Mateo, USA.",
    "entities": [
      {
        "text": "San Mateo",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(65)University of Leeds, Leeds, UK.",
    "entities": [
      {
        "text": "65)University",
        "label": "CARDINAL"
      },
      {
        "text": "Leeds",
        "label": "GPE"
      },
      {
        "text": "Leeds",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(66)University of Groningen, Groningen, Netherlands.",
    "entities": [
      {
        "text": "66)University",
        "label": "CARDINAL"
      },
      {
        "text": "Groningen",
        "label": "PERSON"
      },
      {
        "text": "Groningen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(67)Zuyd University of Applied Sciences, Heerlen, Netherlands.",
    "entities": [
      {
        "text": "University of Applied Sciences",
        "label": "ORG"
      },
      {
        "text": "Heerlen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(68)The University of Western Australia, Perth, Australia.",
    "entities": [
      {
        "text": "68)The University of Western Australia",
        "label": "ORG"
      },
      {
        "text": "Perth",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Tools that can be used to collect behavioural data during pandemics are needed",
    "entities": []
  },
  {
    "text": "to inform policy and practice. The objective of this project was to develop the",
    "entities": []
  },
  {
    "text": "Your COVID-19 Risk tool in response to the global spread of COVID-19, aiming to",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "promote health behaviour change. We developed an online resource based on key",
    "entities": []
  },
  {
    "text": "behavioural evidence-based risk factors related to contracting and spreading",
    "entities": []
  },
  {
    "text": "COVID-19. This tool allows for assessing risk and provides instant support to",
    "entities": []
  },
  {
    "text": "protect individuals from infection. The Risk Estimation Questions assessed",
    "entities": [
      {
        "text": "The Risk Estimation Questions",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "users' location, age, gender, work environment, day-to-day behaviours currently",
    "entities": []
  },
  {
    "text": "performed, and conditions under which these behaviours would change. Users were",
    "entities": []
  },
  {
    "text": "also asked to estimate how often they keep their distance from others in public",
    "entities": []
  },
  {
    "text": "and regularly wash their hands, and the procedures they follow to do so. A",
    "entities": []
  },
  {
    "text": "multidisciplinary research team of more than 150 international experts developed",
    "entities": [
      {
        "text": "more than 150",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the tool. Over 60,000 users in more than 150 countries have assessed their risk",
    "entities": [
      {
        "text": "Over 60,000",
        "label": "CARDINAL"
      },
      {
        "text": "more than 150",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and provided data. The majority of respondents reported that they almost always",
    "entities": []
  },
  {
    "text": "keep their distance from others in public places, and most participants reported",
    "entities": []
  },
  {
    "text": "washing their hands after touching public or shared surfaces or when entering",
    "entities": []
  },
  {
    "text": "buildings. The tool, data, and results were openly shared to support government",
    "entities": []
  },
  {
    "text": "and health agencies developing behaviour change interventions. This tool creates",
    "entities": []
  },
  {
    "text": "a blueprint for similar digital infrastructure that can be replicated and used",
    "entities": []
  },
  {
    "text": "in future pandemics.",
    "entities": []
  },
  {
    "text": "PMID: 40659837 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659837",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval, consent to",
    "entities": []
  },
  {
    "text": "participate and consent for publication: Although this project implemented",
    "entities": []
  },
  {
    "text": "scientific insights, it was itself developed as a risk estimation tool, not as a",
    "entities": []
  },
  {
    "text": "scientific study; hence, no ethical approval was sought at this stage, and tool",
    "entities": []
  },
  {
    "text": "users were not participants in a study, and so there was no informed consent to",
    "entities": []
  },
  {
    "text": "study participation. The tool only stored anonymised data (i.e., no personal",
    "entities": []
  },
  {
    "text": "data as per the General Data Protection Regulation were stored). Competing",
    "entities": [
      {
        "text": "the General Data Protection Regulation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interests: The authors have no competing interests to disclose.",
    "entities": []
  },
  {
    "text": "Identification of host cell surface proteins inhibiting furin dependent",
    "entities": [
      {
        "text": "furin",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "proteolytic processing of viral glycoproteins.",
    "entities": []
  },
  {
    "text": "(1)Department of Microbiology and Molecular Medicine, Faculty of Medicine,",
    "entities": [
      {
        "text": "Microbiology and Molecular Medicine, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Geneva, Geneva, Switzerland.",
    "entities": [
      {
        "text": "University of Geneva",
        "label": "ORG"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Microbiology and Molecular Medicine, Faculty of Medicine,",
    "entities": [
      {
        "text": "Microbiology and Molecular Medicine, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Geneva, Geneva, Switzerland. mirco.schmolke@unige.ch.",
    "entities": [
      {
        "text": "University of Geneva",
        "label": "ORG"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Geneva Center for Inflammation Research, University of Geneva, Geneva,",
    "entities": [
      {
        "text": "Center for Inflammation Research,",
        "label": "ORG"
      },
      {
        "text": "University of Geneva",
        "label": "ORG"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Proteolytic cleavage by furin-like proteases is a crucial first step in the",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "posttranslational modification of various glycoproteins found in enveloped",
    "entities": []
  },
  {
    "text": "emerging viruses, such as SARS-CoV-2 and highly pathogenic avian influenza A",
    "entities": []
  },
  {
    "text": "viruses (IAV). Here, we explored the capacity of host cell proteins identified",
    "entities": []
  },
  {
    "text": "by cell surface proximity ligation to limit the proteolytic cleavage of the",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 spike and the IAV H5N1 hemagglutinin (HA). When co-expressed with",
    "entities": [
      {
        "text": "IAV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recombinant SARS-CoV-2 spike protein, Prom1, Axl, and Ly75 suppress its",
    "entities": [
      {
        "text": "Prom1",
        "label": "ORG"
      },
      {
        "text": "Axl",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "proteolytic cleavage, whereas cleavage of HA was only reduced by Prom1.",
    "entities": [
      {
        "text": "HA",
        "label": "ORG"
      },
      {
        "text": "Prom1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co-immunoprecipitation assays suggest that Axl and Prom1 may form a complex with",
    "entities": []
  },
  {
    "text": "furin. Alteration of Prom1, Axl and Ly75 expression levels in Calu3 cells",
    "entities": [
      {
        "text": "Axl",
        "label": "PERSON"
      },
      {
        "text": "Calu3",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "affected entry of SARS-CoV-2 S pseudotyped VLP and to a lesser extent,",
    "entities": [
      {
        "text": "SARS-CoV-2 S",
        "label": "ORG"
      },
      {
        "text": "VLP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 virions. In contrast, Prom1 levels did not affect entry of H5N1 VLPs",
    "entities": []
  },
  {
    "text": "or H5N1 virions. Our data highlight the differential capacity of SARS-CoV-2 and",
    "entities": []
  },
  {
    "text": "IAV H5N1 to cope with newly identified host restriction factors of furin",
    "entities": []
  },
  {
    "text": "activity.",
    "entities": []
  },
  {
    "text": "PMID: 40659811 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40659811",
        "label": "CARDINAL"
      }
    ]
  }
]